GO Term,Description,P-value,FDR q-value,Enrichment,N,B,n,b,GenesGO:0032502,developmental process,1.78E-10,1.98E-06,1.32,8230,2685,889,382,"[CREB5  -  camp responsive element binding protein 5, GFRA2  -  gdnf family receptor alpha 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, PATZ1  -  poz (btb) and at hook containing zinc finger 1, NAIP  -  nlr family, apoptosis inhibitory protein, PLXNB1  -  plexin b1, BCOR  -  bcl6 corepressor, LIN7A  -  lin-7 homolog a (c. elegans), LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, BTK  -  bruton agammaglobulinemia tyrosine kinase, SAP30  -  sin3a-associated protein, 30kda, NBN  -  nibrin, GCK  -  glucokinase (hexokinase 4), GDF5  -  growth differentiation factor 5, CDKL1  -  cyclin-dependent kinase-like 1 (cdc2-related kinase), EIF4A1  -  eukaryotic translation initiation factor 4a1, SP1  -  sp1 transcription factor, PLP1  -  proteolipid protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, SPRED2  -  sprouty-related, evh1 domain containing 2, NRG2  -  neuregulin 2, PLS3  -  plastin 3, CPM  -  carboxypeptidase m, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, SOX5  -  sry (sex determining region y)-box 5, HOXD13  -  homeobox d13, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, BIK  -  bcl2-interacting killer (apoptosis-inducing), HOXD12  -  homeobox d12, ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), HOXC13  -  homeobox c13, ST8SIA2  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 2, MYO6  -  myosin vi, SPAG6  -  sperm associated antigen 6, GH1  -  growth hormone 1, CR2  -  complement component (3d/epstein barr virus) receptor 2, MYO7A  -  myosin viia, CADM1  -  cell adhesion molecule 1, KRT19  -  keratin 19, COX17  -  cox17 cytochrome c oxidase copper chaperone, GLRB  -  glycine receptor, beta, PPL  -  periplakin, TPH1  -  tryptophan hydroxylase 1, IAPP  -  islet amyloid polypeptide, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, KRT10  -  keratin 10, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, KRT9  -  keratin 9, KRT13  -  keratin 13, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), DCAF7  -  ddb1 and cul4 associated factor 7, KRT15  -  keratin 15, MYO16  -  myosin xvi, KRT14  -  keratin 14, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, LAMC2  -  laminin, gamma 2, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, COL9A3  -  collagen, type ix, alpha 3, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), LCK  -  lymphocyte-specific protein tyrosine kinase, SGCE  -  sarcoglycan, epsilon, C1QB  -  complement component 1, q subcomponent, b chain, E2F5  -  e2f transcription factor 5, p130-binding, POU1F1  -  pou class 1 homeobox 1, COL5A2  -  collagen, type v, alpha 2, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, GMFB  -  glia maturation factor, beta, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, C6  -  complement component 6, COL17A1  -  collagen, type xvii, alpha 1, ECE1  -  endothelin converting enzyme 1, COL13A1  -  collagen, type xiii, alpha 1, CSTA  -  cystatin a (stefin a), AKR1C3  -  aldo-keto reductase family 1, member c3, CAPN2  -  calpain 2, (m/ii) large subunit, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, CTBP1  -  c-terminal binding protein 1, UMOD  -  uromodulin, DYNLL1  -  dynein, light chain, lc8-type 1, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, HLF  -  hepatic leukemia factor, NFASC  -  neurofascin, CTNND2  -  catenin (cadherin-associated protein), delta 2, RPE65  -  retinal pigment epithelium-specific protein 65kda, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS4X  -  ribosomal protein s4, x-linked, RPS3A  -  ribosomal protein s3a, STXBP1  -  syntaxin binding protein 1, HOXB13  -  homeobox b13, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, EVPL  -  envoplakin, EZR  -  ezrin, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), EZH1  -  enhancer of zeste homolog 1 (drosophila), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, CALCA  -  calcitonin-related polypeptide alpha, HIC1  -  hypermethylated in cancer 1, STK4  -  serine/threonine kinase 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), MSN  -  moesin, EDA2R  -  ectodysplasin a2 receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), HPCA  -  hippocalcin, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, HOXA11  -  homeobox a11, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CHRDL1  -  chordin-like 1, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, TXK  -  txk tyrosine kinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR2  -  estrogen receptor 2 (er beta), RPS14  -  ribosomal protein s14, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, NRXN3  -  neurexin 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, TYR  -  tyrosinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ALX1  -  alx homeobox 1, MAPK14  -  mitogen-activated protein kinase 14, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, GBA  -  glucosidase, beta, acid, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, DOK4  -  docking protein 4, PLCE1  -  phospholipase c, epsilon 1, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, EPHA4  -  eph receptor a4, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CCKAR  -  cholecystokinin a receptor, KRIT1  -  krit1, ankyrin repeat containing, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CFDP1  -  craniofacial development protein 1, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1, GAP43  -  growth associated protein 43, STX2  -  syntaxin 2, RTN1  -  reticulon 1, GAS6  -  growth arrest-specific 6, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, CCIN  -  calicin, RREB1  -  ras responsive element binding protein 1, FOXA2  -  forkhead box a2, SCEL  -  sciellin, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), SETDB1  -  set domain, bifurcated 1, FLT4  -  fms-related tyrosine kinase 4, PSAP  -  prosaposin, PVRL3  -  poliovirus receptor-related 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, KLK6  -  kallikrein-related peptidase 6, APOB  -  apolipoprotein b, FLG  -  filaggrin, DCX  -  doublecortin, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, ATXN3  -  ataxin 3, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, SNTG2  -  syntrophin, gamma 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, TIMM8A  -  translocase of inner mitochondrial membrane 8 homolog a (yeast), ODF2  -  outer dense fiber of sperm tails 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, DFFB  -  dna fragmentation factor, 40kda, beta polypeptide (caspase-activated dnase), PRDX1  -  peroxiredoxin 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, MOG  -  myelin oligodendrocyte glycoprotein, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, MSC  -  musculin, FHL2  -  four and a half lim domains 2, FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, TAGLN  -  transgelin, FGFR3  -  fibroblast growth factor receptor 3, NTN3  -  netrin 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MYO3A  -  myosin iiia, FGF8  -  fibroblast growth factor 8 (androgen-induced), CFL1  -  cofilin 1 (non-muscle), NUMA1  -  nuclear mitotic apparatus protein 1, ITGB5  -  integrin, beta 5, FGF1  -  fibroblast growth factor 1 (acidic), ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PTHLH  -  parathyroid hormone-like hormone, PECAM1  -  platelet/endothelial cell adhesion molecule 1, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), S100A4  -  s100 calcium binding protein a4, CDK13  -  cyclin-dependent kinase 13, NLGN4X  -  neuroligin 4, x-linked, TAZ  -  tafazzin, S100A7  -  s100 calcium binding protein a7, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), IREB2  -  iron-responsive element binding protein 2, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, ASGR2  -  asialoglycoprotein receptor 2, NRL  -  neural retina leucine zipper, NRF1  -  nuclear respiratory factor 1, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, NCKAP1  -  nck-associated protein 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, PTS  -  6-pyruvoyltetrahydropterin synthase, TDRD7  -  tudor domain containing 7, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, CHRM3  -  cholinergic receptor, muscarinic 3, SMC3  -  structural maintenance of chromosomes 3, SFN  -  stratifin, INA  -  internexin neuronal intermediate filament protein, alpha, GPC1  -  glypican 1, LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), CNOT3  -  ccr4-not transcription complex, subunit 3, PGR  -  progesterone receptor, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), DPYSL2  -  dihydropyrimidinase-like 2, CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), CHEK1  -  checkpoint kinase 1, NGF  -  nerve growth factor (beta polypeptide), NELFA  -  negative elongation factor complex member a, MAX  -  myc associated factor x, KMT2B  -  lysine (k)-specific methyltransferase 2b, ICK  -  intestinal cell (mak-like) kinase, CLEC3B  -  c-type lectin domain family 3, member b, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, NKX2-2  -  nk2 homeobox 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), NEFH  -  neurofilament, heavy polypeptide, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), RAG2  -  recombination activating gene 2, RARG  -  retinoic acid receptor, gamma, PHGDH  -  phosphoglycerate dehydrogenase, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), PLAG1  -  pleiomorphic adenoma gene 1, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, NF2  -  neurofibromin 2 (merlin), PKP2  -  plakophilin 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), NQO1  -  nad(p)h dehydrogenase, quinone 1, BRSK2  -  br serine/threonine kinase 2, MACF1  -  microtubule-actin crosslinking factor 1, IHH  -  indian hedgehog, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, MXD1  -  max dimerization protein 1, GRIK1  -  glutamate receptor, ionotropic, kainate 1, TGFB1  -  transforming growth factor, beta 1, NEUROG2  -  neurogenin 2, IGFBP1  -  insulin-like growth factor binding protein 1, DIEXF  -  digestive organ expansion factor homolog (zebrafish), TH  -  tyrosine hydroxylase, ARID4A  -  at rich interactive domain 4a (rbp1-like), KALRN  -  kalirin, rhogef kinase, PLK4  -  polo-like kinase 4, EPCAM  -  epithelial cell adhesion molecule, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PIM1  -  pim-1 oncogene, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, CKB  -  creatine kinase, brain, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0048856,anatomical structure development,5.48E-10,3.05E-06,1.42,8230,1742,887,267,"[CREB5  -  camp responsive element binding protein 5, GFRA2  -  gdnf family receptor alpha 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, PATZ1  -  poz (btb) and at hook containing zinc finger 1, NAIP  -  nlr family, apoptosis inhibitory protein, BCOR  -  bcl6 corepressor, LIN7A  -  lin-7 homolog a (c. elegans), BTK  -  bruton agammaglobulinemia tyrosine kinase, GCK  -  glucokinase (hexokinase 4), CDKL1  -  cyclin-dependent kinase-like 1 (cdc2-related kinase), EIF4A1  -  eukaryotic translation initiation factor 4a1, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PLP1  -  proteolipid protein 1, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, NRG2  -  neuregulin 2, PLS3  -  plastin 3, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, HOXD13  -  homeobox d13, SOX3  -  sry (sex determining region y)-box 3, BIK  -  bcl2-interacting killer (apoptosis-inducing), ACTA2  -  actin, alpha 2, smooth muscle, aorta, HOXD12  -  homeobox d12, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), HOXC13  -  homeobox c13, ST8SIA2  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 2, MYO6  -  myosin vi, SPAG6  -  sperm associated antigen 6, MYO7A  -  myosin viia, CADM1  -  cell adhesion molecule 1, COX17  -  cox17 cytochrome c oxidase copper chaperone, TPH1  -  tryptophan hydroxylase 1, GLRB  -  glycine receptor, beta, IAPP  -  islet amyloid polypeptide, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, KRT9  -  keratin 9, KRT15  -  keratin 15, MYO16  -  myosin xvi, KRT14  -  keratin 14, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, LAMC2  -  laminin, gamma 2, COL9A3  -  collagen, type ix, alpha 3, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LCK  -  lymphocyte-specific protein tyrosine kinase, SGCE  -  sarcoglycan, epsilon, C1QB  -  complement component 1, q subcomponent, b chain, COL5A2  -  collagen, type v, alpha 2, POU1F1  -  pou class 1 homeobox 1, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, C6  -  complement component 6, COL17A1  -  collagen, type xvii, alpha 1, ECE1  -  endothelin converting enzyme 1, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPN2  -  calpain 2, (m/ii) large subunit, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, SRGN  -  serglycin, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, UMOD  -  uromodulin, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, FSHR  -  follicle stimulating hormone receptor, NFASC  -  neurofascin, CAPZB  -  capping protein (actin filament) muscle z-line, beta, HOXB13  -  homeobox b13, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, EVPL  -  envoplakin, EZR  -  ezrin, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, AHSG  -  alpha-2-hs-glycoprotein, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), CXADR  -  coxsackie virus and adenovirus receptor, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), FYN  -  fyn oncogene related to src, fgr, yes, CALCA  -  calcitonin-related polypeptide alpha, STK4  -  serine/threonine kinase 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), MSN  -  moesin, EDA2R  -  ectodysplasin a2 receptor, CRIP2  -  cysteine-rich protein 2, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CRIP1  -  cysteine-rich protein 1 (intestinal), HPCA  -  hippocalcin, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, HOXA11  -  homeobox a11, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, SLIT2  -  slit homolog 2 (drosophila), CHRDL1  -  chordin-like 1, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR2  -  estrogen receptor 2 (er beta), HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, SSTR3  -  somatostatin receptor 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, TYR  -  tyrosinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, MAPK14  -  mitogen-activated protein kinase 14, ALX1  -  alx homeobox 1, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), DOK4  -  docking protein 4, PLCE1  -  phospholipase c, epsilon 1, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CCKAR  -  cholecystokinin a receptor, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, STX2  -  syntaxin 2, GAP43  -  growth associated protein 43, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, GAS6  -  growth arrest-specific 6, FOXA2  -  forkhead box a2, SCEL  -  sciellin, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), SETDB1  -  set domain, bifurcated 1, FLT4  -  fms-related tyrosine kinase 4, PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, KLK6  -  kallikrein-related peptidase 6, APOB  -  apolipoprotein b, DCX  -  doublecortin, INHBB  -  inhibin, beta b, CDON  -  cell adhesion associated, oncogene regulated, ATXN3  -  ataxin 3, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, SNTG2  -  syntrophin, gamma 2, CCL2  -  chemokine (c-c motif) ligand 2, TIMM8A  -  translocase of inner mitochondrial membrane 8 homolog a (yeast), ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, DFFB  -  dna fragmentation factor, 40kda, beta polypeptide (caspase-activated dnase), PRDX1  -  peroxiredoxin 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, MOG  -  myelin oligodendrocyte glycoprotein, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, MSC  -  musculin, FHL2  -  four and a half lim domains 2, AQP1  -  aquaporin 1 (colton blood group), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), MDFI  -  myod family inhibitor, TAGLN  -  transgelin, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MYO3A  -  myosin iiia, FGF8  -  fibroblast growth factor 8 (androgen-induced), FGF1  -  fibroblast growth factor 1 (acidic), PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, PTHLH  -  parathyroid hormone-like hormone, PECAM1  -  platelet/endothelial cell adhesion molecule 1, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDK13  -  cyclin-dependent kinase 13, NLGN4X  -  neuroligin 4, x-linked, S100A7  -  s100 calcium binding protein a7, TAZ  -  tafazzin, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, ASGR2  -  asialoglycoprotein receptor 2, NRL  -  neural retina leucine zipper, NRF1  -  nuclear respiratory factor 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CXCL13  -  chemokine (c-x-c motif) ligand 13, NCKAP1  -  nck-associated protein 1, PTS  -  6-pyruvoyltetrahydropterin synthase, NKX2-1  -  nk2 homeobox 1, TDRD7  -  tudor domain containing 7, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, INA  -  internexin neuronal intermediate filament protein, alpha, ATM  -  ataxia telangiectasia mutated, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), DPYSL2  -  dihydropyrimidinase-like 2, CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), NGF  -  nerve growth factor (beta polypeptide), MAX  -  myc associated factor x, CLEC3B  -  c-type lectin domain family 3, member b, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, NKX2-2  -  nk2 homeobox 2, VWF  -  von willebrand factor, NHLH2  -  nescient helix loop helix 2, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RARG  -  retinoic acid receptor, gamma, PHGDH  -  phosphoglycerate dehydrogenase, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), NF2  -  neurofibromin 2 (merlin), PKP2  -  plakophilin 2, IHH  -  indian hedgehog, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, TGFB1  -  transforming growth factor, beta 1, NEUROG2  -  neurogenin 2, IGFBP1  -  insulin-like growth factor binding protein 1, TH  -  tyrosine hydroxylase, ARID4A  -  at rich interactive domain 4a (rbp1-like), KALRN  -  kalirin, rhogef kinase, EPCAM  -  epithelial cell adhesion molecule, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, CKB  -  creatine kinase, brain, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0050896,response to stimulus,1.12E-09,4.17E-06,1.22,8230,4070,804,486,"[GFRA2  -  gdnf family receptor alpha 2, DAPK2  -  death-associated protein kinase 2, AANAT  -  aralkylamine n-acetyltransferase, CD2AP  -  cd2-associated protein, PLXNB1  -  plexin b1, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PLP1  -  proteolipid protein 1, NRG2  -  neuregulin 2, CLDN3  -  claudin 3, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, LPL  -  lipoprotein lipase, ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, RND2  -  rho family gtpase 2, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, CADM1  -  cell adhesion molecule 1, CNGB1  -  cyclic nucleotide gated channel beta 1, KRT19  -  keratin 19, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, ARHGAP19  -  rho gtpase activating protein 19, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, KLRC4  -  killer cell lectin-like receptor subfamily c, member 4, GLRB  -  glycine receptor, beta, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), CREBZF  -  creb/atf bzip transcription factor, GLI3  -  gli family zinc finger 3, COL3A1  -  collagen, type iii, alpha 1, KRT10  -  keratin 10, KRT13  -  keratin 13, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, FZD1  -  frizzled family receptor 1, KRT14  -  keratin 14, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, PLIN2  -  perilipin 2, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, NCR2  -  natural cytotoxicity triggering receptor 2, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, PRG2  -  proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein), KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, PRCP  -  prolylcarboxypeptidase (angiotensinase c), FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, ACE2  -  angiotensin i converting enzyme 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTSL  -  cathepsin l, GRAP2  -  grb2-related adaptor protein 2, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, KPNA3  -  karyopherin alpha 3 (importin alpha 4), AHSG  -  alpha-2-hs-glycoprotein, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, CYBA  -  cytochrome b-245, alpha polypeptide, TRIM31  -  tripartite motif containing 31, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, STK4  -  serine/threonine kinase 4, STMN2  -  stathmin-like 2, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GBA  -  glucosidase, beta, acid, SRP19  -  signal recognition particle 19kda, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), DOK4  -  docking protein 4, CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, NCR3  -  natural cytotoxicity triggering receptor 3, GAP43  -  growth associated protein 43, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, SOCS6  -  suppressor of cytokine signaling 6, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, DCX  -  doublecortin, ATXN3  -  ataxin 3, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), CCL15  -  chemokine (c-c motif) ligand 15, CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, CCL3  -  chemokine (c-c motif) ligand 3, ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, PRDX1  -  peroxiredoxin 1, APP  -  amyloid beta (a4) precursor protein, GUCY2F  -  guanylate cyclase 2f, retinal, AKAP10  -  a kinase (prka) anchor protein 10, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), FZD5  -  frizzled family receptor 5, IL1R2  -  interleukin 1 receptor, type ii, CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ARF5  -  adp-ribosylation factor 5, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, S100A11  -  s100 calcium binding protein a11, S100B  -  s100 calcium binding protein b, S100P  -  s100 calcium binding protein p, NLGN4X  -  neuroligin 4, x-linked, S100A7  -  s100 calcium binding protein a7, FANCL  -  fanconi anemia, complementation group l, ASGR2  -  asialoglycoprotein receptor 2, KITLG  -  kit ligand, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRTR1  -  hypocretin (orexin) receptor 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), DRD3  -  dopamine receptor d3, SMC3  -  structural maintenance of chromosomes 3, SFN  -  stratifin, GPC1  -  glypican 1, GP9  -  glycoprotein ix (platelet), LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, NLGN1  -  neuroligin 1, PGR  -  progesterone receptor, DPYSL2  -  dihydropyrimidinase-like 2, SKP1  -  s-phase kinase-associated protein 1, MBL2  -  mannose-binding lectin (protein c) 2, soluble, MAX  -  myc associated factor x, ICK  -  intestinal cell (mak-like) kinase, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), PLAU  -  plasminogen activator, urokinase, GRN  -  granulin, NQO1  -  nad(p)h dehydrogenase, quinone 1, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), BRSK2  -  br serine/threonine kinase 2, GRIA2  -  glutamate receptor, ionotropic, ampa 2, LTK  -  leukocyte receptor tyrosine kinase, RHOV  -  ras homolog family member v, CCDC88C  -  coiled-coil domain containing 88c, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, PIAS4  -  protein inhibitor of activated stat, 4, LYZ  -  lysozyme, KALRN  -  kalirin, rhogef kinase, EPCAM  -  epithelial cell adhesion molecule, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, CXCL2  -  chemokine (c-x-c motif) ligand 2, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, GRP  -  gastrin-releasing peptide, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, RFC5  -  replication factor c (activator 1) 5, 36.5kda, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, RGR  -  retinal g protein coupled receptor, CARD14  -  caspase recruitment domain family, member 14, RFX1  -  regulatory factor x, 1 (influences hla class ii expression), NAIP  -  nlr family, apoptosis inhibitory protein, PRMT1  -  protein arginine methyltransferase 1, BTK  -  bruton agammaglobulinemia tyrosine kinase, NCAM1  -  neural cell adhesion molecule 1, KSR1  -  kinase suppressor of ras 1, EIF4A1  -  eukaryotic translation initiation factor 4a1, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, WISP2  -  wnt1 inducible signaling pathway protein 2, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, RLN1  -  relaxin 1, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, MAST1  -  microtubule associated serine/threonine kinase 1, EEF1G  -  eukaryotic translation elongation factor 1 gamma, TPH1  -  tryptophan hydroxylase 1, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, MYO16  -  myosin xvi, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SMG1  -  smg1 phosphatidylinositol 3-kinase-related kinase, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), TRH  -  thyrotropin-releasing hormone, C1QA  -  complement component 1, q subcomponent, a chain, C1QB  -  complement component 1, q subcomponent, b chain, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, DNAL4  -  dynein, axonemal, light chain 4, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, C5  -  complement component 5, C6  -  complement component 6, UBE4B  -  ubiquitination factor e4b, BAIAP3  -  bai1-associated protein 3, WAPAL  -  wings apart-like homolog (drosophila), AKR1C3  -  aldo-keto reductase family 1, member c3, HLA-G  -  major histocompatibility complex, class i, g, CAPN2  -  calpain 2, (m/ii) large subunit, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, PDE5A  -  phosphodiesterase 5a, cgmp-specific, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, DYNLL1  -  dynein, light chain, lc8-type 1, RPE65  -  retinal pigment epithelium-specific protein 65kda, FASN  -  fatty acid synthase, HLA-A  -  major histocompatibility complex, class i, a, HMGXB4  -  hmg box domain containing 4, HLA-C  -  major histocompatibility complex, class i, c, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, VIP  -  vasoactive intestinal peptide, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), CFH  -  complement factor h, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, NCOA2  -  nuclear receptor coactivator 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), MSH5  -  muts homolog 5 (e. coli), F2RL2  -  coagulation factor ii (thrombin) receptor-like 2, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, CD1D  -  cd1d molecule, TYROBP  -  tyro protein tyrosine kinase binding protein, TUBA1B  -  tubulin, alpha 1b, CHRDL1  -  chordin-like 1, UBC  -  ubiquitin c, TXK  -  txk tyrosine kinase, CD8B  -  cd8b molecule, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR2  -  estrogen receptor 2 (er beta), CD7  -  cd7 molecule, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, HOXA1  -  homeobox a1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, TUBB4B  -  tubulin, beta 4b class ivb, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, EPHA3  -  eph receptor a3, UCN  -  urocortin, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), MVP  -  major vault protein, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, EPHA4  -  eph receptor a4, CCKAR  -  cholecystokinin a receptor, KRIT1  -  krit1, ankyrin repeat containing, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, LPHN2  -  latrophilin 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, FLT4  -  fms-related tyrosine kinase 4, PSAP  -  prosaposin, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, SMC2  -  structural maintenance of chromosomes 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, POLL  -  polymerase (dna directed), lambda, RGS5  -  regulator of g-protein signaling 5, AHSA1  -  aha1, activator of heat shock 90kda protein atpase homolog 1 (yeast), IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CD53  -  cd53 molecule, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, PSMD1  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 1, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, CD34  -  cd34 molecule, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, FGFR3  -  fibroblast growth factor receptor 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, TAPBP  -  tap binding protein (tapasin), PTH  -  parathyroid hormone, PTHLH  -  parathyroid hormone-like hormone, PTK6  -  protein tyrosine kinase 6, GPR143  -  g protein-coupled receptor 143, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), NPC2  -  niemann-pick disease, type c2, KLHL20  -  kelch-like family member 20, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, NPPA  -  natriuretic peptide a, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, NRL  -  neural retina leucine zipper, CDK2  -  cyclin-dependent kinase 2, NRF1  -  nuclear respiratory factor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, PTPRN  -  protein tyrosine phosphatase, receptor type, n, RIMS2  -  regulating synaptic membrane exocytosis 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), TRAF3IP2  -  traf3 interacting protein 2, CHKA  -  choline kinase alpha, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, CHEK1  -  checkpoint kinase 1, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, NFX1  -  nuclear transcription factor, x-box binding 1, NGF  -  nerve growth factor (beta polypeptide), CLEC3B  -  c-type lectin domain family 3, member b, RAD21  -  rad21 homolog (s. pombe), TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RARG  -  retinoic acid receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), IGSF1  -  immunoglobulin superfamily, member 1, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, TH  -  tyrosine hydroxylase, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, IGFBP1  -  insulin-like growth factor binding protein 1, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, RCVRN  -  recoverin, CIRBP  -  cold inducible rna binding protein, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0010033,response to organic substance,1.79E-09,4.98E-06,1.57,8230,1602,545,167,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, PSAP  -  prosaposin, PAX9  -  paired box 9, APOB  -  apolipoprotein b, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, ATXN3  -  ataxin 3, GCG  -  glucagon, BTK  -  bruton agammaglobulinemia tyrosine kinase, NCAM1  -  neural cell adhesion molecule 1, GDF5  -  growth differentiation factor 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), EIF4A1  -  eukaryotic translation initiation factor 4a1, RRAGB  -  ras-related gtp binding b, SP1  -  sp1 transcription factor, EIF4A2  -  eukaryotic translation initiation factor 4a2, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NRG2  -  neuregulin 2, SOX5  -  sry (sex determining region y)-box 5, IL1R1  -  interleukin 1 receptor, type i, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), KRT19  -  keratin 19, GLUL  -  glutamate-ammonia ligase, IL1R2  -  interleukin 1 receptor, type ii, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, MEIS2  -  meis homeobox 2, PPARA  -  peroxisome proliferator-activated receptor alpha, PTK6  -  protein tyrosine kinase 6, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, PLIN2  -  perilipin 2, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, KLHL20  -  kelch-like family member 20, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, NPPA  -  natriuretic peptide a, COL6A1  -  collagen, type vi, alpha 1, DNAL4  -  dynein, axonemal, light chain 4, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, IRF1  -  interferon regulatory factor 1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, HNF1A  -  hnf1 homeobox a, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, KITLG  -  kit ligand, ADRA1A  -  adrenoceptor alpha 1a, NRF1  -  nuclear respiratory factor 1, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), HLA-G  -  major histocompatibility complex, class i, g, IFI27  -  interferon, alpha-inducible protein 27, HLA-F  -  major histocompatibility complex, class i, f, CAPN2  -  calpain 2, (m/ii) large subunit, NKX2-1  -  nk2 homeobox 1, HLA-E  -  major histocompatibility complex, class i, e, AES  -  amino-terminal enhancer of split, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, RPE65  -  retinal pigment epithelium-specific protein 65kda, DPYSL2  -  dihydropyrimidinase-like 2, CEP57  -  centrosomal protein 57kda, FASN  -  fatty acid synthase, IFNG  -  interferon, gamma, HLA-A  -  major histocompatibility complex, class i, a, CTSL  -  cathepsin l, CHEK1  -  checkpoint kinase 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), FYN  -  fyn oncogene related to src, fgr, yes, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, DARC  -  duffy blood group, atypical chemokine receptor, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CYBA  -  cytochrome b-245, alpha polypeptide, CALCR  -  calcitonin receptor, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CRIP1  -  cysteine-rich protein 1 (intestinal), TUBA1B  -  tubulin, alpha 1b, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, TWIST1  -  twist basic helix-loop-helix transcription factor 1, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, SSTR3  -  somatostatin receptor 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, NQO1  -  nad(p)h dehydrogenase, quinone 1, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, RBL1  -  retinoblastoma-like 1 (p107), ANG  -  angiogenin, ribonuclease, rnase a family, 5, EPHA3  -  eph receptor a3, UCN  -  urocortin, GATA3  -  gata binding protein 3, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), IGFBP1  -  insulin-like growth factor binding protein 1, TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CXCL2  -  chemokine (c-x-c motif) ligand 2, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, THRA  -  thyroid hormone receptor, alpha, FOXA2  -  forkhead box a2]"GO:0044767,single-organism developmental process,4.30E-09,9.58E-06,1.32,8230,2440,889,347,"[CREB5  -  camp responsive element binding protein 5, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, PATZ1  -  poz (btb) and at hook containing zinc finger 1, PLXNB1  -  plexin b1, BCOR  -  bcl6 corepressor, LIN7A  -  lin-7 homolog a (c. elegans), LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, BTK  -  bruton agammaglobulinemia tyrosine kinase, SAP30  -  sin3a-associated protein, 30kda, NBN  -  nibrin, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), CDKL1  -  cyclin-dependent kinase-like 1 (cdc2-related kinase), EIF4A1  -  eukaryotic translation initiation factor 4a1, SP1  -  sp1 transcription factor, PLP1  -  proteolipid protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, SPRED2  -  sprouty-related, evh1 domain containing 2, NRG2  -  neuregulin 2, PLS3  -  plastin 3, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, SOX5  -  sry (sex determining region y)-box 5, HOXD13  -  homeobox d13, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, BIK  -  bcl2-interacting killer (apoptosis-inducing), HOXD12  -  homeobox d12, ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), HOXC13  -  homeobox c13, MYO6  -  myosin vi, SPAG6  -  sperm associated antigen 6, GH1  -  growth hormone 1, CR2  -  complement component (3d/epstein barr virus) receptor 2, MYO7A  -  myosin viia, CADM1  -  cell adhesion molecule 1, KRT19  -  keratin 19, COX17  -  cox17 cytochrome c oxidase copper chaperone, PPL  -  periplakin, TPH1  -  tryptophan hydroxylase 1, IAPP  -  islet amyloid polypeptide, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, KRT10  -  keratin 10, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, KRT13  -  keratin 13, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), DCAF7  -  ddb1 and cul4 associated factor 7, MYO16  -  myosin xvi, KRT14  -  keratin 14, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, COL9A3  -  collagen, type ix, alpha 3, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), LCK  -  lymphocyte-specific protein tyrosine kinase, SGCE  -  sarcoglycan, epsilon, C1QB  -  complement component 1, q subcomponent, b chain, E2F5  -  e2f transcription factor 5, p130-binding, POU1F1  -  pou class 1 homeobox 1, COL5A2  -  collagen, type v, alpha 2, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, C6  -  complement component 6, ECE1  -  endothelin converting enzyme 1, COL13A1  -  collagen, type xiii, alpha 1, CSTA  -  cystatin a (stefin a), AKR1C3  -  aldo-keto reductase family 1, member c3, CAPN2  -  calpain 2, (m/ii) large subunit, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, CTBP1  -  c-terminal binding protein 1, UMOD  -  uromodulin, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, HLF  -  hepatic leukemia factor, NFASC  -  neurofascin, CTNND2  -  catenin (cadherin-associated protein), delta 2, RPE65  -  retinal pigment epithelium-specific protein 65kda, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS4X  -  ribosomal protein s4, x-linked, RPS3A  -  ribosomal protein s3a, STXBP1  -  syntaxin binding protein 1, HOXB13  -  homeobox b13, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, EVPL  -  envoplakin, EZR  -  ezrin, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, CALCA  -  calcitonin-related polypeptide alpha, HIC1  -  hypermethylated in cancer 1, STK4  -  serine/threonine kinase 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), MSN  -  moesin, EDA2R  -  ectodysplasin a2 receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), HPCA  -  hippocalcin, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, HOXA11  -  homeobox a11, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CHRDL1  -  chordin-like 1, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, TXK  -  txk tyrosine kinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR2  -  estrogen receptor 2 (er beta), RPS14  -  ribosomal protein s14, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, SSTR3  -  somatostatin receptor 3, NRXN3  -  neurexin 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, TYR  -  tyrosinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ALX1  -  alx homeobox 1, MAPK14  -  mitogen-activated protein kinase 14, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, GBA  -  glucosidase, beta, acid, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PLCE1  -  phospholipase c, epsilon 1, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, EPHA4  -  eph receptor a4, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CCKAR  -  cholecystokinin a receptor, KRIT1  -  krit1, ankyrin repeat containing, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CFDP1  -  craniofacial development protein 1, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1, GAP43  -  growth associated protein 43, RTN1  -  reticulon 1, STX2  -  syntaxin 2, GAS6  -  growth arrest-specific 6, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, CCIN  -  calicin, RREB1  -  ras responsive element binding protein 1, FOXA2  -  forkhead box a2, SCEL  -  sciellin, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), SETDB1  -  set domain, bifurcated 1, PSAP  -  prosaposin, PVRL3  -  poliovirus receptor-related 3, FLT4  -  fms-related tyrosine kinase 4, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, KLK6  -  kallikrein-related peptidase 6, APOB  -  apolipoprotein b, DCX  -  doublecortin, FLG  -  filaggrin, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, ODF2  -  outer dense fiber of sperm tails 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, DFFB  -  dna fragmentation factor, 40kda, beta polypeptide (caspase-activated dnase), CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, MSC  -  musculin, FASLG  -  fas ligand (tnf superfamily, member 6), FHL2  -  four and a half lim domains 2, AQP1  -  aquaporin 1 (colton blood group), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, TAGLN  -  transgelin, FGFR3  -  fibroblast growth factor receptor 3, NTN3  -  netrin 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MYO3A  -  myosin iiia, FGF8  -  fibroblast growth factor 8 (androgen-induced), CFL1  -  cofilin 1 (non-muscle), NUMA1  -  nuclear mitotic apparatus protein 1, ITGB5  -  integrin, beta 5, FGF1  -  fibroblast growth factor 1 (acidic), ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PTHLH  -  parathyroid hormone-like hormone, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), S100A4  -  s100 calcium binding protein a4, CDK13  -  cyclin-dependent kinase 13, NLGN4X  -  neuroligin 4, x-linked, S100A7  -  s100 calcium binding protein a7, TAZ  -  tafazzin, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), IREB2  -  iron-responsive element binding protein 2, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, NRL  -  neural retina leucine zipper, NRF1  -  nuclear respiratory factor 1, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, NCKAP1  -  nck-associated protein 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, TDRD7  -  tudor domain containing 7, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, SMC3  -  structural maintenance of chromosomes 3, SFN  -  stratifin, INA  -  internexin neuronal intermediate filament protein, alpha, GPC1  -  glypican 1, LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), CNOT3  -  ccr4-not transcription complex, subunit 3, PGR  -  progesterone receptor, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), DPYSL2  -  dihydropyrimidinase-like 2, CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), CHEK1  -  checkpoint kinase 1, NGF  -  nerve growth factor (beta polypeptide), NELFA  -  negative elongation factor complex member a, KMT2B  -  lysine (k)-specific methyltransferase 2b, ICK  -  intestinal cell (mak-like) kinase, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, NKX2-2  -  nk2 homeobox 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), NEFH  -  neurofilament, heavy polypeptide, RAG2  -  recombination activating gene 2, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), RARG  -  retinoic acid receptor, gamma, PHGDH  -  phosphoglycerate dehydrogenase, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), PLAG1  -  pleiomorphic adenoma gene 1, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, NF2  -  neurofibromin 2 (merlin), PKP2  -  plakophilin 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), NQO1  -  nad(p)h dehydrogenase, quinone 1, BRSK2  -  br serine/threonine kinase 2, MACF1  -  microtubule-actin crosslinking factor 1, IHH  -  indian hedgehog, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, MXD1  -  max dimerization protein 1, TGFB1  -  transforming growth factor, beta 1, NEUROG2  -  neurogenin 2, IGFBP1  -  insulin-like growth factor binding protein 1, DIEXF  -  digestive organ expansion factor homolog (zebrafish), TH  -  tyrosine hydroxylase, ARID4A  -  at rich interactive domain 4a (rbp1-like), PLK4  -  polo-like kinase 4, EPCAM  -  epithelial cell adhesion molecule, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), PIM1  -  pim-1 oncogene, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0048545,response to steroid hormone,5.21E-09,9.68E-06,2.31,8230,249,829,58,"[AKR1C3  -  aldo-keto reductase family 1, member c3, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, SOX30  -  sry (sex determining region y)-box 30, HOXB13  -  homeobox b13, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NGF  -  nerve growth factor (beta polypeptide), CCL2  -  chemokine (c-c motif) ligand 2, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, OGG1  -  8-oxoguanine dna glycosylase, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), GH1  -  growth hormone 1, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), AQP1  -  aquaporin 1 (colton blood group), CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, KRT19  -  keratin 19, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SLIT2  -  slit homolog 2 (drosophila), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), CRYAB  -  crystallin, alpha b, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GLI3  -  gli family zinc finger 3, ESR1  -  estrogen receptor 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, SSTR3  -  somatostatin receptor 3, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, PPARG  -  peroxisome proliferator-activated receptor gamma, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, GBA  -  glucosidase, beta, acid, S100B  -  s100 calcium binding protein b, CDK4  -  cyclin-dependent kinase 4, UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, TGFB1  -  transforming growth factor, beta 1, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, TRH  -  thyrotropin-releasing hormone, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), RBBP5  -  retinoblastoma binding protein 5, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BCL2  -  b-cell cll/lymphoma 2, PDX1  -  pancreatic and duodenal homeobox 1, NRF1  -  nuclear respiratory factor 1]"GO:0009725,response to hormone,7.34E-09,1.17E-05,1.87,8230,560,754,96,"[AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, INHBB  -  inhibin, beta b, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, LATS1  -  large tumor suppressor kinase 1, GCG  -  glucagon, RPE65  -  retinal pigment epithelium-specific protein 65kda, GCK  -  glucokinase (hexokinase 4), CTSL  -  cathepsin l, HOXB13  -  homeobox b13, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, NGF  -  nerve growth factor (beta polypeptide), MAX  -  myc associated factor x, CCL2  -  chemokine (c-c motif) ligand 2, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TRIM16  -  tripartite motif containing 16, NKX2-2  -  nk2 homeobox 2, OGG1  -  8-oxoguanine dna glycosylase, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RHEB  -  ras homolog enriched in brain, FYN  -  fyn oncogene related to src, fgr, yes, GH1  -  growth hormone 1, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), AQP1  -  aquaporin 1 (colton blood group), CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, KRT19  -  keratin 19, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, FGFR3  -  fibroblast growth factor receptor 3, STAR  -  steroidogenic acute regulatory protein, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, PTCH1  -  patched 1, SLIT2  -  slit homolog 2 (drosophila), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTGDS  -  prostaglandin d2 synthase 21kda (brain), CRYAB  -  crystallin, alpha b, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, ESR1  -  estrogen receptor 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, SSTR3  -  somatostatin receptor 3, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, SSTR5  -  somatostatin receptor 5, NQO1  -  nad(p)h dehydrogenase, quinone 1, PPARA  -  peroxisome proliferator-activated receptor alpha, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, PPARG  -  peroxisome proliferator-activated receptor gamma, IHH  -  indian hedgehog, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ANG  -  angiogenin, ribonuclease, rnase a family, 5, CDK4  -  cyclin-dependent kinase 4, GBA  -  glucosidase, beta, acid, S100B  -  s100 calcium binding protein b, UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, IGFBP1  -  insulin-like growth factor binding protein 1, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), TRH  -  thyrotropin-releasing hormone, PIAS3  -  protein inhibitor of activated stat, 3, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, NPPA  -  natriuretic peptide a, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, PTPRA  -  protein tyrosine phosphatase, receptor type, a, BCL2  -  b-cell cll/lymphoma 2, PDX1  -  pancreatic and duodenal homeobox 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, NRF1  -  nuclear respiratory factor 1, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0042221,response to chemical,7.43E-09,1.03E-05,1.49,8230,1915,545,189,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), RGR  -  retinal g protein coupled receptor, AANAT  -  aralkylamine n-acetyltransferase, PSAP  -  prosaposin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX9  -  paired box 9, APOB  -  apolipoprotein b, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, ATXN3  -  ataxin 3, GCG  -  glucagon, BTK  -  bruton agammaglobulinemia tyrosine kinase, NCAM1  -  neural cell adhesion molecule 1, GDF5  -  growth differentiation factor 5, CCL17  -  chemokine (c-c motif) ligand 17, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), EIF4A1  -  eukaryotic translation initiation factor 4a1, RRAGB  -  ras-related gtp binding b, SP1  -  sp1 transcription factor, EIF4A2  -  eukaryotic translation initiation factor 4a2, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NRG2  -  neuregulin 2, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, SOX5  -  sry (sex determining region y)-box 5, IL1R1  -  interleukin 1 receptor, type i, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, LPL  -  lipoprotein lipase, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), KRT19  -  keratin 19, ITGA9  -  integrin, alpha 9, GLUL  -  glutamate-ammonia ligase, IL1R2  -  interleukin 1 receptor, type ii, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, KRT10  -  keratin 10, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, MEIS2  -  meis homeobox 2, KRT14  -  keratin 14, PPARA  -  peroxisome proliferator-activated receptor alpha, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, PPARG  -  peroxisome proliferator-activated receptor gamma, PTK6  -  protein tyrosine kinase 6, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, PLIN2  -  perilipin 2, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, KLHL20  -  kelch-like family member 20, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, NPPA  -  natriuretic peptide a, COL6A1  -  collagen, type vi, alpha 1, DNAL4  -  dynein, axonemal, light chain 4, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, IRF1  -  interferon regulatory factor 1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, KITLG  -  kit ligand, ADRA1A  -  adrenoceptor alpha 1a, NRF1  -  nuclear respiratory factor 1, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CDK2  -  cyclin-dependent kinase 2, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, PDE4A  -  phosphodiesterase 4a, camp-specific, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), HLA-G  -  major histocompatibility complex, class i, g, IFI27  -  interferon, alpha-inducible protein 27, HLA-F  -  major histocompatibility complex, class i, f, NKX2-1  -  nk2 homeobox 1, CAPN2  -  calpain 2, (m/ii) large subunit, HLA-E  -  major histocompatibility complex, class i, e, AES  -  amino-terminal enhancer of split, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, ADRB3  -  adrenoceptor beta 3, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, RPE65  -  retinal pigment epithelium-specific protein 65kda, DPYSL2  -  dihydropyrimidinase-like 2, CEP57  -  centrosomal protein 57kda, FASN  -  fatty acid synthase, IFNG  -  interferon, gamma, HLA-A  -  major histocompatibility complex, class i, a, CTSL  -  cathepsin l, CHEK1  -  checkpoint kinase 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, DARC  -  duffy blood group, atypical chemokine receptor, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CYBA  -  cytochrome b-245, alpha polypeptide, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CRIP1  -  cysteine-rich protein 1 (intestinal), TUBA1B  -  tubulin, alpha 1b, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, PLAU  -  plasminogen activator, urokinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, CD9  -  cd9 molecule, SSTR3  -  somatostatin receptor 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, NQO1  -  nad(p)h dehydrogenase, quinone 1, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), RBL1  -  retinoblastoma-like 1 (p107), ANG  -  angiogenin, ribonuclease, rnase a family, 5, SRP19  -  signal recognition particle 19kda, EPHA3  -  eph receptor a3, UCN  -  urocortin, GATA3  -  gata binding protein 3, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), IGFBP1  -  insulin-like growth factor binding protein 1, TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CXCL2  -  chemokine (c-x-c motif) ligand 2, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, THRA  -  thyroid hormone receptor, alpha, FOXA2  -  forkhead box a2]"GO:0032501,multicellular organismal process,1.30E-08,1.61E-05,1.34,8230,1957,979,312,"[HSF1  -  heat shock transcription factor 1, RGR  -  retinal g protein coupled receptor, BTC  -  betacellulin, PLXNB1  -  plexin b1, PMCH  -  pro-melanin-concentrating hormone, BCOR  -  bcl6 corepressor, ACACA  -  acetyl-coa carboxylase alpha, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, NBN  -  nibrin, NTSR2  -  neurotensin receptor 2, SORBS3  -  sorbin and sh3 domain containing 3, BGN  -  biglycan, SP1  -  sp1 transcription factor, LNPEP  -  leucyl/cystinyl aminopeptidase, RLN1  -  relaxin 1, SPRED2  -  sprouty-related, evh1 domain containing 2, HOXD13  -  homeobox d13, SOX2  -  sry (sex determining region y)-box 2, LPL  -  lipoprotein lipase, LPA  -  lipoprotein, lp(a), GHSR  -  growth hormone secretagogue receptor, HOXD12  -  homeobox d12, ACTA2  -  actin, alpha 2, smooth muscle, aorta, LIPC  -  lipase, hepatic, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, PLG  -  plasminogen, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), HOXC13  -  homeobox c13, MYO6  -  myosin vi, LMAN1  -  lectin, mannose-binding, 1, RGS16  -  regulator of g-protein signaling 16, SNTB1  -  syntrophin, beta 1 (dystrophin-associated protein a1, 59kda, basic component 1), MYO7A  -  myosin viia, CNGB1  -  cyclic nucleotide gated channel beta 1, ACTN1  -  actinin, alpha 1, NMU  -  neuromedin u, GLRB  -  glycine receptor, beta, PPL  -  periplakin, TPH1  -  tryptophan hydroxylase 1, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), GDF11  -  growth differentiation factor 11, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, GLI3  -  gli family zinc finger 3, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, USH1C  -  usher syndrome 1c (autosomal recessive, severe), HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, DCAF7  -  ddb1 and cul4 associated factor 7, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ROM1  -  retinal outer segment membrane protein 1, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, COL9A3  -  collagen, type ix, alpha 3, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, FEM1B  -  fem-1 homolog b (c. elegans), LCK  -  lymphocyte-specific protein tyrosine kinase, TRH  -  thyrotropin-releasing hormone, POU1F1  -  pou class 1 homeobox 1, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, SLC22A4  -  solute carrier family 22 (organic cation/zwitterion transporter), member 4, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, COL17A1  -  collagen, type xvii, alpha 1, ECE1  -  endothelin converting enzyme 1, COL13A1  -  collagen, type xiii, alpha 1, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, F13A1  -  coagulation factor xiii, a1 polypeptide, AES  -  amino-terminal enhancer of split, PDE5A  -  phosphodiesterase 5a, cgmp-specific, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, CTGF  -  connective tissue growth factor, KIF3A  -  kinesin family member 3a, PRCP  -  prolylcarboxypeptidase (angiotensinase c), UMOD  -  uromodulin, AGTR2  -  angiotensin ii receptor, type 2, ACE2  -  angiotensin i converting enzyme 2, HLF  -  hepatic leukemia factor, NFASC  -  neurofascin, CTNND2  -  catenin (cadherin-associated protein), delta 2, RPE65  -  retinal pigment epithelium-specific protein 65kda, CTRB1  -  chymotrypsinogen b1, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS4X  -  ribosomal protein s4, x-linked, CTSL  -  cathepsin l, HOXB13  -  homeobox b13, CTSD  -  cathepsin d, EVPL  -  envoplakin, VIP  -  vasoactive intestinal peptide, AHSG  -  alpha-2-hs-glycoprotein, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, KDM6A  -  lysine (k)-specific demethylase 6a, KLC1  -  kinesin light chain 1, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CXADR  -  coxsackie virus and adenovirus receptor, CALD1  -  caldesmon 1, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, F2RL2  -  coagulation factor ii (thrombin) receptor-like 2, CALCA  -  calcitonin-related polypeptide alpha, HIC1  -  hypermethylated in cancer 1, STK4  -  serine/threonine kinase 4, CYBA  -  cytochrome b-245, alpha polypeptide, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, HOXA11  -  homeobox a11, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, NIPBL  -  nipped-b homolog (drosophila), CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CHRDL1  -  chordin-like 1, SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, CRYBB1  -  crystallin, beta b1, TXK  -  txk tyrosine kinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, MYOM1  -  myomesin 1, RCOR1  -  rest corepressor 1, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, CD9  -  cd9 molecule, ITK  -  il2-inducible t-cell kinase, NRXN3  -  neurexin 3, TYR  -  tyrosinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ALX1  -  alx homeobox 1, MAPK14  -  mitogen-activated protein kinase 14, ANGPT1  -  angiopoietin 1, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, EPB41  -  erythrocyte membrane protein band 4.1 (elliptocytosis 1, rh-linked), GATA3  -  gata binding protein 3, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PRKG1  -  protein kinase, cgmp-dependent, type i, CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, CSN3  -  casein kappa, EPHA4  -  eph receptor a4, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CCKAR  -  cholecystokinin a receptor, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CFDP1  -  craniofacial development protein 1, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, PRKCG  -  protein kinase c, gamma, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, CCIN  -  calicin, RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, MPO  -  myeloperoxidase, FOXA2  -  forkhead box a2, PRSS3  -  protease, serine, 3, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), GCM1  -  glial cells missing homolog 1 (drosophila), PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, PAX2  -  paired box 2, IL12RB2  -  interleukin 12 receptor, beta 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), APOA1  -  apolipoprotein a-i, PSAP  -  prosaposin, MID1  -  midline 1 (opitz/bbb syndrome), CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), KLK6  -  kallikrein-related peptidase 6, APOB  -  apolipoprotein b, FLG  -  filaggrin, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, IL1B  -  interleukin 1, beta, ODF2  -  outer dense fiber of sperm tails 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, GUCY2F  -  guanylate cyclase 2f, retinal, CD34  -  cd34 molecule, AKAP10  -  a kinase (prka) anchor protein 10, OPRD1  -  opioid receptor, delta 1, AQP1  -  aquaporin 1 (colton blood group), CEL  -  carboxyl ester lipase, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, MYO3A  -  myosin iiia, PTGDR  -  prostaglandin d2 receptor (dp), FGF8  -  fibroblast growth factor 8 (androgen-induced), CFL1  -  cofilin 1 (non-muscle), ITGB5  -  integrin, beta 5, FGF1  -  fibroblast growth factor 1 (acidic), ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, NTSR1  -  neurotensin receptor 1 (high affinity), ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, PTHLH  -  parathyroid hormone-like hormone, GPR143  -  g protein-coupled receptor 143, S100B  -  s100 calcium binding protein b, PCOLCE  -  procollagen c-endopeptidase enhancer, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), DGKA  -  diacylglycerol kinase, alpha 80kda, CDK13  -  cyclin-dependent kinase 13, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), NLGN4X  -  neuroligin 4, x-linked, NPPA  -  natriuretic peptide a, DGKQ  -  diacylglycerol kinase, theta 110kda, TAZ  -  tafazzin, IREB2  -  iron-responsive element binding protein 2, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, NRL  -  neural retina leucine zipper, HDAC1  -  histone deacetylase 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CDK2  -  cyclin-dependent kinase 2, PDE4A  -  phosphodiesterase 4a, camp-specific, ATP2A1  -  atpase, ca++ transporting, cardiac muscle, fast twitch 1, NCKAP1  -  nck-associated protein 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, CHRM3  -  cholinergic receptor, muscarinic 3, SMC3  -  structural maintenance of chromosomes 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, DSC2  -  desmocollin 2, GP9  -  glycoprotein ix (platelet), ATM  -  ataxia telangiectasia mutated, SERPINC1  -  serpin peptidase inhibitor, clade c (antithrombin), member 1, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), NLGN1  -  neuroligin 1, PGR  -  progesterone receptor, NGF  -  nerve growth factor (beta polypeptide), NELFA  -  negative elongation factor complex member a, ICK  -  intestinal cell (mak-like) kinase, CLEC3B  -  c-type lectin domain family 3, member b, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, TF  -  transferrin, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), CLDN16  -  claudin 16, PLAU  -  plasminogen activator, urokinase, RARG  -  retinoic acid receptor, gamma, PLAG1  -  pleiomorphic adenoma gene 1, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, PKP2  -  plakophilin 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), GRIA1  -  glutamate receptor, ionotropic, ampa 1, IHH  -  indian hedgehog, TRAM2  -  translocation associated membrane protein 2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, MXD1  -  max dimerization protein 1, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, TGFB1  -  transforming growth factor, beta 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), DIEXF  -  digestive organ expansion factor homolog (zebrafish), TH  -  tyrosine hydroxylase, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), GRM8  -  glutamate receptor, metabotropic 8, DDX4  -  dead (asp-glu-ala-asp) box polypeptide 4, PIM1  -  pim-1 oncogene, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, OPN1LW  -  opsin 1 (cone pigments), long-wave-sensitive, SMAD4  -  smad family member 4, THRA  -  thyroid hormone receptor, alpha]"GO:0007166,cell surface receptor signaling pathway,1.30E-08,1.45E-05,1.45,8230,1679,728,215,"[IL1RL2  -  interleukin 1 receptor-like 2, RGR  -  retinal g protein coupled receptor, PLXNB1  -  plexin b1, BTK  -  bruton agammaglobulinemia tyrosine kinase, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, NCAM1  -  neural cell adhesion molecule 1, GDF5  -  growth differentiation factor 5, NTSR2  -  neurotensin receptor 2, EIF4A1  -  eukaryotic translation initiation factor 4a1, EIF4A2  -  eukaryotic translation initiation factor 4a2, SP1  -  sp1 transcription factor, PLP1  -  proteolipid protein 1, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, NRG2  -  neuregulin 2, RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, LDB1  -  lim domain binding 1, ACTG1  -  actin, gamma 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), GH1  -  growth hormone 1, NMU  -  neuromedin u, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, GLRB  -  glycine receptor, beta, GLI3  -  gli family zinc finger 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LBP  -  lipopolysaccharide binding protein, DNAL4  -  dynein, axonemal, light chain 4, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, BAIAP3  -  bai1-associated protein 3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, AES  -  amino-terminal enhancer of split, HLA-E  -  major histocompatibility complex, class i, e, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, KIF3A  -  kinesin family member 3a, AGTR2  -  angiotensin ii receptor, type 2, FSHR  -  follicle stimulating hormone receptor, RPE65  -  retinal pigment epithelium-specific protein 65kda, HLA-A  -  major histocompatibility complex, class i, a, HMGXB4  -  hmg box domain containing 4, HLA-C  -  major histocompatibility complex, class i, c, GRAP2  -  grb2-related adaptor protein 2, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, VIP  -  vasoactive intestinal peptide, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, EYA2  -  eyes absent homolog 2 (drosophila), FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, HIC1  -  hypermethylated in cancer 1, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TYROBP  -  tyro protein tyrosine kinase binding protein, STAT4  -  signal transducer and activator of transcription 4, CHRDL1  -  chordin-like 1, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, CD8B  -  cd8b molecule, CD7  -  cd7 molecule, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, SSTR3  -  somatostatin receptor 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, ITK  -  il2-inducible t-cell kinase, SSTR5  -  somatostatin receptor 5, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, EPHA3  -  eph receptor a3, UCN  -  urocortin, GATA3  -  gata binding protein 3, MVP  -  major vault protein, DOK4  -  docking protein 4, PLCE1  -  phospholipase c, epsilon 1, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, PRKCZ  -  protein kinase c, zeta, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, GAP43  -  growth associated protein 43, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, MPL  -  myeloproliferative leukemia virus oncogene, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, LPHN2  -  latrophilin 2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, S1PR2  -  sphingosine-1-phosphate receptor 2, IL12RB2  -  interleukin 12 receptor, beta 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, CCL17  -  chemokine (c-c motif) ligand 17, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), CCL2  -  chemokine (c-c motif) ligand 2, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, ARF4  -  adp-ribosylation factor 4, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, GUCY2F  -  guanylate cyclase 2f, retinal, FASLG  -  fas ligand (tnf superfamily, member 6), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, IL1R2  -  interleukin 1 receptor, type ii, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, PTH  -  parathyroid hormone, PTHLH  -  parathyroid hormone-like hormone, INSL3  -  insulin-like 3 (leydig cell), NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, NPPA  -  natriuretic peptide a, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CXCL13  -  chemokine (c-x-c motif) ligand 13, HCRTR1  -  hypocretin (orexin) receptor 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, IFI27  -  interferon, alpha-inducible protein 27, DRD3  -  dopamine receptor d3, IFI35  -  interferon-induced protein 35, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, PTPRN  -  protein tyrosine phosphatase, receptor type, n, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, NGF  -  nerve growth factor (beta polypeptide), SKP1  -  s-phase kinase-associated protein 1, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, RARG  -  retinoic acid receptor, gamma, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), GRIA2  -  glutamate receptor, ionotropic, ampa 2, LTK  -  leukocyte receptor tyrosine kinase, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), CCDC88C  -  coiled-coil domain containing 88c, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, PIAS4  -  protein inhibitor of activated stat, 4, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, IGFBP1  -  insulin-like growth factor binding protein 1, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, KALRN  -  kalirin, rhogef kinase, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, SMAD4  -  smad family member 4, THY1  -  thy-1 cell surface antigen, GRP  -  gastrin-releasing peptide, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0065007,biological regulation,1.46E-08,1.48E-05,1.12,8230,5683,920,714,"[CREB5  -  camp responsive element binding protein 5, SPTAN1  -  spectrin, alpha, non-erythrocytic 1, EXOSC10  -  exosome component 10, GFRA2  -  gdnf family receptor alpha 2, ARHGEF39  -  rho guanine nucleotide exchange factor (gef) 39, DAPK2  -  death-associated protein kinase 2, CDKN2AIP  -  cdkn2a interacting protein, AANAT  -  aralkylamine n-acetyltransferase, CD2AP  -  cd2-associated protein, BTG3  -  btg family, member 3, PATZ1  -  poz (btb) and at hook containing zinc finger 1, PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, SPIB  -  spi-b transcription factor (spi-1/pu.1 related), ACACA  -  acetyl-coa carboxylase alpha, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GCHFR  -  gtp cyclohydrolase i feedback regulator, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SP1  -  sp1 transcription factor, PLP1  -  proteolipid protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NRG2  -  neuregulin 2, SOX5  -  sry (sex determining region y)-box 5, CLDN3  -  claudin 3, SOX2  -  sry (sex determining region y)-box 2, H2AFY  -  h2a histone family, member y, SOX3  -  sry (sex determining region y)-box 3, LPL  -  lipoprotein lipase, LPA  -  lipoprotein, lp(a), ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, LIPC  -  lipase, hepatic, RND2  -  rho family gtpase 2, PLG  -  plasminogen, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, LMAN1  -  lectin, mannose-binding, 1, CR2  -  complement component (3d/epstein barr virus) receptor 2, CADM1  -  cell adhesion molecule 1, CNGB1  -  cyclic nucleotide gated channel beta 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, ACTN1  -  actinin, alpha 1, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, ARHGAP19  -  rho gtpase activating protein 19, TRRAP  -  transformation/transcription domain-associated protein, USP20  -  ubiquitin specific peptidase 20, HIST3H3  -  histone cluster 3, h3, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, GLRB  -  glycine receptor, beta, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), CREBZF  -  creb/atf bzip transcription factor, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, SNAPC3  -  small nuclear rna activating complex, polypeptide 3, 50kda, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), CDC45  -  cell division cycle 45, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, MMP24  -  matrix metallopeptidase 24 (membrane-inserted), SUMO3  -  small ubiquitin-like modifier 3, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, PLIN2  -  perilipin 2, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, LDOC1  -  leucine zipper, down-regulated in cancer 1, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LCK  -  lymphocyte-specific protein tyrosine kinase, LBP  -  lipopolysaccharide binding protein, POU1F1  -  pou class 1 homeobox 1, MAPK8IP1  -  mitogen-activated protein kinase 8 interacting protein 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, SLC22A4  -  solute carrier family 22 (organic cation/zwitterion transporter), member 4, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, CSTA  -  cystatin a (stefin a), PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, NCR2  -  natural cytotoxicity triggering receptor 2, FTL  -  ferritin, light polypeptide, AES  -  amino-terminal enhancer of split, ADRB1  -  adrenoceptor beta 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, ADRBK2  -  adrenergic, beta, receptor kinase 2, ZNF350  -  zinc finger protein 350, CTGF  -  connective tissue growth factor, PTPRT  -  protein tyrosine phosphatase, receptor type, t, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, PRCP  -  prolylcarboxypeptidase (angiotensinase c), CTBP1  -  c-terminal binding protein 1, ACE2  -  angiotensin i converting enzyme 2, AGTR2  -  angiotensin ii receptor, type 2, FSHR  -  follicle stimulating hormone receptor, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTSL  -  cathepsin l, STXBP1  -  syntaxin binding protein 1, SOX30  -  sry (sex determining region y)-box 30, GRAP2  -  grb2-related adaptor protein 2, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PDZD3  -  pdz domain containing 3, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, KPNA3  -  karyopherin alpha 3 (importin alpha 4), GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, AHSG  -  alpha-2-hs-glycoprotein, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, PPP1R3D  -  protein phosphatase 1, regulatory subunit 3d, KLC1  -  kinesin light chain 1, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, STK4  -  serine/threonine kinase 4, CYBA  -  cytochrome b-245, alpha polypeptide, TRIM31  -  tripartite motif containing 31, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, EDA2R  -  ectodysplasin a2 receptor, STMN2  -  stathmin-like 2, KISS1  -  kiss-1 metastasis-suppressor, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, STAT4  -  signal transducer and activator of transcription 4, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, ALDOB  -  aldolase b, fructose-bisphosphate, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, NRXN3  -  neurexin 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, ITK  -  il2-inducible t-cell kinase, SSTR5  -  somatostatin receptor 5, DSTN  -  destrin (actin depolymerizing factor), SNIP1  -  smad nuclear interacting protein 1, ALX1  -  alx homeobox 1, MAPK14  -  mitogen-activated protein kinase 14, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANGPT1  -  angiopoietin 1, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GBA  -  glucosidase, beta, acid, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, DOK4  -  docking protein 4, CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, CSN3  -  casein kappa, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, NCR3  -  natural cytotoxicity triggering receptor 3, GLP2R  -  glucagon-like peptide 2 receptor, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, GAP43  -  growth associated protein 43, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, MLLT10  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 10, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, SOCS6  -  suppressor of cytokine signaling 6, APOA1  -  apolipoprotein a-i, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, PAX9  -  paired box 9, MID1  -  midline 1 (opitz/bbb syndrome), APOB  -  apolipoprotein b, DCX  -  doublecortin, MAP3K9  -  mitogen-activated protein kinase kinase kinase 9, CYTH3  -  cytohesin 3, ATXN3  -  ataxin 3, CYTH2  -  cytohesin 2, PCBD1  -  pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, MLLT1  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 1, PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CCL15  -  chemokine (c-c motif) ligand 15, CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, PMF1  -  polyamine-modulated factor 1, CCL1  -  chemokine (c-c motif) ligand 1, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), CCL3  -  chemokine (c-c motif) ligand 3, ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, PRDX1  -  peroxiredoxin 1, ZNF473  -  zinc finger protein 473, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, AKAP10  -  a kinase (prka) anchor protein 10, GUCY2F  -  guanylate cyclase 2f, retinal, KLK3  -  kallikrein-related peptidase 3, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CELF3  -  cugbp, elav-like family member 3, FZD5  -  frizzled family receptor 5, MDFI  -  myod family inhibitor, IL1R2  -  interleukin 1 receptor, type ii, ZNF451  -  zinc finger protein 451, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, SERPINB4  -  serpin peptidase inhibitor, clade b (ovalbumin), member 4, MYO3A  -  myosin iiia, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ARF5  -  adp-ribosylation factor 5, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, BAZ1A  -  bromodomain adjacent to zinc finger domain, 1a, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, S100A11  -  s100 calcium binding protein a11, S100B  -  s100 calcium binding protein b, TMSB10  -  thymosin beta 10, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, S100A4  -  s100 calcium binding protein a4, NLGN4X  -  neuroligin 4, x-linked, S100A7  -  s100 calcium binding protein a7, DGKQ  -  diacylglycerol kinase, theta 110kda, FANCL  -  fanconi anemia, complementation group l, PCSK1  -  proprotein convertase subtilisin/kexin type 1, ZNF227  -  zinc finger protein 227, THAP1  -  thap domain containing, apoptosis associated protein 1, ASGR2  -  asialoglycoprotein receptor 2, KITLG  -  kit ligand, ZNF205  -  zinc finger protein 205, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, ARID3A  -  at rich interactive domain 3a (bright-like), GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CCNE2  -  cyclin e2, RUFY3  -  run and fyve domain containing 3, DRD3  -  dopamine receptor d3, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, SMC3  -  structural maintenance of chromosomes 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, DSC2  -  desmocollin 2, BAHD1  -  bromo adjacent homology domain containing 1, DPP6  -  dipeptidyl-peptidase 6, SFN  -  stratifin, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, GP9  -  glycoprotein ix (platelet), LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, SERPINC1  -  serpin peptidase inhibitor, clade c (antithrombin), member 1, MTMR4  -  myotubularin related protein 4, PGR  -  progesterone receptor, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, SKP1  -  s-phase kinase-associated protein 1, MBL2  -  mannose-binding lectin (protein c) 2, soluble, NELFA  -  negative elongation factor complex member a, LMTK2  -  lemur tyrosine kinase 2, MAX  -  myc associated factor x, ICK  -  intestinal cell (mak-like) kinase, SLC4A3  -  solute carrier family 4 (anion exchanger), member 3, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, CFP  -  complement factor properdin, GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), DLX2  -  distal-less homeobox 2, MZF1  -  myeloid zinc finger 1, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), PLAU  -  plasminogen activator, urokinase, PHGDH  -  phosphoglycerate dehydrogenase, PLAG1  -  pleiomorphic adenoma gene 1, ZNF10  -  zinc finger protein 10, GRN  -  granulin, PKP2  -  plakophilin 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), NQO1  -  nad(p)h dehydrogenase, quinone 1, BRSK2  -  br serine/threonine kinase 2, GRIA2  -  glutamate receptor, ionotropic, ampa 2, LTK  -  leukocyte receptor tyrosine kinase, GRIA1  -  glutamate receptor, ionotropic, ampa 1, RHOV  -  ras homolog family member v, ZFPL1  -  zinc finger protein-like 1, CCDC88C  -  coiled-coil domain containing 88c, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, PIAS4  -  protein inhibitor of activated stat, 4, LYZ  -  lysozyme, KALRN  -  kalirin, rhogef kinase, SRSF6  -  serine/arginine-rich splicing factor 6, EPCAM  -  epithelial cell adhesion molecule, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, TAF1C  -  tata box binding protein (tbp)-associated factor, rna polymerase i, c, 110kda, PIM1  -  pim-1 oncogene, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, GRP  -  gastrin-releasing peptide, INTS1  -  integrator complex subunit 1, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, RFC5  -  replication factor c (activator 1) 5, 36.5kda, NCBP1  -  nuclear cap binding protein subunit 1, 80kda, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, RGR  -  retinal g protein coupled receptor, BRDT  -  bromodomain, testis-specific, CARD14  -  caspase recruitment domain family, member 14, RFX1  -  regulatory factor x, 1 (influences hla class ii expression), NAIP  -  nlr family, apoptosis inhibitory protein, BTC  -  betacellulin, ELL2  -  elongation factor, rna polymerase ii, 2, PRMT1  -  protein arginine methyltransferase 1, BCOR  -  bcl6 corepressor, LIN7A  -  lin-7 homolog a (c. elegans), BTK  -  bruton agammaglobulinemia tyrosine kinase, AGFG2  -  arfgap with fg repeats 2, SAP30  -  sin3a-associated protein, 30kda, NCAM1  -  neural cell adhesion molecule 1, NBN  -  nibrin, KSR1  -  kinase suppressor of ras 1, TTR  -  transthyretin, EIF4A1  -  eukaryotic translation initiation factor 4a1, SORBS3  -  sorbin and sh3 domain containing 3, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, WISP2  -  wnt1 inducible signaling pathway protein 2, RLN1  -  relaxin 1, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, SPRED2  -  sprouty-related, evh1 domain containing 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, HOXD13  -  homeobox d13, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, MPHOSPH10  -  m-phase phosphoprotein 10 (u3 small nucleolar ribonucleoprotein), LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, TSHR  -  thyroid stimulating hormone receptor, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, TSC22D1  -  tsc22 domain family, member 1, RGS16  -  regulator of g-protein signaling 16, MAST1  -  microtubule associated serine/threonine kinase 1, FUBP1  -  far upstream element (fuse) binding protein 1, ICAM2  -  intercellular adhesion molecule 2, TPH1  -  tryptophan hydroxylase 1, GDF11  -  growth differentiation factor 11, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, MYO16  -  myosin xvi, BUD31  -  bud31 homolog (s. cerevisiae), CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), TRH  -  thyrotropin-releasing hormone, C1QA  -  complement component 1, q subcomponent, a chain, C1QB  -  complement component 1, q subcomponent, b chain, E2F5  -  e2f transcription factor 5, p130-binding, C1R  -  complement component 1, r subcomponent, DENND4A  -  denn/madd domain containing 4a, C1S  -  complement component 1, s subcomponent, E2F1  -  e2f transcription factor 1, DNAL4  -  dynein, axonemal, light chain 4, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, C5  -  complement component 5, C6  -  complement component 6, ECE1  -  endothelin converting enzyme 1, KIR2DS2  -  killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2, UBE4B  -  ubiquitination factor e4b, BAIAP3  -  bai1-associated protein 3, WAPAL  -  wings apart-like homolog (drosophila), BLOC1S3  -  biogenesis of lysosomal organelles complex-1, subunit 3, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPNS1  -  calpain, small subunit 1, HLA-G  -  major histocompatibility complex, class i, g, F13A1  -  coagulation factor xiii, a1 polypeptide, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, PDE5A  -  phosphodiesterase 5a, cgmp-specific, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, UMOD  -  uromodulin, DYNLL1  -  dynein, light chain, lc8-type 1, DLK2  -  delta-like 2 homolog (drosophila), RPE65  -  retinal pigment epithelium-specific protein 65kda, FASN  -  fatty acid synthase, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS4X  -  ribosomal protein s4, x-linked, HLA-A  -  major histocompatibility complex, class i, a, RPS3A  -  ribosomal protein s3a, HMGXB4  -  hmg box domain containing 4, HLA-C  -  major histocompatibility complex, class i, c, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, EZR  -  ezrin, VIP  -  vasoactive intestinal peptide, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), CFH  -  complement factor h, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, NCOA2  -  nuclear receptor coactivator 2, EZH1  -  enhancer of zeste homolog 1 (drosophila), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), F2RL2  -  coagulation factor ii (thrombin) receptor-like 2, CALCA  -  calcitonin-related polypeptide alpha, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, MSN  -  moesin, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, HOXA11  -  homeobox a11, CD1D  -  cd1d molecule, TYROBP  -  tyro protein tyrosine kinase binding protein, CHRDL1  -  chordin-like 1, GPAA1  -  glycosylphosphatidylinositol anchor attachment 1, UBC  -  ubiquitin c, CCNG2  -  cyclin g2, TXK  -  txk tyrosine kinase, CD8B  -  cd8b molecule, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR2  -  estrogen receptor 2 (er beta), CD7  -  cd7 molecule, RCOR1  -  rest corepressor 1, RPS14  -  ribosomal protein s14, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, HOXA1  -  homeobox a1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, DLC1  -  deleted in liver cancer 1, CD9  -  cd9 molecule, TYRO3  -  tyro3 protein tyrosine kinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, EPHA3  -  eph receptor a3, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, EPB41  -  erythrocyte membrane protein band 4.1 (elliptocytosis 1, rh-linked), SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), MVP  -  major vault protein, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, NAPG  -  n-ethylmaleimide-sensitive factor attachment protein, gamma, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, EPHA4  -  eph receptor a4, CCKAR  -  cholecystokinin a receptor, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, CCND2  -  cyclin d2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), STX2  -  syntaxin 2, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), LPHN2  -  latrophilin 2, DNMBP  -  dynamin binding protein, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, SETDB1  -  set domain, bifurcated 1, HTRA1  -  htra serine peptidase 1, PSAP  -  prosaposin, FLT4  -  fms-related tyrosine kinase 4, IL13RA1  -  interleukin 13 receptor, alpha 1, ORC2  -  origin recognition complex, subunit 2, KLK6  -  kallikrein-related peptidase 6, ORM1  -  orosomucoid 1, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), PRSS8  -  protease, serine, 8, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), FLG  -  filaggrin, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, PSD  -  pleckstrin and sec7 domain containing, CDON  -  cell adhesion associated, oncogene regulated, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), RGS5  -  regulator of g-protein signaling 5, AHSA1  -  aha1, activator of heat shock 90kda protein atpase homolog 1 (yeast), PSMB3  -  proteasome (prosome, macropain) subunit, beta type, 3, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CD53  -  cd53 molecule, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, PSMD1  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 1, PDIA2  -  protein disulfide isomerase family a, member 2, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, PSMC2  -  proteasome (prosome, macropain) 26s subunit, atpase, 2, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, CD34  -  cd34 molecule, FHL2  -  four and a half lim domains 2, CEL  -  carboxyl ester lipase, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGFR3  -  fibroblast growth factor receptor 3, GNMT  -  glycine n-methyltransferase, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, NTN3  -  netrin 3, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, CFL1  -  cofilin 1 (non-muscle), FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, PTH  -  parathyroid hormone, TRIM2  -  tripartite motif containing 2, PTHLH  -  parathyroid hormone-like hormone, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTK6  -  protein tyrosine kinase 6, GPR143  -  g protein-coupled receptor 143, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDK13  -  cyclin-dependent kinase 13, NPC2  -  niemann-pick disease, type c2, KLHL20  -  kelch-like family member 20, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), LIN37  -  lin-37 homolog (c. elegans), IREB2  -  iron-responsive element binding protein 2, TRIM9  -  tripartite motif containing 9, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, NRL  -  neural retina leucine zipper, NRF1  -  nuclear respiratory factor 1, CDK2  -  cyclin-dependent kinase 2, FBLN2  -  fibulin 2, GIT2  -  g protein-coupled receptor kinase interacting arfgap 2, CXCL13  -  chemokine (c-x-c motif) ligand 13, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, PTS  -  6-pyruvoyltetrahydropterin synthase, IFI27  -  interferon, alpha-inducible protein 27, TDRD7  -  tudor domain containing 7, IFI35  -  interferon-induced protein 35, PTPRN2  -  protein tyrosine phosphatase, receptor type, n polypeptide 2, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, NOS1AP  -  nitric oxide synthase 1 (neuronal) adaptor protein, ZBTB6  -  zinc finger and btb domain containing 6, PTPRN  -  protein tyrosine phosphatase, receptor type, n, NOV  -  nephroblastoma overexpressed, NPAT  -  nuclear protein, ataxia-telangiectasia locus, RIMS2  -  regulating synaptic membrane exocytosis 2, PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), TRAF3IP2  -  traf3 interacting protein 2, CNOT3  -  ccr4-not transcription complex, subunit 3, CHKA  -  choline kinase alpha, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, DHX34  -  deah (asp-glu-ala-his) box polypeptide 34, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), IFNG  -  interferon, gamma, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, CHEK1  -  checkpoint kinase 1, NFX1  -  nuclear transcription factor, x-box binding 1, NGF  -  nerve growth factor (beta polypeptide), CHD1  -  chromodomain helicase dna binding protein 1, KMT2B  -  lysine (k)-specific methyltransferase 2b, RAD51  -  rad51 recombinase, ACAP1  -  arfgap with coiled-coil, ankyrin repeat and ph domains 1, ARHGAP32  -  rho gtpase activating protein 32, CLEC3B  -  c-type lectin domain family 3, member b, RAD21  -  rad21 homolog (s. pombe), TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CGB  -  chorionic gonadotropin, beta polypeptide, RAB27B  -  rab27b, member ras oncogene family, NID1  -  nidogen 1, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, CCR6  -  chemokine (c-c motif) receptor 6, RAN  -  ran, member ras oncogene family, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, TF  -  transferrin, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), NEFM  -  neurofilament, medium polypeptide, RAG2  -  recombination activating gene 2, CLDN16  -  claudin 16, RARG  -  retinoic ac""d receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), NF2  -  neurofibromin 2 (merlin), IGSF1  -  immunoglobulin superfamily, member 1, MACF1  -  microtubule-actin crosslinking factor 1, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), RBL2  -  retinoblastoma-like 2 (p130), TGFB1  -  transforming growth factor, beta 1, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, NEUROG2  -  neurogenin 2, IGF1  -  insulin-like growth factor 1 (somatomedin c), TH  -  tyrosine hydroxylase, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, IGFBP1  -  insulin-like growth factor binding protein 1, ARID4A  -  at rich interactive domain 4a (rbp1-like), PLK4  -  polo-like kinase 4, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, RBBP5  -  retinoblastoma binding protein 5, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), AP3S1  -  adaptor-related protein complex 3, sigma 1 subunit, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, RCVRN  -  recoverin, CIRBP  -  cold inducible rna binding protein, CKB  -  creatine kinase, brain, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]",,,,,,,,,GO:0048513,organ development,1.50E-08,1.39E-05,1.77,8230,751,668,108,"[PAX2  -  paired box 2, BRCA2  -  breast cancer 2, early onset, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), PATZ1  -  poz (btb) and at hook containing zinc finger 1, CXCL12  -  chemokine (c-x-c motif) ligand 12, DCX  -  doublecortin, EIF4A1  -  eukaryotic translation initiation factor 4a1, SP1  -  sp1 transcription factor, CCL2  -  chemokine (c-c motif) ligand 2, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, ARF4  -  adp-ribosylation factor 4, BIK  -  bcl2-interacting killer (apoptosis-inducing), MNAT1  -  mnat cdk-activating kinase assembly factor 1, CRH  -  corticotropin releasing hormone, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, CD34  -  cd34 molecule, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MSC  -  musculin, CADM1  -  cell adhesion molecule 1, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), FZD5  -  frizzled family receptor 5, TAGLN  -  transgelin, COX17  -  cox17 cytochrome c oxidase copper chaperone, FGF12  -  fibroblast growth factor 12, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, KRT9  -  keratin 9, MEIS2  -  meis homeobox 2, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, COL9A3  -  collagen, type ix, alpha 3, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), CDK13  -  cyclin-dependent kinase 13, SGCE  -  sarcoglycan, epsilon, COL5A2  -  collagen, type v, alpha 2, TAZ  -  tafazzin, HNF1A  -  hnf1 homeobox a, ADRA1A  -  adrenoceptor alpha 1a, KITLG  -  kit ligand, NRF1  -  nuclear respiratory factor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, AKR1C3  -  aldo-keto reductase family 1, member c3, NKX2-1  -  nk2 homeobox 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, CTGF  -  connective tissue growth factor, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, ATM  -  ataxia telangiectasia mutated, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), GAB1  -  grb2-associated binding protein 1, NKX2-2  -  nk2 homeobox 2, CXADR  -  coxsackie virus and adenovirus receptor, VWF  -  von willebrand factor, STK4  -  serine/threonine kinase 4, CRIP2  -  cysteine-rich protein 2, PKD1  -  polycystic kidney disease 1 (autosomal dominant), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CRIP1  -  cysteine-rich protein 1 (intestinal), CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLIT2  -  slit homolog 2 (drosophila), CHRDL1  -  chordin-like 1, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, RARG  -  retinoic acid receptor, gamma, TWIST1  -  twist basic helix-loop-helix transcription factor 1, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), ESR1  -  estrogen receptor 1, CD9  -  cd9 molecule, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, PKP2  -  plakophilin 2, TYR  -  tyrosinase, HOXA9  -  homeobox a9, IHH  -  indian hedgehog, ALX1  -  alx homeobox 1, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), TH  -  tyrosine hydroxylase, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, GAS6  -  growth arrest-specific 6, THRA  -  thyroid hormone receptor, alpha]"GO:0007165,signal transduction,1.59E-08,1.37E-05,1.31,8230,2813,730,326,"[DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, DAPK2  -  death-associated protein kinase 2, RGR  -  retinal g protein coupled receptor, CD2AP  -  cd2-associated protein, PLXNB1  -  plexin b1, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, BTK  -  bruton agammaglobulinemia tyrosine kinase, GCG  -  glucagon, NCAM1  -  neural cell adhesion molecule 1, GCK  -  glucokinase (hexokinase 4), GDF5  -  growth differentiation factor 5, NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, EIF4A1  -  eukaryotic translation initiation factor 4a1, SP1  -  sp1 transcription factor, EIF4A2  -  eukaryotic translation initiation factor 4a2, WISP2  -  wnt1 inducible signaling pathway protein 2, RLN1  -  relaxin 1, PLP1  -  proteolipid protein 1, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, NRG2  -  neuregulin 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, CLDN3  -  claudin 3, LPL  -  lipoprotein lipase, RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CRH  -  corticotropin releasing hormone, RND2  -  rho family gtpase 2, LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, ACTG1  -  actin, gamma 1, CALCRL  -  calcitonin receptor-like, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), PLD1  -  phospholipase d1, phosphatidylcholine-specific, MYO6  -  myosin vi, MAST1  -  microtubule associated serine/threonine kinase 1, GH1  -  growth hormone 1, NMU  -  neuromedin u, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, ARHGAP19  -  rho gtpase activating protein 19, GLRB  -  glycine receptor, beta, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, GLI3  -  gli family zinc finger 3, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, MYO16  -  myosin xvi, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, TRH  -  thyrotropin-releasing hormone, LBP  -  lipopolysaccharide binding protein, DNAL4  -  dynein, axonemal, light chain 4, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, GMFB  -  glia maturation factor, beta, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, UBE4B  -  ubiquitination factor e4b, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, BAIAP3  -  bai1-associated protein 3, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, NCR2  -  natural cytotoxicity triggering receptor 2, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, AES  -  amino-terminal enhancer of split, PDE5A  -  phosphodiesterase 5a, cgmp-specific, ADRB1  -  adrenoceptor beta 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, KIF3A  -  kinesin family member 3a, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, FSHR  -  follicle stimulating hormone receptor, CTNND2  -  catenin (cadherin-associated protein), delta 2, RPE65  -  retinal pigment epithelium-specific protein 65kda, HLA-A  -  major histocompatibility complex, class i, a, CTSL  -  cathepsin l, HMGXB4  -  hmg box domain containing 4, GRAP2  -  grb2-related adaptor protein 2, HLA-C  -  major histocompatibility complex, class i, c, TOM1L1  -  target of myb1 (chicken)-like 1, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, VIP  -  vasoactive intestinal peptide, EYA2  -  eyes absent homolog 2 (drosophila), ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, NCOA2  -  nuclear receptor coactivator 2, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, HIC1  -  hypermethylated in cancer 1, STK4  -  serine/threonine kinase 4, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CRIP1  -  cysteine-rich protein 1 (intestinal), CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TYROBP  -  tyro protein tyrosine kinase binding protein, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), CHRDL1  -  chordin-like 1, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, CD8B  -  cd8b molecule, CD7  -  cd7 molecule, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, DLC1  -  deleted in liver cancer 1, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, SSTR5  -  somatostatin receptor 5, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, EPHA3  -  eph receptor a3, UCN  -  urocortin, GATA3  -  gata binding protein 3, MVP  -  major vault protein, DOK4  -  docking protein 4, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PLCE1  -  phospholipase c, epsilon 1, CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, GAP43  -  growth associated protein 43, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, LPHN2  -  latrophilin 2, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, IL12RB2  -  interleukin 12 receptor, beta 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), DCX  -  doublecortin, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, RGS5  -  regulator of g-protein signaling 5, CCL17  -  chemokine (c-c motif) ligand 17, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CD53  -  cd53 molecule, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, GUCY2F  -  guanylate cyclase 2f, retinal, CD34  -  cd34 molecule, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, IL1R2  -  interleukin 1 receptor, type ii, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, ITGB5  -  integrin, beta 5, FGF1  -  fibroblast growth factor 1 (acidic), ITGB7  -  integrin, beta 7, PTH  -  parathyroid hormone, ARF5  -  adp-ribosylation factor 5, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PTHLH  -  parathyroid hormone-like hormone, PECAM1  -  platelet/endothelial cell adhesion molecule 1, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, INSL3  -  insulin-like 3 (leydig cell), S100A11  -  s100 calcium binding protein a11, CDK4  -  cyclin-dependent kinase 4, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, NPPA  -  natriuretic peptide a, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, HCLS1  -  hematopoietic cell-specific lyn substrate 1, CDK2  -  cyclin-dependent kinase 2, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PDE4A  -  phosphodiesterase 4a, camp-specific, IRAK1  -  interleukin-1 receptor-associated kinase 1, HCRTR1  -  hypocretin (orexin) receptor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, NCKAP1  -  nck-associated protein 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, SMC3  -  structural maintenance of chromosomes 3, PTPRN  -  protein tyrosine phosphatase, receptor type, n, SFN  -  stratifin, GPC1  -  glypican 1, ATM  -  ataxia telangiectasia mutated, RIMS2  -  regulating synaptic membrane exocytosis 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), MTMR4  -  myotubularin related protein 4, TRAF3IP2  -  traf3 interacting protein 2, CHKA  -  choline kinase alpha, NLGN1  -  neuroligin 1, PGR  -  progesterone receptor, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), DPYSL2  -  dihydropyrimidinase-like 2, CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, NGF  -  nerve growth factor (beta polypeptide), SKP1  -  s-phase kinase-associated protein 1, ICK  -  intestinal cell (mak-like) kinase, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, PLAU  -  plasminogen activator, urokinase, RARG  -  retinoic acid receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), GRN  -  granulin, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), BRSK2  -  br serine/threonine kinase 2, LTK  -  leukocyte receptor tyrosine kinase, IGSF1  -  immunoglobulin superfamily, member 1, GRIA2  -  glutamate receptor, ionotropic, ampa 2, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), CCDC88C  -  coiled-coil domain containing 88c, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, IGFBP1  -  insulin-like growth factor binding protein 1, KALRN  -  kalirin, rhogef kinase, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, GRP  -  gastrin-releasing peptide, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0044707,single-multicellular organism process,1.82E-08,1.45E-05,1.34,8230,1918,979,306,"[RGR  -  retinal g protein coupled receptor, BTC  -  betacellulin, PLXNB1  -  plexin b1, PMCH  -  pro-melanin-concentrating hormone, BCOR  -  bcl6 corepressor, ACACA  -  acetyl-coa carboxylase alpha, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, NBN  -  nibrin, NTSR2  -  neurotensin receptor 2, SORBS3  -  sorbin and sh3 domain containing 3, BGN  -  biglycan, SP1  -  sp1 transcription factor, SPRED2  -  sprouty-related, evh1 domain containing 2, HOXD13  -  homeobox d13, SOX2  -  sry (sex determining region y)-box 2, LPL  -  lipoprotein lipase, LPA  -  lipoprotein, lp(a), GHSR  -  growth hormone secretagogue receptor, HOXD12  -  homeobox d12, ACTA2  -  actin, alpha 2, smooth muscle, aorta, LIPC  -  lipase, hepatic, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, PLG  -  plasminogen, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), HOXC13  -  homeobox c13, MYO6  -  myosin vi, LMAN1  -  lectin, mannose-binding, 1, RGS16  -  regulator of g-protein signaling 16, SNTB1  -  syntrophin, beta 1 (dystrophin-associated protein a1, 59kda, basic component 1), MYO7A  -  myosin viia, CNGB1  -  cyclic nucleotide gated channel beta 1, NMU  -  neuromedin u, ACTN1  -  actinin, alpha 1, GLRB  -  glycine receptor, beta, PPL  -  periplakin, TPH1  -  tryptophan hydroxylase 1, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), GDF11  -  growth differentiation factor 11, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, GLI3  -  gli family zinc finger 3, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, USH1C  -  usher syndrome 1c (autosomal recessive, severe), HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, DCAF7  -  ddb1 and cul4 associated factor 7, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ROM1  -  retinal outer segment membrane protein 1, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, COL9A3  -  collagen, type ix, alpha 3, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, FEM1B  -  fem-1 homolog b (c. elegans), LCK  -  lymphocyte-specific protein tyrosine kinase, TRH  -  thyrotropin-releasing hormone, POU1F1  -  pou class 1 homeobox 1, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, SLC22A4  -  solute carrier family 22 (organic cation/zwitterion transporter), member 4, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, COL17A1  -  collagen, type xvii, alpha 1, ECE1  -  endothelin converting enzyme 1, COL13A1  -  collagen, type xiii, alpha 1, ERC1  -  elks/rab6-interacting/cast family member 1, AKR1C3  -  aldo-keto reductase family 1, member c3, F13A1  -  coagulation factor xiii, a1 polypeptide, AES  -  amino-terminal enhancer of split, PDE5A  -  phosphodiesterase 5a, cgmp-specific, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, CTGF  -  connective tissue growth factor, KIF3A  -  kinesin family member 3a, PRCP  -  prolylcarboxypeptidase (angiotensinase c), UMOD  -  uromodulin, AGTR2  -  angiotensin ii receptor, type 2, ACE2  -  angiotensin i converting enzyme 2, HLF  -  hepatic leukemia factor, NFASC  -  neurofascin, CTNND2  -  catenin (cadherin-associated protein), delta 2, RPE65  -  retinal pigment epithelium-specific protein 65kda, CTRB1  -  chymotrypsinogen b1, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS4X  -  ribosomal protein s4, x-linked, CTSL  -  cathepsin l, HOXB13  -  homeobox b13, CTSD  -  cathepsin d, EVPL  -  envoplakin, VIP  -  vasoactive intestinal peptide, AHSG  -  alpha-2-hs-glycoprotein, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, KDM6A  -  lysine (k)-specific demethylase 6a, KLC1  -  kinesin light chain 1, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CXADR  -  coxsackie virus and adenovirus receptor, CALD1  -  caldesmon 1, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, F2RL2  -  coagulation factor ii (thrombin) receptor-like 2, CALCA  -  calcitonin-related polypeptide alpha, HIC1  -  hypermethylated in cancer 1, CYBA  -  cytochrome b-245, alpha polypeptide, STK4  -  serine/threonine kinase 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, HOXA11  -  homeobox a11, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, NIPBL  -  nipped-b homolog (drosophila), CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CHRDL1  -  chordin-like 1, SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, CRYBB1  -  crystallin, beta b1, TXK  -  txk tyrosine kinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, MYOM1  -  myomesin 1, RCOR1  -  rest corepressor 1, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, CD9  -  cd9 molecule, NRXN3  -  neurexin 3, ITK  -  il2-inducible t-cell kinase, TYR  -  tyrosinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ALX1  -  alx homeobox 1, MAPK14  -  mitogen-activated protein kinase 14, ANGPT1  -  angiopoietin 1, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, EPB41  -  erythrocyte membrane protein band 4.1 (elliptocytosis 1, rh-linked), GATA3  -  gata binding protein 3, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), PRKG1  -  protein kinase, cgmp-dependent, type i, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, CSN3  -  casein kappa, EPHA4  -  eph receptor a4, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CCKAR  -  cholecystokinin a receptor, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CFDP1  -  craniofacial development protein 1, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, PRKCG  -  protein kinase c, gamma, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, CCIN  -  calicin, RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, MPO  -  myeloperoxidase, FOXA2  -  forkhead box a2, PRSS3  -  protease, serine, 3, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), GCM1  -  glial cells missing homolog 1 (drosophila), PAX2  -  paired box 2, IL12RB2  -  interleukin 12 receptor, beta 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), APOA1  -  apolipoprotein a-i, PSAP  -  prosaposin, MID1  -  midline 1 (opitz/bbb syndrome), CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), KLK6  -  kallikrein-related peptidase 6, APOB  -  apolipoprotein b, FLG  -  filaggrin, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, IL1B  -  interleukin 1, beta, ODF2  -  outer dense fiber of sperm tails 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, GUCY2F  -  guanylate cyclase 2f, retinal, CD34  -  cd34 molecule, AKAP10  -  a kinase (prka) anchor protein 10, OPRD1  -  opioid receptor, delta 1, AQP1  -  aquaporin 1 (colton blood group), CEL  -  carboxyl ester lipase, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, MYO3A  -  myosin iiia, PTGDR  -  prostaglandin d2 receptor (dp), FGF8  -  fibroblast growth factor 8 (androgen-induced), CFL1  -  cofilin 1 (non-muscle), ITGB5  -  integrin, beta 5, FGF1  -  fibroblast growth factor 1 (acidic), ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, NTSR1  -  neurotensin receptor 1 (high affinity), ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PTHLH  -  parathyroid hormone-like hormone, PECAM1  -  platelet/endothelial cell adhesion molecule 1, GPR143  -  g protein-coupled receptor 143, S100B  -  s100 calcium binding protein b, PCOLCE  -  procollagen c-endopeptidase enhancer, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), DGKA  -  diacylglycerol kinase, alpha 80kda, CDK13  -  cyclin-dependent kinase 13, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), NLGN4X  -  neuroligin 4, x-linked, NPPA  -  natriuretic peptide a, DGKQ  -  diacylglycerol kinase, theta 110kda, TAZ  -  tafazzin, IREB2  -  iron-responsive element binding protein 2, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, NRL  -  neural retina leucine zipper, HDAC1  -  histone deacetylase 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CDK2  -  cyclin-dependent kinase 2, PDE4A  -  phosphodiesterase 4a, camp-specific, ATP2A1  -  atpase, ca++ transporting, cardiac muscle, fast twitch 1, NCKAP1  -  nck-associated protein 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, CHRM3  -  cholinergic receptor, muscarinic 3, SMC3  -  structural maintenance of chromosomes 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, DSC2  -  desmocollin 2, GP9  -  glycoprotein ix (platelet), ATM  -  ataxia telangiectasia mutated, SERPINC1  -  serpin peptidase inhibitor, clade c (antithrombin), member 1, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), NLGN1  -  neuroligin 1, PGR  -  progesterone receptor, NGF  -  nerve growth factor (beta polypeptide), NELFA  -  negative elongation factor complex member a, ICK  -  intestinal cell (mak-like) kinase, CLEC3B  -  c-type lectin domain family 3, member b, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, TF  -  transferrin, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), CLDN16  -  claudin 16, PLAU  -  plasminogen activator, urokinase, RARG  -  retinoic acid receptor, gamma, PLAG1  -  pleiomorphic adenoma gene 1, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, PKP2  -  plakophilin 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), GRIA1  -  glutamate receptor, ionotropic, ampa 1, IHH  -  indian hedgehog, TRAM2  -  translocation associated membrane protein 2, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, MXD1  -  max dimerization protein 1, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, TGFB1  -  transforming growth factor, beta 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), DIEXF  -  digestive organ expansion factor homolog (zebrafish), TH  -  tyrosine hydroxylase, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), GRM8  -  glutamate receptor, metabotropic 8, DDX4  -  dead (asp-glu-ala-asp) box polypeptide 4, PIM1  -  pim-1 oncogene, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, OPN1LW  -  opsin 1 (cone pigments), long-wave-sensitive, SMAD4  -  smad family member 4, THRA  -  thyroid hormone receptor, alpha]"GO:0051046,regulation of secretion,5.09E-08,3.78E-05,2.02,8230,396,730,71,"[DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, SRGN  -  serglycin, CHRM3  -  cholinergic receptor, muscarinic 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, GAB2  -  grb2-associated binding protein 2, AGTR2  -  angiotensin ii receptor, type 2, RIMS2  -  regulating synaptic membrane exocytosis 2, GCG  -  glucagon, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, GCK  -  glucokinase (hexokinase 4), IFNG  -  interferon, gamma, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), STXBP1  -  syntaxin binding protein 1, PCLO  -  piccolo presynaptic cytomatrix protein, NGF  -  nerve growth factor (beta polypeptide), IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, CD34  -  cd34 molecule, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, MYO6  -  myosin vi, AQP1  -  aquaporin 1 (colton blood group), KISS1  -  kiss-1 metastasis-suppressor, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, TWIST1  -  twist basic helix-loop-helix transcription factor 1, FES  -  feline sarcoma oncogene, CD14  -  cd14 molecule, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, SSTR5  -  somatostatin receptor 5, BRSK2  -  br serine/threonine kinase 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, UCN  -  urocortin, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GATA3  -  gata binding protein 3, TRH  -  thyrotropin-releasing hormone, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PRKCZ  -  protein kinase c, zeta, EPHA5  -  eph receptor a5, PCSK1  -  proprotein convertase subtilisin/kexin type 1, TRIM9  -  tripartite motif containing 9, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), HNF1A  -  hnf1 homeobox a, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, ADORA1  -  adenosine a1 receptor, PDX1  -  pancreatic and duodenal homeobox 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, GAS6  -  growth arrest-specific 6, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, FOXA2  -  forkhead box a2]"GO:0033993,response to lipid,8.59E-08,5.98E-05,1.88,8230,481,755,83,"[AKR1C3  -  aldo-keto reductase family 1, member c3, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, PAX2  -  paired box 2, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), IL12RB2  -  interleukin 12 receptor, beta 2, APOB  -  apolipoprotein b, PTPRN  -  protein tyrosine phosphatase, receptor type, n, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, IFNG  -  interferon, gamma, HOXB13  -  homeobox b13, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NGF  -  nerve growth factor (beta polypeptide), SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TRIM16  -  tripartite motif containing 16, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, OGG1  -  8-oxoguanine dna glycosylase, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, FASLG  -  fas ligand (tnf superfamily, member 6), GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), F7  -  coagulation factor vii (serum prothrombin conversion accelerator), CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, KRT19  -  keratin 19, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, ALOX12  -  arachidonate 12-lipoxygenase, PTCH1  -  patched 1, SLIT2  -  slit homolog 2 (drosophila), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTGDS  -  prostaglandin d2 synthase 21kda (brain), CRYAB  -  crystallin, alpha b, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RARG  -  retinoic acid receptor, gamma, GLI3  -  gli family zinc finger 3, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, SSTR3  -  somatostatin receptor 3, KRT13  -  keratin 13, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, LTK  -  leukocyte receptor tyrosine kinase, PTK6  -  protein tyrosine kinase 6, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, PPARG  -  peroxisome proliferator-activated receptor gamma, IHH  -  indian hedgehog, CDK4  -  cyclin-dependent kinase 4, EPHA3  -  eph receptor a3, GBA  -  glucosidase, beta, acid, S100B  -  s100 calcium binding protein b, UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), TRH  -  thyrotropin-releasing hormone, LBP  -  lipopolysaccharide binding protein, S100A7  -  s100 calcium binding protein a7, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, COMT  -  catechol-o-methyltransferase, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BCL2  -  b-cell cll/lymphoma 2, PDX1  -  pancreatic and duodenal homeobox 1, NRF1  -  nuclear respiratory factor 1, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:1901700,response to oxygen-containing compound,1.08E-07,7.06E-05,1.64,8230,853,730,124,"[ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, AANAT  -  aralkylamine n-acetyltransferase, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, BTK  -  bruton agammaglobulinemia tyrosine kinase, GCG  -  glucagon, GCK  -  glucokinase (hexokinase 4), RRAGB  -  ras-related gtp binding b, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, FASLG  -  fas ligand (tnf superfamily, member 6), GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), GLUL  -  glutamate-ammonia ligase, FGFR3  -  fibroblast growth factor receptor 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPARA  -  peroxisome proliferator-activated receptor alpha, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, PPARG  -  peroxisome proliferator-activated receptor gamma, PTK6  -  protein tyrosine kinase 6, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, CDK4  -  cyclin-dependent kinase 4, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, TRH  -  thyrotropin-releasing hormone, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, NPPA  -  natriuretic peptide a, COL6A1  -  collagen, type vi, alpha 1, S100A7  -  s100 calcium binding protein a7, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, NRF1  -  nuclear respiratory factor 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CDK2  -  cyclin-dependent kinase 2, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CAPN2  -  calpain 2, (m/ii) large subunit, DRD3  -  dopamine receptor d3, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, RPE65  -  retinal pigment epithelium-specific protein 65kda, DPYSL2  -  dihydropyrimidinase-like 2, IFNG  -  interferon, gamma, HOXB13  -  homeobox b13, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, FYN  -  fyn oncogene related to src, fgr, yes, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), CYBA  -  cytochrome b-245, alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, RARG  -  retinoic acid receptor, gamma, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, CD9  -  cd9 molecule, SSTR3  -  somatostatin receptor 3, NQO1  -  nad(p)h dehydrogenase, quinone 1, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, EPHA3  -  eph receptor a3, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), TH  -  tyrosine hydroxylase, IGFBP1  -  insulin-like growth factor binding protein 1, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0009719,response to endogenous stimulus,1.68E-07,1.04E-04,1.54,8230,926,879,152,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, BTC  -  betacellulin, INHBB  -  inhibin, beta b, GCG  -  glucagon, GCK  -  glucokinase (hexokinase 4), GDF5  -  growth differentiation factor 5, RRAGB  -  ras-related gtp binding b, SP1  -  sp1 transcription factor, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, NRG2  -  neuregulin 2, SOX5  -  sry (sex determining region y)-box 5, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, RHEB  -  ras homolog enriched in brain, FHL2  -  four and a half lim domains 2, GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), KRT19  -  keratin 19, FGFR3  -  fibroblast growth factor receptor 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, FGF12  -  fibroblast growth factor 12, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, CFL1  -  cofilin 1 (non-muscle), FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, S100B  -  s100 calcium binding protein b, CDK4  -  cyclin-dependent kinase 4, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, TRH  -  thyrotropin-releasing hormone, LCK  -  lymphocyte-specific protein tyrosine kinase, E2F5  -  e2f transcription factor 5, p130-binding, COL5A2  -  collagen, type v, alpha 2, NPPA  -  natriuretic peptide a, COL6A1  -  collagen, type vi, alpha 1, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, KITLG  -  kit ligand, ADRA1A  -  adrenoceptor alpha 1a, NRF1  -  nuclear respiratory factor 1, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, IRAK1  -  interleukin-1 receptor-associated kinase 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, CAPN2  -  calpain 2, (m/ii) large subunit, DRD3  -  dopamine receptor d3, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, LATS1  -  large tumor suppressor kinase 1, AGTR2  -  angiotensin ii receptor, type 2, MTMR4  -  myotubularin related protein 4, RPE65  -  retinal pigment epithelium-specific protein 65kda, DPYSL2  -  dihydropyrimidinase-like 2, CEP57  -  centrosomal protein 57kda, CTSL  -  cathepsin l, SOX30  -  sry (sex determining region y)-box 30, CHEK1  -  checkpoint kinase 1, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, HOXB13  -  homeobox b13, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), MAX  -  myc associated factor x, RAD51  -  rad51 recombinase, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), FYN  -  fyn oncogene related to src, fgr, yes, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), CYBA  -  cytochrome b-245, alpha polypeptide, STMN2  -  stathmin-like 2, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, UBC  -  ubiquitin c, CRYAB  -  crystallin, alpha b, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), ESR2  -  estrogen receptor 2 (er beta), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), ESR1  -  estrogen receptor 1, SSTR3  -  somatostatin receptor 3, SSTR5  -  somatostatin receptor 5, NQO1  -  nad(p)h dehydrogenase, quinone 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, MAPK14  -  mitogen-activated protein kinase 14, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), ANG  -  angiogenin, ribonuclease, rnase a family, 5, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, TGFB1  -  transforming growth factor, beta 1, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, IGFBP1  -  insulin-like growth factor binding protein 1, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PIAS3  -  protein inhibitor of activated stat, 3, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, RBBP5  -  retinoblastoma binding protein 5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), AP3S1  -  adaptor-related protein complex 3, sigma 1 subunit, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0051716,cellular response to stimulus,1.73E-07,1.02E-04,1.23,8230,3401,804,409,"[GFRA2  -  gdnf family receptor alpha 2, DAPK2  -  death-associated protein kinase 2, AANAT  -  aralkylamine n-acetyltransferase, CD2AP  -  cd2-associated protein, PLXNB1  -  plexin b1, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GCK  -  glucokinase (hexokinase 4), GDF5  -  growth differentiation factor 5, NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PLP1  -  proteolipid protein 1, NRG2  -  neuregulin 2, CLDN3  -  claudin 3, SOX5  -  sry (sex determining region y)-box 5, LPL  -  lipoprotein lipase, CRH  -  corticotropin releasing hormone, RND2  -  rho family gtpase 2, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, CNGB1  -  cyclic nucleotide gated channel beta 1, NMU  -  neuromedin u, ARHGAP19  -  rho gtpase activating protein 19, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, GLRB  -  glycine receptor, beta, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), GLI3  -  gli family zinc finger 3, COL3A1  -  collagen, type iii, alpha 1, KRT10  -  keratin 10, KRT13  -  keratin 13, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, NCR2  -  natural cytotoxicity triggering receptor 2, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTSL  -  cathepsin l, GRAP2  -  grb2-related adaptor protein 2, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, RECQL5  -  recq protein-like 5, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, KPNA3  -  karyopherin alpha 3 (importin alpha 4), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, CYBA  -  cytochrome b-245, alpha polypeptide, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, STK4  -  serine/threonine kinase 4, STMN2  -  stathmin-like 2, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GBA  -  glucosidase, beta, acid, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), DOK4  -  docking protein 4, CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, GAP43  -  growth associated protein 43, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAX2  -  paired box 2, S1PR2  -  sphingosine-1-phosphate receptor 2, SOCS6  -  suppressor of cytokine signaling 6, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, DCX  -  doublecortin, ATXN3  -  ataxin 3, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), CCL15  -  chemokine (c-c motif) ligand 15, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, PRDX1  -  peroxiredoxin 1, APP  -  amyloid beta (a4) precursor protein, GUCY2F  -  guanylate cyclase 2f, retinal, AKAP10  -  a kinase (prka) anchor protein 10, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), FZD5  -  frizzled family receptor 5, IL1R2  -  interleukin 1 receptor, type ii, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ARF5  -  adp-ribosylation factor 5, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, S100A11  -  s100 calcium binding protein a11, S100B  -  s100 calcium binding protein b, FANCL  -  fanconi anemia, complementation group l, ASGR2  -  asialoglycoprotein receptor 2, KITLG  -  kit ligand, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRTR1  -  hypocretin (orexin) receptor 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), DRD3  -  dopamine receptor d3, SMC3  -  structural maintenance of chromosomes 3, SFN  -  stratifin, GPC1  -  glypican 1, LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, NLGN1  -  neuroligin 1, PGR  -  progesterone receptor, DPYSL2  -  dihydropyrimidinase-like 2, SKP1  -  s-phase kinase-associated protein 1, MAX  -  myc associated factor x, ICK  -  intestinal cell (mak-like) kinase, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), PLAU  -  plasminogen activator, urokinase, GRN  -  granulin, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), BRSK2  -  br serine/threonine kinase 2, GRIA2  -  glutamate receptor, ionotropic, ampa 2, LTK  -  leukocyte receptor tyrosine kinase, RHOV  -  ras homolog family member v, CCDC88C  -  coiled-coil domain containing 88c, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, PIAS4  -  protein inhibitor of activated stat, 4, KALRN  -  kalirin, rhogef kinase, EPCAM  -  epithelial cell adhesion molecule, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, CXCL2  -  chemokine (c-x-c motif) ligand 2, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, GRP  -  gastrin-releasing peptide, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, RFC5  -  replication factor c (activator 1) 5, 36.5kda, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, RGR  -  retinal g protein coupled receptor, CARD14  -  caspase recruitment domain family, member 14, PRMT1  -  protein arginine methyltransferase 1, BTK  -  bruton agammaglobulinemia tyrosine kinase, NCAM1  -  neural cell adhesion molecule 1, EIF4A1  -  eukaryotic translation initiation factor 4a1, KSR1  -  kinase suppressor of ras 1, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, WISP2  -  wnt1 inducible signaling pathway protein 2, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, RLN1  -  relaxin 1, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, MAST1  -  microtubule associated serine/threonine kinase 1, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, MYO16  -  myosin xvi, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SMG1  -  smg1 phosphatidylinositol 3-kinase-related kinase, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), TRH  -  thyrotropin-releasing hormone, DNAL4  -  dynein, axonemal, light chain 4, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, C5  -  complement component 5, UBE4B  -  ubiquitination factor e4b, BAIAP3  -  bai1-associated protein 3, AKR1C3  -  aldo-keto reductase family 1, member c3, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, CAPN2  -  calpain 2, (m/ii) large subunit, HLA-E  -  major histocompatibility complex, class i, e, PDE5A  -  phosphodiesterase 5a, cgmp-specific, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, DYNLL1  -  dynein, light chain, lc8-type 1, RPE65  -  retinal pigment epithelium-specific protein 65kda, FASN  -  fatty acid synthase, HLA-A  -  major histocompatibility complex, class i, a, HMGXB4  -  hmg box domain containing 4, HLA-C  -  major histocompatibility complex, class i, c, TOM1L1  -  target of myb1 (chicken)-like 1, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, VIP  -  vasoactive intestinal peptide, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, NCOA2  -  nuclear receptor coactivator 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), MSH5  -  muts homolog 5 (e. coli), HIC1  -  hypermethylated in cancer 1, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TUBA1B  -  tubulin, alpha 1b, TYROBP  -  tyro protein tyrosine kinase binding protein, CHRDL1  -  chordin-like 1, UBC  -  ubiquitin c, CD8B  -  cd8b molecule, TXK  -  txk tyrosine kinase, ESR2  -  estrogen receptor 2 (er beta), TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD7  -  cd7 molecule, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, DLC1  -  deleted in liver cancer 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, EPHA3  -  eph receptor a3, UCN  -  urocortin, MVP  -  major vault protein, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, CCKAR  -  cholecystokinin a receptor, KRIT1  -  krit1, ankyrin repeat containing, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, LPHN2  -  latrophilin 2, IL12RB2  -  interleukin 12 receptor, beta 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), FLT4  -  fms-related tyrosine kinase 4, PSAP  -  prosaposin, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, SMC2  -  structural maintenance of chromosomes 2, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, POLL  -  polymerase (dna directed), lambda, RGS5  -  regulator of g-protein signaling 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CD53  -  cd53 molecule, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, PSMD1  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 1, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, CD34  -  cd34 molecule, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, FGFR3  -  fibroblast growth factor receptor 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, ITGB5  -  integrin, beta 5, FGF1  -  fibroblast growth factor 1 (acidic), ITGB7  -  integrin, beta 7, PTH  -  parathyroid hormone, PTHLH  -  parathyroid hormone-like hormone, PTK6  -  protein tyrosine kinase 6, GPR143  -  g protein-coupled receptor 143, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, NPPA  -  natriuretic peptide a, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, CDK2  -  cyclin-dependent kinase 2, CXCL13  -  chemokine (c-x-c motif) ligand 13, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, PTPRN  -  protein tyrosine phosphatase, receptor type, n, RIMS2  -  regulating synaptic membrane exocytosis 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), TRAF3IP2  -  traf3 interacting protein 2, CHKA  -  choline kinase alpha, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, CHEK1  -  checkpoint kinase 1, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, NGF  -  nerve growth factor (beta polypeptide), RAD21  -  rad21 homolog (s. pombe), CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), RARG  -  retinoic acid receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), IGSF1  -  immunoglobulin superfamily, member 1, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, IGFBP1  -  insulin-like growth factor binding protein 1, TH  -  tyrosine hydroxylase, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, CUL4B  -  cullin 4b, RCVRN  -  recoverin, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0050789,regulation of biological process,3.36E-07,1.87E-04,1.14,8230,5444,732,551,"[SPTAN1  -  spectrin, alpha, non-erythrocytic 1, ARHGEF39  -  rho guanine nucleotide exchange factor (gef) 39, DAPK2  -  death-associated protein kinase 2, CDKN2AIP  -  cdkn2a interacting protein, CD2AP  -  cd2-associated protein, BTG3  -  btg family, member 3, PATZ1  -  poz (btb) and at hook containing zinc finger 1, PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, ACACA  -  acetyl-coa carboxylase alpha, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PLP1  -  proteolipid protein 1, NRG2  -  neuregulin 2, SOX5  -  sry (sex determining region y)-box 5, CLDN3  -  claudin 3, SOX2  -  sry (sex determining region y)-box 2, H2AFY  -  h2a histone family, member y, SOX3  -  sry (sex determining region y)-box 3, LPL  -  lipoprotein lipase, LPA  -  lipoprotein, lp(a), CRH  -  corticotropin releasing hormone, RND2  -  rho family gtpase 2, ACTG1  -  actin, gamma 1, PLG  -  plasminogen, ATF2  -  activating transcription factor 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, LMAN1  -  lectin, mannose-binding, 1, CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, ACTN1  -  actinin, alpha 1, ARHGAP19  -  rho gtpase activating protein 19, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, TRRAP  -  transformation/transcription domain-associated protein, USP20  -  ubiquitin specific peptidase 20, GLRB  -  glycine receptor, beta, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), CREBZF  -  creb/atf bzip transcription factor, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, COL3A1  -  collagen, type iii, alpha 1, POU3F4  -  pou class 3 homeobox 4, SNAPC3  -  small nuclear rna activating complex, polypeptide 3, 50kda, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), CDC45  -  cell division cycle 45, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, MMP24  -  matrix metallopeptidase 24 (membrane-inserted), SUMO3  -  small ubiquitin-like modifier 3, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LDOC1  -  leucine zipper, down-regulated in cancer 1, LBP  -  lipopolysaccharide binding protein, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, CSTA  -  cystatin a (stefin a), PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, NCR2  -  natural cytotoxicity triggering receptor 2, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, ZNF350  -  zinc finger protein 350, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, CTBP1  -  c-terminal binding protein 1, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTSL  -  cathepsin l, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, STK4  -  serine/threonine kinase 4, CYBA  -  cytochrome b-245, alpha polypeptide, TRIM31  -  tripartite motif containing 31, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, KISS1  -  kiss-1 metastasis-suppressor, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, STAT4  -  signal transducer and activator of transcription 4, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, ALDOB  -  aldolase b, fructose-bisphosphate, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, DSTN  -  destrin (actin depolymerizing factor), ALX1  -  alx homeobox 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GBA  -  glucosidase, beta, acid, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, DOK4  -  docking protein 4, CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, NCR3  -  natural cytotoxicity triggering receptor 3, GAP43  -  growth associated protein 43, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, MLLT10  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 10, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, MID1  -  midline 1 (opitz/bbb syndrome), PAX9  -  paired box 9, APOB  -  apolipoprotein b, DCX  -  doublecortin, CYTH3  -  cytohesin 3, ATXN3  -  ataxin 3, PCBD1  -  pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, MLLT1  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 1, PCGF2  -  polycomb group ring finger 2, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), CCL3  -  chemokine (c-c motif) ligand 3, ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, ZNF473  -  zinc finger protein 473, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, GUCY2F  -  guanylate cyclase 2f, retinal, KLK3  -  kallikrein-related peptidase 3, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CELF3  -  cugbp, elav-like family member 3, FZD5  -  frizzled family receptor 5, MDFI  -  myod family inhibitor, IL1R2  -  interleukin 1 receptor, type ii, ZNF451  -  zinc finger protein 451, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, SERPINB4  -  serpin peptidase inhibitor, clade b (ovalbumin), member 4, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ARF5  -  adp-ribosylation factor 5, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, BAZ1A  -  bromodomain adjacent to zinc finger domain, 1a, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, S100A11  -  s100 calcium binding protein a11, S100B  -  s100 calcium binding protein b, TMSB10  -  thymosin beta 10, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, S100A4  -  s100 calcium binding protein a4, S100A7  -  s100 calcium binding protein a7, FANCL  -  fanconi anemia, complementation group l, PCSK1  -  proprotein convertase subtilisin/kexin type 1, KITLG  -  kit ligand, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRTR1  -  hypocretin (orexin) receptor 1, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, ARID3A  -  at rich interactive domain 3a (bright-like), GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CCNE2  -  cyclin e2, RUFY3  -  run and fyve domain containing 3, DRD3  -  dopamine receptor d3, SMC3  -  structural maintenance of chromosomes 3, DSC2  -  desmocollin 2, BAHD1  -  bromo adjacent homology domain containing 1, DPP6  -  dipeptidyl-peptidase 6, SFN  -  stratifin, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, NLGN1  -  neuroligin 1, PGR  -  progesterone receptor, DPYSL2  -  dihydropyrimidinase-like 2, SKP1  -  s-phase kinase-associated protein 1, MBL2  -  mannose-binding lectin (protein c) 2, soluble, NELFA  -  negative elongation factor complex member a, LMTK2  -  lemur tyrosine kinase 2, ICK  -  intestinal cell (mak-like) kinase, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), DLX2  -  distal-less homeobox 2, MZF1  -  myeloid zinc finger 1, PLAU  -  plasminogen activator, urokinase, ZNF10  -  zinc finger protein 10, GRN  -  granulin, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), BRSK2  -  br serine/threonine kinase 2, GRIA2  -  glutamate receptor, ionotropic, ampa 2, LTK  -  leukocyte receptor tyrosine kinase, ZFPL1  -  zinc finger protein-like 1, CCDC88C  -  coiled-coil domain containing 88c, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, PIAS4  -  protein inhibitor of activated stat, 4, KALRN  -  kalirin, rhogef kinase, SRSF6  -  serine/arginine-rich splicing factor 6, TAF1C  -  tata box binding protein (tbp)-associated factor, rna polymerase i, c, 110kda, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, GRP  -  gastrin-releasing peptide, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, NCBP1  -  nuclear cap binding protein subunit 1, 80kda, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, RGR  -  retinal g protein coupled receptor, RFX1  -  regulatory factor x, 1 (influences hla class ii expression), NAIP  -  nlr family, apoptosis inhibitory protein, ELL2  -  elongation factor, rna polymerase ii, 2, BCOR  -  bcl6 corepressor, BTK  -  bruton agammaglobulinemia tyrosine kinase, AGFG2  -  arfgap with fg repeats 2, SAP30  -  sin3a-associated protein, 30kda, NCAM1  -  neural cell adhesion molecule 1, EIF4A1  -  eukaryotic translation initiation factor 4a1, SORBS3  -  sorbin and sh3 domain containing 3, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, WISP2  -  wnt1 inducible signaling pathway protein 2, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, RLN1  -  relaxin 1, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, MPHOSPH10  -  m-phase phosphoprotein 10 (u3 small nucleolar ribonucleoprotein), LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, TSC22D1  -  tsc22 domain family, member 1, MAST1  -  microtubule associated serine/threonine kinase 1, RGS16  -  regulator of g-protein signaling 16, FUBP1  -  far upstream element (fuse) binding protein 1, ICAM2  -  intercellular adhesion molecule 2, TPH1  -  tryptophan hydroxylase 1, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, MYO16  -  myosin xvi, BUD31  -  bud31 homolog (s. cerevisiae), CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), TRH  -  thyrotropin-releasing hormone, C1QA  -  complement component 1, q subcomponent, a chain, C1QB  -  complement component 1, q subcomponent, b chain, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, DENND4A  -  denn/madd domain containing 4a, DNAL4  -  dynein, axonemal, light chain 4, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, C5  -  complement component 5, C6  -  complement component 6, UBE4B  -  ubiquitination factor e4b, BAIAP3  -  bai1-associated protein 3, WAPAL  -  wings apart-like homolog (drosophila), AKR1C3  -  aldo-keto reductase family 1, member c3, CAPNS1  -  calpain, small subunit 1, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, PDE5A  -  phosphodiesterase 5a, cgmp-specific, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, DYNLL1  -  dynein, light chain, lc8-type 1, RPE65  -  retinal pigment epithelium-specific protein 65kda, FASN  -  fatty acid synthase, CAPZB  -  capping protein (actin filament) muscle z-line, beta, HLA-A  -  major histocompatibility complex, class i, a, RPS4X  -  ribosomal protein s4, x-linked, RPS3A  -  ribosomal protein s3a, HMGXB4  -  hmg box domain containing 4, HLA-C  -  major histocompatibility complex, class i, c, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, EZR  -  ezrin, VIP  -  vasoactive intestinal peptide, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, EYA2  -  eyes absent homolog 2 (drosophila), CFH  -  complement factor h, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, EZH1  -  enhancer of zeste homolog 1 (drosophila), NCOA2  -  nuclear receptor coactivator 2, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, CALCR  -  calcitonin receptor, MSN  -  moesin, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TYROBP  -  tyro protein tyrosine kinase binding protein, CHRDL1  -  chordin-like 1, UBC  -  ubiquitin c, CCNG2  -  cyclin g2, CD8B  -  cd8b molecule, TWIST1  -  twist basic helix-loop-helix transcription factor 1, RCOR1  -  rest corepressor 1, CD7  -  cd7 molecule, CD14  -  cd14 molecule, RPS14  -  ribosomal protein s14, ESR1  -  estrogen receptor 1, HOXA1  -  homeobox a1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, EPHA3  -  eph receptor a3, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), MVP  -  major vault protein, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, NAPG  -  n-ethylmaleimide-sensitive factor attachment protein, gamma, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, CCND2  -  cyclin d2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), LPHN2  -  latrophilin 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, HTRA1  -  htra serine peptidase 1, PSAP  -  prosaposin, ORC2  -  origin recognition complex, subunit 2, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PRSS8  -  protease, serine, 8, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, RGS5  -  regulator of g-protein signaling 5, AHSA1  -  aha1, activator of heat shock 90kda protein atpase homolog 1 (yeast), IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CD53  -  cd53 molecule, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, CD34  -  cd34 molecule, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGFR3  -  fibroblast growth factor receptor 3, GNMT  -  glycine n-methyltransferase, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, NTN3  -  netrin 3, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, PTH  -  parathyroid hormone, TRIM2  -  tripartite motif containing 2, PTHLH  -  parathyroid hormone-like hormone, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDK13  -  cyclin-dependent kinase 13, NPC2  -  niemann-pick disease, type c2, KLHL20  -  kelch-like family member 20, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), TRIM9  -  tripartite motif containing 9, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, NRL  -  neural retina leucine zipper, FBLN2  -  fibulin 2, CDK2  -  cyclin-dependent kinase 2, NRF1  -  nuclear respiratory factor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, IFI27  -  interferon, alpha-inducible protein 27, TDRD7  -  tudor domain containing 7, IFI35  -  interferon-induced protein 35, PTPRN2  -  protein tyrosine phosphatase, receptor type, n polypeptide 2, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, NOS1AP  -  nitric oxide synthase 1 (neuronal) adaptor protein, PTPRN  -  protein tyrosine phosphatase, receptor type, n, NPAT  -  nuclear protein, ataxia-telangiectasia locus, RIMS2  -  regulating synaptic membrane exocytosis 2, PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), TRAF3IP2  -  traf3 interacting protein 2, CHKA  -  choline kinase alpha, CNOT3  -  ccr4-not transcription complex, subunit 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, DHX34  -  deah (asp-glu-ala-his) box polypeptide 34, IFNG  -  interferon, gamma, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, CHEK1  -  checkpoint kinase 1, NFX1  -  nuclear transcription factor, x-box binding 1, CHD1  -  chromodomain helicase dna binding protein 1, NGF  -  nerve growth factor (beta polypeptide), KMT2B  -  lysine (k)-specific methyltransferase 2b, ACAP1  -  arfgap with coiled-coil, ankyrin repeat and ph domains 1, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RAG2  -  recombination activating gene 2, RARG  -  retinoic acid receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), NF2  -  neurofibromin 2 (merlin), IGSF1  -  immunoglobulin superfamily, member 1, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), RBL2  -  retinoblastoma-like 2 (p130), ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, TH  -  tyrosine hydroxylase, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, IGFBP1  -  insulin-like growth factor binding protein 1, ARID4A  -  at rich interactive domain 4a (rbp1-like), PLK4  -  polo-like kinase 4, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, RCVRN  -  recoverin, CIRBP  -  cold inducible rna binding protein, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0002791,regulation of peptide secretion,6.32E-07,3.35E-04,2.74,8230,140,730,34,"[GLUL  -  glutamate-ammonia ligase, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), CHRM3  -  cholinergic receptor, muscarinic 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, SSTR5  -  somatostatin receptor 5, GCG  -  glucagon, BRSK2  -  br serine/threonine kinase 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, GCK  -  glucokinase (hexokinase 4), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, IFNG  -  interferon, gamma, STXBP1  -  syntaxin binding protein 1, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, UCN  -  urocortin, TRH  -  thyrotropin-releasing hormone, EPHA5  -  eph receptor a5, IL1B  -  interleukin 1, beta, PCSK1  -  proprotein convertase subtilisin/kexin type 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CRH  -  corticotropin releasing hormone, HNF1A  -  hnf1 homeobox a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, ADORA1  -  adenosine a1 receptor, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, FOXA2  -  forkhead box a2, KISS1  -  kiss-1 metastasis-suppressor]"GO:0001101,response to acid,6.93E-07,3.51E-04,2.6,8230,203,562,36,"[AKR1C3  -  aldo-keto reductase family 1, member c3, PAX2  -  paired box 2, CAPN2  -  calpain 2, (m/ii) large subunit, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, APOB  -  apolipoprotein b, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RARG  -  retinoic acid receptor, gamma, CTGF  -  connective tissue growth factor, COL3A1  -  collagen, type iii, alpha 1, CD9  -  cd9 molecule, LTK  -  leukocyte receptor tyrosine kinase, PTK6  -  protein tyrosine kinase 6, PPARG  -  peroxisome proliferator-activated receptor gamma, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, RRAGB  -  ras-related gtp binding b, EPHA3  -  eph receptor a3, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NGF  -  nerve growth factor (beta polypeptide), TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), COL5A2  -  collagen, type v, alpha 2, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, COL6A1  -  collagen, type vi, alpha 1, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, BCL2  -  b-cell cll/lymphoma 2, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, NRF1  -  nuclear respiratory factor 1, CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group)]"GO:0043627,response to estrogen,8.41E-07,4.07E-04,2.63,8230,132,829,35,"[CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, KRT19  -  keratin 19, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, CRYAB  -  crystallin, alpha b, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, GLI3  -  gli family zinc finger 3, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, ESR1  -  estrogen receptor 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, SSTR3  -  somatostatin receptor 3, NQO1  -  nad(p)h dehydrogenase, quinone 1, PPARG  -  peroxisome proliferator-activated receptor gamma, IHH  -  indian hedgehog, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, TGFB1  -  transforming growth factor, beta 1, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, RBBP5  -  retinoblastoma binding protein 5, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), CRH  -  corticotropin releasing hormone, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, OGG1  -  8-oxoguanine dna glycosylase, GH1  -  growth hormone 1, NRF1  -  nuclear respiratory factor 1, F7  -  coagulation factor vii (serum prothrombin conversion accelerator)]"GO:0090087,regulation of peptide transport,8.75E-07,4.06E-04,2.7,8230,142,730,34,"[GLUL  -  glutamate-ammonia ligase, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), CHRM3  -  cholinergic receptor, muscarinic 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, SSTR5  -  somatostatin receptor 5, GCG  -  glucagon, BRSK2  -  br serine/threonine kinase 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, GCK  -  glucokinase (hexokinase 4), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, IFNG  -  interferon, gamma, STXBP1  -  syntaxin binding protein 1, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, UCN  -  urocortin, TRH  -  thyrotropin-releasing hormone, EPHA5  -  eph receptor a5, IL1B  -  interleukin 1, beta, PCSK1  -  proprotein convertase subtilisin/kexin type 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CRH  -  corticotropin releasing hormone, HNF1A  -  hnf1 homeobox a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, ADORA1  -  adenosine a1 receptor, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, FOXA2  -  forkhead box a2, KISS1  -  kiss-1 metastasis-suppressor]"GO:0097305,response to alcohol,1.11E-06,4.93E-04,2.28,8230,213,747,44,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), STAR  -  steroidogenic acute regulatory protein, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, AGTR2  -  angiotensin ii receptor, type 2, SSTR3  -  somatostatin receptor 3, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, NQO1  -  nad(p)h dehydrogenase, quinone 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, CDK4  -  cyclin-dependent kinase 4, GBA  -  glucosidase, beta, acid, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, UCN  -  urocortin, HOXB13  -  homeobox b13, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, TRH  -  thyrotropin-releasing hormone, CCL2  -  chemokine (c-c motif) ligand 2, CCL3  -  chemokine (c-c motif) ligand 3, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, OGG1  -  8-oxoguanine dna glycosylase, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), FYN  -  fyn oncogene related to src, fgr, yes, NRF1  -  nuclear respiratory factor 1, GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group)]"GO:0007186,G-protein coupled receptor signaling pathway,1.17E-06,5.01E-04,1.76,8230,396,980,83,"[AKR1C3  -  aldo-keto reductase family 1, member c3, LPHN2  -  latrophilin 2, S1PR2  -  sphingosine-1-phosphate receptor 2, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, APOA1  -  apolipoprotein a-i, RGR  -  retinal g protein coupled receptor, ADRB3  -  adrenoceptor beta 3, CHRM3  -  cholinergic receptor, muscarinic 3, CXCL12  -  chemokine (c-x-c motif) ligand 12, PMCH  -  pro-melanin-concentrating hormone, FLNA  -  filamin a, alpha, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, GCGR  -  glucagon receptor, GCG  -  glucagon, NTSR2  -  neurotensin receptor 2, CCL17  -  chemokine (c-c motif) ligand 17, VIP  -  vasoactive intestinal peptide, CCL2  -  chemokine (c-c motif) ligand 2, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, GHSR  -  growth hormone secretagogue receptor, RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CXCR2  -  chemokine (c-x-c motif) receptor 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), GUCY2F  -  guanylate cyclase 2f, retinal, CALCRL  -  calcitonin receptor-like, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, TSHR  -  thyroid stimulating hormone receptor, CALCA  -  calcitonin-related polypeptide alpha, OPRD1  -  opioid receptor, delta 1, CALCR  -  calcitonin receptor, GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), CNGB1  -  cyclic nucleotide gated channel beta 1, NMU  -  neuromedin u, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, GLRB  -  glycine receptor, beta, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTGDR  -  prostaglandin d2 receptor (dp), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NTSR1  -  neurotensin receptor 1 (high affinity), ESR1  -  estrogen receptor 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, SSTR3  -  somatostatin receptor 3, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, SSTR5  -  somatostatin receptor 5, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, RGS6  -  regulator of g-protein signaling 6, GPR143  -  g protein-coupled receptor 143, INSL3  -  insulin-like 3 (leydig cell), GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, UCN  -  urocortin, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, DGKA  -  diacylglycerol kinase, alpha 80kda, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PLCE1  -  phospholipase c, epsilon 1, DGKQ  -  diacylglycerol kinase, theta 110kda, CCKAR  -  cholecystokinin a receptor, GRM8  -  glutamate receptor, metabotropic 8, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, GLP2R  -  glucagon-like peptide 2 receptor, NPY1R  -  neuropeptide y receptor y1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, RCVRN  -  recoverin, ADORA1  -  adenosine a1 receptor, GAP43  -  growth associated protein 43, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, GRP  -  gastrin-releasing peptide, BAIAP3  -  bai1-associated protein 3, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1]"GO:0048583,regulation of response to stimulus,1.42E-06,5.85E-04,1.33,8230,2003,786,254,"[G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, CDKN2AIP  -  cdkn2a interacting protein, CARD14  -  caspase recruitment domain family, member 14, PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, BTK  -  bruton agammaglobulinemia tyrosine kinase, GCG  -  glucagon, SORBS3  -  sorbin and sh3 domain containing 3, RRAGB  -  ras-related gtp binding b, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, SPRED2  -  sprouty-related, evh1 domain containing 2, NRG2  -  neuregulin 2, SOX2  -  sry (sex determining region y)-box 2, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CRH  -  corticotropin releasing hormone, PLG  -  plasminogen, ACTG1  -  actin, gamma 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), RGS16  -  regulator of g-protein signaling 16, GH1  -  growth hormone 1, CADM1  -  cell adhesion molecule 1, CNGB1  -  cyclic nucleotide gated channel beta 1, ARHGAP19  -  rho gtpase activating protein 19, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, USP20  -  ubiquitin specific peptidase 20, ICAM2  -  intercellular adhesion molecule 2, GLI3  -  gli family zinc finger 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, COL3A1  -  collagen, type iii, alpha 1, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, FEM1B  -  fem-1 homolog b (c. elegans), TRH  -  thyrotropin-releasing hormone, LBP  -  lipopolysaccharide binding protein, C1QA  -  complement component 1, q subcomponent, a chain, C1QB  -  complement component 1, q subcomponent, b chain, POU1F1  -  pou class 1 homeobox 1, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, C6  -  complement component 6, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, AES  -  amino-terminal enhancer of split, HLA-E  -  major histocompatibility complex, class i, e, ADRB1  -  adrenoceptor beta 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, ADRBK2  -  adrenergic, beta, receptor kinase 2, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, CAPZB  -  capping protein (actin filament) muscle z-line, beta, CTSL  -  cathepsin l, HLA-A  -  major histocompatibility complex, class i, a, HMGXB4  -  hmg box domain containing 4, GRAP2  -  grb2-related adaptor protein 2, HLA-C  -  major histocompatibility complex, class i, c, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, VIP  -  vasoactive intestinal peptide, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, AHSG  -  alpha-2-hs-glycoprotein, CFH  -  complement factor h, CXADR  -  coxsackie virus and adenovirus receptor, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), FYN  -  fyn oncogene related to src, fgr, yes, STK4  -  serine/threonine kinase 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, KISS1  -  kiss-1 metastasis-suppressor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, CD1D  -  cd1d molecule, TYROBP  -  tyro protein tyrosine kinase binding protein, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, CD8B  -  cd8b molecule, ESR2  -  estrogen receptor 2 (er beta), TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, HOXA1  -  homeobox a1, DLC1  -  deleted in liver cancer 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GBA  -  glucosidase, beta, acid, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PLCE1  -  phospholipase c, epsilon 1, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, EPHA4  -  eph receptor a4, NCR3  -  natural cytotoxicity triggering receptor 3, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, GAS6  -  growth arrest-specific 6, FOXA2  -  forkhead box a2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, S1PR2  -  sphingosine-1-phosphate receptor 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), SOCS6  -  suppressor of cytokine signaling 6, HTRA1  -  htra serine peptidase 1, PSAP  -  prosaposin, FLT4  -  fms-related tyrosine kinase 4, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), CXCL12  -  chemokine (c-x-c motif) ligand 12, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, CYTH3  -  cytohesin 3, RGS5  -  regulator of g-protein signaling 5, PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), CCL4  -  chemokine (c-c motif) ligand 4, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TRIM16  -  tripartite motif containing 16, PRDX1  -  peroxiredoxin 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, MOG  -  myelin oligodendrocyte glycoprotein, APP  -  amyloid beta (a4) precursor protein, NUAK1  -  nuak family, snf1-like kinase, 1, CD34  -  cd34 molecule, AKAP10  -  a kinase (prka) anchor protein 10, GUCY2F  -  guanylate cyclase 2f, retinal, FASLG  -  fas ligand (tnf superfamily, member 6), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, PTH  -  parathyroid hormone, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, GPR143  -  g protein-coupled receptor 143, S100B  -  s100 calcium binding protein b, S100A4  -  s100 calcium binding protein a4, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, S100A7  -  s100 calcium binding protein a7, IRF1  -  interferon regulatory factor 1, HNF1A  -  hnf1 homeobox a, KITLG  -  kit ligand, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, ZNF205  -  zinc finger protein 205, PDE4A  -  phosphodiesterase 4a, camp-specific, IRAK1  -  interleukin-1 receptor-associated kinase 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SFN  -  stratifin, GPC1  -  glypican 1, LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, TRAF3IP2  -  traf3 interacting protein 2, NLGN1  -  neuroligin 1, IFNG  -  interferon, gamma, CHEK1  -  checkpoint kinase 1, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, TEK  -  tek tyrosine kinase, endothelial, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PLAU  -  plasminogen activator, urokinase, NF2  -  neurofibromin 2 (merlin), BRSK2  -  br serine/threonine kinase 2, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RHOV  -  ras homolog family member v, PIAS4  -  protein inhibitor of activated stat, 4, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, KALRN  -  kalirin, rhogef kinase, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, SRSF6  -  serine/arginine-rich splicing factor 6, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0008150,biological_process,2.08E-06,8.27E-04,1.04,8230,7776,631,621,"[POP1  -  processing of precursor 1, ribonuclease p/mrp subunit (s. cerevisiae), SPTAN1  -  spectrin, alpha, non-erythrocytic 1, SVEP1  -  sushi, von willebrand factor type a, egf and pentraxin domain containing 1, DAPK2  -  death-associated protein kinase 2, AANAT  -  aralkylamine n-acetyltransferase, PATZ1  -  poz (btb) and at hook containing zinc finger 1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, ACACA  -  acetyl-coa carboxylase alpha, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, PMM1  -  phosphomannomutase 1, GDF5  -  growth differentiation factor 5, NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PLP1  -  proteolipid protein 1, NRG2  -  neuregulin 2, CPM  -  carboxypeptidase m, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, H2AFY  -  h2a histone family, member y, LPL  -  lipoprotein lipase, SOX3  -  sry (sex determining region y)-box 3, LPA  -  lipoprotein, lp(a), PLTP  -  phospholipid transfer protein, ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, LMAN1  -  lectin, mannose-binding, 1, CADM1  -  cell adhesion molecule 1, KRT19  -  keratin 19, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, ACTN1  -  actinin, alpha 1, ARHGAP19  -  rho gtpase activating protein 19, TRRAP  -  transformation/transcription domain-associated protein, USP20  -  ubiquitin specific peptidase 20, GLRB  -  glycine receptor, beta, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, PPL  -  periplakin, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), CREBZF  -  creb/atf bzip transcription factor, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, COL3A1  -  collagen, type iii, alpha 1, POU3F4  -  pou class 3 homeobox 4, KRT7  -  keratin 7, GLE1  -  gle1 rna export mediator, KRT10  -  keratin 10, KRT9  -  keratin 9, SNAPC3  -  small nuclear rna activating complex, polypeptide 3, 50kda, CDC45  -  cell division cycle 45, KRT15  -  keratin 15, KRT14  -  keratin 14, PPARA  -  peroxisome proliferator-activated receptor alpha, MMP24  -  matrix metallopeptidase 24 (membrane-inserted), GLB1  -  galactosidase, beta 1, PPARG  -  peroxisome proliferator-activated receptor gamma, SUMO3  -  small ubiquitin-like modifier 3, PCYT1B  -  phosphate cytidylyltransferase 1, choline, beta, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, PLIN2  -  perilipin 2, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, LAMP1  -  lysosomal-associated membrane protein 1, LAMC2  -  laminin, gamma 2, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, LDOC1  -  leucine zipper, down-regulated in cancer 1, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, ADRA1A  -  adrenoceptor alpha 1a, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, CSTA  -  cystatin a (stefin a), PTPN21  -  protein tyrosine phosphatase, non-receptor type 21, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, CSTF1  -  cleavage stimulation factor, 3' pre-rna, subunit 1, 50kda, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, PRG2  -  proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein), SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, PRCP  -  prolylcarboxypeptidase (angiotensinase c), FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTRB1  -  chymotrypsinogen b1, CTSL  -  cathepsin l, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, CTSD  -  cathepsin d, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, TRIM31  -  tripartite motif containing 31, CYBA  -  cytochrome b-245, alpha polypeptide, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, STK4  -  serine/threonine kinase 4, KISS1  -  kiss-1 metastasis-suppressor, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), ST14  -  suppression of tumorigenicity 14 (colon carcinoma), NIPBL  -  nipped-b homolog (drosophila), MFAP5  -  microfibrillar associated protein 5, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, GALNT1  -  udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyltransferase 1 (galnac-t1), ALDOB  -  aldolase b, fructose-bisphosphate, CRYBB1  -  crystallin, beta b1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, ALX1  -  alx homeobox 1, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, SRP19  -  signal recognition particle 19kda, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), DOK4  -  docking protein 4, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, CSN3  -  casein kappa, PRKCZ  -  protein kinase c, zeta, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, NCR3  -  natural cytotoxicity triggering receptor 3, KCNF1  -  potassium voltage-gated channel, subfamily f, member 1, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, RPL23  -  ribosomal protein l23, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, FBXL2  -  f-box and leucine-rich repeat protein 2, MLLT10  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 10, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, PVRL3  -  poliovirus receptor-related 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX9  -  paired box 9, SYT17  -  synaptotagmin xvii, APOB  -  apolipoprotein b, CYTH3  -  cytohesin 3, ATXN3  -  ataxin 3, PC  -  pyruvate carboxylase, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, MLLT1  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 1, PCGF2  -  polycomb group ring finger 2, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, TIMM8A  -  translocase of inner mitochondrial membrane 8 homolog a (yeast), MMP11  -  matrix metallopeptidase 11 (stromelysin 3), BZRAP1  -  benzodiazapine receptor (peripheral) associated protein 1, CCL3  -  chemokine (c-c motif) ligand 3, ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, GUCY2F  -  guanylate cyclase 2f, retinal, KLK3  -  kallikrein-related peptidase 3, MSC  -  musculin, DLG5  -  discs, large homolog 5 (drosophila), AQP1  -  aquaporin 1 (colton blood group), CELF3  -  cugbp, elav-like family member 3, MDFI  -  myod family inhibitor, IL1R2  -  interleukin 1 receptor, type ii, ZNF451  -  zinc finger protein 451, TUBA1A  -  tubulin, alpha 1a, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, ABCB8  -  atp-binding cassette, sub-family b (mdr/tap), member 8, SERPINB4  -  serpin peptidase inhibitor, clade b (ovalbumin), member 4, WBP4  -  ww domain binding protein 4, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, HADH  -  hydroxyacyl-coa dehydrogenase, ARF5  -  adp-ribosylation factor 5, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, BAZ1A  -  bromodomain adjacent to zinc finger domain, 1a, LAPTM5  -  lysosomal protein transmembrane 5, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, S100A11  -  s100 calcium binding protein a11, S100B  -  s100 calcium binding protein b, TMSB10  -  thymosin beta 10, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, S100A4  -  s100 calcium binding protein a4, FANCL  -  fanconi anemia, complementation group l, PCSK1  -  proprotein convertase subtilisin/kexin type 1, KITLG  -  kit ligand, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRTR1  -  hypocretin (orexin) receptor 1, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, ARID3A  -  at rich interactive domain 3a (bright-like), GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), RUFY3  -  run and fyve domain containing 3, DRD3  -  dopamine receptor d3, SMC3  -  structural maintenance of chromosomes 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, DSC2  -  desmocollin 2, BAHD1  -  bromo adjacent homology domain containing 1, SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, DPP6  -  dipeptidyl-peptidase 6, PHKA2  -  phosphorylase kinase, alpha 2 (liver), SFN  -  stratifin, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, GP9  -  glycoprotein ix (platelet), ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, MBL2  -  mannose-binding lectin (protein c) 2, soluble, NELFA  -  negative elongation factor complex member a, LMTK2  -  lemur tyrosine kinase 2, PIGQ  -  phosphatidylinositol glycan anchor biosynthesis, class q, ICK  -  intestinal cell (mak-like) kinase, SLC4A3  -  solute carrier family 4 (anion exchanger), member 3, PEX1  -  peroxisomal biogenesis factor 1, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), SHMT1  -  serine hydroxymethyltransferase 1 (soluble), DLX2  -  distal-less homeobox 2, MZF1  -  myeloid zinc finger 1, PLAU  -  plasminogen activator, urokinase, ZNF10  -  zinc finger protein 10, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), BRSK2  -  br serine/threonine kinase 2, LTK  -  leukocyte receptor tyrosine kinase, ZFPL1  -  zinc finger protein-like 1, CCDC88C  -  coiled-coil domain containing 88c, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, MXD1  -  max dimerization protein 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, LYZ  -  lysozyme, SRSF6  -  serine/arginine-rich splicing factor 6, TM4SF1  -  transmembrane 4 l six family member 1, TAF1C  -  tata box binding protein (tbp)-associated factor, rna polymerase i, c, 110kda, CXCL2  -  chemokine (c-x-c motif) ligand 2, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, GRP  -  gastrin-releasing peptide, MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, NCBP1  -  nuclear cap binding protein subunit 1, 80kda, RFC5  -  replication factor c (activator 1) 5, 36.5kda, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, RGR  -  retinal g protein coupled receptor, C9orf16  -  chromosome 9 open reading frame 16, NAIP  -  nlr family, apoptosis inhibitory protein, ELL2  -  elongation factor, rna polymerase ii, 2, LIN7A  -  lin-7 homolog a (c. elegans), BTK  -  bruton agammaglobulinemia tyrosine kinase, NCAM1  -  neural cell adhesion molecule 1, EIF4A1  -  eukaryotic translation initiation factor 4a1, RRAGB  -  ras-related gtp binding b, SORBS3  -  sorbin and sh3 domain containing 3, EIF4A2  -  eukaryotic translation initiation factor 4a2, BGN  -  biglycan, WISP2  -  wnt1 inducible signaling pathway protein 2, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, RLN1  -  relaxin 1, GGTLC1  -  gamma-glutamyltransferase light chain 1, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, MPHOSPH10  -  m-phase phosphoprotein 10 (u3 small nucleolar ribonucleoprotein), LDB1  -  lim domain binding 1, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, MAST1  -  microtubule associated serine/threonine kinase 1, TSC22D1  -  tsc22 domain family, member 1, RGS16  -  regulator of g-protein signaling 16, FUBP1  -  far upstream element (fuse) binding protein 1, ISG20L2  -  interferon stimulated exonuclease gene 20kda-like 2, EEF1G  -  eukaryotic translation elongation factor 1 gamma, COX17  -  cox17 cytochrome c oxidase copper chaperone, ICAM2  -  intercellular adhesion molecule 2, TPH1  -  tryptophan hydroxylase 1, NUP62CL  -  nucleoporin 62kda c-terminal like, RNASE1  -  ribonuclease, rnase a family, 1 (pancreatic), HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, MYO16  -  myosin xvi, GIPC2  -  gipc pdz domain containing family, member 2, BUD31  -  bud31 homolog (s. cerevisiae), CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PALLD  -  palladin, cytoskeletal associated protein, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ROM1  -  retinal outer segment membrane protein 1, SMG1  -  smg1 phosphatidylinositol 3-kinase-related kinase, RORB  -  rar-related orphan receptor b, BSN  -  bassoon presynaptic cytomatrix protein, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), SGCE  -  sarcoglycan, epsilon, C1QA  -  complement component 1, q subcomponent, a chain, C1QB  -  complement component 1, q subcomponent, b chain, C1R  -  complement component 1, r subcomponent, DENND4A  -  denn/madd domain containing 4a, C1S  -  complement component 1, s subcomponent, DNAL4  -  dynein, axonemal, light chain 4, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, C6  -  complement component 6, UBE4B  -  ubiquitination factor e4b, WAPAL  -  wings apart-like homolog (drosophila), BAIAP3  -  bai1-associated protein 3, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPNS1  -  calpain, small subunit 1, RPL23A  -  ribosomal protein l23a, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, F13A1  -  coagulation factor xiii, a1 polypeptide, CAPN2  -  calpain 2, (m/ii) large subunit, HLA-E  -  major histocompatibility complex, class i, e, RPL21  -  ribosomal protein l21, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL13  -  ribosomal protein l13, RPL11  -  ribosomal protein l11, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), RPL9  -  ribosomal protein l9, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, DYNLL1  -  dynein, light chain, lc8-type 1, NFASC  -  neurofascin, HLF  -  hepatic leukemia factor, RPE65  -  retinal pigment epithelium-specific protein 65kda, SLC4A4  -  solute carrier family 4 (sodium bicarbonate cotransporter), member 4, FASN  -  fatty acid synthase, CAPZB  -  capping protein (actin filament) muscle z-line, beta, HLA-A  -  major histocompatibility complex, class i, a, RPS4X  -  ribosomal protein s4, x-linked, RPS3A  -  ribosomal protein s3a, HMGXB4  -  hmg box domain containing 4, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, EZR  -  ezrin, SLC25A17  -  solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kda), member 17, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, HGFAC  -  hgf activator, EYA2  -  eyes absent homolog 2 (drosophila), CFH  -  complement factor h, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, NCOA2  -  nuclear receptor coactivator 2, EZH1  -  enhancer of zeste homolog 1 (drosophila), CALD1  -  caldesmon 1, MSH5  -  muts homolog 5 (e. coli), RPL30  -  ribosomal protein l30, HIC1  -  hypermethylated in cancer 1, CALCR  -  calcitonin receptor, MSN  -  moesin, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, HPCA  -  hippocalcin, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TUBA1B  -  tubulin, alpha 1b, TYROBP  -  tyro protein tyrosine kinase binding protein, CHRDL1  -  chordin-like 1, GPAA1  -  glycosylphosphatidylinositol anchor attachment 1, UBC  -  ubiquitin c, RNMT  -  rna (guanine-7-) methyltransferase, CCNG2  -  cyclin g2, RPS18  -  ribosomal protein s18, CD8B  -  cd8b molecule, TWIST1  -  twist basic helix-loop-helix transcription factor 1, RCOR1  -  rest corepressor 1, CORO2B  -  coronin, actin binding protein, 2b, MYOM1  -  myomesin 1, CD7  -  cd7 molecule, CD14  -  cd14 molecule, RPS14  -  ribosomal protein s14, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, DLC1  -  deleted in liver cancer 1, CD9  -  cd9 molecule, TUBB4B  -  tubulin, beta 4b class ivb, TYRO3  -  tyro3 protein tyrosine kinase, TUBB3  -  tubulin, beta 3 class iii, TYR  -  tyrosinase, TUBB4A  -  tubulin, beta 4a class iva, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ONECUT1  -  one cut homeobox 1, EPHA3  -  eph receptor a3, UCN  -  urocortin, EPB41  -  erythrocyte membrane protein band 4.1 (elliptocytosis 1, rh-linked), SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), MVP  -  major vault protein, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, NAPG  -  n-ethylmaleimide-sensitive factor attachment protein, gamma, TUBGCP3  -  tubulin, gamma complex associated protein 3, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CCND2  -  cyclin d2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), RTN1  -  reticulon 1, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, EXOC6B  -  exocyst complex component 6b, RREB1  -  ras responsive element binding protein 1, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, SCEL  -  sciellin, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), LPHN2  -  latrophilin 2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, HTRA1  -  htra serine peptidase 1, PSAP  -  prosaposin, ORC2  -  origin recognition complex, subunit 2, ORC5  -  origin recognition complex, subunit 5, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PRSS8  -  protease, serine, 8, INHBB  -  inhibin, beta b, SMC2  -  structural maintenance of chromosomes 2, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, RGS5  -  regulator of g-protein signaling 5, AHSA1  -  aha1, activator of heat shock 90kda protein atpase homolog 1 (yeast), IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, SNTG2  -  syntrophin, gamma 2, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, CD22  -  cd22 molecule, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, CD34  -  cd34 molecule, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, TAGLN  -  transgelin, CENPC  -  centromere protein c, GNMT  -  glycine n-methyltransferase, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, NTN3  -  netrin 3, BCAP29  -  b-cell receptor-associated protein 29, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, NUMA1  -  nuclear mitotic apparatus protein 1, APPBP2  -  amyloid beta precursor protein (cytoplasmic tail) binding protein 2, ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, TAPBP  -  tap binding protein (tapasin), CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTHLH  -  parathyroid hormone-like hormone, FDXR  -  ferredoxin reductase, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, KLHL20  -  kelch-like family member 20, NPC2  -  niemann-pick disease, type c2, CDK13  -  cyclin-dependent kinase 13, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, TAZ  -  tafazzin, NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), TRIM9  -  tripartite motif containing 9, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PTPN12  -  protein tyrosine phosphatase, non-receptor type 12, PTPN13  -  protein tyrosine phosphatase, non-receptor type 13 (apo-1/cd95 (fas)-associated phosphatase), NXT2  -  nuclear transport factor 2-like export factor 2, FBLN2  -  fibulin 2, CDK2  -  cyclin-dependent kinase 2, NRF1  -  nuclear respiratory factor 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, IFI27  -  interferon, alpha-inducible protein 27, TDRD7  -  tudor domain containing 7, IFI35  -  interferon-induced protein 35, IFNA5  -  interferon, alpha 5, PTPRN2  -  protein tyrosine phosphatase, receptor type, n polypeptide 2, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, NOS1AP  -  nitric oxide synthase 1 (neuronal) adaptor protein, PTPRN  -  protein tyrosine phosphatase, receptor type, n, NPAT  -  nuclear protein, ataxia-telangiectasia locus, RIMS2  -  regulating synaptic membrane exocytosis 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), TRAF3IP2  -  traf3 interacting protein 2, CNOT4  -  ccr4-not transcription complex, subunit 4, ABCD4  -  atp-binding cassette, sub-family d (ald), member 4, CHKA  -  choline kinase alpha, CNOT3  -  ccr4-not transcription complex, subunit 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, CHEK1  -  checkpoint kinase 1, NFX1  -  nuclear transcription factor, x-box binding 1, CHD1  -  chromodomain helicase dna binding protein 1, NGF  -  nerve growth factor (beta polypeptide), KMT2B  -  lysine (k)-specific methyltransferase 2b, ACAP1  -  arfgap with coiled-coil, ankyrin repeat and ph domains 1, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, NEK3  -  nima-related kinase 3, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RAG2  -  recombination activating gene 2, RARG  -  retinoic acid receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), NF2  -  neurofibromin 2 (merlin), IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), TRAM2  -  translocation associated membrane protein 2, RBL2  -  retinoblastoma-like 2 (p130), ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, DIEXF  -  digestive organ expansion factor homolog (zebrafish), TH  -  tyrosine hydroxylase, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, IGFBP1  -  insulin-like growth factor binding protein 1, ARID4A  -  at rich interactive domain 4a (rbp1-like), AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, GEMIN4  -  gem (nuclear organelle) associated protein 4, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, RCVRN  -  recoverin, CIRBP  -  cold inducible rna binding protein, CKB  -  creatine kinase, brain, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0023051,regulation of signaling,4.13E-06,1.59E-03,1.35,8230,1697,786,219,"[G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, CDKN2AIP  -  cdkn2a interacting protein, CARD14  -  caspase recruitment domain family, member 14, PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GCK  -  glucokinase (hexokinase 4), SORBS3  -  sorbin and sh3 domain containing 3, RRAGB  -  ras-related gtp binding b, SPRED2  -  sprouty-related, evh1 domain containing 2, SOX2  -  sry (sex determining region y)-box 2, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CRH  -  corticotropin releasing hormone, RHEB  -  ras homolog enriched in brain, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, RGS16  -  regulator of g-protein signaling 16, GH1  -  growth hormone 1, CNGB1  -  cyclic nucleotide gated channel beta 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, ARHGAP19  -  rho gtpase activating protein 19, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, USP20  -  ubiquitin specific peptidase 20, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), GLI3  -  gli family zinc finger 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, FEM1B  -  fem-1 homolog b (c. elegans), TRH  -  thyrotropin-releasing hormone, LBP  -  lipopolysaccharide binding protein, POU1F1  -  pou class 1 homeobox 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, AES  -  amino-terminal enhancer of split, ADRB1  -  adrenoceptor beta 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, ADRBK2  -  adrenergic, beta, receptor kinase 2, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CAPZB  -  capping protein (actin filament) muscle z-line, beta, STXBP1  -  syntaxin binding protein 1, HMGXB4  -  hmg box domain containing 4, GRAP2  -  grb2-related adaptor protein 2, PEA15  -  phosphoprotein enriched in astrocytes 15, GAB1  -  grb2-associated binding protein 1, VIP  -  vasoactive intestinal peptide, AHSG  -  alpha-2-hs-glycoprotein, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, STK4  -  serine/threonine kinase 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, KISS1  -  kiss-1 metastasis-suppressor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, ESR2  -  estrogen receptor 2 (er beta), TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR1  -  estrogen receptor 1, DLC1  -  deleted in liver cancer 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, SSTR5  -  somatostatin receptor 5, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GBA  -  glucosidase, beta, acid, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, GATA3  -  gata binding protein 3, MVP  -  major vault protein, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), PLCE1  -  phospholipase c, epsilon 1, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, FOXA2  -  forkhead box a2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, S1PR2  -  sphingosine-1-phosphate receptor 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), HTRA1  -  htra serine peptidase 1, SOCS6  -  suppressor of cytokine signaling 6, PSAP  -  prosaposin, FLT4  -  fms-related tyrosine kinase 4, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, MID1  -  midline 1 (opitz/bbb syndrome), KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, CYTH3  -  cytohesin 3, RGS5  -  regulator of g-protein signaling 5, PCGF2  -  polycomb group ring finger 2, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), CCL4  -  chemokine (c-c motif) ligand 4, ARHGAP44  -  rho gtpase activating protein 44, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TRIM16  -  tripartite motif containing 16, PRDX1  -  peroxiredoxin 1, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, AKAP10  -  a kinase (prka) anchor protein 10, GUCY2F  -  guanylate cyclase 2f, retinal, FASLG  -  fas ligand (tnf superfamily, member 6), FZD5  -  frizzled family receptor 5, MDFI  -  myod family inhibitor, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGFR3  -  fibroblast growth factor receptor 3, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), PTH  -  parathyroid hormone, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, GPR143  -  g protein-coupled receptor 143, S100B  -  s100 calcium binding protein b, S100A4  -  s100 calcium binding protein a4, S100A7  -  s100 calcium binding protein a7, PCSK1  -  proprotein convertase subtilisin/kexin type 1, IRF1  -  interferon regulatory factor 1, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, ZNF205  -  zinc finger protein 205, PDE4A  -  phosphodiesterase 4a, camp-specific, IRAK1  -  interleukin-1 receptor-associated kinase 1, NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, SFN  -  stratifin, GPC1  -  glypican 1, ATM  -  ataxia telangiectasia mutated, LATS1  -  large tumor suppressor kinase 1, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, TRAF3IP2  -  traf3 interacting protein 2, NLGN1  -  neuroligin 1, IFNG  -  interferon, gamma, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, NGF  -  nerve growth factor (beta polypeptide), TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), TEK  -  tek tyrosine kinase, endothelial, DLX2  -  distal-less homeobox 2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PLAU  -  plasminogen activator, urokinase, NF2  -  neurofibromin 2 (merlin), BRSK2  -  br serine/threonine kinase 2, RGS6  -  regulator of g-protein signaling 6, RHOV  -  ras homolog family member v, IHH  -  indian hedgehog, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, KALRN  -  kalirin, rhogef kinase, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0065008,regulation of biological quality,4.23E-06,1.57E-03,1.32,8230,1711,936,256,"[SPTAN1  -  spectrin, alpha, non-erythrocytic 1, RFC5  -  replication factor c (activator 1) 5, 36.5kda, CDKN2AIP  -  cdkn2a interacting protein, AANAT  -  aralkylamine n-acetyltransferase, BTC  -  betacellulin, PLXNB1  -  plexin b1, LIN7A  -  lin-7 homolog a (c. elegans), ACACA  -  acetyl-coa carboxylase alpha, BTK  -  bruton agammaglobulinemia tyrosine kinase, GCHFR  -  gtp cyclohydrolase i feedback regulator, NBN  -  nibrin, GCK  -  glucokinase (hexokinase 4), NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, TTR  -  transthyretin, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, LPL  -  lipoprotein lipase, GHSR  -  growth hormone secretagogue receptor, ACTA2  -  actin, alpha 2, smooth muscle, aorta, LIPC  -  lipase, hepatic, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, PLG  -  plasminogen, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, LMAN1  -  lectin, mannose-binding, 1, CNGB1  -  cyclic nucleotide gated channel beta 1, GLUL  -  glutamate-ammonia ligase, ACTN1  -  actinin, alpha 1, HIST3H3  -  histone cluster 3, h3, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, GLRB  -  glycine receptor, beta, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, COL2A1  -  collagen, type ii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, PLIN2  -  perilipin 2, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, LCK  -  lymphocyte-specific protein tyrosine kinase, E2F1  -  e2f transcription factor 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, SLC22A4  -  solute carrier family 22 (organic cation/zwitterion transporter), member 4, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, ECE1  -  endothelin converting enzyme 1, BAIAP3  -  bai1-associated protein 3, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, F13A1  -  coagulation factor xiii, a1 polypeptide, FTL  -  ferritin, light polypeptide, PDE5A  -  phosphodiesterase 5a, cgmp-specific, ADRB1  -  adrenoceptor beta 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), KIF3A  -  kinesin family member 3a, PRCP  -  prolylcarboxypeptidase (angiotensinase c), UMOD  -  uromodulin, AGTR2  -  angiotensin ii receptor, type 2, ACE2  -  angiotensin i converting enzyme 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CAPZB  -  capping protein (actin filament) muscle z-line, beta, STXBP1  -  syntaxin binding protein 1, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, EZR  -  ezrin, VIP  -  vasoactive intestinal peptide, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, KLC1  -  kinesin light chain 1, EYA2  -  eyes absent homolog 2 (drosophila), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, F2RL2  -  coagulation factor ii (thrombin) receptor-like 2, CALCA  -  calcitonin-related polypeptide alpha, CYBA  -  cytochrome b-245, alpha polypeptide, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), KISS1  -  kiss-1 metastasis-suppressor, CALCR  -  calcitonin receptor, STAR  -  steroidogenic acute regulatory protein, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), GPAA1  -  glycosylphosphatidylinositol anchor attachment 1, UBC  -  ubiquitin c, CD7  -  cd7 molecule, RCOR1  -  rest corepressor 1, ESR1  -  estrogen receptor 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, NRXN3  -  neurexin 3, TYRO3  -  tyro3 protein tyrosine kinase, SSTR5  -  somatostatin receptor 5, DSTN  -  destrin (actin depolymerizing factor), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, MAPK14  -  mitogen-activated protein kinase 14, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), ANGPT1  -  angiopoietin 1, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, GATA3  -  gata binding protein 3, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), PLCE1  -  phospholipase c, epsilon 1, PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, CSN3  -  casein kappa, NAPG  -  n-ethylmaleimide-sensitive factor attachment protein, gamma, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CCKAR  -  cholecystokinin a receptor, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, PRKCG  -  protein kinase c, gamma, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, MPL  -  myeloproliferative leukemia virus oncogene, FOXA2  -  forkhead box a2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), APOA1  -  apolipoprotein a-i, PSAP  -  prosaposin, CXCL12  -  chemokine (c-x-c motif) ligand 12, KLK6  -  kallikrein-related peptidase 6, APOB  -  apolipoprotein b, FLG  -  filaggrin, FLNA  -  filamin a, alpha, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, PCLO  -  piccolo presynaptic cytomatrix protein, CCL15  -  chemokine (c-c motif) ligand 15, CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL1  -  chemokine (c-c motif) ligand 1, CCL3  -  chemokine (c-c motif) ligand 3, PDIA2  -  protein disulfide isomerase family a, member 2, PRDX1  -  peroxiredoxin 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, AKAP10  -  a kinase (prka) anchor protein 10, FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CEL  -  carboxyl ester lipase, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), MDFI  -  myod family inhibitor, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, CFL1  -  cofilin 1 (non-muscle), FES  -  feline sarcoma oncogene, PTH  -  parathyroid hormone, PTHLH  -  parathyroid hormone-like hormone, PECAM1  -  platelet/endothelial cell adhesion molecule 1, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), TMSB10  -  thymosin beta 10, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), NPC2  -  niemann-pick disease, type c2, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), NLGN4X  -  neuroligin 4, x-linked, NPPA  -  natriuretic peptide a, S100A7  -  s100 calcium binding protein a7, DGKQ  -  diacylglycerol kinase, theta 110kda, PCSK1  -  proprotein convertase subtilisin/kexin type 1, IREB2  -  iron-responsive element binding protein 2, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, ASGR2  -  asialoglycoprotein receptor 2, HDAC1  -  histone deacetylase 1, CDK2  -  cyclin-dependent kinase 2, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, HCRT  -  hypocretin (orexin) neuropeptide precursor, CXCL13  -  chemokine (c-x-c motif) ligand 13, ATP2A1  -  atpase, ca++ transporting, cardiac muscle, fast twitch 1, NCKAP1  -  nck-associated protein 1, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, DSC2  -  desmocollin 2, DPP6  -  dipeptidyl-peptidase 6, GP9  -  glycoprotein ix (platelet), LATS1  -  large tumor suppressor kinase 1, RIMS2  -  regulating synaptic membrane exocytosis 2, SERPINC1  -  serpin peptidase inhibitor, clade c (antithrombin), member 1, NLGN1  -  neuroligin 1, CEP57  -  centrosomal protein 57kda, IFNG  -  interferon, gamma, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, PLA2G10  -  phospholipase a2, group x, SLC4A3  -  solute carrier family 4 (anion exchanger), member 3, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), VWF  -  von willebrand factor, CGB  -  chorionic gonadotropin, beta polypeptide, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, CCR6  -  chemokine (c-c motif) receptor 6, TF  -  transferrin, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), NEFM  -  neurofilament, medium polypeptide, CLDN16  -  claudin 16, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), RARG  -  retinoic acid receptor, gamma, PLAU  -  plasminogen activator, urokinase, PKP2  -  plakophilin 2, IHH  -  indian hedgehog, CCDC88C  -  coiled-coil domain containing 88c, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, TGFB1  -  transforming growth factor, beta 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), TH  -  tyrosine hydroxylase, LYZ  -  lysozyme, BCL2  -  b-cell cll/lymphoma 2, CIRBP  -  cold inducible rna binding protein, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, CKB  -  creatine kinase, brain, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0045110,intermediate filament bundle assembly,4.30E-06,1.55E-03,9.9,8230,6,831,6,"[NEFL  -  neurofilament, light polypeptide, PKP2  -  plakophilin 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), KRT14  -  keratin 14, NEFM  -  neurofilament, medium polypeptide, NEFH  -  neurofilament, heavy polypeptide]"GO:0060341,regulation of cellular localization,4.72E-06,1.64E-03,1.66,8230,652,716,94,"[DRD3  -  dopamine receptor d3, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), ADRB1  -  adrenoceptor beta 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SRGN  -  serglycin, CHRM3  -  cholinergic receptor, muscarinic 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), INHBB  -  inhibin, beta b, SFN  -  stratifin, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, RIMS2  -  regulating synaptic membrane exocytosis 2, GCG  -  glucagon, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, GCK  -  glucokinase (hexokinase 4), IFNG  -  interferon, gamma, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), STXBP1  -  syntaxin binding protein 1, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PCLO  -  piccolo presynaptic cytomatrix protein, NGF  -  nerve growth factor (beta polypeptide), IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TRIM16  -  tripartite motif containing 16, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, OGG1  -  8-oxoguanine dna glycosylase, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, CD34  -  cd34 molecule, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, KISS1  -  kiss-1 metastasis-suppressor, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CADM1  -  cell adhesion molecule 1, PKD1  -  polycystic kidney disease 1 (autosomal dominant), GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, MDFI  -  myod family inhibitor, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), SNCG  -  synuclein, gamma (breast cancer-specific protein 1), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), CRYAB  -  crystallin, alpha b, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, GLI3  -  gli family zinc finger 3, FES  -  feline sarcoma oncogene, CD14  -  cd14 molecule, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, SSTR5  -  somatostatin receptor 5, FZD1  -  frizzled family receptor 1, BRSK2  -  br serine/threonine kinase 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GATA3  -  gata binding protein 3, EPHA5  -  eph receptor a5, PRKCZ  -  protein kinase c, zeta, PCSK1  -  proprotein convertase subtilisin/kexin type 1, TRIM9  -  tripartite motif containing 9, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, HNF1A  -  hnf1 homeobox a, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, BCL2  -  b-cell cll/lymphoma 2, ADORA1  -  adenosine a1 receptor, PDX1  -  pancreatic and duodenal homeobox 1, SMAD4  -  smad family member 4, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, THRA  -  thyroid hormone receptor, alpha, WAPAL  -  wings apart-like homolog (drosophila), FOXA2  -  forkhead box a2, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0050776,regulation of immune response,6.55E-06,2.21E-03,2.92,8230,582,126,26,"[CADM1  -  cell adhesion molecule 1, ICAM2  -  intercellular adhesion molecule 2, TYROBP  -  tyro protein tyrosine kinase binding protein, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), UBC  -  ubiquitin c, FGF1  -  fibroblast growth factor 1 (acidic), HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, CD14  -  cd14 molecule, TYRO3  -  tyro3 protein tyrosine kinase, HLA-A  -  major histocompatibility complex, class i, a, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, NRG2  -  neuregulin 2, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, C1QB  -  complement component 1, q subcomponent, b chain, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, C1R  -  complement component 1, r subcomponent, IL1B  -  interleukin 1, beta, C1S  -  complement component 1, s subcomponent, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, ACTG1  -  actin, gamma 1, FYN  -  fyn oncogene related to src, fgr, yes, ATF2  -  activating transcription factor 2, KITLG  -  kit ligand, THY1  -  thy-1 cell surface antigen]"GO:0071310,cellular response to organic substance,6.64E-06,2.17E-03,1.57,8230,1183,482,109,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, PSAP  -  prosaposin, PAX9  -  paired box 9, APOB  -  apolipoprotein b, INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, ATXN3  -  ataxin 3, GCG  -  glucagon, NCAM1  -  neural cell adhesion molecule 1, GDF5  -  growth differentiation factor 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), EIF4A1  -  eukaryotic translation initiation factor 4a1, RRAGB  -  ras-related gtp binding b, SP1  -  sp1 transcription factor, EIF4A2  -  eukaryotic translation initiation factor 4a2, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NRG2  -  neuregulin 2, SOX5  -  sry (sex determining region y)-box 5, IL1R1  -  interleukin 1 receptor, type i, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CXCR2  -  chemokine (c-x-c motif) receptor 2, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), IL1R2  -  interleukin 1 receptor, type ii, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, DNAL4  -  dynein, axonemal, light chain 4, IRF1  -  interferon regulatory factor 1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, KITLG  -  kit ligand, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, CAPN2  -  calpain 2, (m/ii) large subunit, IFI27  -  interferon, alpha-inducible protein 27, HLA-E  -  major histocompatibility complex, class i, e, IFNA5  -  interferon, alpha 5, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, CEP57  -  centrosomal protein 57kda, FASN  -  fatty acid synthase, IFNG  -  interferon, gamma, HLA-A  -  major histocompatibility complex, class i, a, CTSL  -  cathepsin l, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, FYN  -  fyn oncogene related to src, fgr, yes, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, DARC  -  duffy blood group, atypical chemokine receptor, CYBA  -  cytochrome b-245, alpha polypeptide, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TUBA1B  -  tubulin, alpha 1b, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, TWIST1  -  twist basic helix-loop-helix transcription factor 1, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, RBL1  -  retinoblastoma-like 1 (p107), GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), TH  -  tyrosine hydroxylase, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, BCL2  -  b-cell cll/lymphoma 2, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, SMAD4  -  smad family member 4, THRA  -  thyroid hormone receptor, alpha]"GO:0090276,regulation of peptide hormone secretion,8.45E-06,2.69E-03,2.59,8230,135,730,31,"[GLUL  -  glutamate-ammonia ligase, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), CHRM3  -  cholinergic receptor, muscarinic 3, INHBB  -  inhibin, beta b, GCG  -  glucagon, SSTR5  -  somatostatin receptor 5, BRSK2  -  br serine/threonine kinase 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, GCK  -  glucokinase (hexokinase 4), IFNG  -  interferon, gamma, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, STXBP1  -  syntaxin binding protein 1, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, UCN  -  urocortin, TRH  -  thyrotropin-releasing hormone, EPHA5  -  eph receptor a5, IL1B  -  interleukin 1, beta, PCSK1  -  proprotein convertase subtilisin/kexin type 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CRH  -  corticotropin releasing hormone, HNF1A  -  hnf1 homeobox a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, FOXA2  -  forkhead box a2, KISS1  -  kiss-1 metastasis-suppressor]"GO:0010646,regulation of cell communication,9.21E-06,2.85E-03,1.34,8230,1704,786,218,"[G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, CDKN2AIP  -  cdkn2a interacting protein, CARD14  -  caspase recruitment domain family, member 14, PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GCK  -  glucokinase (hexokinase 4), SORBS3  -  sorbin and sh3 domain containing 3, RRAGB  -  ras-related gtp binding b, SPRED2  -  sprouty-related, evh1 domain containing 2, SOX2  -  sry (sex determining region y)-box 2, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CRH  -  corticotropin releasing hormone, RHEB  -  ras homolog enriched in brain, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, RGS16  -  regulator of g-protein signaling 16, GH1  -  growth hormone 1, CNGB1  -  cyclic nucleotide gated channel beta 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, ARHGAP19  -  rho gtpase activating protein 19, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, USP20  -  ubiquitin specific peptidase 20, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), GLI3  -  gli family zinc finger 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, FEM1B  -  fem-1 homolog b (c. elegans), TRH  -  thyrotropin-releasing hormone, LBP  -  lipopolysaccharide binding protein, POU1F1  -  pou class 1 homeobox 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, AES  -  amino-terminal enhancer of split, ADRB1  -  adrenoceptor beta 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, ADRBK2  -  adrenergic, beta, receptor kinase 2, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CAPZB  -  capping protein (actin filament) muscle z-line, beta, STXBP1  -  syntaxin binding protein 1, HMGXB4  -  hmg box domain containing 4, GRAP2  -  grb2-related adaptor protein 2, PEA15  -  phosphoprotein enriched in astrocytes 15, GAB1  -  grb2-associated binding protein 1, VIP  -  vasoactive intestinal peptide, AHSG  -  alpha-2-hs-glycoprotein, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, STK4  -  serine/threonine kinase 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, KISS1  -  kiss-1 metastasis-suppressor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, ESR2  -  estrogen receptor 2 (er beta), TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR1  -  estrogen receptor 1, DLC1  -  deleted in liver cancer 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, SSTR5  -  somatostatin receptor 5, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GBA  -  glucosidase, beta, acid, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), PLCE1  -  phospholipase c, epsilon 1, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, FOXA2  -  forkhead box a2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, S1PR2  -  sphingosine-1-phosphate receptor 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), HTRA1  -  htra serine peptidase 1, SOCS6  -  suppressor of cytokine signaling 6, PSAP  -  prosaposin, FLT4  -  fms-related tyrosine kinase 4, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, MID1  -  midline 1 (opitz/bbb syndrome), KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, CYTH3  -  cytohesin 3, RGS5  -  regulator of g-protein signaling 5, PCGF2  -  polycomb group ring finger 2, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), CCL4  -  chemokine (c-c motif) ligand 4, ARHGAP44  -  rho gtpase activating protein 44, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TRIM16  -  tripartite motif containing 16, PRDX1  -  peroxiredoxin 1, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, AKAP10  -  a kinase (prka) anchor protein 10, GUCY2F  -  guanylate cyclase 2f, retinal, FASLG  -  fas ligand (tnf superfamily, member 6), FZD5  -  frizzled family receptor 5, MDFI  -  myod family inhibitor, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGFR3  -  fibroblast growth factor receptor 3, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), PTH  -  parathyroid hormone, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, GPR143  -  g protein-coupled receptor 143, S100B  -  s100 calcium binding protein b, S100A4  -  s100 calcium binding protein a4, S100A7  -  s100 calcium binding protein a7, PCSK1  -  proprotein convertase subtilisin/kexin type 1, IRF1  -  interferon regulatory factor 1, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, ZNF205  -  zinc finger protein 205, PDE4A  -  phosphodiesterase 4a, camp-specific, IRAK1  -  interleukin-1 receptor-associated kinase 1, NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, SFN  -  stratifin, GPC1  -  glypican 1, ATM  -  ataxia telangiectasia mutated, LATS1  -  large tumor suppressor kinase 1, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, TRAF3IP2  -  traf3 interacting protein 2, NLGN1  -  neuroligin 1, IFNG  -  interferon, gamma, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, NGF  -  nerve growth factor (beta polypeptide), TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), TEK  -  tek tyrosine kinase, endothelial, DLX2  -  distal-less homeobox 2, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PLAU  -  plasminogen activator, urokinase, NF2  -  neurofibromin 2 (merlin), BRSK2  -  br serine/threonine kinase 2, RGS6  -  regulator of g-protein signaling 6, RHOV  -  ras homolog family member v, IHH  -  indian hedgehog, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, KALRN  -  kalirin, rhogef kinase, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0032879,regulation of localization,9.23E-06,2.78E-03,1.44,8230,1221,721,154,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, ARHGEF39  -  rho guanine nucleotide exchange factor (gef) 39, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), CD2AP  -  cd2-associated protein, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, PRSS8  -  protease, serine, 8, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, GCG  -  glucagon, GCK  -  glucokinase (hexokinase 4), IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PCLO  -  piccolo presynaptic cytomatrix protein, CCL4  -  chemokine (c-c motif) ligand 4, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, LPL  -  lipoprotein lipase, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, CD34  -  cd34 molecule, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, AQP1  -  aquaporin 1 (colton blood group), CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, ACTN1  -  actinin, alpha 1, NMU  -  neuromedin u, MDFI  -  myod family inhibitor, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGF12  -  fibroblast growth factor 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, FES  -  feline sarcoma oncogene, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), LBP  -  lipopolysaccharide binding protein, S100A7  -  s100 calcium binding protein a7, PCSK1  -  proprotein convertase subtilisin/kexin type 1, TRIM9  -  tripartite motif containing 9, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, HNF1A  -  hnf1 homeobox a, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, ADORA1  -  adenosine a1 receptor, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, WAPAL  -  wings apart-like homolog (drosophila), CXCL13  -  chemokine (c-x-c motif) ligand 13, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, NCKAP1  -  nck-associated protein 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SRGN  -  serglycin, CHRM3  -  cholinergic receptor, muscarinic 3, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), DPP6  -  dipeptidyl-peptidase 6, SFN  -  stratifin, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, RIMS2  -  regulating synaptic membrane exocytosis 2, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, IFNG  -  interferon, gamma, STXBP1  -  syntaxin binding protein 1, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, VIP  -  vasoactive intestinal peptide, AHSG  -  alpha-2-hs-glycoprotein, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), MSN  -  moesin, KISS1  -  kiss-1 metastasis-suppressor, PKD1  -  polycystic kidney disease 1 (autosomal dominant), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, PLAU  -  plasminogen activator, urokinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, DLC1  -  deleted in liver cancer 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, NF2  -  neurofibromin 2 (merlin), SSTR5  -  somatostatin receptor 5, PKP2  -  plakophilin 2, BRSK2  -  br serine/threonine kinase 2, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GATA3  -  gata binding protein 3, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, FOXA2  -  forkhead box a2]"GO:0014070,response to organic cyclic compound,1.12E-05,3.28E-03,1.86,8230,493,555,62,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, DPYSL2  -  dihydropyrimidinase-like 2, CHEK1  -  checkpoint kinase 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NGF  -  nerve growth factor (beta polypeptide), CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, OGG1  -  8-oxoguanine dna glycosylase, GH1  -  growth hormone 1, CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group), CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, KRT19  -  keratin 19, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PTCH1  -  patched 1, SLIT2  -  slit homolog 2 (drosophila), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTGDS  -  prostaglandin d2 synthase 21kda (brain), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ESR1  -  estrogen receptor 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, SSTR3  -  somatostatin receptor 3, NQO1  -  nad(p)h dehydrogenase, quinone 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, PLIN2  -  perilipin 2, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, COMT  -  catechol-o-methyltransferase, BCL2  -  b-cell cll/lymphoma 2, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NRF1  -  nuclear respiratory factor 1]"GO:0070887,cellular response to chemical stimulus,1.36E-05,3.90E-03,1.47,8230,1378,544,134,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, PSAP  -  prosaposin, PAX9  -  paired box 9, APOB  -  apolipoprotein b, INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, ATXN3  -  ataxin 3, GCG  -  glucagon, NCAM1  -  neural cell adhesion molecule 1, GDF5  -  growth differentiation factor 5, CCL17  -  chemokine (c-c motif) ligand 17, EIF4A1  -  eukaryotic translation initiation factor 4a1, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NRG2  -  neuregulin 2, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, SOX5  -  sry (sex determining region y)-box 5, CCL2  -  chemokine (c-c motif) ligand 2, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), ITGA9  -  integrin, alpha 9, IL1R2  -  interleukin 1 receptor, type ii, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, KRT10  -  keratin 10, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, PPARG  -  peroxisome proliferator-activated receptor gamma, PTK6  -  protein tyrosine kinase 6, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, S100B  -  s100 calcium binding protein b, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, DNAL4  -  dynein, axonemal, light chain 4, IRF1  -  interferon regulatory factor 1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, KITLG  -  kit ligand, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, CDK2  -  cyclin-dependent kinase 2, PDE4A  -  phosphodiesterase 4a, camp-specific, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, HLA-G  -  major histocompatibility complex, class i, g, CAPN2  -  calpain 2, (m/ii) large subunit, HLA-F  -  major histocompatibility complex, class i, f, IFI27  -  interferon, alpha-inducible protein 27, HLA-E  -  major histocompatibility complex, class i, e, IFNA5  -  interferon, alpha 5, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, RPE65  -  retinal pigment epithelium-specific protein 65kda, CEP57  -  centrosomal protein 57kda, FASN  -  fatty acid synthase, IFNG  -  interferon, gamma, HLA-A  -  major histocompatibility complex, class i, a, CTSL  -  cathepsin l, CHEK1  -  checkpoint kinase 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, DARC  -  duffy blood group, atypical chemokine receptor, CYBA  -  cytochrome b-245, alpha polypeptide, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CRIP1  -  cysteine-rich protein 1 (intestinal), TUBA1B  -  tubulin, alpha 1b, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, TWIST1  -  twist basic helix-loop-helix transcription factor 1, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, SSTR3  -  somatostatin receptor 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, RBL1  -  retinoblastoma-like 1 (p107), EPHA3  -  eph receptor a3, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), TH  -  tyrosine hydroxylase, IGFBP1  -  insulin-like growth factor binding protein 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, CXCL2  -  chemokine (c-x-c motif) ligand 2, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, THRA  -  thyroid hormone receptor, alpha, FOXA2  -  forkhead box a2]"GO:0031960,response to corticosteroid,1.38E-05,3.86E-03,2.65,8230,106,821,28,"[AKR1C3  -  aldo-keto reductase family 1, member c3, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), STAR  -  steroidogenic acute regulatory protein, SLIT2  -  slit homolog 2 (drosophila), PTGDS  -  prostaglandin d2 synthase 21kda (brain), CTGF  -  connective tissue growth factor, AGTR2  -  angiotensin ii receptor, type 2, SSTR3  -  somatostatin receptor 3, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, SOX30  -  sry (sex determining region y)-box 30, S100B  -  s100 calcium binding protein b, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, TGFB1  -  transforming growth factor, beta 1, NGF  -  nerve growth factor (beta polypeptide), TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), TRH  -  thyrotropin-releasing hormone, CCL2  -  chemokine (c-c motif) ligand 2, CRH  -  corticotropin releasing hormone, BCL2  -  b-cell cll/lymphoma 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), PDX1  -  pancreatic and duodenal homeobox 1, AQP1  -  aquaporin 1 (colton blood group), CALCR  -  calcitonin receptor]"GO:0009628,response to abiotic stimulus,1.39E-05,3.77E-03,1.68,8230,698,582,83,"[AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, PAX2  -  paired box 2, CAPN2  -  calpain 2, (m/ii) large subunit, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, BRCA2  -  breast cancer 2, early onset, RGR  -  retinal g protein coupled receptor, ADRB3  -  adrenoceptor beta 3, APOB  -  apolipoprotein b, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), CTGF  -  connective tissue growth factor, INHBB  -  inhibin, beta b, GPC1  -  glypican 1, ATM  -  ataxia telangiectasia mutated, RPE65  -  retinal pigment epithelium-specific protein 65kda, MICA  -  mhc class i polypeptide-related sequence a, CHEK1  -  checkpoint kinase 1, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, NGF  -  nerve growth factor (beta polypeptide), SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, LPL  -  lipoprotein lipase, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, OGG1  -  8-oxoguanine dna glycosylase, APP  -  amyloid beta (a4) precursor protein, FYN  -  fyn oncogene related to src, fgr, yes, ATF2  -  activating transcription factor 2, GUCY2F  -  guanylate cyclase 2f, retinal, MYO6  -  myosin vi, CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, CRIP1  -  cysteine-rich protein 1 (intestinal), ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, NMU  -  neuromedin u, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, UBC  -  ubiquitin c, CRYAB  -  crystallin, alpha b, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), PLAU  -  plasminogen activator, urokinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, COL3A1  -  collagen, type iii, alpha 1, HOXA1  -  homeobox a1, CD9  -  cd9 molecule, MEIS2  -  meis homeobox 2, KRT14  -  keratin 14, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, PPARG  -  peroxisome proliferator-activated receptor gamma, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, NPPA  -  natriuretic peptide a, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, IRF1  -  interferon regulatory factor 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, CIRBP  -  cold inducible rna binding protein, SMAD4  -  smad family member 4, NRF1  -  nuclear respiratory factor 1, UBE4B  -  ubiquitination factor e4b, THRA  -  thyroid hormone receptor, alpha, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:0050794,regulation of cellular process,1.70E-05,4.50E-03,1.13,8230,5165,732,519,"[SPTAN1  -  spectrin, alpha, non-erythrocytic 1, ARHGEF39  -  rho guanine nucleotide exchange factor (gef) 39, DAPK2  -  death-associated protein kinase 2, CDKN2AIP  -  cdkn2a interacting protein, BTG3  -  btg family, member 3, CD2AP  -  cd2-associated protein, PATZ1  -  poz (btb) and at hook containing zinc finger 1, PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, ACACA  -  acetyl-coa carboxylase alpha, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SP1  -  sp1 transcription factor, PLP1  -  proteolipid protein 1, NRG2  -  neuregulin 2, CLDN3  -  claudin 3, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, LPL  -  lipoprotein lipase, CRH  -  corticotropin releasing hormone, RND2  -  rho family gtpase 2, ACTG1  -  actin, gamma 1, PLG  -  plasminogen, ATF2  -  activating transcription factor 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, LMAN1  -  lectin, mannose-binding, 1, CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, ACTN1  -  actinin, alpha 1, NMU  -  neuromedin u, ARHGAP19  -  rho gtpase activating protein 19, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, TRRAP  -  transformation/transcription domain-associated protein, USP20  -  ubiquitin specific peptidase 20, GLRB  -  glycine receptor, beta, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), CREBZF  -  creb/atf bzip transcription factor, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, COL3A1  -  collagen, type iii, alpha 1, POU3F4  -  pou class 3 homeobox 4, SNAPC3  -  small nuclear rna activating complex, polypeptide 3, 50kda, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), CDC45  -  cell division cycle 45, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, SUMO3  -  small ubiquitin-like modifier 3, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LDOC1  -  leucine zipper, down-regulated in cancer 1, LBP  -  lipopolysaccharide binding protein, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, NCR2  -  natural cytotoxicity triggering receptor 2, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, KIR2DL1  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, ZNF350  -  zinc finger protein 350, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, CTBP1  -  c-terminal binding protein 1, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTSL  -  cathepsin l, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, STK4  -  serine/threonine kinase 4, CYBA  -  cytochrome b-245, alpha polypeptide, TRIM31  -  tripartite motif containing 31, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, KISS1  -  kiss-1 metastasis-suppressor, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, STAT4  -  signal transducer and activator of transcription 4, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, ALDOB  -  aldolase b, fructose-bisphosphate, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, DSTN  -  destrin (actin depolymerizing factor), ALX1  -  alx homeobox 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GBA  -  glucosidase, beta, acid, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), DOK4  -  docking protein 4, CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, GAP43  -  growth associated protein 43, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, MLLT10  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 10, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, MID1  -  midline 1 (opitz/bbb syndrome), PAX9  -  paired box 9, APOB  -  apolipoprotein b, DCX  -  doublecortin, CYTH3  -  cytohesin 3, ATXN3  -  ataxin 3, PCBD1  -  pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, MLLT1  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 1, PCGF2  -  polycomb group ring finger 2, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), CCL3  -  chemokine (c-c motif) ligand 3, ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, ZNF473  -  zinc finger protein 473, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, GUCY2F  -  guanylate cyclase 2f, retinal, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CELF3  -  cugbp, elav-like family member 3, FZD5  -  frizzled family receptor 5, MDFI  -  myod family inhibitor, IL1R2  -  interleukin 1 receptor, type ii, ZNF451  -  zinc finger protein 451, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, ARF5  -  adp-ribosylation factor 5, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, BAZ1A  -  bromodomain adjacent to zinc finger domain, 1a, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, S100A11  -  s100 calcium binding protein a11, S100B  -  s100 calcium binding protein b, TMSB10  -  thymosin beta 10, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, S100A4  -  s100 calcium binding protein a4, S100A7  -  s100 calcium binding protein a7, FANCL  -  fanconi anemia, complementation group l, PCSK1  -  proprotein convertase subtilisin/kexin type 1, KITLG  -  kit ligand, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRTR1  -  hypocretin (orexin) receptor 1, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, ARID3A  -  at rich interactive domain 3a (bright-like), GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CCNE2  -  cyclin e2, RUFY3  -  run and fyve domain containing 3, DRD3  -  dopamine receptor d3, SMC3  -  structural maintenance of chromosomes 3, BAHD1  -  bromo adjacent homology domain containing 1, SFN  -  stratifin, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, NLGN1  -  neuroligin 1, PGR  -  progesterone receptor, DPYSL2  -  dihydropyrimidinase-like 2, SKP1  -  s-phase kinase-associated protein 1, MBL2  -  mannose-binding lectin (protein c) 2, soluble, NELFA  -  negative elongation factor complex member a, ICK  -  intestinal cell (mak-like) kinase, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), DLX2  -  distal-less homeobox 2, MZF1  -  myeloid zinc finger 1, PLAU  -  plasminogen activator, urokinase, ZNF10  -  zinc finger protein 10, GRN  -  granulin, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), BRSK2  -  br serine/threonine kinase 2, GRIA2  -  glutamate receptor, ionotropic, ampa 2, LTK  -  leukocyte receptor tyrosine kinase, ZFPL1  -  zinc finger protein-like 1, CCDC88C  -  coiled-coil domain containing 88c, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, PIAS4  -  protein inhibitor of activated stat, 4, KALRN  -  kalirin, rhogef kinase, SRSF6  -  serine/arginine-rich splicing factor 6, TAF1C  -  tata box binding protein (tbp)-associated factor, rna polymerase i, c, 110kda, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, GRP  -  gastrin-releasing peptide, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, NCBP1  -  nuclear cap binding protein subunit 1, 80kda, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, RGR  -  retinal g protein coupled receptor, RFX1  -  regulatory factor x, 1 (influences hla class ii expression), NAIP  -  nlr family, apoptosis inhibitory protein, ELL2  -  elongation factor, rna polymerase ii, 2, BCOR  -  bcl6 corepressor, BTK  -  bruton agammaglobulinemia tyrosine kinase, AGFG2  -  arfgap with fg repeats 2, SAP30  -  sin3a-associated protein, 30kda, NCAM1  -  neural cell adhesion molecule 1, EIF4A1  -  eukaryotic translation initiation factor 4a1, SORBS3  -  sorbin and sh3 domain containing 3, EIF4A2  -  eukaryotic translation initiation factor 4a2, RRAGB  -  ras-related gtp binding b, WISP2  -  wnt1 inducible signaling pathway protein 2, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, RLN1  -  relaxin 1, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, MPHOSPH10  -  m-phase phosphoprotein 10 (u3 small nucleolar ribonucleoprotein), LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, TSC22D1  -  tsc22 domain family, member 1, MAST1  -  microtubule associated serine/threonine kinase 1, RGS16  -  regulator of g-protein signaling 16, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, MYO16  -  myosin xvi, BUD31  -  bud31 homolog (s. cerevisiae), CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), TRH  -  thyrotropin-releasing hormone, DENND4A  -  denn/madd domain containing 4a, DNAL4  -  dynein, axonemal, light chain 4, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, C5  -  complement component 5, UBE4B  -  ubiquitination factor e4b, BAIAP3  -  bai1-associated protein 3, WAPAL  -  wings apart-like homolog (drosophila), AKR1C3  -  aldo-keto reductase family 1, member c3, CAPNS1  -  calpain, small subunit 1, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, PDE5A  -  phosphodiesterase 5a, cgmp-specific, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, DYNLL1  -  dynein, light chain, lc8-type 1, RPE65  -  retinal pigment epithelium-specific protein 65kda, FASN  -  fatty acid synthase, CAPZB  -  capping protein (actin filament) muscle z-line, beta, HLA-A  -  major histocompatibility complex, class i, a, RPS4X  -  ribosomal protein s4, x-linked, RPS3A  -  ribosomal protein s3a, HMGXB4  -  hmg box domain containing 4, HLA-C  -  major histocompatibility complex, class i, c, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, EZR  -  ezrin, VIP  -  vasoactive intestinal peptide, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, EYA2  -  eyes absent homolog 2 (drosophila), ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, EZH1  -  enhancer of zeste homolog 1 (drosophila), NCOA2  -  nuclear receptor coactivator 2, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, CALCR  -  calcitonin receptor, MSN  -  moesin, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TYROBP  -  tyro protein tyrosine kinase binding protein, CHRDL1  -  chordin-like 1, UBC  -  ubiquitin c, CCNG2  -  cyclin g2, CD8B  -  cd8b molecule, TWIST1  -  twist basic helix-loop-helix transcription factor 1, RCOR1  -  rest corepressor 1, CD7  -  cd7 molecule, CD14  -  cd14 molecule, RPS14  -  ribosomal protein s14, ESR1  -  estrogen receptor 1, HOXA1  -  homeobox a1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, EPHA3  -  eph receptor a3, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, MVP  -  major vault protein, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, CCND2  -  cyclin d2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), LPHN2  -  latrophilin 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, HTRA1  -  htra serine peptidase 1, PSAP  -  prosaposin, ORC2  -  origin recognition complex, subunit 2, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, RGS5  -  regulator of g-protein signaling 5, AHSA1  -  aha1, activator of heat shock 90kda protein atpase homolog 1 (yeast), IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CD53  -  cd53 molecule, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, CD34  -  cd34 molecule, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGFR3  -  fibroblast growth factor receptor 3, GNMT  -  glycine n-methyltransferase, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, NTN3  -  netrin 3, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, PTH  -  parathyroid hormone, TRIM2  -  tripartite motif containing 2, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTHLH  -  parathyroid hormone-like hormone, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDK13  -  cyclin-dependent kinase 13, NPC2  -  niemann-pick disease, type c2, KLHL20  -  kelch-like family member 20, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), TRIM9  -  tripartite motif containing 9, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, NRL  -  neural retina leucine zipper, FBLN2  -  fibulin 2, CDK2  -  cyclin-dependent kinase 2, NRF1  -  nuclear respiratory factor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, IFI27  -  interferon, alpha-inducible protein 27, IFI35  -  interferon-induced protein 35, IFNA5  -  interferon, alpha 5, PTPRN2  -  protein tyrosine phosphatase, receptor type, n polypeptide 2, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, NOS1AP  -  nitric oxide synthase 1 (neuronal) adaptor protein, PTPRN  -  protein tyrosine phosphatase, receptor type, n, NPAT  -  nuclear protein, ataxia-telangiectasia locus, RIMS2  -  regulating synaptic membrane exocytosis 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), TRAF3IP2  -  traf3 interacting protein 2, CHKA  -  choline kinase alpha, CNOT3  -  ccr4-not transcription complex, subunit 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, DHX34  -  deah (asp-glu-ala-his) box polypeptide 34, IFNG  -  interferon, gamma, CHEK1  -  checkpoint kinase 1, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, NFX1  -  nuclear transcription factor, x-box binding 1, CHD1  -  chromodomain helicase dna binding protein 1, NGF  -  nerve growth factor (beta polypeptide), KMT2B  -  lysine (k)-specific methyltransferase 2b, ACAP1  -  arfgap with coiled-coil, ankyrin repeat and ph domains 1, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RARG  -  retinoic acid receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), NF2  -  neurofibromin 2 (merlin), IGSF1  -  immunoglobulin superfamily, member 1, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), RBL2  -  retinoblastoma-like 2 (p130), ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, IGFBP1  -  insulin-like growth factor binding protein 1, ARID4A  -  at rich interactive domain 4a (rbp1-like), PLK4  -  polo-like kinase 4, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, RCVRN  -  recoverin, CIRBP  -  cold inducible rna binding protein, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0050796,regulation of insulin secretion,1.74E-05,4.52E-03,2.59,8230,126,730,29,"[GLUL  -  glutamate-ammonia ligase, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), CHRM3  -  cholinergic receptor, muscarinic 3, INHBB  -  inhibin, beta b, GCG  -  glucagon, SSTR5  -  somatostatin receptor 5, BRSK2  -  br serine/threonine kinase 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, GCK  -  glucokinase (hexokinase 4), IFNG  -  interferon, gamma, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, STXBP1  -  syntaxin binding protein 1, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, TRH  -  thyrotropin-releasing hormone, EPHA5  -  eph receptor a5, IL1B  -  interleukin 1, beta, PCSK1  -  proprotein convertase subtilisin/kexin type 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CRH  -  corticotropin releasing hormone, HNF1A  -  hnf1 homeobox a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, FOXA2  -  forkhead box a2]"GO:0046460,neutral lipid biosynthetic process,1.83E-05,4.64E-03,17.65,8230,9,259,5,"[ANG  -  angiogenin, ribonuclease, rnase a family, 5, ACACA  -  acetyl-coa carboxylase alpha, PLCE1  -  phospholipase c, epsilon 1, FASN  -  fatty acid synthase, LPL  -  lipoprotein lipase]"GO:0046463,acylglycerol biosynthetic process,1.83E-05,4.54E-03,17.65,8230,9,259,5,"[ANG  -  angiogenin, ribonuclease, rnase a family, 5, ACACA  -  acetyl-coa carboxylase alpha, PLCE1  -  phospholipase c, epsilon 1, LPL  -  lipoprotein lipase, FASN  -  fatty acid synthase]"GO:0046883,regulation of hormone secretion,2.20E-05,5.34E-03,2.28,8230,168,730,34,"[GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), CHRM3  -  cholinergic receptor, muscarinic 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, INHBB  -  inhibin, beta b, SSTR5  -  somatostatin receptor 5, GCG  -  glucagon, BRSK2  -  br serine/threonine kinase 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, GCK  -  glucokinase (hexokinase 4), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, IFNG  -  interferon, gamma, STXBP1  -  syntaxin binding protein 1, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, UCN  -  urocortin, TRH  -  thyrotropin-releasing hormone, EPHA5  -  eph receptor a5, IL1B  -  interleukin 1, beta, PCSK1  -  proprotein convertase subtilisin/kexin type 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CRH  -  corticotropin releasing hormone, HNF1A  -  hnf1 homeobox a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, ADORA1  -  adenosine a1 receptor, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, FOXA2  -  forkhead box a2, KISS1  -  kiss-1 metastasis-suppressor]"GO:0001916,positive regulation of T cell mediated cytotoxicity,2.28E-05,5.40E-03,4.7,8230,20,963,11,"[HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), IL23R  -  interleukin 23 receptor, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)]"GO:0007507,heart development,2.38E-05,5.52E-03,2.77,8230,136,569,26,"[PKD1  -  polycystic kidney disease 1 (autosomal dominant), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), TEK  -  tek tyrosine kinase, endothelial, CRIP1  -  cysteine-rich protein 1 (intestinal), COX17  -  cox17 cytochrome c oxidase copper chaperone, NKX2-5  -  nk2 homeobox 5, FGF12  -  fibroblast growth factor 12, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), KIF3A  -  kinesin family member 3a, COL3A1  -  collagen, type iii, alpha 1, ATM  -  ataxia telangiectasia mutated, MAP2K5  -  mitogen-activated protein kinase kinase 5, PKP2  -  plakophilin 2, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, GAB1  -  grb2-associated binding protein 1, TH  -  tyrosine hydroxylase, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, TAZ  -  tafazzin, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, MNAT1  -  mnat cdk-activating kinase assembly factor 1, CXADR  -  coxsackie virus and adenovirus receptor, CALCRL  -  calcitonin receptor-like, ADRA1A  -  adrenoceptor alpha 1a]"GO:0051049,regulation of transport,2.47E-05,5.61E-03,1.5,8230,910,716,119,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), CD2AP  -  cd2-associated protein, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, PRSS8  -  protease, serine, 8, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, GCG  -  glucagon, GCK  -  glucokinase (hexokinase 4), IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PCLO  -  piccolo presynaptic cytomatrix protein, CCL4  -  chemokine (c-c motif) ligand 4, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CD34  -  cd34 molecule, MYO6  -  myosin vi, AQP1  -  aquaporin 1 (colton blood group), CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, MDFI  -  myod family inhibitor, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGF12  -  fibroblast growth factor 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, GLI3  -  gli family zinc finger 3, FES  -  feline sarcoma oncogene, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PCSK1  -  proprotein convertase subtilisin/kexin type 1, TRIM9  -  tripartite motif containing 9, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), HNF1A  -  hnf1 homeobox a, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, ADORA1  -  adenosine a1 receptor, PDX1  -  pancreatic and duodenal homeobox 1, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, HCLS1  -  hematopoietic cell-specific lyn substrate 1, ZNF205  -  zinc finger protein 205, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SRGN  -  serglycin, CHRM3  -  cholinergic receptor, muscarinic 3, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), DPP6  -  dipeptidyl-peptidase 6, SFN  -  stratifin, KIF3A  -  kinesin family member 3a, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, RIMS2  -  regulating synaptic membrane exocytosis 2, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, IFNG  -  interferon, gamma, STXBP1  -  syntaxin binding protein 1, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, VIP  -  vasoactive intestinal peptide, AHSG  -  alpha-2-hs-glycoprotein, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, KISS1  -  kiss-1 metastasis-suppressor, PKD1  -  polycystic kidney disease 1 (autosomal dominant), RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), CRYAB  -  crystallin, alpha b, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, PKP2  -  plakophilin 2, SSTR5  -  somatostatin receptor 5, BRSK2  -  br serine/threonine kinase 2, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, UCN  -  urocortin, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GATA3  -  gata binding protein 3, EPHA5  -  eph receptor a5, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, SMAD4  -  smad family member 4, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, FOXA2  -  forkhead box a2]"GO:0031343,positive regulation of cell killing,2.79E-05,6.22E-03,3.66,8230,35,963,15,"[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), NCR3  -  natural cytotoxicity triggering receptor 3, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), BCL2L11  -  bcl2-like 11 (apoptosis facilitator), IL23R  -  interleukin 23 receptor, IFNG  -  interferon, gamma, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b)]"GO:0007154,cell communication,2.94E-05,6.43E-03,1.51,8230,647,962,114,"[INHBB  -  inhibin, beta b, ATXN3  -  ataxin 3, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), CCL17  -  chemokine (c-c motif) ligand 17, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, WISP2  -  wnt1 inducible signaling pathway protein 2, LNPEP  -  leucyl/cystinyl aminopeptidase, PLP1  -  proteolipid protein 1, CCL15  -  chemokine (c-c motif) ligand 15, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, DLGAP1  -  discs, large (drosophila) homolog-associated protein 1, CRH  -  corticotropin releasing hormone, CD34  -  cd34 molecule, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), TSHR  -  thyroid stimulating hormone receptor, FASLG  -  fas ligand (tnf superfamily, member 6), MYO6  -  myosin vi, GLUL  -  glutamate-ammonia ligase, FGFR3  -  fibroblast growth factor receptor 3, GLRB  -  glycine receptor, beta, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, IAPP  -  islet amyloid polypeptide, FGF1  -  fibroblast growth factor 1 (acidic), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NTSR1  -  neurotensin receptor 1 (high affinity), SNCB  -  synuclein, beta, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, INSL3  -  insulin-like 3 (leydig cell), GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, BSN  -  bassoon presynaptic cytomatrix protein, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), TRH  -  thyrotropin-releasing hormone, C1QA  -  complement component 1, q subcomponent, a chain, PCSK1  -  proprotein convertase subtilisin/kexin type 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, ADRA1A  -  adrenoceptor alpha 1a, HCRT  -  hypocretin (orexin) neuropeptide precursor, CXCL13  -  chemokine (c-x-c motif) ligand 13, HCRTR1  -  hypocretin (orexin) receptor 1, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, AES  -  amino-terminal enhancer of split, DRD3  -  dopamine receptor d3, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, DSC2  -  desmocollin 2, PGR  -  progesterone receptor, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, MAX  -  myc associated factor x, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, CXADR  -  coxsackie virus and adenovirus receptor, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, CGB  -  chorionic gonadotropin, beta polypeptide, CALCA  -  calcitonin-related polypeptide alpha, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, TEK  -  tek tyrosine kinase, endothelial, HOXA11  -  homeobox a11, NEFL  -  neurofilament, light polypeptide, ESR2  -  estrogen receptor 2 (er beta), GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, GRIA2  -  glutamate receptor, ionotropic, ampa 2, GRIA1  -  glutamate receptor, ionotropic, ampa 1, IHH  -  indian hedgehog, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), ANG  -  angiogenin, ribonuclease, rnase a family, 5, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, KCNJ6  -  potassium inwardly-rectifying channel, subfamily j, member 6, KCNF1  -  potassium voltage-gated channel, subfamily f, member 1, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, PRKCG  -  protein kinase c, gamma, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, BCL2  -  b-cell cll/lymphoma 2, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1, GAS6  -  growth arrest-specific 6, FOXA2  -  forkhead box a2]"GO:0006950,response to stress,3.20E-05,6.85E-03,1.37,8230,1769,584,172,"[DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, RFC5  -  replication factor c (activator 1) 5, 36.5kda, PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, SMC2  -  structural maintenance of chromosomes 2, ATXN3  -  ataxin 3, GCG  -  glucagon, BTK  -  bruton agammaglobulinemia tyrosine kinase, AHSA1  -  aha1, activator of heat shock 90kda protein atpase homolog 1 (yeast), CCL17  -  chemokine (c-c motif) ligand 17, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), RIF1  -  rap1 interacting factor homolog (yeast), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, NRG2  -  neuregulin 2, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, LPL  -  lipoprotein lipase, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, CRH  -  corticotropin releasing hormone, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, ACTG1  -  actin, gamma 1, APP  -  amyloid beta (a4) precursor protein, NUAK1  -  nuak family, snf1-like kinase, 1, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), PLD1  -  phospholipase d1, phosphatidylcholine-specific, MYO6  -  myosin vi, AQP1  -  aquaporin 1 (colton blood group), ITGA9  -  integrin, alpha 9, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, TPH1  -  tryptophan hydroxylase 1, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), FGF12  -  fibroblast growth factor 12, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, TAPBP  -  tap binding protein (tapasin), PPARA  -  peroxisome proliferator-activated receptor alpha, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, SMG1  -  smg1 phosphatidylinositol 3-kinase-related kinase, LBP  -  lipopolysaccharide binding protein, C1QB  -  complement component 1, q subcomponent, b chain, NPPA  -  natriuretic peptide a, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, FANCL  -  fanconi anemia, complementation group l, COMT  -  catechol-o-methyltransferase, IRF1  -  interferon regulatory factor 1, HNF1A  -  hnf1 homeobox a, KITLG  -  kit ligand, C6  -  complement component 6, NRF1  -  nuclear respiratory factor 1, CDK2  -  cyclin-dependent kinase 2, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, NCKAP1  -  nck-associated protein 1, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, HLA-G  -  major histocompatibility complex, class i, g, CAPN2  -  calpain 2, (m/ii) large subunit, HLA-E  -  major histocompatibility complex, class i, e, IFNA5  -  interferon, alpha 5, ADRB1  -  adrenoceptor beta 1, PRG2  -  proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein), ADRB3  -  adrenoceptor beta 3, SMC3  -  structural maintenance of chromosomes 3, PTPRN  -  protein tyrosine phosphatase, receptor type, n, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, SFN  -  stratifin, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, ATM  -  ataxia telangiectasia mutated, IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, CTSL  -  cathepsin l, CHEK1  -  checkpoint kinase 1, GRAP2  -  grb2-related adaptor protein 2, NFX1  -  nuclear transcription factor, x-box binding 1, RECQL5  -  recq protein-like 5, HOXB13  -  homeobox b13, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, EYA2  -  eyes absent homolog 2 (drosophila), CFH  -  complement factor h, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), CXADR  -  coxsackie virus and adenovirus receptor, MSH5  -  muts homolog 5 (e. coli), VWF  -  von willebrand factor, FYN  -  fyn oncogene related to src, fgr, yes, DARC  -  duffy blood group, atypical chemokine receptor, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, HIC1  -  hypermethylated in cancer 1, TRIM31  -  tripartite motif containing 31, CYBA  -  cytochrome b-245, alpha polypeptide, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CRIP1  -  cysteine-rich protein 1 (intestinal), ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, TYROBP  -  tyro protein tyrosine kinase binding protein, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, PLAU  -  plasminogen activator, urokinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, CD9  -  cd9 molecule, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, TUBB4B  -  tubulin, beta 4b class ivb, MAP2K5  -  mitogen-activated protein kinase kinase 5, NQO1  -  nad(p)h dehydrogenase, quinone 1, BRSK2  -  br serine/threonine kinase 2, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, UCN  -  urocortin, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GATA3  -  gata binding protein 3, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), IGFBP1  -  insulin-like growth factor binding protein 1, TH  -  tyrosine hydroxylase, LYZ  -  lysozyme, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, NCR3  -  natural cytotoxicity triggering receptor 3, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, CXCL2  -  chemokine (c-x-c motif) ligand 2, BCL2  -  b-cell cll/lymphoma 2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), SMAD4  -  smad family member 4, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, CIRBP  -  cold inducible rna binding protein, THRA  -  thyroid hormone receptor, alpha]"GO:0044699,single-organism process,3.20E-05,6.72E-03,1.09,8230,5973,907,716,"[CREB5  -  camp responsive element binding protein 5, SPTAN1  -  spectrin, alpha, non-erythrocytic 1, SVEP1  -  sushi, von willebrand factor type a, egf and pentraxin domain containing 1, DAPK2  -  death-associated protein kinase 2, AANAT  -  aralkylamine n-acetyltransferase, CD2AP  -  cd2-associated protein, PATZ1  -  poz (btb) and at hook containing zinc finger 1, PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, ACACA  -  acetyl-coa carboxylase alpha, PMM1  -  phosphomannomutase 1, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GCHFR  -  gtp cyclohydrolase i feedback regulator, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), NTSR2  -  neurotensin receptor 2, SP1  -  sp1 transcription factor, PLP1  -  proteolipid protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NRG2  -  neuregulin 2, PLS3  -  plastin 3, SOX5  -  sry (sex determining region y)-box 5, CLDN3  -  claudin 3, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, LPL  -  lipoprotein lipase, PLTP  -  phospholipid transfer protein, LPA  -  lipoprotein, lp(a), ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, LIPC  -  lipase, hepatic, RND2  -  rho family gtpase 2, PLG  -  plasminogen, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, ST8SIA2  -  st8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, SPAG6  -  sperm associated antigen 6, SNTB1  -  syntrophin, beta 1 (dystrophin-associated protein a1, 59kda, basic component 1), GH1  -  growth hormone 1, LMAN1  -  lectin, mannose-binding, 1, CR2  -  complement component (3d/epstein barr virus) receptor 2, CADM1  -  cell adhesion molecule 1, CNGB1  -  cyclic nucleotide gated channel beta 1, KRT19  -  keratin 19, GLUL  -  glutamate-ammonia ligase, ACTN1  -  actinin, alpha 1, NMU  -  neuromedin u, TRRAP  -  transformation/transcription domain-associated protein, HIST3H3  -  histone cluster 3, h3, PPL  -  periplakin, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, GLRB  -  glycine receptor, beta, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, GLE1  -  gle1 rna export mediator, KRT10  -  keratin 10, KRT9  -  keratin 9, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, KRT13  -  keratin 13, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), CDC45  -  cell division cycle 45, FZD1  -  frizzled family receptor 1, KRT14  -  keratin 14, PPARA  -  peroxisome proliferator-activated receptor alpha, GLB1  -  galactosidase, beta 1, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, PCYT1B  -  phosphate cytidylyltransferase 1, choline, beta, PLIN2  -  perilipin 2, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, LAMP1  -  lysosomal-associated membrane protein 1, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, LAMC2  -  laminin, gamma 2, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, COL9A3  -  collagen, type ix, alpha 3, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LCK  -  lymphocyte-specific protein tyrosine kinase, LBP  -  lipopolysaccharide binding protein, POU1F1  -  pou class 1 homeobox 1, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, SLC22A4  -  solute carrier family 22 (organic cation/zwitterion transporter), member 4, TRPV6  -  transient receptor potential cation channel, subfamily v, member 6, ADORA1  -  adenosine a1 receptor, SLC4A8  -  solute carrier family 4, sodium bicarbonate cotransporter, member 8, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, COL17A1  -  collagen, type xvii, alpha 1, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, COL13A1  -  collagen, type xiii, alpha 1, CSTA  -  cystatin a (stefin a), PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, FTL  -  ferritin, light polypeptide, AES  -  amino-terminal enhancer of split, ADRB1  -  adrenoceptor beta 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, CTGF  -  connective tissue growth factor, PTPRT  -  protein tyrosine phosphatase, receptor type, t, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, PRCP  -  prolylcarboxypeptidase (angiotensinase c), CTBP1  -  c-terminal binding protein 1, ACE2  -  angiotensin i converting enzyme 2, AGTR2  -  angiotensin ii receptor, type 2, FSHR  -  follicle stimulating hormone receptor, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTRB1  -  chymotrypsinogen b1, CTSL  -  cathepsin l, STXBP1  -  syntaxin binding protein 1, SOX30  -  sry (sex determining region y)-box 30, GRAP2  -  grb2-related adaptor protein 2, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PDZD3  -  pdz domain containing 3, CTSD  -  cathepsin d, GAB1  -  grb2-associated binding protein 1, STRN  -  striatin, calmodulin binding protein, KPNA3  -  karyopherin alpha 3 (importin alpha 4), GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, AHSG  -  alpha-2-hs-glycoprotein, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, PPP1R3D  -  protein phosphatase 1, regulatory subunit 3d, KLC1  -  kinesin light chain 1, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, STK4  -  serine/threonine kinase 4, CYBA  -  cytochrome b-245, alpha polypeptide, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, EDA2R  -  ectodysplasin a2 receptor, KISS1  -  kiss-1 metastasis-suppressor, CRIP2  -  cysteine-rich protein 2, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, MFAP5  -  microfibrillar associated protein 5, CRX  -  cone-rod homeobox, STAT4  -  signal transducer and activator of transcription 4, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, GALNT1  -  udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyltransferase 1 (galnac-t1), ALDOB  -  aldolase b, fructose-bisphosphate, CRYBB1  -  crystallin, beta b1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, NRXN3  -  neurexin 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, ITK  -  il2-inducible t-cell kinase, DSTN  -  destrin (actin depolymerizing factor), ALX1  -  alx homeobox 1, MAPK14  -  mitogen-activated protein kinase 14, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, SRP19  -  signal recognition particle 19kda, GBA  -  glucosidase, beta, acid, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, DOK4  -  docking protein 4, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, CSN3  -  casein kappa, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, NCR3  -  natural cytotoxicity triggering receptor 3, KCNF1  -  potassium voltage-gated channel, subfamily f, member 1, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, RPL23  -  ribosomal protein l23, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, GAP43  -  growth associated protein 43, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, PAX2  -  paired box 2, PVRL3  -  poliovirus receptor-related 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, PAX9  -  paired box 9, MID1  -  midline 1 (opitz/bbb syndrome), APOB  -  apolipoprotein b, SYT17  -  synaptotagmin xvii, DCX  -  doublecortin, MAP3K9  -  mitogen-activated protein kinase kinase kinase 9, CYTH3  -  cytohesin 3, PC  -  pyruvate carboxylase, ATXN3  -  ataxin 3, CYTH2  -  cytohesin 2, PCBD1  -  pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CCL15  -  chemokine (c-c motif) ligand 15, CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, PMF1  -  polyamine-modulated factor 1, CCL1  -  chemokine (c-c motif) ligand 1, TIMM8A  -  translocase of inner mitochondrial membrane 8 homolog a (yeast), MMP11  -  matrix metallopeptidase 11 (stromelysin 3), CCL3  -  chemokine (c-c motif) ligand 3, ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, DLGAP1  -  discs, large (drosophila) homolog-associated protein 1, DFFB  -  dna fragmentation factor, 40kda, beta polypeptide (caspase-activated dnase), PRDX1  -  peroxiredoxin 1, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, AKAP10  -  a kinase (prka) anchor protein 10, GUCY2F  -  guanylate cyclase 2f, retinal, MSC  -  musculin, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CELF3  -  cugbp, elav-like family member 3, FZD5  -  frizzled family receptor 5, MDFI  -  myod family inhibitor, TUBA1A  -  tubulin, alpha 1a, CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, ABCB8  -  atp-binding cassette, sub-family b (mdr/tap), member 8, MYO3A  -  myosin iiia, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, HADH  -  hydroxyacyl-coa dehydrogenase, ARF5  -  adp-ribosylation factor 5, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, SLC37A1  -  solute carrier family 37 (glucose-6-phosphate transporter), member 1, DNALI1  -  dynein, axonemal, light intermediate chain 1, S100B  -  s100 calcium binding protein b, S100P  -  s100 calcium binding protein p, TMSB10  -  thymosin beta 10, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, S100A4  -  s100 calcium binding protein a4, NLGN4X  -  neuroligin 4, x-linked, S100A7  -  s100 calcium binding protein a7, FANCL  -  fanconi anemia, complementation group l, PCSK1  -  proprotein convertase subtilisin/kexin type 1, THAP1  -  thap domain containing, apoptosis associated protein 1, KITLG  -  kit ligand, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CCNE2  -  cyclin e2, DRD3  -  dopamine receptor d3, GOLGA1  -  golgin a1, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, SMC3  -  structural maintenance of chromosomes 3, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, DSC2  -  desmocollin 2, SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, PHKA2  -  phosphorylase kinase, alpha 2 (liver), DPP6  -  dipeptidyl-peptidase 6, SFN  -  stratifin, INA  -  internexin neuronal intermediate filament protein, alpha, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, GP9  -  glycoprotein ix (platelet), LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, CLSTN1  -  calsyntenin 1, SERPINC1  -  serpin peptidase inhibitor, clade c (antithrombin), member 1, MTMR4  -  myotubularin related protein 4, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), PGR  -  progesterone receptor, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, SKP1  -  s-phase kinase-associated protein 1, MBL2  -  mannose-binding lectin (protein c) 2, soluble, NELFA  -  negative elongation factor complex member a, PIGQ  -  phosphatidylinositol glycan anchor biosynthesis, class q, LMTK2  -  lemur tyrosine kinase 2, MAX  -  myc associated factor x, ICK  -  intestinal cell (mak-like) kinase, SLC4A3  -  solute carrier family 4 (anion exchanger), member 3, PEX1  -  peroxisomal biogenesis factor 1, SLC3A1  -  solute carrier family 3 (amino acid transporter heavy chain), member 1, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, CFP  -  complement factor properdin, SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, PKD1  -  polycystic kidney disease 1 (autosomal dominant), SHMT1  -  serine hydroxymethyltransferase 1 (soluble), DLX2  -  distal-less homeobox 2, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), PLAU  -  plasminogen activator, urokinase, PHGDH  -  phosphoglycerate dehydrogenase, LY9  -  lymphocyte antigen 9, PLAG1  -  pleiomorphic adenoma gene 1, DIAPH2  -  diaphanous-related formin 2, GRN  -  granulin, PKP2  -  plakophilin 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), NQO1  -  nad(p)h dehydrogenase, quinone 1, BRSK2  -  br serine/threonine kinase 2, GRIA2  -  glutamate receptor, ionotropic, ampa 2, LTK  -  leukocyte receptor tyrosine kinase, GRIA1  -  glutamate receptor, ionotropic, ampa 1, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, MXD1  -  max dimerization protein 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, EPCAM  -  epithelial cell adhesion molecule, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, CXCL2  -  chemokine (c-x-c motif) ligand 2, PIM1  -  pim-1 oncogene, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, INTS1  -  integrator complex subunit 1, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, RFC5  -  replication factor c (activator 1) 5, 36.5kda, NCBP1  -  nuclear cap binding protein subunit 1, 80kda, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, RGR  -  retinal g protein coupled receptor, BRDT  -  bromodomain, testis-specific, CARD14  -  caspase recruitment domain family, member 14, BTC  -  betacellulin, PRMT1  -  protein arginine methyltransferase 1, BCOR  -  bcl6 corepressor, LIN7A  -  lin-7 homolog a (c. elegans), BTK  -  bruton agammaglobulinemia tyrosine kinase, SAP30  -  sin3a-associated protein, 30kda, NCAM1  -  neural cell adhesion molecule 1, NBN  -  nibrin, CDKL1  -  cyclin-dependent kinase-like 1 (cdc2-related kinase), TTR  -  transthyretin, EIF4A1  -  eukaryotic translation initiation factor 4a1, SORBS3  -  sorbin and sh3 domain containing 3, BGN  -  biglycan, WISP2  -  wnt1 inducible signaling pathway protein 2, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, SPRED2  -  sprouty-related, evh1 domain containing 2, GGTLC1  -  gamma-glutamyltransferase light chain 1, EHHADH  -  enoyl-coa, hydratase/3-hydroxyacyl coa dehydrogenase, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, HOXD13  -  homeobox d13, BIK  -  bcl2-interacting killer (apoptosis-inducing), HOXD12  -  homeobox d12, LDB1  -  lim domain binding 1, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), CEP152  -  centrosomal protein 152kda, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, TSHR  -  thyroid stimulating hormone receptor, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), HOXC13  -  homeobox c13, MYO6  -  myosin vi, RGS16  -  regulator of g-protein signaling 16, MYO7A  -  myosin viia, COX17  -  cox17 cytochrome c oxidase copper chaperone, ICAM2  -  intercellular adhesion molecule 2, TPH1  -  tryptophan hydroxylase 1, GDF11  -  growth differentiation factor 11, VNN2  -  vanin 2, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, DCAF7  -  ddb1 and cul4 associated factor 7, MYO16  -  myosin xvi, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ROM1  -  retinal outer segment membrane protein 1, RORB  -  rar-related orphan receptor b, SMG1  -  smg1 phosphatidylinositol 3-kinase-related kinase, BSN  -  bassoon presynaptic cytomatrix protein, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), TRH  -  thyrotropin-releasing hormone, SGCE  -  sarcoglycan, epsilon, C1QA  -  complement component 1, q subcomponent, a chain, C1QB  -  complement component 1, q subcomponent, b chain, E2F5  -  e2f transcription factor 5, p130-binding, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, E2F1  -  e2f transcription factor 1, DNAL4  -  dynein, axonemal, light chain 4, TOP3B  -  topoisomerase (dna) iii beta, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, C5  -  complement component 5, C6  -  complement component 6, RPA4  -  replication protein a4, 30kda, ECE1  -  endothelin converting enzyme 1, BAIAP3  -  bai1-associated protein 3, WAPAL  -  wings apart-like homolog (drosophila), AKR1C3  -  aldo-keto reductase family 1, member c3, RPL23A  -  ribosomal protein l23a, CAPNS1  -  calpain, small subunit 1, CAPN2  -  calpain 2, (m/ii) large subunit, F13A1  -  coagulation factor xiii, a1 polypeptide, RPL21  -  ribosomal protein l21, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL13  -  ribosomal protein l13, RPL11  -  ribosomal protein l11, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), RPL9  -  ribosomal protein l9, UMOD  -  uromodulin, DYNLL1  -  dynein, light chain, lc8-type 1, NFASC  -  neurofascin, HLF  -  hepatic leukemia factor, RPE65  -  retinal pigment epithelium-specific protein 65kda, SLC4A4  -  solute carrier family 4 (sodium bicarbonate cotransporter), member 4, FASN  -  fatty acid synthase, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS4X  -  ribosomal protein s4, x-linked, RPS3A  -  ribosomal protein s3a, HMGXB4  -  hmg box domain containing 4, PEA15  -  phosphoprotein enriched in astrocytes 15, MTAP  -  methylthioadenosine phosphorylase, HOXB13  -  homeobox b13, STX11  -  syntaxin 11, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, EVPL  -  envoplakin, EZR  -  ezrin, VIP  -  vasoactive intestinal peptide, SLC25A17  -  solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kda), member 17, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), CFH  -  complement factor h, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, NCOA2  -  nuclear receptor coactivator 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), MSH5  -  muts homolog 5 (e. coli), CALD1  -  caldesmon 1, F2RL2  -  coagulation factor ii (thrombin) receptor-like 2, CALCA  -  calcitonin-related polypeptide alpha, RPL30  -  ribosomal protein l30, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), HIC1  -  hypermethylated in cancer 1, MSN  -  moesin, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, HPCA  -  hippocalcin, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, HOXA11  -  homeobox a11, CD1D  -  cd1d molecule, TYROBP  -  tyro protein tyrosine kinase binding protein, TUBA1B  -  tubulin, alpha 1b, CHRDL1  -  chordin-like 1, GPAA1  -  glycosylphosphatidylinositol anchor attachment 1, UBC  -  ubiquitin c, CCNG2  -  cyclin g2, RPS18  -  ribosomal protein s18, TXK  -  txk tyrosine kinase, CD8B  -  cd8b molecule, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR2  -  estrogen receptor 2 (er beta), MYOM1  -  myomesin 1, CORO2B  -  coronin, actin binding protein, 2b, CD7  -  cd7 molecule, RCOR1  -  rest corepressor 1, RPS14  -  ribosomal protein s14, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, HOXA1  -  homeobox a1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, TUBB4B  -  tubulin, beta 4b class ivb, TYR  -  tyrosinase, TUBB3  -  tubulin, beta 3 class iii, TUBB4A  -  tubulin, beta 4a class iva, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, EPHA3  -  eph receptor a3, ONECUT1  -  one cut homeobox 1, UCN  -  urocortin, EPB41  -  erythrocyte membrane protein band 4.1 (elliptocytosis 1, rh-linked), SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), MVP  -  major vault protein, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, NAPG  -  n-ethylmaleimide-sensitive factor attachment protein, gamma, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, EPHA4  -  eph receptor a4, CCKAR  -  cholecystokinin a receptor, TUBGCP3  -  tubulin, gamma complex associated protein 3, KRIT1  -  krit1, ankyrin repeat containing, CFDP1  -  craniofacial development protein 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CCND2  -  cyclin d2, RTN1  -  reticulon 1, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), STX2  -  syntaxin 2, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, EXOC6B  -  exocyst complex component 6b, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, CCIN  -  calicin, RREB1  -  ras responsive element binding protein 1, MPL  -  myeloproliferative leukemia virus oncogene, SCEL  -  sciellin, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, SETDB1  -  set domain, bifurcated 1, PSAP  -  prosaposin, FLT4  -  fms-related tyrosine kinase 4, ORC2  -  origin recognition complex, subunit 2, ORC5  -  origin recognition complex, subunit 5, KLK6  -  kallikrein-related peptidase 6, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), FLG  -  filaggrin, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, SMC2  -  structural maintenance of chromosomes 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, PSD  -  pleckstrin and sec7 domain containing, CDON  -  cell adhesion associated, oncogene regulated, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), POLL  -  polymerase (dna directed), lambda, PSMB3  -  proteasome (prosome, macropain) subunit, beta type, 3, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, ARHGAP44  -  rho gtpase activating protein 44, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ODF2  -  outer dense fiber of sperm tails 2, PSMD1  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 1, CD22  -  cd22 molecule, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, PSMC2  -  proteasome (prosome, macropain) 26s subunit, atpase, 2, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, CD34  -  cd34 molecule, FHL2  -  four and a half lim domains 2, CEL  -  carboxyl ester lipase, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, TAGLN  -  transgelin, CENPC  -  centromere protein c, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), FGFR3  -  fibroblast growth factor receptor 3, GNMT  -  glycine n-methyltransferase, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, NTN3  -  netrin 3, BCAP29  -  b-cell receptor-associated protein 29, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), CFL1  -  cofilin 1 (non-muscle), NUMA1  -  nuclear mitotic apparatus protein 1, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, TAPBP  -  tap binding protein (tapasin), PTH  -  parathyroid hormone, CDC14A  -  cell division cycle 14a, PTHLH  -  parathyroid hormone-like hormone, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, FDXR  -  ferredoxin reductase, PTK6  -  protein tyrosine kinase 6, GPR143  -  g protein-coupled receptor 143, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), CDK13  -  cyclin-dependent kinase 13, NPC2  -  niemann-pick disease, type c2, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, TAZ  -  tafazzin, NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), LIN37  -  lin-37 homolog (c. elegans), IREB2  -  iron-responsive element binding protein 2, TRIM9  -  tripartite motif containing 9, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PDX1  -  pancreatic and duodenal homeobox 1, NRL  -  neural retina leucine zipper, NRF1  -  nuclear respiratory factor 1, CDK2  -  cyclin-dependent kinase 2, FBLN2  -  fibulin 2, CXCL13  -  chemokine (c-x-c motif) ligand 13, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, PTS  -  6-pyruvoyltetrahydropterin synthase, TDRD7  -  tudor domain containing 7, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, NPAT  -  nuclear protein, ataxia-telangiectasia locus, RIMS2  -  regulating synaptic membrane exocytosis 2, ABCD4  -  atp-binding cassette, sub-family d (ald), member 4, TRAF3IP2  -  traf3 interacting protein 2, CNOT3  -  ccr4-not transcription complex, subunit 3, CHKA  -  choline kinase alpha, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, CHEK1  -  checkpoint kinase 1, BPY2C  -  basic charge, y-linked, 2c, NGF  -  nerve growth factor (beta polypeptide), KMT2B  -  lysine (k)-specific methyltransferase 2b, RAD51  -  rad51 recombinase, CLEC3B  -  c-type lectin domain family 3, member b, RAD21  -  rad21 homolog (s. pombe), TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RAB27B  -  rab27b, member ras oncogene family, NID1  -  nidogen 1, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, CCR6  -  chemokine (c-c motif) receptor 6, RAN  -  ran, member ras oncogene family, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, NEK3  -  nima-related kinase 3, TF  -  transferrin, NEFL  -  neurofilament, light polypeptide, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), NEFM  -  neurofilament, medium polypeptide, RAG2  -  recombination activating gene 2, NEFH  -  neurofilament, heavy polypeptide, CLDN16  -  claudin 16, RARG  -  retinoic acid receptor, gamma, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), EEA1  -  early endosome antigen 1, NF2  -  neurofibromin 2 (merlin), MACF1  -  microtubule-actin crosslinking factor 1, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), TRAM2  -  translocation associated membrane protein 2, RBL2  -  retinoblastoma-like 2 (p130), TGFB1  -  transforming growth factor, beta 1, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, NEUROG2  -  neurogenin 2, IGF1  -  insulin-like growth factor 1 (somatomedin c), TH  -  tyrosine hydroxylase, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, IGFBP1  -  insulin-like growth factor binding protein 1, DIEXF  -  digestive organ expansion factor homolog (zebrafish), ARID4A  -  at rich inte""active domain 4a (rbp1-like), PLK4  -  polo-like kinase 4, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, RBBP5  -  retinoblastoma binding protein 5, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), AP3S1  -  adaptor-related protein complex 3, sigma 1 subunit, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, RCVRN  -  recoverin, CKB  -  creatine kinase, brain, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]",,,,,,,,,GO:0071639,positive regulation of monocyte chemotactic protein-1 production,3.30E-05,6.81E-03,274.33,8230,3,20,2,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, IL1B  -  interleukin 1, beta]"GO:0003006,developmental process involved in reproduction,3.63E-05,7.36E-03,2,8230,278,666,45,"[PKD1  -  polycystic kidney disease 1 (autosomal dominant), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, AKR1C3  -  aldo-keto reductase family 1, member c3, CRIP1  -  cysteine-rich protein 1 (intestinal), FZD5  -  frizzled family receptor 5, PAX2  -  paired box 2, NKX2-1  -  nk2 homeobox 1, NIPBL  -  nipped-b homolog (drosophila), TDRD7  -  tudor domain containing 7, STAR  -  steroidogenic acute regulatory protein, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, BRCA2  -  breast cancer 2, early onset, PSAP  -  prosaposin, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), PATZ1  -  poz (btb) and at hook containing zinc finger 1, CXCL12  -  chemokine (c-x-c motif) ligand 12, UBC  -  ubiquitin c, FGF8  -  fibroblast growth factor 8 (androgen-induced), RARG  -  retinoic acid receptor, gamma, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), INHBB  -  inhibin, beta b, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, ESR1  -  estrogen receptor 1, ATM  -  ataxia telangiectasia mutated, FSHR  -  follicle stimulating hormone receptor, TYRO3  -  tyro3 protein tyrosine kinase, FZD1  -  frizzled family receptor 1, CEP57  -  centrosomal protein 57kda, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, INSL3  -  insulin-like 3 (leydig cell), ANG  -  angiogenin, ribonuclease, rnase a family, 5, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, HOXB13  -  homeobox b13, COL9A3  -  collagen, type ix, alpha 3, GATA3  -  gata binding protein 3, FEM1B  -  fem-1 homolog b (c. elegans), PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, KMT2B  -  lysine (k)-specific methyltransferase 2b, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, SOX3  -  sry (sex determining region y)-box 3, BIK  -  bcl2-interacting killer (apoptosis-inducing), BCL2  -  b-cell cll/lymphoma 2, HNF1A  -  hnf1 homeobox a, KITLG  -  kit ligand]"GO:0003008,system process,3.68E-05,7.33E-03,1.48,8230,705,954,121,"[PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), RGR  -  retinal g protein coupled receptor, CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), BTC  -  betacellulin, NBN  -  nibrin, NTSR2  -  neurotensin receptor 2, SORBS3  -  sorbin and sh3 domain containing 3, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, LPA  -  lipoprotein, lp(a), ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, GUCY2F  -  guanylate cyclase 2f, retinal, CD34  -  cd34 molecule, MYO6  -  myosin vi, SNTB1  -  syntrophin, beta 1 (dystrophin-associated protein a1, 59kda, basic component 1), RGS16  -  regulator of g-protein signaling 16, AQP1  -  aquaporin 1 (colton blood group), MYO7A  -  myosin viia, CEL  -  carboxyl ester lipase, CNGB1  -  cyclic nucleotide gated channel beta 1, NMU  -  neuromedin u, GLRB  -  glycine receptor, beta, FGF12  -  fibroblast growth factor 12, MYO3A  -  myosin iiia, IAPP  -  islet amyloid polypeptide, ITGB5  -  integrin, beta 5, POU3F4  -  pou class 3 homeobox 4, COL2A1  -  collagen, type ii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, USH1C  -  usher syndrome 1c (autosomal recessive, severe), PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, GPR143  -  g protein-coupled receptor 143, S100B  -  s100 calcium binding protein b, ROM1  -  retinal outer segment membrane protein 1, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), RORB  -  rar-related orphan receptor b, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), NLGN4X  -  neuroligin 4, x-linked, TAZ  -  tafazzin, NPPA  -  natriuretic peptide a, COMT  -  catechol-o-methyltransferase, IREB2  -  iron-responsive element binding protein 2, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, ADORA1  -  adenosine a1 receptor, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, NRL  -  neural retina leucine zipper, ECE1  -  endothelin converting enzyme 1, PDE4A  -  phosphodiesterase 4a, camp-specific, ATP2A1  -  atpase, ca++ transporting, cardiac muscle, fast twitch 1, AKR1C3  -  aldo-keto reductase family 1, member c3, CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, CHRM3  -  cholinergic receptor, muscarinic 3, UMOD  -  uromodulin, ACE2  -  angiotensin i converting enzyme 2, AGTR2  -  angiotensin ii receptor, type 2, NFASC  -  neurofascin, CTNND2  -  catenin (cadherin-associated protein), delta 2, RPE65  -  retinal pigment epithelium-specific protein 65kda, NLGN1  -  neuroligin 1, NGF  -  nerve growth factor (beta polypeptide), VIP  -  vasoactive intestinal peptide, KDM6A  -  lysine (k)-specific demethylase 6a, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CALD1  -  caldesmon 1, FYN  -  fyn oncogene related to src, fgr, yes, CALCA  -  calcitonin-related polypeptide alpha, CYBA  -  cytochrome b-245, alpha polypeptide, TEK  -  tek tyrosine kinase, endothelial, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, NIPBL  -  nipped-b homolog (drosophila), CRX  -  cone-rod homeobox, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, CLDN16  -  claudin 16, CRYBB1  -  crystallin, beta b1, MYOM1  -  myomesin 1, HOXA1  -  homeobox a1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, NRXN3  -  neurexin 3, TYR  -  tyrosinase, GRIA1  -  glutamate receptor, ionotropic, ampa 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ANGPT1  -  angiopoietin 1, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, UCN  -  urocortin, EPB41  -  erythrocyte membrane protein band 4.1 (elliptocytosis 1, rh-linked), IGF1  -  insulin-like growth factor 1 (somatomedin c), TH  -  tyrosine hydroxylase, PRKCZ  -  protein kinase c, zeta, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, PRKCG  -  protein kinase c, gamma, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, OPN1LW  -  opsin 1 (cone pigments), long-wave-sensitive, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, THRA  -  thyroid hormone receptor, alpha]"GO:0002711,positive regulation of T cell mediated immunity,3.79E-05,7.40E-03,3.75,8230,31,991,14,"[HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, IL1B  -  interleukin 1, beta, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), FOXP3  -  forkhead box p3, IL23R  -  interleukin 23 receptor, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b)]"GO:0051047,positive regulation of secretion,3.84E-05,7.37E-03,2.22,8230,202,642,35,"[CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, TWIST1  -  twist basic helix-loop-helix transcription factor 1, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD14  -  cd14 molecule, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, AGTR2  -  angiotensin ii receptor, type 2, GCG  -  glucagon, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, IFNG  -  interferon, gamma, STXBP1  -  syntaxin binding protein 1, ANG  -  angiogenin, ribonuclease, rnase a family, 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), UCN  -  urocortin, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GATA3  -  gata binding protein 3, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PRKCZ  -  protein kinase c, zeta, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, ADORA1  -  adenosine a1 receptor, CD34  -  cd34 molecule, C5  -  complement component 5, AQP1  -  aquaporin 1 (colton blood group), KISS1  -  kiss-1 metastasis-suppressor]"GO:0072330,monocarboxylic acid biosynthetic process,3.98E-05,7.52E-03,5.58,8230,69,235,11,"[BGN  -  biglycan, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, ACACA  -  acetyl-coa carboxylase alpha, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SHMT1  -  serine hydroxymethyltransferase 1 (soluble), ALOX12  -  arachidonate 12-lipoxygenase, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), LPL  -  lipoprotein lipase, FASN  -  fatty acid synthase]"GO:0048518,positive regulation of biological process,4.62E-05,8.58E-03,1.24,8230,2878,675,292,"[NCBP1  -  nuclear cap binding protein subunit 1, 80kda, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, DAPK2  -  death-associated protein kinase 2, CDKN2AIP  -  cdkn2a interacting protein, BRDT  -  bromodomain, testis-specific, PATZ1  -  poz (btb) and at hook containing zinc finger 1, PLXNB1  -  plexin b1, ACACA  -  acetyl-coa carboxylase alpha, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, BTK  -  bruton agammaglobulinemia tyrosine kinase, GCG  -  glucagon, GDF5  -  growth differentiation factor 5, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SORBS3  -  sorbin and sh3 domain containing 3, RRAGB  -  ras-related gtp binding b, SP1  -  sp1 transcription factor, PLP1  -  proteolipid protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, LPL  -  lipoprotein lipase, BIK  -  bcl2-interacting killer (apoptosis-inducing), CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, ACTG1  -  actin, gamma 1, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, LMAN1  -  lectin, mannose-binding, 1, TSC22D1  -  tsc22 domain family, member 1, GH1  -  growth hormone 1, CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, FUBP1  -  far upstream element (fuse) binding protein 1, NMU  -  neuromedin u, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, SUMO3  -  small ubiquitin-like modifier 3, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), LBP  -  lipopolysaccharide binding protein, C1QA  -  complement component 1, q subcomponent, a chain, C1QB  -  complement component 1, q subcomponent, b chain, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, COMT  -  catechol-o-methyltransferase, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, C6  -  complement component 6, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, CAPNS1  -  calpain, small subunit 1, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, AES  -  amino-terminal enhancer of split, PDE5A  -  phosphodiesterase 5a, cgmp-specific, ADRB1  -  adrenoceptor beta 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, CTBP1  -  c-terminal binding protein 1, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, FASN  -  fatty acid synthase, HLA-A  -  major histocompatibility complex, class i, a, RPS4X  -  ribosomal protein s4, x-linked, CTSL  -  cathepsin l, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, HLA-C  -  major histocompatibility complex, class i, c, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, EZR  -  ezrin, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, VIP  -  vasoactive intestinal peptide, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, CFH  -  complement factor h, NCOA2  -  nuclear receptor coactivator 2, FYN  -  fyn oncogene related to src, fgr, yes, HIC1  -  hypermethylated in cancer 1, CYBA  -  cytochrome b-245, alpha polypeptide, STK4  -  serine/threonine kinase 4, MSN  -  moesin, KISS1  -  kiss-1 metastasis-suppressor, CALCR  -  calcitonin receptor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CRIP2  -  cysteine-rich protein 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, DLC1  -  deleted in liver cancer 1, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, ALX1  -  alx homeobox 1, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, EPHA3  -  eph receptor a3, UCN  -  urocortin, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PLCE1  -  phospholipase c, epsilon 1, PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, NCR3  -  natural cytotoxicity triggering receptor 3, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, UBE2D2  -  ubiquitin-conjugating enzyme e2d 2, CCND2  -  cyclin d2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, RREB1  -  ras responsive element binding protein 1, MLLT10  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 10, FOXA2  -  forkhead box a2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, IL12RB2  -  interleukin 12 receptor, beta 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, KLK6  -  kallikrein-related peptidase 6, APOB  -  apolipoprotein b, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PRSS8  -  protease, serine, 8, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, CYTH3  -  cytohesin 3, PCBD1  -  pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CCL14  -  chemokine (c-c motif) ligand 14, CD53  -  cd53 molecule, CCL4  -  chemokine (c-c motif) ligand 4, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, TRIM16  -  tripartite motif containing 16, CXCR2  -  chemokine (c-x-c motif) receptor 2, MOG  -  myelin oligodendrocyte glycoprotein, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CELF3  -  cugbp, elav-like family member 3, MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, NTN3  -  netrin 3, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), FES  -  feline sarcoma oncogene, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, PTHLH  -  parathyroid hormone-like hormone, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, S100A4  -  s100 calcium binding protein a4, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, CDK13  -  cyclin-dependent kinase 13, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), IRF1  -  interferon regulatory factor 1, HNF1A  -  hnf1 homeobox a, KITLG  -  kit ligand, NRL  -  neural retina leucine zipper, CDK2  -  cyclin-dependent kinase 2, FBLN2  -  fibulin 2, HCLS1  -  hematopoietic cell-specific lyn substrate 1, ZNF205  -  zinc finger protein 205, IRAK1  -  interleukin-1 receptor-associated kinase 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, ARID3A  -  at rich interactive domain 3a (bright-like), NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, SFN  -  stratifin, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, NPAT  -  nuclear protein, ataxia-telangiectasia locus, ATM  -  ataxia telangiectasia mutated, TRAF3IP2  -  traf3 interacting protein 2, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, CHEK1  -  checkpoint kinase 1, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, NELFA  -  negative elongation factor complex member a, KMT2B  -  lysine (k)-specific methyltransferase 2b, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RAG2  -  recombination activating gene 2, RARG  -  retinoic acid receptor, gamma, TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), GRN  -  granulin, NF2  -  neurofibromin 2 (merlin), PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, LTK  -  leukocyte receptor tyrosine kinase, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), GRIK1  -  glutamate receptor, ionotropic, kainate 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, IGFBP1  -  insulin-like growth factor binding protein 1, PLK4  -  polo-like kinase 4, SRSF6  -  serine/arginine-rich splicing factor 6, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, CIRBP  -  cold inducible rna binding protein, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0022414,reproductive process,4.83E-05,8.82E-03,1.51,8230,596,999,109,"[PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, PAX2  -  paired box 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, PVRL3  -  poliovirus receptor-related 3, PSAP  -  prosaposin, PATZ1  -  poz (btb) and at hook containing zinc finger 1, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), PMCH  -  pro-melanin-concentrating hormone, INHBB  -  inhibin, beta b, SP1  -  sp1 transcription factor, LNPEP  -  leucyl/cystinyl aminopeptidase, RLN1  -  relaxin 1, CCL2  -  chemokine (c-c motif) ligand 2, SOX2  -  sry (sex determining region y)-box 2, HOXD13  -  homeobox d13, SOX3  -  sry (sex determining region y)-box 3, IL1B  -  interleukin 1, beta, ODF2  -  outer dense fiber of sperm tails 2, BIK  -  bcl2-interacting killer (apoptosis-inducing), GHSR  -  growth hormone secretagogue receptor, TSSK1B  -  testis-specific serine kinase 1b, CRH  -  corticotropin releasing hormone, APP  -  amyloid beta (a4) precursor protein, SPAG6  -  sperm associated antigen 6, AKAP4  -  a kinase (prka) anchor protein 4, CADM1  -  cell adhesion molecule 1, CELF3  -  cugbp, elav-like family member 3, FZD5  -  frizzled family receptor 5, PTGDR  -  prostaglandin d2 receptor (dp), FGF8  -  fibroblast growth factor 8 (androgen-induced), PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, DNALI1  -  dynein, axonemal, light intermediate chain 1, PCYT1B  -  phosphate cytidylyltransferase 1, choline, beta, INSL3  -  insulin-like 3 (leydig cell), DAZ1  -  deleted in azoospermia 1, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, COL9A3  -  collagen, type ix, alpha 3, FEM1B  -  fem-1 homolog b (c. elegans), NPPA  -  natriuretic peptide a, FANCL  -  fanconi anemia, complementation group l, E2F1  -  e2f transcription factor 1, COMT  -  catechol-o-methyltransferase, HNF1A  -  hnf1 homeobox a, ADRA2A  -  adrenoceptor alpha 2a, KITLG  -  kit ligand, AKR1C3  -  aldo-keto reductase family 1, member c3, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, TDRD7  -  tudor domain containing 7, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, DYNLL1  -  dynein, light chain, lc8-type 1, ATM  -  ataxia telangiectasia mutated, FSHR  -  follicle stimulating hormone receptor, PGR  -  progesterone receptor, CEP57  -  centrosomal protein 57kda, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), SOX30  -  sry (sex determining region y)-box 30, BPY2C  -  basic charge, y-linked, 2c, HOXB13  -  homeobox b13, KMT2B  -  lysine (k)-specific methyltransferase 2b, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, NHLH2  -  nescient helix loop helix 2, CGB  -  chorionic gonadotropin, beta polypeptide, CALCA  -  calcitonin-related polypeptide alpha, PKD1  -  polycystic kidney disease 1 (autosomal dominant), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, UBC  -  ubiquitin c, RARG  -  retinoic acid receptor, gamma, ESR2  -  estrogen receptor 2 (er beta), AMH  -  anti-mullerian hormone, PLAG1  -  pleiomorphic adenoma gene 1, ESR1  -  estrogen receptor 1, SSTR3  -  somatostatin receptor 3, CD9  -  cd9 molecule, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, ANG  -  angiogenin, ribonuclease, rnase a family, 5, UCN  -  urocortin, IGF1R  -  insulin-like growth factor 1 receptor, TGFB1  -  transforming growth factor, beta 1, GATA3  -  gata binding protein 3, IGF1  -  insulin-like growth factor 1 (somatomedin c), TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), CSH1  -  chorionic somatomammotropin hormone 1 (placental lactogen), PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, CSN3  -  casein kappa, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), ELL3  -  elongation factor rna polymerase ii-like 3, TUBGCP3  -  tubulin, gamma complex associated protein 3, DDX4  -  dead (asp-glu-ala-asp) box polypeptide 4, BCL2  -  b-cell cll/lymphoma 2, CCIN  -  calicin, THRA  -  thyroid hormone receptor, alpha]"GO:0002089,lens morphogenesis in camera-type eye,4.91E-05,8.82E-03,6.52,8230,9,982,7,"[CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, FGFR3  -  fibroblast growth factor receptor 3, SOX11  -  sry (sex determining region y)-box 11, TDRD7  -  tudor domain containing 7, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), PVRL3  -  poliovirus receptor-related 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c)]"GO:0042127,regulation of cell proliferation,5.39E-05,9.54E-03,1.48,8230,991,668,119,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, S1PR2  -  sphingosine-1-phosphate receptor 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), IL12RB2  -  interleukin 12 receptor, beta 2, BRCA2  -  breast cancer 2, early onset, BTG3  -  btg family, member 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PLXNB1  -  plexin b1, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, CDON  -  cell adhesion associated, oncogene regulated, GDF5  -  growth differentiation factor 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), CCL14  -  chemokine (c-c motif) ligand 14, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, MNAT1  -  mnat cdk-activating kinase assembly factor 1, CRH  -  corticotropin releasing hormone, CXCR2  -  chemokine (c-x-c motif) receptor 2, PLG  -  plasminogen, NUAK1  -  nuak family, snf1-like kinase, 1, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), FASLG  -  fas ligand (tnf superfamily, member 6), DLG5  -  discs, large homolog 5 (drosophila), TSC22D1  -  tsc22 domain family, member 1, AQP1  -  aquaporin 1 (colton blood group), GLUL  -  glutamate-ammonia ligase, FZD5  -  frizzled family receptor 5, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, FES  -  feline sarcoma oncogene, MYO16  -  myosin xvi, PTHLH  -  parathyroid hormone-like hormone, PPARG  -  peroxisome proliferator-activated receptor gamma, INSL3  -  insulin-like 3 (leydig cell), S100A11  -  s100 calcium binding protein a11, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), LDOC1  -  leucine zipper, down-regulated in cancer 1, CDK13  -  cyclin-dependent kinase 13, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FANCL  -  fanconi anemia, complementation group l, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), COMT  -  catechol-o-methyltransferase, IRF1  -  interferon regulatory factor 1, ADORA1  -  adenosine a1 receptor, ADRA1A  -  adrenoceptor alpha 1a, KITLG  -  kit ligand, HCLS1  -  hematopoietic cell-specific lyn substrate 1, CDK2  -  cyclin-dependent kinase 2, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, CAPNS1  -  calpain, small subunit 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), HLA-G  -  major histocompatibility complex, class i, g, DRD3  -  dopamine receptor d3, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CTGF  -  connective tissue growth factor, SFN  -  stratifin, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, CTBP1  -  c-terminal binding protein 1, ATM  -  ataxia telangiectasia mutated, AGTR2  -  angiotensin ii receptor, type 2, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, RPS4X  -  ribosomal protein s4, x-linked, CHEK1  -  checkpoint kinase 1, NGF  -  nerve growth factor (beta polypeptide), VIP  -  vasoactive intestinal peptide, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, CXADR  -  coxsackie virus and adenovirus receptor, STK4  -  serine/threonine kinase 4, CYBA  -  cytochrome b-245, alpha polypeptide, KISS1  -  kiss-1 metastasis-suppressor, CRIP2  -  cysteine-rich protein 2, TEK  -  tek tyrosine kinase, endothelial, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLIT2  -  slit homolog 2 (drosophila), PLAU  -  plasminogen activator, urokinase, RARG  -  retinoic acid receptor, gamma, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR1  -  estrogen receptor 1, CD9  -  cd9 molecule, DLC1  -  deleted in liver cancer 1, SSTR3  -  somatostatin receptor 3, GRN  -  granulin, MAP2K5  -  mitogen-activated protein kinase kinase 5, NF2  -  neurofibromin 2 (merlin), PKP2  -  plakophilin 2, SSTR5  -  somatostatin receptor 5, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), FADD  -  fas (tnfrsf6)-associated via death domain, SRSF6  -  serine/arginine-rich splicing factor 6, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, GAS6  -  growth arrest-specific 6]"GO:0048660,regulation of smooth muscle cell proliferation,5.39E-05,9.39E-03,3.88,8230,70,455,15,"[ANG  -  angiogenin, ribonuclease, rnase a family, 5, ALOX12  -  arachidonate 12-lipoxygenase, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), MNAT1  -  mnat cdk-activating kinase assembly factor 1, COMT  -  catechol-o-methyltransferase, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CALCRL  -  calcitonin receptor-like, NOTCH3  -  notch 3, PPARG  -  peroxisome proliferator-activated receptor gamma, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, IFNG  -  interferon, gamma]"GO:1901701,cellular response to oxygen-containing compound,5.70E-05,9.77E-03,1.78,8230,521,541,61,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAX2  -  paired box 2, CAPN2  -  calpain 2, (m/ii) large subunit, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, APOB  -  apolipoprotein b, INHBB  -  inhibin, beta b, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, GCG  -  glucagon, RPE65  -  retinal pigment epithelium-specific protein 65kda, IFNG  -  interferon, gamma, RRAGB  -  ras-related gtp binding b, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, RHEB  -  ras homolog enriched in brain, FYN  -  fyn oncogene related to src, fgr, yes, CALCRL  -  calcitonin receptor-like, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, GH1  -  growth hormone 1, CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group), GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), SLIT2  -  slit homolog 2 (drosophila), PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, SSTR3  -  somatostatin receptor 3, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, LTK  -  leukocyte receptor tyrosine kinase, PTK6  -  protein tyrosine kinase 6, PPARG  -  peroxisome proliferator-activated receptor gamma, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, EPHA3  -  eph receptor a3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), IGFBP1  -  insulin-like growth factor binding protein 1, TH  -  tyrosine hydroxylase, LBP  -  lipopolysaccharide binding protein, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, CDK2  -  cyclin-dependent kinase 2, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:0002682,regulation of immune system process,6.18E-05,1.04E-02,2.34,8230,860,127,31,"[CADM1  -  cell adhesion molecule 1, ICAM2  -  intercellular adhesion molecule 2, TYROBP  -  tyro protein tyrosine kinase binding protein, SLIT2  -  slit homolog 2 (drosophila), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), UBC  -  ubiquitin c, FGF1  -  fibroblast growth factor 1 (acidic), CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CD14  -  cd14 molecule, TYRO3  -  tyro3 protein tyrosine kinase, MEIS2  -  meis homeobox 2, HOXA9  -  homeobox a9, HLA-A  -  major histocompatibility complex, class i, a, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, NRG2  -  neuregulin 2, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, C1QB  -  complement component 1, q subcomponent, b chain, CCL2  -  chemokine (c-c motif) ligand 2, C1R  -  complement component 1, r subcomponent, IL1B  -  interleukin 1, beta, C1S  -  complement component 1, s subcomponent, CCL3  -  chemokine (c-c motif) ligand 3, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, ACTG1  -  actin, gamma 1, FYN  -  fyn oncogene related to src, fgr, yes, ATF2  -  activating transcription factor 2, KITLG  -  kit ligand, THY1  -  thy-1 cell surface antigen]"GO:0009987,cellular process,6.68E-05,1.11E-02,1.07,8230,7023,631,574,"[POP1  -  processing of precursor 1, ribonuclease p/mrp subunit (s. cerevisiae), SPTAN1  -  spectrin, alpha, non-erythrocytic 1, SVEP1  -  sushi, von willebrand factor type a, egf and pentraxin domain containing 1, DAPK2  -  death-associated protein kinase 2, AANAT  -  aralkylamine n-acetyltransferase, PATZ1  -  poz (btb) and at hook containing zinc finger 1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, ACACA  -  acetyl-coa carboxylase alpha, GCG  -  glucagon, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, PMM1  -  phosphomannomutase 1, GDF5  -  growth differentiation factor 5, NTSR2  -  neurotensin receptor 2, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PLP1  -  proteolipid protein 1, NRG2  -  neuregulin 2, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, H2AFY  -  h2a histone family, member y, LPL  -  lipoprotein lipase, SOX3  -  sry (sex determining region y)-box 3, PLTP  -  phospholipid transfer protein, ACTA2  -  actin, alpha 2, smooth muscle, aorta, CRH  -  corticotropin releasing hormone, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, PLD1  -  phospholipase d1, phosphatidylcholine-specific, GH1  -  growth hormone 1, LMAN1  -  lectin, mannose-binding, 1, CADM1  -  cell adhesion molecule 1, KRT19  -  keratin 19, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, ACTN1  -  actinin, alpha 1, ARHGAP19  -  rho gtpase activating protein 19, TRRAP  -  transformation/transcription domain-associated protein, USP20  -  ubiquitin specific peptidase 20, GLRB  -  glycine receptor, beta, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), CREBZF  -  creb/atf bzip transcription factor, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, COL3A1  -  collagen, type iii, alpha 1, POU3F4  -  pou class 3 homeobox 4, KRT7  -  keratin 7, KRT10  -  keratin 10, KRT9  -  keratin 9, SNAPC3  -  small nuclear rna activating complex, polypeptide 3, 50kda, CDC45  -  cell division cycle 45, KRT14  -  keratin 14, PPARA  -  peroxisome proliferator-activated receptor alpha, GLB1  -  galactosidase, beta 1, PPARG  -  peroxisome proliferator-activated receptor gamma, SUMO3  -  small ubiquitin-like modifier 3, PCYT1B  -  phosphate cytidylyltransferase 1, choline, beta, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, PLIN2  -  perilipin 2, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, LAMP1  -  lysosomal-associated membrane protein 1, LAMC2  -  laminin, gamma 2, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LBP  -  lipopolysaccharide binding protein, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, GMFB  -  glia maturation factor, beta, ADRA1A  -  adrenoceptor alpha 1a, MBTPS2  -  membrane-bound transcription factor peptidase, site 2, CSTA  -  cystatin a (stefin a), PTPN21  -  protein tyrosine phosphatase, non-receptor type 21, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, CSTF1  -  cleavage stimulation factor, 3' pre-rna, subunit 1, 50kda, KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, KIF3A  -  kinesin family member 3a, FSHR  -  follicle stimulating hormone receptor, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, CTRB1  -  chymotrypsinogen b1, CTSL  -  cathepsin l, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, CTSD  -  cathepsin d, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, RAPGEF4  -  rap guanine nucleotide exchange factor (gef) 4, DARC  -  duffy blood group, atypical chemokine receptor, TRIM31  -  tripartite motif containing 31, CYBA  -  cytochrome b-245, alpha polypeptide, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, STK4  -  serine/threonine kinase 4, KISS1  -  kiss-1 metastasis-suppressor, CRIP1  -  cysteine-rich protein 1 (intestinal), NIPBL  -  nipped-b homolog (drosophila), MFAP5  -  microfibrillar associated protein 5, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, STAT4  -  signal transducer and activator of transcription 4, SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, CRYAB  -  crystallin, alpha b, GALNT1  -  udp-n-acetyl-alpha-d-galactosamine:polypeptide n-acetylgalactosaminyltransferase 1 (galnac-t1), ALDOB  -  aldolase b, fructose-bisphosphate, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, ITK  -  il2-inducible t-cell kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, SSTR5  -  somatostatin receptor 5, ALX1  -  alx homeobox 1, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, TRIP11  -  thyroid hormone receptor interactor 11, ANG  -  angiogenin, ribonuclease, rnase a family, 5, SRP19  -  signal recognition particle 19kda, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), DOK4  -  docking protein 4, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, NCR3  -  natural cytotoxicity triggering receptor 3, KCNF1  -  potassium voltage-gated channel, subfamily f, member 1, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, RPL23  -  ribosomal protein l23, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, FBXL2  -  f-box and leucine-rich repeat protein 2, MLLT10  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 10, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, S1PR2  -  sphingosine-1-phosphate receptor 2, PAX2  -  paired box 2, PVRL3  -  poliovirus receptor-related 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), MID1  -  midline 1 (opitz/bbb syndrome), PAX9  -  paired box 9, SYT17  -  synaptotagmin xvii, APOB  -  apolipoprotein b, CYTH3  -  cytohesin 3, ATXN3  -  ataxin 3, PC  -  pyruvate carboxylase, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, MLLT1  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 1, PCGF2  -  polycomb group ring finger 2, CCL17  -  chemokine (c-c motif) ligand 17, RIF1  -  rap1 interacting factor homolog (yeast), CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, TRIM23  -  tripartite motif containing 23, CCL2  -  chemokine (c-c motif) ligand 2, TIMM8A  -  translocase of inner mitochondrial membrane 8 homolog a (yeast), MMP11  -  matrix metallopeptidase 11 (stromelysin 3), ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, GUCY2F  -  guanylate cyclase 2f, retinal, KLK3  -  kallikrein-related peptidase 3, MSC  -  musculin, DLG5  -  discs, large homolog 5 (drosophila), AQP1  -  aquaporin 1 (colton blood group), CELF3  -  cugbp, elav-like family member 3, MDFI  -  myod family inhibitor, IL1R2  -  interleukin 1 receptor, type ii, ZNF451  -  zinc finger protein 451, TUBA1A  -  tubulin, alpha 1a, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, ABCB8  -  atp-binding cassette, sub-family b (mdr/tap), member 8, WBP4  -  ww domain binding protein 4, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, HADH  -  hydroxyacyl-coa dehydrogenase, ARF5  -  adp-ribosylation factor 5, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PECAM1  -  platelet/endothelial cell adhesion molecule 1, BAZ1A  -  bromodomain adjacent to zinc finger domain, 1a, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, S100A11  -  s100 calcium binding protein a11, S100B  -  s100 calcium binding protein b, TMSB10  -  thymosin beta 10, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, S100A4  -  s100 calcium binding protein a4, FANCL  -  fanconi anemia, complementation group l, PCSK1  -  proprotein convertase subtilisin/kexin type 1, KITLG  -  kit ligand, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, PDE4A  -  phosphodiesterase 4a, camp-specific, HCRTR1  -  hypocretin (orexin) receptor 1, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, ARID3A  -  at rich interactive domain 3a (bright-like), GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), DRD3  -  dopamine receptor d3, SMC3  -  structural maintenance of chromosomes 3, DSC2  -  desmocollin 2, SLC8A2  -  solute carrier family 8 (sodium/calcium exchanger), member 2, BAHD1  -  bromo adjacent homology domain containing 1, DPP6  -  dipeptidyl-peptidase 6, PHKA2  -  phosphorylase kinase, alpha 2 (liver), SLC12A1  -  solute carrier family 12 (sodium/potassium/chloride transporter), member 1, SFN  -  stratifin, GPC1  -  glypican 1, ABLIM3  -  actin binding lim protein family, member 3, GP9  -  glycoprotein ix (platelet), ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, GPD2  -  glycerol-3-phosphate dehydrogenase 2 (mitochondrial), NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, NELFA  -  negative elongation factor complex member a, LMTK2  -  lemur tyrosine kinase 2, PIGQ  -  phosphatidylinositol glycan anchor biosynthesis, class q, ICK  -  intestinal cell (mak-like) kinase, SLC4A3  -  solute carrier family 4 (anion exchanger), member 3, PEX1  -  peroxisomal biogenesis factor 1, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, SLC2A2  -  solute carrier family 2 (facilitated glucose transporter), member 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), VWF  -  von willebrand factor, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, GPR37  -  g protein-coupled receptor 37 (endothelin receptor type b-like), PKD1  -  polycystic kidney disease 1 (autosomal dominant), DLX2  -  distal-less homeobox 2, SHMT1  -  serine hydroxymethyltransferase 1 (soluble), MZF1  -  myeloid zinc finger 1, PLAU  -  plasminogen activator, urokinase, ZNF10  -  zinc finger protein 10, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), BRSK2  -  br serine/threonine kinase 2, LTK  -  leukocyte receptor tyrosine kinase, CCDC88C  -  coiled-coil domain containing 88c, MARCKS  -  myristoylated alanine-rich protein kinase c substrate, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, MXD1  -  max dimerization protein 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, LYZ  -  lysozyme, SRSF6  -  serine/arginine-rich splicing factor 6, TAF1C  -  tata box binding protein (tbp)-associated factor, rna polymerase i, c, 110kda, CXCL2  -  chemokine (c-x-c motif) ligand 2, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, GRP  -  gastrin-releasing peptide, MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, NCBP1  -  nuclear cap binding protein subunit 1, 80kda, RFC5  -  replication factor c (activator 1) 5, 36.5kda, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, RGR  -  retinal g protein coupled receptor, ELL2  -  elongation factor, rna polymerase ii, 2, LIN7A  -  lin-7 homolog a (c. elegans), BTK  -  bruton agammaglobulinemia tyrosine kinase, NCAM1  -  neural cell adhesion molecule 1, EIF4A1  -  eukaryotic translation initiation factor 4a1, RRAGB  -  ras-related gtp binding b, SORBS3  -  sorbin and sh3 domain containing 3, EIF4A2  -  eukaryotic translation initiation factor 4a2, BGN  -  biglycan, WISP2  -  wnt1 inducible signaling pathway protein 2, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, RLN1  -  relaxin 1, GGTLC1  -  gamma-glutamyltransferase light chain 1, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, MPHOSPH10  -  m-phase phosphoprotein 10 (u3 small nucleolar ribonucleoprotein), LDB1  -  lim domain binding 1, BLVRB  -  biliverdin reductase b (flavin reductase (nadph)), RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), MYO6  -  myosin vi, MAST1  -  microtubule associated serine/threonine kinase 1, TSC22D1  -  tsc22 domain family, member 1, FUBP1  -  far upstream element (fuse) binding protein 1, EEF1G  -  eukaryotic translation elongation factor 1 gamma, COX17  -  cox17 cytochrome c oxidase copper chaperone, ICAM2  -  intercellular adhesion molecule 2, TPH1  -  tryptophan hydroxylase 1, RNASE1  -  ribonuclease, rnase a family, 1 (pancreatic), HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, MYO16  -  myosin xvi, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PALLD  -  palladin, cytoskeletal associated protein, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, ROM1  -  retinal outer segment membrane protein 1, SMG1  -  smg1 phosphatidylinositol 3-kinase-related kinase, RORB  -  rar-related orphan receptor b, BSN  -  bassoon presynaptic cytomatrix protein, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), SGCE  -  sarcoglycan, epsilon, C1QA  -  complement component 1, q subcomponent, a chain, DENND4A  -  denn/madd domain containing 4a, DNAL4  -  dynein, axonemal, light chain 4, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, C6  -  complement component 6, UBE4B  -  ubiquitination factor e4b, WAPAL  -  wings apart-like homolog (drosophila), BAIAP3  -  bai1-associated protein 3, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPNS1  -  calpain, small subunit 1, RPL23A  -  ribosomal protein l23a, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, F13A1  -  coagulation factor xiii, a1 polypeptide, CAPN2  -  calpain 2, (m/ii) large subunit, HLA-E  -  major histocompatibility complex, class i, e, RPL21  -  ribosomal protein l21, PDE5A  -  phosphodiesterase 5a, cgmp-specific, RPL13  -  ribosomal protein l13, RPL11  -  ribosomal protein l11, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), RPL9  -  ribosomal protein l9, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, DYNLL1  -  dynein, light chain, lc8-type 1, NFASC  -  neurofascin, HLF  -  hepatic leukemia factor, RPE65  -  retinal pigment epithelium-specific protein 65kda, SLC4A4  -  solute carrier family 4 (sodium bicarbonate cotransporter), member 4, FASN  -  fatty acid synthase, CAPZB  -  capping protein (actin filament) muscle z-line, beta, HLA-A  -  major histocompatibility complex, class i, a, RPS4X  -  ribosomal protein s4, x-linked, RPS3A  -  ribosomal protein s3a, HMGXB4  -  hmg box domain containing 4, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, HOXB13  -  homeobox b13, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, EZR  -  ezrin, SLC25A17  -  solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kda), member 17, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, EYA2  -  eyes absent homolog 2 (drosophila), ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, NCOA2  -  nuclear receptor coactivator 2, EZH1  -  enhancer of zeste homolog 1 (drosophila), CALD1  -  caldesmon 1, MSH5  -  muts homolog 5 (e. coli), RPL30  -  ribosomal protein l30, HIC1  -  hypermethylated in cancer 1, CALCR  -  calcitonin receptor, MSN  -  moesin, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TUBA1B  -  tubulin, alpha 1b, TYROBP  -  tyro protein tyrosine kinase binding protein, CHRDL1  -  chordin-like 1, GPAA1  -  glycosylphosphatidylinositol anchor attachment 1, UBC  -  ubiquitin c, RNMT  -  rna (guanine-7-) methyltransferase, CCNG2  -  cyclin g2, RPS18  -  ribosomal protein s18, CD8B  -  cd8b molecule, TWIST1  -  twist basic helix-loop-helix transcription factor 1, RCOR1  -  rest corepressor 1, CORO2B  -  coronin, actin binding protein, 2b, CD7  -  cd7 molecule, CD14  -  cd14 molecule, RPS14  -  ribosomal protein s14, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, RGL1  -  ral guanine nucleotide dissociation stimulator-like 1, DLC1  -  deleted in liver cancer 1, CD9  -  cd9 molecule, TUBB4B  -  tubulin, beta 4b class ivb, TYRO3  -  tyro3 protein tyrosine kinase, TUBB3  -  tubulin, beta 3 class iii, TYR  -  tyrosinase, TUBB4A  -  tubulin, beta 4a class iva, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ONECUT1  -  one cut homeobox 1, EPHA3  -  eph receptor a3, UCN  -  urocortin, EPB41  -  erythrocyte membrane protein band 4.1 (elliptocytosis 1, rh-linked), SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), MVP  -  major vault protein, HNRNPA1  -  heterogeneous nuclear ribonucleoprotein a1, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PIAS3  -  protein inhibitor of activated stat, 3, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, TUBGCP3  -  tubulin, gamma complex associated protein 3, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CCND2  -  cyclin d2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), RTN1  -  reticulon 1, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, EXOC6B  -  exocyst complex component 6b, RREB1  -  ras responsive element binding protein 1, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, SCEL  -  sciellin, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), LPHN2  -  latrophilin 2, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), IL12RB2  -  interleukin 12 receptor, beta 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), PSAP  -  prosaposin, ORC2  -  origin recognition complex, subunit 2, ORC5  -  origin recognition complex, subunit 5, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, SMC2  -  structural maintenance of chromosomes 2, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, RGS5  -  regulator of g-protein signaling 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PCLO  -  piccolo presynaptic cytomatrix protein, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, ARHGAP44  -  rho gtpase activating protein 44, IL1R1  -  interleukin 1 receptor, type i, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, CD22  -  cd22 molecule, TRIM16  -  tripartite motif containing 16, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, NUAK1  -  nuak family, snf1-like kinase, 1, DYNLT3  -  dynein, light chain, tctex-type 3, CD34  -  cd34 molecule, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, TAGLN  -  transgelin, CENPC  -  centromere protein c, GNMT  -  glycine n-methyltransferase, SPCS2  -  signal peptidase complex subunit 2 homolog (s. cerevisiae), GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, NTN3  -  netrin 3, BCAP29  -  b-cell receptor-associated protein 29, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, NUMA1  -  nuclear mitotic apparatus protein 1, ITGB7  -  integrin, beta 7, FES  -  feline sarcoma oncogene, TAPBP  -  tap binding protein (tapasin), CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTHLH  -  parathyroid hormone-like hormone, FDXR  -  ferredoxin reductase, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, KLHL20  -  kelch-like family member 20, CDK13  -  cyclin-dependent kinase 13, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), FCGRT  -  fc fragment of igg, receptor, transporter, alpha, TAZ  -  tafazzin, NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), TRIM9  -  tripartite motif containing 9, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, HNF1A  -  hnf1 homeobox a, PTPRA  -  protein tyrosine phosphatase, receptor type, a, PTPN12  -  protein tyrosine phosphatase, non-receptor type 12, PTPN13  -  protein tyrosine phosphatase, non-receptor type 13 (apo-1/cd95 (fas)-associated phosphatase), FBLN2  -  fibulin 2, CDK2  -  cyclin-dependent kinase 2, NRF1  -  nuclear respiratory factor 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, NCKAP1  -  nck-associated protein 1, NKX2-1  -  nk2 homeobox 1, IFI27  -  interferon, alpha-inducible protein 27, TDRD7  -  tudor domain containing 7, IFI35  -  interferon-induced protein 35, IFNA5  -  interferon, alpha 5, PTPRN2  -  protein tyrosine phosphatase, receptor type, n polypeptide 2, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CHRM3  -  cholinergic receptor, muscarinic 3, PTPRN  -  protein tyrosine phosphatase, receptor type, n, NPAT  -  nuclear protein, ataxia-telangiectasia locus, RIMS2  -  regulating synaptic membrane exocytosis 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), PWP2  -  pwp2 periodic tryptophan protein homolog (yeast), TRAF3IP2  -  traf3 interacting protein 2, CNOT4  -  ccr4-not transcription complex, subunit 4, ABCD4  -  atp-binding cassette, sub-family d (ald), member 4, CHKA  -  choline kinase alpha, CNOT3  -  ccr4-not transcription complex, subunit 3, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, CHEK1  -  checkpoint kinase 1, NFX1  -  nuclear transcription factor, x-box binding 1, CHD1  -  chromodomain helicase dna binding protein 1, NGF  -  nerve growth factor (beta polypeptide), KMT2B  -  lysine (k)-specific methyltransferase 2b, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, NHLH2  -  nescient helix loop helix 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), TEK  -  tek tyrosine kinase, endothelial, RAN  -  ran, member ras oncogene family, NEK3  -  nima-related kinase 3, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RAG2  -  recombination activating gene 2, RARG  -  retinoic acid receptor, gamma, SPARCL1  -  sparc-like 1 (hevin), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), NF2  -  neurofibromin 2 (merlin), IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), RBL2  -  retinoblastoma-like 2 (p130), ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, TH  -  tyrosine hydroxylase, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, IGFBP1  -  insulin-like growth factor binding protein 1, ARID4A  -  at rich interactive domain 4a (rbp1-like), AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, GEMIN4  -  gem (nuclear organelle) associated protein 4, CUL4B  -  cullin 4b, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, RCVRN  -  recoverin, CKB  -  creatine kinase, brain, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0006955,immune response,7.18E-05,1.18E-02,3.1,8230,742,68,19,"[HLA-A  -  major histocompatibility complex, class i, a, TYROBP  -  tyro protein tyrosine kinase binding protein, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, C1QB  -  complement component 1, q subcomponent, b chain, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL1B  -  interleukin 1, beta, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, FGF1  -  fibroblast growth factor 1 (acidic), HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CD14  -  cd14 molecule, TAPBP  -  tap binding protein (tapasin), ACTG1  -  actin, gamma 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, ATF2  -  activating transcription factor 2, FYN  -  fyn oncogene related to src, fgr, yes, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0009605,response to external stimulus,7.51E-05,1.21E-02,1.44,8230,867,865,131,"[PAX2  -  paired box 2, HSF1  -  heat shock transcription factor 1, IL12RB2  -  interleukin 12 receptor, beta 2, RGR  -  retinal g protein coupled receptor, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GCG  -  glucagon, GCK  -  glucokinase (hexokinase 4), CCL17  -  chemokine (c-c motif) ligand 17, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CCL15  -  chemokine (c-c motif) ligand 15, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, CCL2  -  chemokine (c-c motif) ligand 2, SOX2  -  sry (sex determining region y)-box 2, CCL1  -  chemokine (c-c motif) ligand 1, IL1B  -  interleukin 1, beta, LPL  -  lipoprotein lipase, CCL3  -  chemokine (c-c motif) ligand 3, ACTA2  -  actin, alpha 2, smooth muscle, aorta, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, GUCY2F  -  guanylate cyclase 2f, retinal, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), PLD1  -  phospholipase d1, phosphatidylcholine-specific, FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CNGB1  -  cyclic nucleotide gated channel beta 1, ITGA9  -  integrin, alpha 9, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, FZD5  -  frizzled family receptor 5, EEF1G  -  eukaryotic translation elongation factor 1 gamma, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, GLRB  -  glycine receptor, beta, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, CREBZF  -  creb/atf bzip transcription factor, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PTGER1  -  prostaglandin e receptor 1 (subtype ep1), 42kda, CFL1  -  cofilin 1 (non-muscle), COL3A1  -  collagen, type iii, alpha 1, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, PPARG  -  peroxisome proliferator-activated receptor gamma, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, NPC2  -  niemann-pick disease, type c2, LCK  -  lymphocyte-specific protein tyrosine kinase, LBP  -  lipopolysaccharide binding protein, NPPA  -  natriuretic peptide a, S100A7  -  s100 calcium binding protein a7, COMT  -  catechol-o-methyltransferase, IRF1  -  interferon regulatory factor 1, ADORA1  -  adenosine a1 receptor, PDX1  -  pancreatic and duodenal homeobox 1, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, NRF1  -  nuclear respiratory factor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, DRD3  -  dopamine receptor d3, AES  -  amino-terminal enhancer of split, IFNA5  -  interferon, alpha 5, PRG2  -  proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein), MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), BCL2L11  -  bcl2-like 11 (apoptosis facilitator), GPC1  -  glypican 1, ACE2  -  angiotensin i converting enzyme 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), RPE65  -  retinal pigment epithelium-specific protein 65kda, IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, HLA-A  -  major histocompatibility complex, class i, a, CHEK1  -  checkpoint kinase 1, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, MAX  -  myc associated factor x, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CXADR  -  coxsackie virus and adenovirus receptor, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), FYN  -  fyn oncogene related to src, fgr, yes, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CALCA  -  calcitonin-related polypeptide alpha, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), CYBA  -  cytochrome b-245, alpha polypeptide, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, PKD1  -  polycystic kidney disease 1 (autosomal dominant), RALA  -  v-ral simian leukemia viral oncogene homolog a (ras related), CCR6  -  chemokine (c-c motif) receptor 6, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, RRH  -  retinal pigment epithelium-derived rhodopsin homolog, CD1D  -  cd1d molecule, STAR  -  steroidogenic acute regulatory protein, SLIT2  -  slit homolog 2 (drosophila), PLAU  -  plasminogen activator, urokinase, CD14  -  cd14 molecule, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, SSTR3  -  somatostatin receptor 3, NQO1  -  nad(p)h dehydrogenase, quinone 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, MAPK14  -  mitogen-activated protein kinase 14, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, TGFB1  -  transforming growth factor, beta 1, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), TH  -  tyrosine hydroxylase, AP1S1  -  adaptor-related protein complex 1, sigma 1 subunit, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), LYZ  -  lysozyme, FADD  -  fas (tnfrsf6)-associated via death domain, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, CCKAR  -  cholecystokinin a receptor, CXCL2  -  chemokine (c-x-c motif) ligand 2, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, HIST1H2BJ  -  histone cluster 1, h2bj, GAS6  -  growth arrest-specific 6, FOXA2  -  forkhead box a2]"GO:0048869,cellular developmental process,8.24E-05,1.31E-02,1.32,8230,1403,887,200,"[CREB5  -  camp responsive element binding protein 5, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, PATZ1  -  poz (btb) and at hook containing zinc finger 1, PLXNB1  -  plexin b1, BTK  -  bruton agammaglobulinemia tyrosine kinase, SAP30  -  sin3a-associated protein, 30kda, GDF5  -  growth differentiation factor 5, SP1  -  sp1 transcription factor, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, PLP1  -  proteolipid protein 1, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, ACTA2  -  actin, alpha 2, smooth muscle, aorta, LDB1  -  lim domain binding 1, PLG  -  plasminogen, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), SPAG6  -  sperm associated antigen 6, MYO6  -  myosin vi, CR2  -  complement component (3d/epstein barr virus) receptor 2, MYO7A  -  myosin viia, CADM1  -  cell adhesion molecule 1, KRT19  -  keratin 19, GLI3  -  gli family zinc finger 3, KRT6A  -  keratin 6a, POU3F4  -  pou class 3 homeobox 4, COL2A1  -  collagen, type ii, alpha 1, KRT10  -  keratin 10, PARD6B  -  par-6 partitioning defective 6 homolog beta (c. elegans), MYO16  -  myosin xvi, FZD1  -  frizzled family receptor 1, KRT14  -  keratin 14, PPARG  -  peroxisome proliferator-activated receptor gamma, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, LCK  -  lymphocyte-specific protein tyrosine kinase, FEM1B  -  fem-1 homolog b (c. elegans), POU1F1  -  pou class 1 homeobox 1, COL13A1  -  collagen, type xiii, alpha 1, CSTA  -  cystatin a (stefin a), AKR1C3  -  aldo-keto reductase family 1, member c3, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, CTGF  -  connective tissue growth factor, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, CTBP1  -  c-terminal binding protein 1, HLF  -  hepatic leukemia factor, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS3A  -  ribosomal protein s3a, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, HOXB13  -  homeobox b13, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, EVPL  -  envoplakin, EZR  -  ezrin, MAFF  -  v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog f, KDM6A  -  lysine (k)-specific demethylase 6a, EYA2  -  eyes absent homolog 2 (drosophila), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, STK4  -  serine/threonine kinase 4, EDA2R  -  ectodysplasin a2 receptor, MSN  -  moesin, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, HOXA11  -  homeobox a11, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, NIPBL  -  nipped-b homolog (drosophila), CHRDL1  -  chordin-like 1, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, TXK  -  txk tyrosine kinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR2  -  estrogen receptor 2 (er beta), RPS14  -  ribosomal protein s14, HOXA1  -  homeobox a1, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, CD9  -  cd9 molecule, ITK  -  il2-inducible t-cell kinase, TYRO3  -  tyro3 protein tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ALX1  -  alx homeobox 1, MAPK14  -  mitogen-activated protein kinase 14, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, CCKAR  -  cholecystokinin a receptor, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, RTN1  -  reticulon 1, GAP43  -  growth associated protein 43, STX2  -  syntaxin 2, GAS6  -  growth arrest-specific 6, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, CCIN  -  calicin, SCEL  -  sciellin, FOXA2  -  forkhead box a2, GCM1  -  glial cells missing homolog 1 (drosophila), PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), PSAP  -  prosaposin, CXCL12  -  chemokine (c-x-c motif) ligand 12, DCX  -  doublecortin, FLG  -  filaggrin, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, PSD  -  pleckstrin and sec7 domain containing, CDON  -  cell adhesion associated, oncogene regulated, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, IL1B  -  interleukin 1, beta, ODF2  -  outer dense fiber of sperm tails 2, CCL3  -  chemokine (c-c motif) ligand 3, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, FASLG  -  fas ligand (tnf superfamily, member 6), FHL2  -  four and a half lim domains 2, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), FZD5  -  frizzled family receptor 5, MDFI  -  myod family inhibitor, TAGLN  -  transgelin, FGFR3  -  fibroblast growth factor receptor 3, NTN3  -  netrin 3, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), NUMA1  -  nuclear mitotic apparatus protein 1, PTHLH  -  parathyroid hormone-like hormone, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), S100B  -  s100 calcium binding protein b, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), S100A4  -  s100 calcium binding protein a4, NLGN4X  -  neuroligin 4, x-linked, S100A7  -  s100 calcium binding protein a7, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), IREB2  -  iron-responsive element binding protein 2, IRF1  -  interferon regulatory factor 1, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, NRL  -  neural retina leucine zipper, HCLS1  -  hematopoietic cell-specific lyn substrate 1, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, NKX2-1  -  nk2 homeobox 1, TDRD7  -  tudor domain containing 7, IFNA5  -  interferon, alpha 5, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SFN  -  stratifin, GPC1  -  glypican 1, INA  -  internexin neuronal intermediate filament protein, alpha, ATM  -  ataxia telangiectasia mutated, LATS1  -  large tumor suppressor kinase 1, PGR  -  progesterone receptor, CNOT3  -  ccr4-not transcription complex, subunit 3, CEP57  -  centrosomal protein 57kda, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), NGF  -  nerve growth factor (beta polypeptide), KMT2B  -  lysine (k)-specific methyltransferase 2b, NKX2-2  -  nk2 homeobox 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), NHLH2  -  nescient helix loop helix 2, TEK  -  tek tyrosine kinase, endothelial, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), NEFH  -  neurofilament, heavy polypeptide, RAG2  -  recombination activating gene 2, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), PHGDH  -  phosphoglycerate dehydrogenase, DIAPH2  -  diaphanous-related formin 2, NF2  -  neurofibromin 2 (merlin), BRSK2  -  br serine/threonine kinase 2, IHH  -  indian hedgehog, TGFB1  -  transforming growth factor, beta 1, NEUROG2  -  neurogenin 2, TH  -  tyrosine hydroxylase, ARID4A  -  at rich interactive domain 4a (rbp1-like), PLK4  -  polo-like kinase 4, EPCAM  -  epithelial cell adhesion molecule, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0007631,feeding behavior,8.80E-05,1.38E-02,2.68,8230,68,992,22,"[GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, UCN  -  urocortin, NMU  -  neuromedin u, TH  -  tyrosine hydroxylase, TRH  -  thyrotropin-releasing hormone, ADRB3  -  adrenoceptor beta 3, IAPP  -  islet amyloid polypeptide, CCKAR  -  cholecystokinin a receptor, GHSR  -  growth hormone secretagogue receptor, PMCH  -  pro-melanin-concentrating hormone, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HAND2  -  heart and neural crest derivatives expressed 2, CRH  -  corticotropin releasing hormone, NPY1R  -  neuropeptide y receptor y1, ACE2  -  angiotensin i converting enzyme 2, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, APP  -  amyloid beta (a4) precursor protein, GCG  -  glucagon, FYN  -  fyn oncogene related to src, fgr, yes, CALCA  -  calcitonin-related polypeptide alpha, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1]"GO:0008406,gonad development,9.54E-05,1.48E-02,2.94,8230,84,666,20,"[CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, INSL3  -  insulin-like 3 (leydig cell), AKR1C3  -  aldo-keto reductase family 1, member c3, FZD5  -  frizzled family receptor 5, COL9A3  -  collagen, type ix, alpha 3, GATA3  -  gata binding protein 3, STAR  -  steroidogenic acute regulatory protein, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, BRCA2  -  breast cancer 2, early onset, PATZ1  -  poz (btb) and at hook containing zinc finger 1, UBC  -  ubiquitin c, FGF8  -  fibroblast growth factor 8 (androgen-induced), BIK  -  bcl2-interacting killer (apoptosis-inducing), BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, BCL2  -  b-cell cll/lymphoma 2, ESR1  -  estrogen receptor 1, FSHR  -  follicle stimulating hormone receptor, KITLG  -  kit ligand, FZD1  -  frizzled family receptor 1]"GO:0001912,positive regulation of leukocyte mediated cytotoxicity,9.64E-05,1.47E-02,3.7,8230,30,963,13,"[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), NCR3  -  natural cytotoxicity triggering receptor 3, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), IL23R  -  interleukin 23 receptor]"GO:0042493,response to drug,1.01E-04,1.52E-02,1.92,8230,273,707,45,"[DRD3  -  dopamine receptor d3, STAR  -  steroidogenic acute regulatory protein, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, FZD1  -  frizzled family receptor 1, DPYSL2  -  dihydropyrimidinase-like 2, PPARG  -  peroxisome proliferator-activated receptor gamma, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IFNG  -  interferon, gamma, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), PLIN2  -  perilipin 2, CDK4  -  cyclin-dependent kinase 4, SRP19  -  signal recognition particle 19kda, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, GATA3  -  gata binding protein 3, NGF  -  nerve growth factor (beta polypeptide), TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, LPL  -  lipoprotein lipase, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, COMT  -  catechol-o-methyltransferase, CRH  -  corticotropin releasing hormone, BCL2  -  b-cell cll/lymphoma 2, OGG1  -  8-oxoguanine dna glycosylase, PDX1  -  pancreatic and duodenal homeobox 1, FYN  -  fyn oncogene related to src, fgr, yes, SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, ADRA1A  -  adrenoceptor alpha 1a, GAS6  -  growth arrest-specific 6, MYO6  -  myosin vi, PDE4A  -  phosphodiesterase 4a, camp-specific, AQP1  -  aquaporin 1 (colton blood group), CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0042592,homeostatic process,1.10E-04,1.63E-02,1.48,8230,664,922,110,"[ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, RFC5  -  replication factor c (activator 1) 5, 36.5kda, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), APOA1  -  apolipoprotein a-i, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, FLG  -  filaggrin, ACACA  -  acetyl-coa carboxylase alpha, GCK  -  glucokinase (hexokinase 4), NBN  -  nibrin, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CCL15  -  chemokine (c-c motif) ligand 15, CCL14  -  chemokine (c-c motif) ligand 14, CCL8  -  chemokine (c-c motif) ligand 8, CCL2  -  chemokine (c-c motif) ligand 2, CCL1  -  chemokine (c-c motif) ligand 1, LPL  -  lipoprotein lipase, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, LIPC  -  lipase, hepatic, PDIA2  -  protein disulfide isomerase family a, member 2, PRDX1  -  peroxiredoxin 1, LDB1  -  lim domain binding 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, PLG  -  plasminogen, ACTG1  -  actin, gamma 1, CD34  -  cd34 molecule, FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), CNGB1  -  cyclic nucleotide gated channel beta 1, HIST3H3  -  histone cluster 3, h3, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, COL2A1  -  collagen, type ii, alpha 1, PTH  -  parathyroid hormone, PTHLH  -  parathyroid hormone-like hormone, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, LCK  -  lymphocyte-specific protein tyrosine kinase, NPC2  -  niemann-pick disease, type c2, IREB2  -  iron-responsive element binding protein 2, HNF1A  -  hnf1 homeobox a, ADORA1  -  adenosine a1 receptor, PDX1  -  pancreatic and duodenal homeobox 1, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, ASGR2  -  asialoglycoprotein receptor 2, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCRT  -  hypocretin (orexin) neuropeptide precursor, CXCL13  -  chemokine (c-x-c motif) ligand 13, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, ATP2A1  -  atpase, ca++ transporting, cardiac muscle, fast twitch 1, FTL  -  ferritin, light polypeptide, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, ADRB3  -  adrenoceptor beta 3, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), UMOD  -  uromodulin, AGTR2  -  angiotensin ii receptor, type 2, SLC4A3  -  solute carrier family 4 (anion exchanger), member 3, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CXADR  -  coxsackie virus and adenovirus receptor, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), CALCA  -  calcitonin-related polypeptide alpha, CYBA  -  cytochrome b-245, alpha polypeptide, KISS1  -  kiss-1 metastasis-suppressor, CALCR  -  calcitonin receptor, PKD1  -  polycystic kidney disease 1 (autosomal dominant), CCR6  -  chemokine (c-c motif) receptor 6, STAR  -  steroidogenic acute regulatory protein, TF  -  transferrin, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), UBC  -  ubiquitin c, CLDN16  -  claudin 16, CD7  -  cd7 molecule, ESR1  -  estrogen receptor 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, TYRO3  -  tyro3 protein tyrosine kinase, SSTR5  -  somatostatin receptor 5, PKP2  -  plakophilin 2, IHH  -  indian hedgehog, ANG  -  angiogenin, ribonuclease, rnase a family, 5, GBA  -  glucosidase, beta, acid, GRIK2  -  glutamate receptor, ionotropic, kainate 2, TGFB1  -  transforming growth factor, beta 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), TH  -  tyrosine hydroxylase, LYZ  -  lysozyme, PLCE1  -  phospholipase c, epsilon 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, CCKAR  -  cholecystokinin a receptor, KRIT1  -  krit1, ankyrin repeat containing, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, BCL2  -  b-cell cll/lymphoma 2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), CKB  -  creatine kinase, brain, GAS6  -  growth arrest-specific 6, MPL  -  myeloproliferative leukemia virus oncogene, FOXA2  -  forkhead box a2]"GO:0007267,cell-cell signaling,1.12E-04,1.64E-02,1.52,8230,546,962,97,"[ATXN3  -  ataxin 3, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, GDF5  -  growth differentiation factor 5, CCL17  -  chemokine (c-c motif) ligand 17, WISP2  -  wnt1 inducible signaling pathway protein 2, PLP1  -  proteolipid protein 1, LNPEP  -  leucyl/cystinyl aminopeptidase, CCL15  -  chemokine (c-c motif) ligand 15, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, DLGAP1  -  discs, large (drosophila) homolog-associated protein 1, CRH  -  corticotropin releasing hormone, CD34  -  cd34 molecule, TSHR  -  thyroid stimulating hormone receptor, FASLG  -  fas ligand (tnf superfamily, member 6), MYO6  -  myosin vi, GLUL  -  glutamate-ammonia ligase, FGFR3  -  fibroblast growth factor receptor 3, GLRB  -  glycine receptor, beta, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), FGF12  -  fibroblast growth factor 12, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, IAPP  -  islet amyloid polypeptide, FGF1  -  fibroblast growth factor 1 (acidic), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NTSR1  -  neurotensin receptor 1 (high affinity), SNCB  -  synuclein, beta, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, INSL3  -  insulin-like 3 (leydig cell), BSN  -  bassoon presynaptic cytomatrix protein, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), TRH  -  thyrotropin-releasing hormone, C1QA  -  complement component 1, q subcomponent, a chain, PCSK1  -  proprotein convertase subtilisin/kexin type 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, ADRA1A  -  adrenoceptor alpha 1a, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, PGR  -  progesterone receptor, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, CGB  -  chorionic gonadotropin, beta polypeptide, CALCA  -  calcitonin-related polypeptide alpha, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, TEK  -  tek tyrosine kinase, endothelial, HOXA11  -  homeobox a11, NEFL  -  neurofilament, light polypeptide, ESR2  -  estrogen receptor 2 (er beta), GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, GRIA2  -  glutamate receptor, ionotropic, ampa 2, GRIA1  -  glutamate receptor, ionotropic, ampa 1, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), IHH  -  indian hedgehog, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, KCNJ6  -  potassium inwardly-rectifying channel, subfamily j, member 6, KCNF1  -  potassium voltage-gated channel, subfamily f, member 1, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, PRKCG  -  protein kinase c, gamma, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1]"GO:0003085,negative regulation of systemic arterial blood pressure,1.12E-04,1.62E-02,11.26,8230,8,457,5,"[AGTR2  -  angiotensin ii receptor, type 2, ADRB1  -  adrenoceptor beta 1, ADRB3  -  adrenoceptor beta 3, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), NPPA  -  natriuretic peptide a]"GO:0048511,rhythmic process,1.13E-04,1.61E-02,2.28,8230,152,689,29,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, STAR  -  steroidogenic acute regulatory protein, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, TPH1  -  tryptophan hydroxylase 1, AANAT  -  aralkylamine n-acetyltransferase, CRX  -  cone-rod homeobox, PTGDS  -  prostaglandin d2 synthase 21kda (brain), INHBB  -  inhibin, beta b, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, ESR1  -  estrogen receptor 1, FSHR  -  follicle stimulating hormone receptor, TYRO3  -  tyro3 protein tyrosine kinase, HLF  -  hepatic leukemia factor, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, PGR  -  progesterone receptor, ANG  -  angiogenin, ribonuclease, rnase a family, 5, PCYT1B  -  phosphate cytidylyltransferase 1, choline, beta, CDK4  -  cyclin-dependent kinase 4, TH  -  tyrosine hydroxylase, KMT2B  -  lysine (k)-specific methyltransferase 2b, CRH  -  corticotropin releasing hormone, BCL2  -  b-cell cll/lymphoma 2, ADORA1  -  adenosine a1 receptor, NHLH2  -  nescient helix loop helix 2, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), KISS1  -  kiss-1 metastasis-suppressor]"GO:0050778,positive regulation of immune response,1.15E-04,1.62E-02,3.3,8230,366,116,17,"[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, C1QB  -  complement component 1, q subcomponent, b chain, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, IL1B  -  interleukin 1, beta, C1R  -  complement component 1, r subcomponent, UBC  -  ubiquitin c, C1S  -  complement component 1, s subcomponent, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CD14  -  cd14 molecule, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, FYN  -  fyn oncogene related to src, fgr, yes, THY1  -  thy-1 cell surface antigen]"GO:0019882,antigen processing and presentation,1.21E-04,1.69E-02,6.8,8230,176,55,8,"[HLA-A  -  major histocompatibility complex, class i, a, ITGB5  -  integrin, beta 5, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, TAPBP  -  tap binding protein (tapasin), HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0002699,positive regulation of immune effector process,1.22E-04,1.67E-02,3.19,8230,98,474,18,"[HLA-A  -  major histocompatibility complex, class i, a, CADM1  -  cell adhesion molecule 1, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, LBP  -  lipopolysaccharide binding protein, FADD  -  fas (tnfrsf6)-associated via death domain, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, NCR3  -  natural cytotoxicity triggering receptor 3, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FES  -  feline sarcoma oncogene, C6  -  complement component 6, IFNG  -  interferon, gamma]"GO:1901698,response to nitrogen compound,1.30E-04,1.77E-02,1.72,8230,558,541,63,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, CAPN2  -  calpain 2, (m/ii) large subunit, DRD3  -  dopamine receptor d3, IFNA5  -  interferon, alpha 5, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, INHBB  -  inhibin, beta b, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, GCG  -  glucagon, RPE65  -  retinal pigment epithelium-specific protein 65kda, DPYSL2  -  dihydropyrimidinase-like 2, CHEK1  -  checkpoint kinase 1, RRAGB  -  ras-related gtp binding b, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, NGF  -  nerve growth factor (beta polypeptide), CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TRIM16  -  tripartite motif containing 16, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, OGG1  -  8-oxoguanine dna glycosylase, RHEB  -  ras homolog enriched in brain, FYN  -  fyn oncogene related to src, fgr, yes, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, GH1  -  growth hormone 1, CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group), ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, TH  -  tyrosine hydroxylase, IGFBP1  -  insulin-like growth factor binding protein 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COL5A2  -  collagen, type v, alpha 2, NPPA  -  natriuretic peptide a, COL6A1  -  collagen, type vi, alpha 1, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, BCL2  -  b-cell cll/lymphoma 2, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, CDK2  -  cyclin-dependent kinase 2, NRF1  -  nuclear respiratory factor 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:0044700,single organism signaling,1.41E-04,1.89E-02,1.5,8230,570,962,100,"[ATXN3  -  ataxin 3, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, GDF5  -  growth differentiation factor 5, CCL17  -  chemokine (c-c motif) ligand 17, WISP2  -  wnt1 inducible signaling pathway protein 2, LNPEP  -  leucyl/cystinyl aminopeptidase, PLP1  -  proteolipid protein 1, CCL15  -  chemokine (c-c motif) ligand 15, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, DLGAP1  -  discs, large (drosophila) homolog-associated protein 1, CRH  -  corticotropin releasing hormone, CD34  -  cd34 molecule, TSHR  -  thyroid stimulating hormone receptor, FASLG  -  fas ligand (tnf superfamily, member 6), MYO6  -  myosin vi, GLUL  -  glutamate-ammonia ligase, FGFR3  -  fibroblast growth factor receptor 3, GLRB  -  glycine receptor, beta, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), FGF12  -  fibroblast growth factor 12, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, IAPP  -  islet amyloid polypeptide, FGF1  -  fibroblast growth factor 1 (acidic), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NTSR1  -  neurotensin receptor 1 (high affinity), SNCB  -  synuclein, beta, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, INSL3  -  insulin-like 3 (leydig cell), BSN  -  bassoon presynaptic cytomatrix protein, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), TRH  -  thyrotropin-releasing hormone, C1QA  -  complement component 1, q subcomponent, a chain, PCSK1  -  proprotein convertase subtilisin/kexin type 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, ADRA1A  -  adrenoceptor alpha 1a, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, DSC2  -  desmocollin 2, NFASC  -  neurofascin, PGR  -  progesterone receptor, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, CGB  -  chorionic gonadotropin, beta polypeptide, CALCA  -  calcitonin-related polypeptide alpha, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, TEK  -  tek tyrosine kinase, endothelial, HOXA11  -  homeobox a11, NEFL  -  neurofilament, light polypeptide, ESR2  -  estrogen receptor 2 (er beta), GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, SSTR3  -  somatostatin receptor 3, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, GRIA2  -  glutamate receptor, ionotropic, ampa 2, GRIA1  -  glutamate receptor, ionotropic, ampa 1, IHH  -  indian hedgehog, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, KCNJ6  -  potassium inwardly-rectifying channel, subfamily j, member 6, KCNF1  -  potassium voltage-gated channel, subfamily f, member 1, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, PRKCG  -  protein kinase c, gamma, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1]"GO:0023052,signaling,1.41E-04,1.87E-02,1.5,8230,570,962,100,"[ATXN3  -  ataxin 3, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, GDF5  -  growth differentiation factor 5, CCL17  -  chemokine (c-c motif) ligand 17, WISP2  -  wnt1 inducible signaling pathway protein 2, PLP1  -  proteolipid protein 1, LNPEP  -  leucyl/cystinyl aminopeptidase, CCL15  -  chemokine (c-c motif) ligand 15, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, DLGAP1  -  discs, large (drosophila) homolog-associated protein 1, CRH  -  corticotropin releasing hormone, CD34  -  cd34 molecule, TSHR  -  thyroid stimulating hormone receptor, FASLG  -  fas ligand (tnf superfamily, member 6), MYO6  -  myosin vi, GLUL  -  glutamate-ammonia ligase, FGFR3  -  fibroblast growth factor receptor 3, GLRB  -  glycine receptor, beta, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), FGF12  -  fibroblast growth factor 12, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, IAPP  -  islet amyloid polypeptide, FGF1  -  fibroblast growth factor 1 (acidic), HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, NTSR1  -  neurotensin receptor 1 (high affinity), SNCB  -  synuclein, beta, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, INSL3  -  insulin-like 3 (leydig cell), BSN  -  bassoon presynaptic cytomatrix protein, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), TRH  -  thyrotropin-releasing hormone, C1QA  -  complement component 1, q subcomponent, a chain, PCSK1  -  proprotein convertase subtilisin/kexin type 1, COMT  -  catechol-o-methyltransferase, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, ADORA1  -  adenosine a1 receptor, ADRA1A  -  adrenoceptor alpha 1a, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, DSC2  -  desmocollin 2, NFASC  -  neurofascin, PGR  -  progesterone receptor, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, GABRA3  -  gamma-aminobutyric acid (gaba) a receptor, alpha 3, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, CGB  -  chorionic gonadotropin, beta polypeptide, CALCA  -  calcitonin-related polypeptide alpha, DLGAP4  -  discs, large (drosophila) homolog-associated protein 4, TEK  -  tek tyrosine kinase, endothelial, HOXA11  -  homeobox a11, NEFL  -  neurofilament, light polypeptide, ESR2  -  estrogen receptor 2 (er beta), GABRB1  -  gamma-aminobutyric acid (gaba) a receptor, beta 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, SSTR3  -  somatostatin receptor 3, GABRD  -  gamma-aminobutyric acid (gaba) a receptor, delta, PKP2  -  plakophilin 2, NQO1  -  nad(p)h dehydrogenase, quinone 1, GRIA2  -  glutamate receptor, ionotropic, ampa 2, GRIA1  -  glutamate receptor, ionotropic, ampa 1, IHH  -  indian hedgehog, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GATA3  -  gata binding protein 3, TH  -  tyrosine hydroxylase, KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, KCNJ6  -  potassium inwardly-rectifying channel, subfamily j, member 6, KCNF1  -  potassium voltage-gated channel, subfamily f, member 1, KCND2  -  potassium voltage-gated channel, shal-related subfamily, member 2, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, PRKCG  -  protein kinase c, gamma, KCNH1  -  potassium voltage-gated channel, subfamily h (eag-related), member 1]"GO:0006952,defense response,1.53E-04,2.00E-02,1.6,8230,827,491,79,"[KIR2DL4  -  killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4, HLA-G  -  major histocompatibility complex, class i, g, HLA-E  -  major histocompatibility complex, class i, e, IFNA5  -  interferon, alpha 5, PRG2  -  proteoglycan 2, bone marrow (natural killer cell activator, eosinophil granule major basic protein), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, AGTR2  -  angiotensin ii receptor, type 2, IFNG  -  interferon, gamma, MICA  -  mhc class i polypeptide-related sequence a, CCL17  -  chemokine (c-c motif) ligand 17, CTSL  -  cathepsin l, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), GRAP2  -  grb2-related adaptor protein 2, NFX1  -  nuclear transcription factor, x-box binding 1, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, NRG2  -  neuregulin 2, CCL4  -  chemokine (c-c motif) ligand 4, CCL8  -  chemokine (c-c motif) ligand 8, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, CFH  -  complement factor h, ABCC9  -  atp-binding cassette, sub-family c (cftr/mrp), member 9, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, OGG1  -  8-oxoguanine dna glycosylase, CXCR2  -  chemokine (c-x-c motif) receptor 2, CXADR  -  coxsackie virus and adenovirus receptor, ACTG1  -  actin, gamma 1, APP  -  amyloid beta (a4) precursor protein, FYN  -  fyn oncogene related to src, fgr, yes, ATF2  -  activating transcription factor 2, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, DARC  -  duffy blood group, atypical chemokine receptor, TRIM31  -  tripartite motif containing 31, CYBA  -  cytochrome b-245, alpha polypeptide, KIR3DS1  -  killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1, TYROBP  -  tyro protein tyrosine kinase binding protein, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, UBC  -  ubiquitin c, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), CD14  -  cd14 molecule, TAPBP  -  tap binding protein (tapasin), TUBB4B  -  tubulin, beta 4b class ivb, ITK  -  il2-inducible t-cell kinase, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, PPARG  -  peroxisome proliferator-activated receptor gamma, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, S100B  -  s100 calcium binding protein b, UCN  -  urocortin, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GATA3  -  gata binding protein 3, LYZ  -  lysozyme, LBP  -  lipopolysaccharide binding protein, C1QB  -  complement component 1, q subcomponent, b chain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, KCNJ8  -  potassium inwardly-rectifying channel, subfamily j, member 8, NCR3  -  natural cytotoxicity triggering receptor 3, CXCL2  -  chemokine (c-x-c motif) ligand 2, IRF1  -  interferon regulatory factor 1, BCL2  -  b-cell cll/lymphoma 2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, KITLG  -  kit ligand, C6  -  complement component 6, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:2000341,regulation of chemokine (C-X-C motif) ligand 2 production,1.53E-04,1.98E-02,38.46,8230,6,107,3,"[CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, MAP2K5  -  mitogen-activated protein kinase kinase 5, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor)]"GO:0045471,response to ethanol,1.55E-04,1.99E-02,2.75,8230,86,730,21,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), GATA3  -  gata binding protein 3, STAR  -  steroidogenic acute regulatory protein, TH  -  tyrosine hydroxylase, TRH  -  thyrotropin-releasing hormone, CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, CCL2  -  chemokine (c-c motif) ligand 2, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, CD14  -  cd14 molecule, OGG1  -  8-oxoguanine dna glycosylase, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, FYN  -  fyn oncogene related to src, fgr, yes, NQO1  -  nad(p)h dehydrogenase, quinone 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2]"GO:0048608,reproductive structure development,1.58E-04,2.00E-02,2.58,8230,115,666,24,"[PKD1  -  polycystic kidney disease 1 (autosomal dominant), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, INSL3  -  insulin-like 3 (leydig cell), AKR1C3  -  aldo-keto reductase family 1, member c3, FZD5  -  frizzled family receptor 5, COL9A3  -  collagen, type ix, alpha 3, GATA3  -  gata binding protein 3, STAR  -  steroidogenic acute regulatory protein, BRCA2  -  breast cancer 2, early onset, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, PATZ1  -  poz (btb) and at hook containing zinc finger 1, SOX2  -  sry (sex determining region y)-box 2, UBC  -  ubiquitin c, FGF8  -  fibroblast growth factor 8 (androgen-induced), BIK  -  bcl2-interacting killer (apoptosis-inducing), BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, BCL2  -  b-cell cll/lymphoma 2, ESR1  -  estrogen receptor 1, HNF1A  -  hnf1 homeobox a, FSHR  -  follicle stimulating hormone receptor, TYRO3  -  tyro3 protein tyrosine kinase, KITLG  -  kit ligand, FZD1  -  frizzled family receptor 1]"GO:0050793,regulation of developmental process,1.60E-04,2.01E-02,1.4,8230,1227,667,139,"[VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, GCM1  -  glial cells missing homolog 1 (drosophila), PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PLXNB1  -  plexin b1, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, CDON  -  cell adhesion associated, oncogene regulated, BTK  -  bruton agammaglobulinemia tyrosine kinase, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GDF5  -  growth differentiation factor 5, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, RIF1  -  rap1 interacting factor homolog (yeast), IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, CD53  -  cd53 molecule, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, SOX3  -  sry (sex determining region y)-box 3, LPL  -  lipoprotein lipase, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), CCL3  -  chemokine (c-c motif) ligand 3, TRIM16  -  tripartite motif containing 16, LDB1  -  lim domain binding 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, NUAK1  -  nuak family, snf1-like kinase, 1, CD34  -  cd34 molecule, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), KLK3  -  kallikrein-related peptidase 3, FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), NTN3  -  netrin 3, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, FES  -  feline sarcoma oncogene, COL3A1  -  collagen, type iii, alpha 1, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, PTK6  -  protein tyrosine kinase 6, S100B  -  s100 calcium binding protein b, ARPC2  -  actin related protein 2/3 complex, subunit 2, 34kda, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), IRF1  -  interferon regulatory factor 1, C5  -  complement component 5, KITLG  -  kit ligand, C6  -  complement component 6, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), HLA-G  -  major histocompatibility complex, class i, g, NKX2-1  -  nk2 homeobox 1, RUFY3  -  run and fyve domain containing 3, DRD3  -  dopamine receptor d3, PDE5A  -  phosphodiesterase 5a, cgmp-specific, ADRB1  -  adrenoceptor beta 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SRGN  -  serglycin, SMC3  -  structural maintenance of chromosomes 3, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, GPC1  -  glypican 1, AGTR2  -  angiotensin ii receptor, type 2, CNOT3  -  ccr4-not transcription complex, subunit 3, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), NOTCH3  -  notch 3, CAPZB  -  capping protein (actin filament) muscle z-line, beta, IFNG  -  interferon, gamma, NGF  -  nerve growth factor (beta polypeptide), EZR  -  ezrin, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TYROBP  -  tyro protein tyrosine kinase binding protein, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, DLX2  -  distal-less homeobox 2, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLIT2  -  slit homolog 2 (drosophila), RARG  -  retinoic acid receptor, gamma, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR1  -  estrogen receptor 1, DLC1  -  deleted in liver cancer 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, PKP2  -  plakophilin 2, HOXA9  -  homeobox a9, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, EPHA3  -  eph receptor a3, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), SRSF6  -  serine/arginine-rich splicing factor 6, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, THRA  -  thyroid hormone receptor, alpha, FOXA2  -  forkhead box a2]"GO:0050996,positive regulation of lipid catabolic process,1.61E-04,2.00E-02,21.89,8230,16,94,4,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PPARA  -  peroxisome proliferator-activated receptor alpha, IL1B  -  interleukin 1, beta]"GO:0010243,response to organonitrogen compound,1.67E-04,2.04E-02,1.62,8230,531,709,74,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, CAPN2  -  calpain 2, (m/ii) large subunit, DRD3  -  dopamine receptor d3, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CXCL12  -  chemokine (c-x-c motif) ligand 12, PTPRN  -  protein tyrosine phosphatase, receptor type, n, CTGF  -  connective tissue growth factor, INHBB  -  inhibin, beta b, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, AGTR2  -  angiotensin ii receptor, type 2, GCG  -  glucagon, RPE65  -  retinal pigment epithelium-specific protein 65kda, DPYSL2  -  dihydropyrimidinase-like 2, GCK  -  glucokinase (hexokinase 4), CHEK1  -  checkpoint kinase 1, RRAGB  -  ras-related gtp binding b, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, NGF  -  nerve growth factor (beta polypeptide), CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TRIM16  -  tripartite motif containing 16, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, OGG1  -  8-oxoguanine dna glycosylase, RHEB  -  ras homolog enriched in brain, FYN  -  fyn oncogene related to src, fgr, yes, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, GH1  -  growth hormone 1, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group), TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, CYP2E1  -  cytochrome p450, family 2, subfamily e, polypeptide 1, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), SLIT2  -  slit homolog 2 (drosophila), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPARA  -  peroxisome proliferator-activated receptor alpha, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, PPARG  -  peroxisome proliferator-activated receptor gamma, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, TH  -  tyrosine hydroxylase, IGFBP1  -  insulin-like growth factor binding protein 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, COL5A2  -  collagen, type v, alpha 2, PRKCZ  -  protein kinase c, zeta, NPPA  -  natriuretic peptide a, COL6A1  -  collagen, type vi, alpha 1, GNAI1  -  guanine nucleotide binding protein (g protein), alpha inhibiting activity polypeptide 1, PTPRA  -  protein tyrosine phosphatase, receptor type, a, BCL2  -  b-cell cll/lymphoma 2, PDX1  -  pancreatic and duodenal homeobox 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, NRF1  -  nuclear respiratory factor 1, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, IRAK1  -  interleukin-1 receptor-associated kinase 1, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0019883,antigen processing and presentation of endogenous antigen,1.70E-04,2.06E-02,19.25,8230,10,171,4,"[HLA-A  -  major histocompatibility complex, class i, a, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, TAPBP  -  tap binding protein (tapasin), HLA-E  -  major histocompatibility complex, class i, e]"GO:0048584,positive regulation of response to stimulus,1.79E-04,2.14E-02,1.72,8230,1113,253,59,"[AKR1C3  -  aldo-keto reductase family 1, member c3, S1PR2  -  sphingosine-1-phosphate receptor 2, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, DRD3  -  dopamine receptor d3, ADRB3  -  adrenoceptor beta 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), KLK6  -  kallikrein-related peptidase 6, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, FLNA  -  filamin a, alpha, ATM  -  ataxia telangiectasia mutated, NLGN1  -  neuroligin 1, HLA-A  -  major histocompatibility complex, class i, a, CTSL  -  cathepsin l, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), SORBS3  -  sorbin and sh3 domain containing 3, RRAGB  -  ras-related gtp binding b, GRAP2  -  grb2-related adaptor protein 2, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, CCL4  -  chemokine (c-c motif) ligand 4, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, ACTG1  -  actin, gamma 1, RHEB  -  ras homolog enriched in brain, FYN  -  fyn oncogene related to src, fgr, yes, ATF2  -  activating transcription factor 2, STK4  -  serine/threonine kinase 4, CADM1  -  cell adhesion molecule 1, MDFI  -  myod family inhibitor, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, FGF1  -  fibroblast growth factor 1 (acidic), CD14  -  cd14 molecule, COL3A1  -  collagen, type iii, alpha 1, ESR1  -  estrogen receptor 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, S100B  -  s100 calcium binding protein b, PIAS4  -  protein inhibitor of activated stat, 4, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), S100A4  -  s100 calcium binding protein a4, C1QB  -  complement component 1, q subcomponent, b chain, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, KITLG  -  kit ligand, THY1  -  thy-1 cell surface antigen, C6  -  complement component 6]"GO:0071637,regulation of monocyte chemotactic protein-1 production,1.81E-04,2.14E-02,164.6,8230,5,20,2,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, IL1B  -  interleukin 1, beta]"GO:0044283,small molecule biosynthetic process,1.86E-04,2.18E-02,3.41,8230,154,235,15,"[AKR1C3  -  aldo-keto reductase family 1, member c3, BGN  -  biglycan, GLUL  -  glutamate-ammonia ligase, SHMT1  -  serine hydroxymethyltransferase 1 (soluble), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), ALOX12  -  arachidonate 12-lipoxygenase, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PTGDS  -  prostaglandin d2 synthase 21kda (brain), LPL  -  lipoprotein lipase, PLTP  -  phospholipid transfer protein, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, ACACA  -  acetyl-coa carboxylase alpha, CHKA  -  choline kinase alpha, FASN  -  fatty acid synthase]"GO:0043200,response to amino acid,1.93E-04,2.24E-02,3.69,8230,72,434,14,"[RRAGB  -  ras-related gtp binding b, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CAPN2  -  calpain 2, (m/ii) large subunit, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), CCL2  -  chemokine (c-c motif) ligand 2, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, CTGF  -  connective tissue growth factor, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, COL3A1  -  collagen, type iii, alpha 1, OGG1  -  8-oxoguanine dna glycosylase, NRF1  -  nuclear respiratory factor 1, CYBA  -  cytochrome b-245, alpha polypeptide, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1]"GO:0032000,positive regulation of fatty acid beta-oxidation,1.93E-04,2.22E-02,37.52,8230,7,94,3,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PPARA  -  peroxisome proliferator-activated receptor alpha]"GO:0051050,positive regulation of transport,2.11E-04,2.40E-02,1.64,8230,456,747,68,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, DRD3  -  dopamine receptor d3, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, PRSS8  -  protease, serine, 8, INHBB  -  inhibin, beta b, SFN  -  stratifin, GAB2  -  grb2-associated binding protein 2, FLNA  -  filamin a, alpha, KIF3A  -  kinesin family member 3a, AGTR2  -  angiotensin ii receptor, type 2, GCG  -  glucagon, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, GCK  -  glucokinase (hexokinase 4), IFNG  -  interferon, gamma, KMT2A  -  lysine (k)-specific methyltransferase 2a, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), STXBP1  -  syntaxin binding protein 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, MBL2  -  mannose-binding lectin (protein c) 2, soluble, CCL4  -  chemokine (c-c motif) ligand 4, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, AHSG  -  alpha-2-hs-glycoprotein, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TRIM16  -  tripartite motif containing 16, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CD34  -  cd34 molecule, AQP1  -  aquaporin 1 (colton blood group), KISS1  -  kiss-1 metastasis-suppressor, CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, NMU  -  neuromedin u, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GLI3  -  gli family zinc finger 3, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, PTH  -  parathyroid hormone, PKP2  -  plakophilin 2, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, ANG  -  angiogenin, ribonuclease, rnase a family, 5, UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GATA3  -  gata binding protein 3, SLC30A3  -  solute carrier family 30 (zinc transporter), member 3, TRH  -  thyrotropin-releasing hormone, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PRKCZ  -  protein kinase c, zeta, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), ADORA1  -  adenosine a1 receptor, PDX1  -  pancreatic and duodenal homeobox 1, SMAD4  -  smad family member 4, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, HCLS1  -  hematopoietic cell-specific lyn substrate 1]"GO:2000026,regulation of multicellular organismal development,2.12E-04,2.39E-02,1.46,8230,951,666,112,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), BRCA2  -  breast cancer 2, early onset, PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PLXNB1  -  plexin b1, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, CDON  -  cell adhesion associated, oncogene regulated, BTK  -  bruton agammaglobulinemia tyrosine kinase, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GDF5  -  growth differentiation factor 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, SOX3  -  sry (sex determining region y)-box 3, CCL3  -  chemokine (c-c motif) ligand 3, TRIM16  -  tripartite motif containing 16, LDB1  -  lim domain binding 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), KLK3  -  kallikrein-related peptidase 3, FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, FES  -  feline sarcoma oncogene, COL3A1  -  collagen, type iii, alpha 1, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, PPARG  -  peroxisome proliferator-activated receptor gamma, PTK6  -  protein tyrosine kinase 6, S100B  -  s100 calcium binding protein b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), IRF1  -  interferon regulatory factor 1, C5  -  complement component 5, KITLG  -  kit ligand, C6  -  complement component 6, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), HLA-G  -  major histocompatibility complex, class i, g, NKX2-1  -  nk2 homeobox 1, RUFY3  -  run and fyve domain containing 3, DRD3  -  dopamine receptor d3, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, SRGN  -  serglycin, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, GPC1  -  glypican 1, AGTR2  -  angiotensin ii receptor, type 2, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), DPYSL2  -  dihydropyrimidinase-like 2, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, NGF  -  nerve growth factor (beta polypeptide), GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, NIPBL  -  nipped-b homolog (drosophila), TYROBP  -  tyro protein tyrosine kinase binding protein, STAR  -  steroidogenic acute regulatory protein, CRX  -  cone-rod homeobox, DLX2  -  distal-less homeobox 2, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), RARG  -  retinoic acid receptor, gamma, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR1  -  estrogen receptor 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, HOXA9  -  homeobox a9, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, EPHA3  -  eph receptor a3, GATA3  -  gata binding protein 3, FADD  -  fas (tnfrsf6)-associated via death domain, SRSF6  -  serine/arginine-rich splicing factor 6, EPHA5  -  eph receptor a5, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, FOXA2  -  forkhead box a2]"GO:0050994,regulation of lipid catabolic process,2.16E-04,2.41E-02,13.68,8230,32,94,5,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PPARA  -  peroxisome proliferator-activated receptor alpha, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, IL1B  -  interleukin 1, beta]"GO:0008284,positive regulation of cell proliferation,2.24E-04,2.47E-02,1.61,8230,567,657,73,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, PAX2  -  paired box 2, S1PR2  -  sphingosine-1-phosphate receptor 2, CAPNS1  -  calpain, small subunit 1, DRD3  -  dopamine receptor d3, IL12RB2  -  interleukin 12 receptor, beta 2, NKX2-5  -  nk2 homeobox 5, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), CTGF  -  connective tissue growth factor, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, GAB2  -  grb2-associated binding protein 2, CDON  -  cell adhesion associated, oncogene regulated, AGTR2  -  angiotensin ii receptor, type 2, NOTCH3  -  notch 3, IFNG  -  interferon, gamma, RPS4X  -  ribosomal protein s4, x-linked, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), NGF  -  nerve growth factor (beta polypeptide), CCL14  -  chemokine (c-c motif) ligand 14, VIP  -  vasoactive intestinal peptide, CCL2  -  chemokine (c-c motif) ligand 2, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, MNAT1  -  mnat cdk-activating kinase assembly factor 1, CRH  -  corticotropin releasing hormone, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CXCR2  -  chemokine (c-x-c motif) receptor 2, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), FASLG  -  fas ligand (tnf superfamily, member 6), TSC22D1  -  tsc22 domain family, member 1, CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group), CRIP2  -  cysteine-rich protein 2, TEK  -  tek tyrosine kinase, endothelial, GLUL  -  glutamate-ammonia ligase, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RARG  -  retinoic acid receptor, gamma, FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, TWIST1  -  twist basic helix-loop-helix transcription factor 1, KRT6A  -  keratin 6a, ESR1  -  estrogen receptor 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, GRN  -  granulin, PTHLH  -  parathyroid hormone-like hormone, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, INSL3  -  insulin-like 3 (leydig cell), ANG  -  angiogenin, ribonuclease, rnase a family, 5, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), CDK13  -  cyclin-dependent kinase 13, SRSF6  -  serine/arginine-rich splicing factor 6, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, KITLG  -  kit ligand, GAS6  -  growth arrest-specific 6, CDK2  -  cyclin-dependent kinase 2, HCLS1  -  hematopoietic cell-specific lyn substrate 1, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:0002478,antigen processing and presentation of exogenous peptide antigen,2.26E-04,2.47E-02,2.78,8230,139,447,21,"[HLA-A  -  major histocompatibility complex, class i, a, CTSL  -  cathepsin l, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, CTSD  -  cathepsin d, HLA-G  -  major histocompatibility complex, class i, g, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, HLA-F  -  major histocompatibility complex, class i, f, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, HLA-E  -  major histocompatibility complex, class i, e, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, UBC  -  ubiquitin c, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ITGB5  -  integrin, beta 5, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, KIF3A  -  kinesin family member 3a, TAPBP  -  tap binding protein (tapasin), DYNLL1  -  dynein, light chain, lc8-type 1, CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0044711,single-organism biosynthetic process,2.26E-04,2.45E-02,2.04,8230,478,312,37,"[AKR1C3  -  aldo-keto reductase family 1, member c3, GLUL  -  glutamate-ammonia ligase, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SHMT1  -  serine hydroxymethyltransferase 1 (soluble), ALOX12  -  arachidonate 12-lipoxygenase, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), UBC  -  ubiquitin c, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PC  -  pyruvate carboxylase, ATM  -  ataxia telangiectasia mutated, ACACA  -  acetyl-coa carboxylase alpha, PMM1  -  phosphomannomutase 1, MTMR4  -  myotubularin related protein 4, TYR  -  tyrosinase, CHKA  -  choline kinase alpha, FDXR  -  ferredoxin reductase, FASN  -  fatty acid synthase, GAD1  -  glutamate decarboxylase 1 (brain, 67kda), TRAM2  -  translocation associated membrane protein 2, ANG  -  angiogenin, ribonuclease, rnase a family, 5, CHST15  -  carbohydrate (n-acetylgalactosamine 4-sulfate 6-o) sulfotransferase 15, BGN  -  biglycan, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, SERPINH1  -  serpin peptidase inhibitor, clade h (heat shock protein 47), member 1, (collagen binding protein 1), TH  -  tyrosine hydroxylase, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PLCE1  -  phospholipase c, epsilon 1, PIKFYVE  -  phosphoinositide kinase, fyve finger containing, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, LPL  -  lipoprotein lipase, PLTP  -  phospholipid transfer protein, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, CALCRL  -  calcitonin receptor-like, AQP1  -  aquaporin 1 (colton blood group)]"GO:0010661,positive regulation of muscle cell apoptotic process,2.33E-04,2.49E-02,10.05,8230,9,455,5,"[HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CXCR2  -  chemokine (c-x-c motif) receptor 2, LTK  -  leukocyte receptor tyrosine kinase, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), IFNG  -  interferon, gamma]"GO:2000793,cell proliferation involved in heart valve development,2.43E-04,2.58E-02,"4,115.00",8230,1,2,1,[TWIST1  -  twist basic helix-loop-helix transcription factor 1]GO:2000802,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,2.43E-04,2.55E-02,"4,115.00",8230,1,2,1,[TWIST1  -  twist basic helix-loop-helix transcription factor 1]GO:2000800,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,2.43E-04,2.53E-02,"4,115.00",8230,1,2,1,[TWIST1  -  twist basic helix-loop-helix transcription factor 1]GO:0035359,negative regulation of peroxisome proliferator activated receptor signaling pathway,2.43E-04,2.51E-02,"4,115.00",8230,1,2,1,[TWIST1  -  twist basic helix-loop-helix transcription factor 1]GO:0060900,embryonic camera-type eye formation,2.43E-04,2.48E-02,"4,115.00",8230,1,2,1,[TWIST1  -  twist basic helix-loop-helix transcription factor 1]GO:0019216,regulation of lipid metabolic process,2.71E-04,2.74E-02,9.1,8230,175,31,6,"[FGF1  -  fibroblast growth factor 1 (acidic), TWIST1  -  twist basic helix-loop-helix transcription factor 1, NPC2  -  niemann-pick disease, type c2, PSAP  -  prosaposin, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, IL1B  -  interleukin 1, beta]"GO:0045776,negative regulation of blood pressure,2.74E-04,2.75E-02,4.47,8230,30,614,10,"[CRH  -  corticotropin releasing hormone, UCN  -  urocortin, ADORA1  -  adenosine a1 receptor, AGTR2  -  angiotensin ii receptor, type 2, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), ADRB3  -  adrenoceptor beta 3, PPARA  -  peroxisome proliferator-activated receptor alpha, NPPA  -  natriuretic peptide a]"GO:0009888,tissue development,2.81E-04,2.80E-02,1.63,8230,374,907,67,"[CREB5  -  camp responsive element binding protein 5, NCKAP1  -  nck-associated protein 1, PAX2  -  paired box 2, NKX2-1  -  nk2 homeobox 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, SRGN  -  serglycin, PAX9  -  paired box 9, KLK6  -  kallikrein-related peptidase 6, CTGF  -  connective tissue growth factor, BTK  -  bruton agammaglobulinemia tyrosine kinase, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), HOXB13  -  homeobox b13, GAB1  -  grb2-associated binding protein 1, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, EVPL  -  envoplakin, SOX5  -  sry (sex determining region y)-box 5, CLEC3B  -  c-type lectin domain family 3, member b, EYA2  -  eyes absent homolog 2 (drosophila), LDB1  -  lim domain binding 1, PLG  -  plasminogen, ATF2  -  activating transcription factor 2, CD34  -  cd34 molecule, HOXC13  -  homeobox c13, MSC  -  musculin, EDA2R  -  ectodysplasin a2 receptor, PKD1  -  polycystic kidney disease 1 (autosomal dominant), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, HOXA11  -  homeobox a11, FGFR3  -  fibroblast growth factor receptor 3, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), GDF11  -  growth differentiation factor 11, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, UBC  -  ubiquitin c, RARG  -  retinoic acid receptor, gamma, FGF1  -  fibroblast growth factor 1 (acidic), KRT6A  -  keratin 6a, COL2A1  -  collagen, type ii, alpha 1, KRT9  -  keratin 9, NF2  -  neurofibromin 2 (merlin), KRT15  -  keratin 15, PECAM1  -  platelet/endothelial cell adhesion molecule 1, PTHLH  -  parathyroid hormone-like hormone, KRT14  -  keratin 14, PPARA  -  peroxisome proliferator-activated receptor alpha, IHH  -  indian hedgehog, MAPK14  -  mitogen-activated protein kinase 14, ONECUT1  -  one cut homeobox 1, LAMC2  -  laminin, gamma 2, NPHS1  -  nephrosis 1, congenital, finnish type (nephrin), TGFB1  -  transforming growth factor, beta 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), IGFBP1  -  insulin-like growth factor binding protein 1, S100A7  -  s100 calcium binding protein a7, TAZ  -  tafazzin, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), STX2  -  syntaxin 2, GAP43  -  growth associated protein 43, SMAD4  -  smad family member 4, ASGR2  -  asialoglycoprotein receptor 2, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, COL17A1  -  collagen, type xvii, alpha 1, FOXA2  -  forkhead box a2, SCEL  -  sciellin]"GO:0032642,regulation of chemokine production,2.86E-04,2.82E-02,9.61,8230,48,107,6,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, MAP2K5  -  mitogen-activated protein kinase kinase 5, DARC  -  duffy blood group, atypical chemokine receptor, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL1B  -  interleukin 1, beta]"GO:0043491,protein kinase B signaling,2.89E-04,2.82E-02,12.46,8230,26,127,5,"[TYRO3  -  tyro3 protein tyrosine kinase, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, CCL3  -  chemokine (c-c motif) ligand 3]"GO:0032880,regulation of protein localization,2.90E-04,2.81E-02,3.75,8230,375,76,13,"[ANG  -  angiogenin, ribonuclease, rnase a family, 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, MDFI  -  myod family inhibitor, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, FLNA  -  filamin a, alpha, OGG1  -  8-oxoguanine dna glycosylase, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, FYN  -  fyn oncogene related to src, fgr, yes]"GO:0003014,renal system process,3.02E-04,2.90E-02,3.02,8230,51,856,16,"[AKR1C3  -  aldo-keto reductase family 1, member c3, ADRB1  -  adrenoceptor beta 1, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLC22A6  -  solute carrier family 22 (organic anion transporter), member 6, BTC  -  betacellulin, KCNJ1  -  potassium inwardly-rectifying channel, subfamily j, member 1, HNF1A  -  hnf1 homeobox a, BCL2  -  b-cell cll/lymphoma 2, ADORA1  -  adenosine a1 receptor, AGTR2  -  angiotensin ii receptor, type 2, CD34  -  cd34 molecule, ADRA1A  -  adrenoceptor alpha 1a, GAS6  -  growth arrest-specific 6, AQP1  -  aquaporin 1 (colton blood group)]"GO:0060548,negative regulation of cell death,3.02E-04,2.88E-02,1.61,8230,554,666,72,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, PAX2  -  paired box 2, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, NKX2-5  -  nk2 homeobox 5, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, CTGF  -  connective tissue growth factor, NAIP  -  nlr family, apoptosis inhibitory protein, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, GCG  -  glucagon, GDF5  -  growth differentiation factor 5, STXBP1  -  syntaxin binding protein 1, RPS3A  -  ribosomal protein s3a, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, NGF  -  nerve growth factor (beta polypeptide), PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, VIP  -  vasoactive intestinal peptide, CCL2  -  chemokine (c-c motif) ligand 2, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ARF4  -  adp-ribosylation factor 4, MNAT1  -  mnat cdk-activating kinase assembly factor 1, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, CXCR2  -  chemokine (c-x-c motif) receptor 2, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), CD34  -  cd34 molecule, TSC22D1  -  tsc22 domain family, member 1, AQP1  -  aquaporin 1 (colton blood group), CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, STAR  -  steroidogenic acute regulatory protein, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GLI3  -  gli family zinc finger 3, TWIST1  -  twist basic helix-loop-helix transcription factor 1, POU3F4  -  pou class 3 homeobox 4, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, TYRO3  -  tyro3 protein tyrosine kinase, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PPARA  -  peroxisome proliferator-activated receptor alpha, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, INSL3  -  insulin-like 3 (leydig cell), UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GRIK2  -  glutamate receptor, ionotropic, kainate 2, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), KLHL20  -  kelch-like family member 20, FADD  -  fas (tnfrsf6)-associated via death domain, SRSF6  -  serine/arginine-rich splicing factor 6, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, ADORA1  -  adenosine a1 receptor, SMAD4  -  smad family member 4, KITLG  -  kit ligand, GAS6  -  growth arrest-specific 6, HCLS1  -  hematopoietic cell-specific lyn substrate 1, IRAK1  -  interleukin-1 receptor-associated kinase 1]"GO:0043518,"negative regulation of DNA damage response, signal transduction by p53 class mediator",3.20E-04,3.03E-02,33.87,8230,9,81,3,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor)]"GO:0001914,regulation of T cell mediated cytotoxicity,3.39E-04,3.17E-02,3.76,8230,25,963,11,"[HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), IL23R  -  interleukin 23 receptor, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)]"GO:0007610,behavior,3.48E-04,3.23E-02,1.62,8230,339,992,66,"[CHRNA7  -  cholinergic receptor, nicotinic, alpha 7 (neuronal), NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, ADRB1  -  adrenoceptor beta 1, ADRB3  -  adrenoceptor beta 3, CXCL12  -  chemokine (c-x-c motif) ligand 12, PMCH  -  pro-melanin-concentrating hormone, HAND2  -  heart and neural crest derivatives expressed 2, ACE2  -  angiotensin i converting enzyme 2, AGTR2  -  angiotensin ii receptor, type 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, GCG  -  glucagon, NGF  -  nerve growth factor (beta polypeptide), STRN  -  striatin, calmodulin binding protein, VIP  -  vasoactive intestinal peptide, CCL3  -  chemokine (c-c motif) ligand 3, GHSR  -  growth hormone secretagogue receptor, CRH  -  corticotropin releasing hormone, APP  -  amyloid beta (a4) precursor protein, FYN  -  fyn oncogene related to src, fgr, yes, NHLH2  -  nescient helix loop helix 2, MYO6  -  myosin vi, CALCA  -  calcitonin-related polypeptide alpha, OPRD1  -  opioid receptor, delta 1, NMU  -  neuromedin u, STAR  -  steroidogenic acute regulatory protein, GLRB  -  glycine receptor, beta, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), FGF12  -  fibroblast growth factor 12, PTGDS  -  prostaglandin d2 synthase 21kda (brain), IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, HOXA1  -  homeobox a1, NTSR1  -  neurotensin receptor 1 (high affinity), HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, NRXN3  -  neurexin 3, PPARA  -  peroxisome proliferator-activated receptor alpha, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, GRIA1  -  glutamate receptor, ionotropic, ampa 1, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, S100B  -  s100 calcium binding protein b, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, UCN  -  urocortin, GRIK1  -  glutamate receptor, ionotropic, kainate 1, GRIK2  -  glutamate receptor, ionotropic, kainate 2, TH  -  tyrosine hydroxylase, TRH  -  thyrotropin-releasing hormone, NLGN4X  -  neuroligin 4, x-linked, PRKCZ  -  protein kinase c, zeta, GRIN2D  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2d, EPHA4  -  eph receptor a4, CCKAR  -  cholecystokinin a receptor, COMT  -  catechol-o-methyltransferase, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, NPY1R  -  neuropeptide y receptor y1, BCL2  -  b-cell cll/lymphoma 2, PRKCG  -  protein kinase c, gamma, ADORA1  -  adenosine a1 receptor, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, THRA  -  thyroid hormone receptor, alpha, HCRT  -  hypocretin (orexin) neuropeptide precursor, HCRTR1  -  hypocretin (orexin) receptor 1, FOXA2  -  forkhead box a2]"GO:0051239,regulation of multicellular organismal process,3.56E-04,3.28E-02,1.32,8230,1475,726,172,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, BRCA2  -  breast cancer 2, early onset, IL12RB2  -  interleukin 12 receptor, beta 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, PAX9  -  paired box 9, KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PLXNB1  -  plexin b1, INHBB  -  inhibin, beta b, BCOR  -  bcl6 corepressor, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, CDON  -  cell adhesion associated, oncogene regulated, BTK  -  bruton agammaglobulinemia tyrosine kinase, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GDF5  -  growth differentiation factor 5, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX5  -  sry (sex determining region y)-box 5, CCL2  -  chemokine (c-c motif) ligand 2, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, RND2  -  rho family gtpase 2, LDB1  -  lim domain binding 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, ATF2  -  activating transcription factor 2, CD34  -  cd34 molecule, KLK3  -  kallikrein-related peptidase 3, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), FASLG  -  fas ligand (tnf superfamily, member 6), GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), CADM1  -  cell adhesion molecule 1, NMU  -  neuromedin u, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, TPH1  -  tryptophan hydroxylase 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, PTGDS  -  prostaglandin d2 synthase 21kda (brain), FGF8  -  fibroblast growth factor 8 (androgen-induced), IAPP  -  islet amyloid polypeptide, FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, FES  -  feline sarcoma oncogene, COL3A1  -  collagen, type iii, alpha 1, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, PTHLH  -  parathyroid hormone-like hormone, FZD1  -  frizzled family receptor 1, CACNA1D  -  calcium channel, voltage-dependent, l type, alpha 1d subunit, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit, PTK6  -  protein tyrosine kinase 6, S100B  -  s100 calcium binding protein b, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), LBP  -  lipopolysaccharide binding protein, IRF1  -  interferon regulatory factor 1, NPY1R  -  neuropeptide y receptor y1, ADORA1  -  adenosine a1 receptor, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, KITLG  -  kit ligand, ADRA1A  -  adrenoceptor alpha 1a, C6  -  complement component 6, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), HLA-G  -  major histocompatibility complex, class i, g, NKX2-1  -  nk2 homeobox 1, RUFY3  -  run and fyve domain containing 3, DRD3  -  dopamine receptor d3, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB1  -  adrenoceptor beta 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, CHRM3  -  cholinergic receptor, muscarinic 3, DSC2  -  desmocollin 2, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, GPC1  -  glypican 1, AGTR2  -  angiotensin ii receptor, type 2, CNOT3  -  ccr4-not transcription complex, subunit 3, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), NOTCH3  -  notch 3, IFNG  -  interferon, gamma, HLA-A  -  major histocompatibility complex, class i, a, NGF  -  nerve growth factor (beta polypeptide), VIP  -  vasoactive intestinal peptide, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NKX2-2  -  nk2 homeobox 2, CXADR  -  coxsackie virus and adenovirus receptor, RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), FYN  -  fyn oncogene related to src, fgr, yes, DARC  -  duffy blood group, atypical chemokine receptor, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), STK4  -  serine/threonine kinase 4, KISS1  -  kiss-1 metastasis-suppressor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TYROBP  -  tyro protein tyrosine kinase binding protein, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, DLX2  -  distal-less homeobox 2, CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, RAG2  -  recombination activating gene 2, PLAU  -  plasminogen activator, urokinase, RARG  -  retinoic acid receptor, gamma, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, PKP2  -  plakophilin 2, HOXA9  -  homeobox a9, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, EPHA3  -  eph receptor a3, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), KCNB2  -  potassium voltage-gated channel, shab-related subfamily, member 2, PLCE1  -  phospholipase c, epsilon 1, SRSF6  -  serine/arginine-rich splicing factor 6, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, FADD  -  fas (tnfrsf6)-associated via death domain, EPHA5  -  eph receptor a5, PRKCZ  -  protein kinase c, zeta, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, THRA  -  thyroid hormone receptor, alpha, MPL  -  myeloproliferative leukemia virus oncogene, FOXA2  -  forkhead box a2]"GO:0051222,positive regulation of protein transport,3.66E-04,3.34E-02,5.78,8230,170,67,8,"[ANG  -  angiogenin, ribonuclease, rnase a family, 5, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, FLNA  -  filamin a, alpha, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3]"GO:0006633,fatty acid biosynthetic process,3.68E-04,3.34E-02,6.09,8230,47,230,8,"[CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, ACACA  -  acetyl-coa carboxylase alpha, ALOX12  -  arachidonate 12-lipoxygenase, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PTGDS  -  prostaglandin d2 synthase 21kda (brain), LPL  -  lipoprotein lipase, FASN  -  fatty acid synthase]"GO:0071346,cellular response to interferon-gamma,3.89E-04,3.50E-02,3.98,8230,73,340,12,"[HLA-A  -  major histocompatibility complex, class i, a, IRF1  -  interferon regulatory factor 1, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, CCL2  -  chemokine (c-c motif) ligand 2, NCAM1  -  neural cell adhesion molecule 1, CCL3  -  chemokine (c-c motif) ligand 3]"GO:0051240,positive regulation of multicellular organismal process,3.99E-04,3.56E-02,1.53,8230,446,991,82,"[ATP2A1  -  atpase, ca++ transporting, cardiac muscle, fast twitch 1, DHX58  -  dexh (asp-glu-x-his) box polypeptide 58, PAX2  -  paired box 2, IL1RL2  -  interleukin 1 receptor-like 2, HLA-G  -  major histocompatibility complex, class i, g, DRD3  -  dopamine receptor d3, HSF1  -  heat shock transcription factor 1, IL12RB2  -  interleukin 12 receptor, beta 2, ADRB1  -  adrenoceptor beta 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, FLT4  -  fms-related tyrosine kinase 4, ADRB3  -  adrenoceptor beta 3, CHRM3  -  cholinergic receptor, muscarinic 3, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), CTGF  -  connective tissue growth factor, INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, AGTR2  -  angiotensin ii receptor, type 2, FOXP3  -  forkhead box p3, IFNG  -  interferon, gamma, HLA-A  -  major histocompatibility complex, class i, a, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, SOX11  -  sry (sex determining region y)-box 11, VIP  -  vasoactive intestinal peptide, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, GHSR  -  growth hormone secretagogue receptor, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TRIM16  -  tripartite motif containing 16, PLG  -  plasminogen, CD34  -  cd34 molecule, ATF2  -  activating transcription factor 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), CALCA  -  calcitonin-related polypeptide alpha, GH1  -  growth hormone 1, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), AQP1  -  aquaporin 1 (colton blood group), IL23R  -  interleukin 23 receptor, HOXA11  -  homeobox a11, NMU  -  neuromedin u, FZD5  -  frizzled family receptor 5, NIPBL  -  nipped-b homolog (drosophila), CRX  -  cone-rod homeobox, ALOX12  -  arachidonate 12-lipoxygenase, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, UBC  -  ubiquitin c, FGF8  -  fibroblast growth factor 8 (androgen-induced), RAG2  -  recombination activating gene 2, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), FGF1  -  fibroblast growth factor 1 (acidic), TXK  -  txk tyrosine kinase, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, PTH  -  parathyroid hormone, IHH  -  indian hedgehog, UCN  -  urocortin, TGFB1  -  transforming growth factor, beta 1, GATA3  -  gata binding protein 3, IGF1  -  insulin-like growth factor 1 (somatomedin c), CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), LCK  -  lymphocyte-specific protein tyrosine kinase, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), LBP  -  lipopolysaccharide binding protein, FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, IL1RL1  -  interleukin 1 receptor-like 1, PRKCZ  -  protein kinase c, zeta, POU1F1  -  pou class 1 homeobox 1, IRF1  -  interferon regulatory factor 1, BCL2  -  b-cell cll/lymphoma 2, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, ADRA1A  -  adrenoceptor alpha 1a, GAS6  -  growth arrest-specific 6, HCRT  -  hypocretin (orexin) neuropeptide precursor]"GO:0002684,positive regulation of immune system process,4.05E-04,3.58E-02,2.69,8230,527,116,20,"[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, C1QB  -  complement component 1, q subcomponent, b chain, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL1B  -  interleukin 1, beta, UBC  -  ubiquitin c, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent, CCL3  -  chemokine (c-c motif) ligand 3, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CD14  -  cd14 molecule, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, ACTG1  -  actin, gamma 1, ATF2  -  activating transcription factor 2, FYN  -  fyn oncogene related to src, fgr, yes, THY1  -  thy-1 cell surface antigen]"GO:0048519,negative regulation of biological process,4.20E-04,3.69E-02,1.22,8230,2470,795,290,"[MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, NCBP1  -  nuclear cap binding protein subunit 1, 80kda, SPTAN1  -  spectrin, alpha, non-erythrocytic 1, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, GFRA2  -  gdnf family receptor alpha 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, CDKN2AIP  -  cdkn2a interacting protein, BTG3  -  btg family, member 3, CARD14  -  caspase recruitment domain family, member 14, PATZ1  -  poz (btb) and at hook containing zinc finger 1, NAIP  -  nlr family, apoptosis inhibitory protein, PLXNB1  -  plexin b1, BCOR  -  bcl6 corepressor, GCG  -  glucagon, SAP30  -  sin3a-associated protein, 30kda, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), SORBS3  -  sorbin and sh3 domain containing 3, SPRED2  -  sprouty-related, evh1 domain containing 2, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, PLG  -  plasminogen, CALCRL  -  calcitonin receptor-like, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), TSC22D1  -  tsc22 domain family, member 1, RGS16  -  regulator of g-protein signaling 16, ACTN1  -  actinin, alpha 1, TRRAP  -  transformation/transcription domain-associated protein, TPH1  -  tryptophan hydroxylase 1, CREBZF  -  creb/atf bzip transcription factor, IAPP  -  islet amyloid polypeptide, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, GLI3  -  gli family zinc finger 3, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, MYO16  -  myosin xvi, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), LDOC1  -  leucine zipper, down-regulated in cancer 1, TRH  -  thyrotropin-releasing hormone, LBP  -  lipopolysaccharide binding protein, POU1F1  -  pou class 1 homeobox 1, COMT  -  catechol-o-methyltransferase, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, GMFB  -  glia maturation factor, beta, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, WAPAL  -  wings apart-like homolog (drosophila), AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, HLA-G  -  major histocompatibility complex, class i, g, HLA-E  -  major histocompatibility complex, class i, e, AES  -  amino-terminal enhancer of split, PDE5A  -  phosphodiesterase 5a, cgmp-specific, ADRB1  -  adrenoceptor beta 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, ZNF350  -  zinc finger protein 350, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, CTBP1  -  c-terminal binding protein 1, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS3A  -  ribosomal protein s3a, STXBP1  -  syntaxin binding protein 1, HMGXB4  -  hmg box domain containing 4, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, STRN  -  striatin, calmodulin binding protein, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, VIP  -  vasoactive intestinal peptide, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, NCOA2  -  nuclear receptor coactivator 2, EZH1  -  enhancer of zeste homolog 1 (drosophila), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, HIC1  -  hypermethylated in cancer 1, TRIM31  -  tripartite motif containing 31, STK4  -  serine/threonine kinase 4, KISS1  -  kiss-1 metastasis-suppressor, STMN2  -  stathmin-like 2, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, ESR2  -  estrogen receptor 2 (er beta), TWIST1  -  twist basic helix-loop-helix transcription factor 1, RCOR1  -  rest corepressor 1, RPS14  -  ribosomal protein s14, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, DLC1  -  deleted in liver cancer 1, CD9  -  cd9 molecule, SSTR3  -  somatostatin receptor 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, SSTR5  -  somatostatin receptor 5, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ALX1  -  alx homeobox 1, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, GATA3  -  gata binding protein 3, MVP  -  major vault protein, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, KRIT1  -  krit1, ankyrin repeat containing, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, RREB1  -  ras responsive element binding protein 1, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), SOCS6  -  suppressor of cytokine signaling 6, HTRA1  -  htra serine peptidase 1, FLT4  -  fms-related tyrosine kinase 4, ORC2  -  origin recognition complex, subunit 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), MLLT1  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 1, RGS5  -  regulator of g-protein signaling 5, PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, RIF1  -  rap1 interacting factor homolog (yeast), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CCL4  -  chemokine (c-c motif) ligand 4, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, PSMD1  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, AKAP10  -  a kinase (prka) anchor protein 10, KLK3  -  kallikrein-related peptidase 3, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, FGF12  -  fibroblast growth factor 12, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, PTHLH  -  parathyroid hormone-like hormone, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), S100A11  -  s100 calcium binding protein a11, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, TMSB10  -  thymosin beta 10, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), KLHL20  -  kelch-like family member 20, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), IRF1  -  interferon regulatory factor 1, TRIM9  -  tripartite motif containing 9, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, CDK2  -  cyclin-dependent kinase 2, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCLS1  -  hematopoietic cell-specific lyn substrate 1, ZNF205  -  zinc finger protein 205, IRAK1  -  interleukin-1 receptor-associated kinase 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), RUFY3  -  run and fyve domain containing 3, NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SMC3  -  structural maintenance of chromosomes 3, BAHD1  -  bromo adjacent homology domain containing 1, SFN  -  stratifin, GPC1  -  glypican 1, LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, CNOT3  -  ccr4-not transcription complex, subunit 3, PGR  -  progesterone receptor, NOTCH3  -  notch 3, DHX34  -  deah (asp-glu-ala-his) box polypeptide 34, IFNG  -  interferon, gamma, CHEK1  -  checkpoint kinase 1, NFX1  -  nuclear transcription factor, x-box binding 1, NGF  -  nerve growth factor (beta polypeptide), MBL2  -  mannose-binding lectin (protein c) 2, soluble, NELFA  -  negative elongation factor complex member a, MAX  -  myc associated factor x, KMT2B  -  lysine (k)-specific methyltransferase 2b, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RARG  -  retinoic acid receptor, gamma, PLAU  -  plasminogen activator, urokinase, NF2  -  neurofibromin 2 (merlin), PKP2  -  plakophilin 2, LTK  -  leukocyte receptor tyrosine kinase, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), GRIK1  -  glutamate receptor, ionotropic, kainate 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, ARID4A  -  at rich interactive domain 4a (rbp1-like), AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, SRSF6  -  serine/arginine-rich splicing factor 6, EPCAM  -  epithelial cell adhesion molecule, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0048002,antigen processing and presentation of peptide antigen,4.26E-04,3.71E-02,2.67,8230,145,447,21,"[CTSL  -  cathepsin l, HLA-A  -  major histocompatibility complex, class i, a, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, CTSD  -  cathepsin d, HLA-G  -  major histocompatibility complex, class i, g, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, HLA-F  -  major histocompatibility complex, class i, f, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, HLA-E  -  major histocompatibility complex, class i, e, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, UBC  -  ubiquitin c, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ITGB5  -  integrin, beta 5, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, KIF3A  -  kinesin family member 3a, TAPBP  -  tap binding protein (tapasin), DYNLL1  -  dynein, light chain, lc8-type 1, CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0019884,antigen processing and presentation of exogenous antigen,4.26E-04,3.68E-02,2.67,8230,145,447,21,"[CTSL  -  cathepsin l, HLA-A  -  major histocompatibility complex, class i, a, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, CTSD  -  cathepsin d, HLA-G  -  major histocompatibility complex, class i, g, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, HLA-F  -  major histocompatibility complex, class i, f, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, HLA-E  -  major histocompatibility complex, class i, e, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, UBC  -  ubiquitin c, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ITGB5  -  integrin, beta 5, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, KIF3A  -  kinesin family member 3a, TAPBP  -  tap binding protein (tapasin), DYNLL1  -  dynein, light chain, lc8-type 1, CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0033127,regulation of histone phosphorylation,4.29E-04,3.67E-02,117.57,8230,7,20,2,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, IL1B  -  interleukin 1, beta]"GO:0033555,multicellular organismal response to stress,4.30E-04,3.66E-02,3.28,8230,49,716,14,"[GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, GRIN2B  -  glutamate receptor, ionotropic, n-methyl d-aspartate 2b, UCN  -  urocortin, GRIK1  -  glutamate receptor, ionotropic, kainate 1, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, GRIK2  -  glutamate receptor, ionotropic, kainate 2, ADRB1  -  adrenoceptor beta 1, COMT  -  catechol-o-methyltransferase, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, CRH  -  corticotropin releasing hormone, BCL2  -  b-cell cll/lymphoma 2, ADRA2A  -  adrenoceptor alpha 2a, SLC6A2  -  solute carrier family 6 (neurotransmitter transporter), member 2, CACNA1B  -  calcium channel, voltage-dependent, n type, alpha 1b subunit]"GO:0048878,chemical homeostasis,4.35E-04,3.67E-02,1.54,8230,452,935,79,"[PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, ATP2A1  -  atpase, ca++ transporting, cardiac muscle, fast twitch 1, ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, PAX2  -  paired box 2, FTL  -  ferritin, light polypeptide, DRD3  -  dopamine receptor d3, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), ADRB1  -  adrenoceptor beta 1, APOA1  -  apolipoprotein a-i, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, FLG  -  filaggrin, UMOD  -  uromodulin, AGTR2  -  angiotensin ii receptor, type 2, ACACA  -  acetyl-coa carboxylase alpha, GCK  -  glucokinase (hexokinase 4), P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CCL15  -  chemokine (c-c motif) ligand 15, CCL14  -  chemokine (c-c motif) ligand 14, CCL8  -  chemokine (c-c motif) ligand 8, CCL2  -  chemokine (c-c motif) ligand 2, PLA2G10  -  phospholipase a2, group x, LPL  -  lipoprotein lipase, CCL1  -  chemokine (c-c motif) ligand 1, SLC4A3  -  solute carrier family 4 (anion exchanger), member 3, CCL3  -  chemokine (c-c motif) ligand 3, LIPC  -  lipase, hepatic, CRH  -  corticotropin releasing hormone, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, CALCA  -  calcitonin-related polypeptide alpha, FASLG  -  fas ligand (tnf superfamily, member 6), CYBA  -  cytochrome b-245, alpha polypeptide, AQP1  -  aquaporin 1 (colton blood group), CALCR  -  calcitonin receptor, KISS1  -  kiss-1 metastasis-suppressor, PKD1  -  polycystic kidney disease 1 (autosomal dominant), CNGB1  -  cyclic nucleotide gated channel beta 1, CCR6  -  chemokine (c-c motif) receptor 6, STAR  -  steroidogenic acute regulatory protein, TF  -  transferrin, ABCC2  -  atp-binding cassette, sub-family c (cftr/mrp), member 2, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), PTCH1  -  patched 1, CLDN16  -  claudin 16, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, ESR1  -  estrogen receptor 1, PTH  -  parathyroid hormone, SSTR5  -  somatostatin receptor 5, PKP2  -  plakophilin 2, PTHLH  -  parathyroid hormone-like hormone, CACNA1C  -  calcium channel, voltage-dependent, l type, alpha 1c subunit, PPARG  -  peroxisome proliferator-activated receptor gamma, GBA  -  glucosidase, beta, acid, GRIK2  -  glutamate receptor, ionotropic, kainate 2, TGFB1  -  transforming growth factor, beta 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), TH  -  tyrosine hydroxylase, NPC2  -  niemann-pick disease, type c2, LCK  -  lymphocyte-specific protein tyrosine kinase, PLCE1  -  phospholipase c, epsilon 1, CCKAR  -  cholecystokinin a receptor, IREB2  -  iron-responsive element binding protein 2, HNF1A  -  hnf1 homeobox a, BCL2  -  b-cell cll/lymphoma 2, PDX1  -  pancreatic and duodenal homeobox 1, CKB  -  creatine kinase, brain, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, ASGR2  -  asialoglycoprotein receptor 2, GAS6  -  growth arrest-specific 6, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, HCRT  -  hypocretin (orexin) neuropeptide precursor, CXCL13  -  chemokine (c-x-c motif) ligand 13, FOXA2  -  forkhead box a2]"GO:0002708,positive regulation of lymphocyte mediated immunity,4.45E-04,3.73E-02,2.89,8230,46,991,16,"[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, IL1B  -  interleukin 1, beta, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), NCR3  -  natural cytotoxicity triggering receptor 3, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), FOXP3  -  forkhead box p3, IL23R  -  interleukin 23 receptor, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b)]"GO:0071495,cellular response to endogenous stimulus,4.52E-04,3.76E-02,1.47,8230,625,879,98,"[ATP6V1F  -  atpase, h+ transporting, lysosomal 14kda, v1 subunit f, MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), AANAT  -  aralkylamine n-acetyltransferase, APOB  -  apolipoprotein b, BTC  -  betacellulin, INHBB  -  inhibin, beta b, GCG  -  glucagon, GCK  -  glucokinase (hexokinase 4), GDF5  -  growth differentiation factor 5, SP1  -  sp1 transcription factor, RRAGB  -  ras-related gtp binding b, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, NRG2  -  neuregulin 2, SOX5  -  sry (sex determining region y)-box 5, CCL2  -  chemokine (c-c motif) ligand 2, CRH  -  corticotropin releasing hormone, RHEB  -  ras homolog enriched in brain, GH1  -  growth hormone 1, AQP1  -  aquaporin 1 (colton blood group), FGFR3  -  fibroblast growth factor receptor 3, GNG12  -  guanine nucleotide binding protein (g protein), gamma 12, FGF12  -  fibroblast growth factor 12, LAMTOR5  -  late endosomal/lysosomal adaptor, mapk and mtor activator 5, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), COL3A1  -  collagen, type iii, alpha 1, COL2A1  -  collagen, type ii, alpha 1, PTH  -  parathyroid hormone, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPARG  -  peroxisome proliferator-activated receptor gamma, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, LCK  -  lymphocyte-specific protein tyrosine kinase, TRH  -  thyrotropin-releasing hormone, E2F5  -  e2f transcription factor 5, p130-binding, COL5A2  -  collagen, type v, alpha 2, COL6A1  -  collagen, type vi, alpha 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, PTPRA  -  protein tyrosine phosphatase, receptor type, a, ADRA2A  -  adrenoceptor alpha 2a, KITLG  -  kit ligand, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, CXCL13  -  chemokine (c-x-c motif) ligand 13, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, CAPN2  -  calpain 2, (m/ii) large subunit, SLC8A1  -  solute carrier family 8 (sodium/calcium exchanger), member 1, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, LATS1  -  large tumor suppressor kinase 1, AGTR2  -  angiotensin ii receptor, type 2, MTMR4  -  myotubularin related protein 4, RPE65  -  retinal pigment epithelium-specific protein 65kda, CEP57  -  centrosomal protein 57kda, CTSL  -  cathepsin l, CHEK1  -  checkpoint kinase 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, GAB1  -  grb2-associated binding protein 1, MAX  -  myc associated factor x, RAD51  -  rad51 recombinase, CLEC3B  -  c-type lectin domain family 3, member b, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), FYN  -  fyn oncogene related to src, fgr, yes, CYBA  -  cytochrome b-245, alpha polypeptide, STMN2  -  stathmin-like 2, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, STAR  -  steroidogenic acute regulatory protein, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, PIK3R1  -  phosphoinositide-3-kinase, regulatory subunit 1 (alpha), ESR2  -  estrogen receptor 2 (er beta), TFDP2  -  transcription factor dp-2 (e2f dimerization partner 2), ESR1  -  estrogen receptor 1, SSTR3  -  somatostatin receptor 3, SSTR5  -  somatostatin receptor 5, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ITPR2  -  inositol 1,4,5-trisphosphate receptor, type 2, RBL1  -  retinoblastoma-like 1 (p107), GATA3  -  gata binding protein 3, TGFB1  -  transforming growth factor, beta 1, IGFBP1  -  insulin-like growth factor binding protein 1, TH  -  tyrosine hydroxylase, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, PRKCZ  -  protein kinase c, zeta, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), AP3S1  -  adaptor-related protein complex 3, sigma 1 subunit, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, SMAD4  -  smad family member 4, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0060333,interferon-gamma-mediated signaling pathway,4.71E-04,3.89E-02,4.57,8230,53,340,10,"[HLA-A  -  major histocompatibility complex, class i, a, IRF1  -  interferon regulatory factor 1, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, NCAM1  -  neural cell adhesion molecule 1]"GO:2000568,positive regulation of memory T cell activation,4.79E-04,3.93E-02,"4,115.00",8230,2,1,1,"[HLA-A  -  major histocompatibility complex, class i, a]"GO:2000567,regulation of memory T cell activation,4.79E-04,3.90E-02,"4,115.00",8230,2,1,1,"[HLA-A  -  major histocompatibility complex, class i, a]"GO:0010666,positive regulation of cardiac muscle cell apoptotic process,4.87E-04,3.93E-02,21.07,8230,4,293,3,"[HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CXCR2  -  chemokine (c-x-c motif) receptor 2, LTK  -  leukocyte receptor tyrosine kinase]"GO:0010663,positive regulation of striated muscle cell apoptotic process,4.87E-04,3.90E-02,21.07,8230,4,293,3,"[HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, CXCR2  -  chemokine (c-x-c motif) receptor 2, LTK  -  leukocyte receptor tyrosine kinase]"GO:0046321,positive regulation of fatty acid oxidation,4.94E-04,3.93E-02,29.18,8230,9,94,3,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PPARA  -  peroxisome proliferator-activated receptor alpha]"GO:0009966,regulation of signal transduction,4.94E-04,3.90E-02,1.3,8230,1509,786,187,"[MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, S1PR2  -  sphingosine-1-phosphate receptor 2, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), SOCS6  -  suppressor of cytokine signaling 6, CDKN2AIP  -  cdkn2a interacting protein, HTRA1  -  htra serine peptidase 1, FLT4  -  fms-related tyrosine kinase 4, PSAP  -  prosaposin, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CARD14  -  caspase recruitment domain family, member 14, CXCL12  -  chemokine (c-x-c motif) ligand 12, MID1  -  midline 1 (opitz/bbb syndrome), KLK6  -  kallikrein-related peptidase 6, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), PLXNB1  -  plexin b1, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CDON  -  cell adhesion associated, oncogene regulated, PSD  -  pleckstrin and sec7 domain containing, CYTH3  -  cytohesin 3, LFNG  -  lfng o-fucosylpeptide 3-beta-n-acetylglucosaminyltransferase, GCG  -  glucagon, RGS5  -  regulator of g-protein signaling 5, PCGF2  -  polycomb group ring finger 2, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), SORBS3  -  sorbin and sh3 domain containing 3, RRAGB  -  ras-related gtp binding b, SPRED2  -  sprouty-related, evh1 domain containing 2, CCL4  -  chemokine (c-c motif) ligand 4, ARHGAP44  -  rho gtpase activating protein 44, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, BIK  -  bcl2-interacting killer (apoptosis-inducing), RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CRH  -  corticotropin releasing hormone, TRIM16  -  tripartite motif containing 16, PRDX1  -  peroxiredoxin 1, MOG  -  myelin oligodendrocyte glycoprotein, APP  -  amyloid beta (a4) precursor protein, RHEB  -  ras homolog enriched in brain, AKAP10  -  a kinase (prka) anchor protein 10, GUCY2F  -  guanylate cyclase 2f, retinal, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), FASLG  -  fas ligand (tnf superfamily, member 6), GH1  -  growth hormone 1, RGS16  -  regulator of g-protein signaling 16, CNGB1  -  cyclic nucleotide gated channel beta 1, MDFI  -  myod family inhibitor, ARHGAP19  -  rho gtpase activating protein 19, FZD5  -  frizzled family receptor 5, PPEF1  -  protein phosphatase, ef-hand calcium binding domain 1, FGFR3  -  fibroblast growth factor receptor 3, USP20  -  ubiquitin specific peptidase 20, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, FGF1  -  fibroblast growth factor 1 (acidic), GLI3  -  gli family zinc finger 3, HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, COL3A1  -  collagen, type iii, alpha 1, PTH  -  parathyroid hormone, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, FZD1  -  frizzled family receptor 1, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, PPARG  -  peroxisome proliferator-activated receptor gamma, GPR143  -  g protein-coupled receptor 143, BRAP  -  brca1 associated protein, GNG7  -  guanine nucleotide binding protein (g protein), gamma 7, S100B  -  s100 calcium binding protein b, S100A4  -  s100 calcium binding protein a4, GNAT1  -  guanine nucleotide binding protein (g protein), alpha transducing activity polypeptide 1, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), FEM1B  -  fem-1 homolog b (c. elegans), LBP  -  lipopolysaccharide binding protein, POU1F1  -  pou class 1 homeobox 1, S100A7  -  s100 calcium binding protein a7, IRF1  -  interferon regulatory factor 1, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, HNF1A  -  hnf1 homeobox a, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, KITLG  -  kit ligand, ADRA1A  -  adrenoceptor alpha 1a, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, PDE4A  -  phosphodiesterase 4a, camp-specific, IRAK1  -  interleukin-1 receptor-associated kinase 1, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, AKR1C3  -  aldo-keto reductase family 1, member c3, NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, AES  -  amino-terminal enhancer of split, IFNA5  -  interferon, alpha 5, ADRB1  -  adrenoceptor beta 1, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, ADRB3  -  adrenoceptor beta 3, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), ADRBK2  -  adrenergic, beta, receptor kinase 2, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), CTGF  -  connective tissue growth factor, SFN  -  stratifin, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, GPC1  -  glypican 1, DYNLL1  -  dynein, light chain, lc8-type 1, LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, AGTR2  -  angiotensin ii receptor, type 2, IFNGR2  -  interferon gamma receptor 2 (interferon gamma transducer 1), MTMR4  -  myotubularin related protein 4, TRAF3IP2  -  traf3 interacting protein 2, NLGN1  -  neuroligin 1, IFNG  -  interferon, gamma, CAPZB  -  capping protein (actin filament) muscle z-line, beta, MAP4K2  -  mitogen-activated protein kinase kinase kinase kinase 2, HMGXB4  -  hmg box domain containing 4, GRAP2  -  grb2-related adaptor protein 2, PEA15  -  phosphoprotein enriched in astrocytes 15, GAB1  -  grb2-associated binding protein 1, NGF  -  nerve growth factor (beta polypeptide), VIP  -  vasoactive intestinal peptide, AHSG  -  alpha-2-hs-glycoprotein, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), CALM3  -  calmodulin 3 (phosphorylase kinase, delta), RAC1  -  ras-related c3 botulinum toxin substrate 1 (rho family, small gtp binding protein rac1), FYN  -  fyn oncogene related to src, fgr, yes, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), STK4  -  serine/threonine kinase 4, HIC1  -  hypermethylated in cancer 1, KISS1  -  kiss-1 metastasis-suppressor, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, PLAU  -  plasminogen activator, urokinase, ESR2  -  estrogen receptor 2 (er beta), TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR1  -  estrogen receptor 1, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, NF2  -  neurofibromin 2 (merlin), RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RHOV  -  ras homolog family member v, GBA  -  glucosidase, beta, acid, ONECUT1  -  one cut homeobox 1, PIAS4  -  protein inhibitor of activated stat, 4, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), PLCE1  -  phospholipase c, epsilon 1, KALRN  -  kalirin, rhogef kinase, AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, EPHA4  -  eph receptor a4, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, RCVRN  -  recoverin, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide, FOXA2  -  forkhead box a2]"GO:0031341,regulation of cell killing,4.97E-04,3.90E-02,2.98,8230,43,963,15,"[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), NCR3  -  natural cytotoxicity triggering receptor 3, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), BCL2L11  -  bcl2-like 11 (apoptosis facilitator), IL23R  -  interleukin 23 receptor, IFNG  -  interferon, gamma, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b)]"GO:0016337,cell-cell adhesion,5.08E-04,3.96E-02,1.78,8230,231,902,45,"[PKD1  -  polycystic kidney disease 1 (autosomal dominant), CSTA  -  cystatin a (stefin a), CADM1  -  cell adhesion molecule 1, TEK  -  tek tyrosine kinase, endothelial, ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), CD1D  -  cd1d molecule, ICAM2  -  intercellular adhesion molecule 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), PVRL3  -  poliovirus receptor-related 3, CD2AP  -  cd2-associated protein, SLIT2  -  slit homolog 2 (drosophila), DSC2  -  desmocollin 2, CLDN16  -  claudin 16, PTPRT  -  protein tyrosine phosphatase, receptor type, t, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, COL2A1  -  collagen, type ii, alpha 1, CLSTN1  -  calsyntenin 1, TYRO3  -  tyro3 protein tyrosine kinase, NRXN3  -  neurexin 3, PKP2  -  plakophilin 2, CTNND2  -  catenin (cadherin-associated protein), delta 2, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, NLGN1  -  neuroligin 1, PVRL1  -  poliovirus receptor-related 1 (herpesvirus entry mediator c), IHH  -  indian hedgehog, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), MAPK14  -  mitogen-activated protein kinase 14, ALX1  -  alx homeobox 1, STXBP1  -  syntaxin binding protein 1, EZR  -  ezrin, NLGN4X  -  neuroligin 4, x-linked, CLDN3  -  claudin 3, IL1B  -  interleukin 1, beta, BCL2  -  b-cell cll/lymphoma 2, CXADR  -  coxsackie virus and adenovirus receptor, CD34  -  cd34 molecule, THY1  -  thy-1 cell surface antigen, GAS6  -  growth arrest-specific 6, DLG5  -  discs, large homolog 5 (drosophila), CALCA  -  calcitonin-related polypeptide alpha, THRA  -  thyroid hormone receptor, alpha, COL13A1  -  collagen, type xiii, alpha 1, MSN  -  moesin]"GO:0051952,regulation of amine transport,5.16E-04,3.99E-02,3.22,8230,49,730,14,"[GRIK1  -  glutamate receptor, ionotropic, kainate 1, DRD3  -  dopamine receptor d3, TRH  -  thyrotropin-releasing hormone, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), CXCL12  -  chemokine (c-x-c motif) ligand 12, CRH  -  corticotropin releasing hormone, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, ADORA1  -  adenosine a1 receptor, AGTR2  -  angiotensin ii receptor, type 2, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, DPYSL2  -  dihydropyrimidinase-like 2, GCK  -  glucokinase (hexokinase 4)]"GO:0050433,regulation of catecholamine secretion,5.19E-04,3.98E-02,4.11,8230,28,716,10,"[CRH  -  corticotropin releasing hormone, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, AGTR2  -  angiotensin ii receptor, type 2, DRD3  -  dopamine receptor d3, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, ADRA2A  -  adrenoceptor alpha 2a, C5  -  complement component 5, SNCG  -  synuclein, gamma (breast cancer-specific protein 1), GCK  -  glucokinase (hexokinase 4), CXCL12  -  chemokine (c-x-c motif) ligand 12]"GO:0010941,regulation of cell death,5.19E-04,3.96E-02,1.42,8230,1027,650,115,"[BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), DAPK2  -  death-associated protein kinase 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), NAIP  -  nlr family, apoptosis inhibitory protein, INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, BTK  -  bruton agammaglobulinemia tyrosine kinase, GCG  -  glucagon, GDF5  -  growth differentiation factor 5, PCGF2  -  polycomb group ring finger 2, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, BIK  -  bcl2-interacting killer (apoptosis-inducing), ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, CRH  -  corticotropin releasing hormone, CXCR2  -  chemokine (c-x-c motif) receptor 2, CD34  -  cd34 molecule, FASLG  -  fas ligand (tnf superfamily, member 6), DLG5  -  discs, large homolog 5 (drosophila), TSC22D1  -  tsc22 domain family, member 1, AQP1  -  aquaporin 1 (colton blood group), ACTN1  -  actinin, alpha 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, GLI3  -  gli family zinc finger 3, POU3F4  -  pou class 3 homeobox 4, TRIM2  -  tripartite motif containing 2, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PPARA  -  peroxisome proliferator-activated receptor alpha, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, PPARG  -  peroxisome proliferator-activated receptor gamma, INSL3  -  insulin-like 3 (leydig cell), CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, KLHL20  -  kelch-like family member 20, FEM1B  -  fem-1 homolog b (c. elegans), ADORA1  -  adenosine a1 receptor, KITLG  -  kit ligand, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), IFI27  -  interferon, alpha-inducible protein 27, AES  -  amino-terminal enhancer of split, ADRB1  -  adrenoceptor beta 1, NKX2-5  -  nk2 homeobox 5, NOS1AP  -  nitric oxide synthase 1 (neuronal) adaptor protein, CTGF  -  connective tissue growth factor, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), SFN  -  stratifin, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, DYNLL1  -  dynein, light chain, lc8-type 1, ATM  -  ataxia telangiectasia mutated, AGTR2  -  angiotensin ii receptor, type 2, IFNG  -  interferon, gamma, RPS3A  -  ribosomal protein s3a, STXBP1  -  syntaxin binding protein 1, PEA15  -  phosphoprotein enriched in astrocytes 15, NGF  -  nerve growth factor (beta polypeptide), VIP  -  vasoactive intestinal peptide, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), FYN  -  fyn oncogene related to src, fgr, yes, STK4  -  serine/threonine kinase 4, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, TEK  -  tek tyrosine kinase, endothelial, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, ALOX12  -  arachidonate 12-lipoxygenase, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, CRYAB  -  crystallin, alpha b, RARG  -  retinoic acid receptor, gamma, TWIST1  -  twist basic helix-loop-helix transcription factor 1, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, DLC1  -  deleted in liver cancer 1, TYRO3  -  tyro3 protein tyrosine kinase, MAP2K5  -  mitogen-activated protein kinase kinase 5, NQO1  -  nad(p)h dehydrogenase, quinone 1, LTK  -  leukocyte receptor tyrosine kinase, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, IHH  -  indian hedgehog, UCN  -  urocortin, GRIK2  -  glutamate receptor, ionotropic, kainate 2, PIAS4  -  protein inhibitor of activated stat, 4, ARHGEF4  -  rho guanine nucleotide exchange factor (gef) 4, GATA3  -  gata binding protein 3, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), FADD  -  fas (tnfrsf6)-associated via death domain, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, SRSF6  -  serine/arginine-rich splicing factor 6, PRKCZ  -  protein kinase c, zeta, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, BCL2  -  b-cell cll/lymphoma 2, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, SMAD4  -  smad family member 4, THRA  -  thyroid hormone receptor, alpha]"GO:0048386,positive regulation of retinoic acid receptor signaling pathway,5.27E-04,3.99E-02,15.38,8230,3,535,3,"[ESR1  -  estrogen receptor 1, TRIM16  -  tripartite motif containing 16, NR2C1  -  nuclear receptor subfamily 2, group c, member 1]"GO:0051384,response to glucocorticoid,5.30E-04,3.99E-02,2.47,8230,98,747,22,"[GBA  -  glucosidase, beta, acid, PAPPA  -  pregnancy-associated plasma protein a, pappalysin 1, S100B  -  s100 calcium binding protein b, UCN  -  urocortin, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, STAR  -  steroidogenic acute regulatory protein, NGF  -  nerve growth factor (beta polypeptide), TH  -  tyrosine hydroxylase, SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), TRH  -  thyrotropin-releasing hormone, SLIT2  -  slit homolog 2 (drosophila), CCL2  -  chemokine (c-c motif) ligand 2, PTGDS  -  prostaglandin d2 synthase 21kda (brain), CRH  -  corticotropin releasing hormone, BCL2  -  b-cell cll/lymphoma 2, SSTR3  -  somatostatin receptor 3, AGTR2  -  angiotensin ii receptor, type 2, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), PDX1  -  pancreatic and duodenal homeobox 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, AQP1  -  aquaporin 1 (colton blood group), CALCR  -  calcitonin receptor]"GO:0048523,negative regulation of cellular process,5.52E-04,4.12E-02,1.22,8230,2265,795,268,"[MAPRE1  -  microtubule-associated protein, rp/eb family, member 1, SPTAN1  -  spectrin, alpha, non-erythrocytic 1, BNIP1  -  bcl2/adenovirus e1b 19kda interacting protein 1, G3BP1  -  gtpase activating protein (sh3 domain) binding protein 1, GFRA2  -  gdnf family receptor alpha 2, HSF1  -  heat shock transcription factor 1, BRCA2  -  breast cancer 2, early onset, CDKN2AIP  -  cdkn2a interacting protein, BTG3  -  btg family, member 3, PATZ1  -  poz (btb) and at hook containing zinc finger 1, CARD14  -  caspase recruitment domain family, member 14, NAIP  -  nlr family, apoptosis inhibitory protein, PLXNB1  -  plexin b1, BCOR  -  bcl6 corepressor, GCG  -  glucagon, SAP30  -  sin3a-associated protein, 30kda, GDF5  -  growth differentiation factor 5, GCK  -  glucokinase (hexokinase 4), SORBS3  -  sorbin and sh3 domain containing 3, EIF4EBP2  -  eukaryotic translation initiation factor 4e binding protein 2, SPRED2  -  sprouty-related, evh1 domain containing 2, SOX5  -  sry (sex determining region y)-box 5, SOX2  -  sry (sex determining region y)-box 2, SOX3  -  sry (sex determining region y)-box 3, RGS7  -  regulator of g-protein signaling 7, RGS13  -  regulator of g-protein signaling 13, CRH  -  corticotropin releasing hormone, LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, PLG  -  plasminogen, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), TSC22D1  -  tsc22 domain family, member 1, RGS16  -  regulator of g-protein signaling 16, ACTN1  -  actinin, alpha 1, TRRAP  -  transformation/transcription domain-associated protein, CREBZF  -  creb/atf bzip transcription factor, IAPP  -  islet amyloid polypeptide, GLI3  -  gli family zinc finger 3, POU3F4  -  pou class 3 homeobox 4, COL3A1  -  collagen, type iii, alpha 1, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, HTR1B  -  5-hydroxytryptamine (serotonin) receptor 1b, g protein-coupled, PPEF2  -  protein phosphatase, ef-hand calcium binding domain 2, MYO16  -  myosin xvi, FZD1  -  frizzled family receptor 1, PPARA  -  peroxisome proliferator-activated receptor alpha, PPARG  -  peroxisome proliferator-activated receptor gamma, BRAP  -  brca1 associated protein, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), LDOC1  -  leucine zipper, down-regulated in cancer 1, TRH  -  thyrotropin-releasing hormone, POU1F1  -  pou class 1 homeobox 1, COMT  -  catechol-o-methyltransferase, RAMP3  -  receptor (g protein-coupled) activity modifying protein 3, ADORA1  -  adenosine a1 receptor, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, GMFB  -  glia maturation factor, beta, C5  -  complement component 5, ADRA2A  -  adrenoceptor alpha 2a, ADRA1A  -  adrenoceptor alpha 1a, WAPAL  -  wings apart-like homolog (drosophila), AKR1C3  -  aldo-keto reductase family 1, member c3, PRKAA1  -  protein kinase, amp-activated, alpha 1 catalytic subunit, HLA-G  -  major histocompatibility complex, class i, g, AES  -  amino-terminal enhancer of split, PDE5A  -  phosphodiesterase 5a, cgmp-specific, NKX2-5  -  nk2 homeobox 5, SRGN  -  serglycin, ADRBK2  -  adrenergic, beta, receptor kinase 2, ZNF350  -  zinc finger protein 350, CTGF  -  connective tissue growth factor, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, CTBP1  -  c-terminal binding protein 1, DYNLL1  -  dynein, light chain, lc8-type 1, AGTR2  -  angiotensin ii receptor, type 2, CAPZB  -  capping protein (actin filament) muscle z-line, beta, RPS3A  -  ribosomal protein s3a, STXBP1  -  syntaxin binding protein 1, HMGXB4  -  hmg box domain containing 4, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, RECQL5  -  recq protein-like 5, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, STRN  -  striatin, calmodulin binding protein, VHL  -  von hippel-lindau tumor suppressor, e3 ubiquitin protein ligase, VIP  -  vasoactive intestinal peptide, GABPA  -  ga binding protein transcription factor, alpha subunit 60kda, AHSG  -  alpha-2-hs-glycoprotein, NCOA2  -  nuclear receptor coactivator 2, EZH1  -  enhancer of zeste homolog 1 (drosophila), CXADR  -  coxsackie virus and adenovirus receptor, FYN  -  fyn oncogene related to src, fgr, yes, HIC1  -  hypermethylated in cancer 1, TRIM31  -  tripartite motif containing 31, STK4  -  serine/threonine kinase 4, KISS1  -  kiss-1 metastasis-suppressor, STMN2  -  stathmin-like 2, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, ERCC5  -  excision repair cross-complementing rodent repair deficiency, complementation group 5, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), CRYAB  -  crystallin, alpha b, UBC  -  ubiquitin c, ESR2  -  estrogen receptor 2 (er beta), TWIST1  -  twist basic helix-loop-helix transcription factor 1, RCOR1  -  rest corepressor 1, RPS14  -  ribosomal protein s14, ESR1  -  estrogen receptor 1, GABRB3  -  gamma-aminobutyric acid (gaba) a receptor, beta 3, TNFSF14  -  tumor necrosis factor (ligand) superfamily, member 14, DLC1  -  deleted in liver cancer 1, CD9  -  cd9 molecule, SSTR3  -  somatostatin receptor 3, MAP2K5  -  mitogen-activated protein kinase kinase 5, TYRO3  -  tyro3 protein tyrosine kinase, SSTR5  -  somatostatin receptor 5, HOXA9  -  homeobox a9, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ALX1  -  alx homeobox 1, ANG  -  angiogenin, ribonuclease, rnase a family, 5, ONECUT1  -  one cut homeobox 1, GBA  -  glucosidase, beta, acid, UCN  -  urocortin, GATA3  -  gata binding protein 3, MVP  -  major vault protein, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, EPHA5  -  eph receptor a5, EPHA4  -  eph receptor a4, SMURF1  -  smad specific e3 ubiquitin protein ligase 1, KRIT1  -  krit1, ankyrin repeat containing, HMGCR  -  3-hydroxy-3-methylglutaryl-coa reductase, MRE11A  -  mre11 meiotic recombination 11 homolog a (s. cerevisiae), PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, GAS6  -  growth arrest-specific 6, RREB1  -  ras responsive element binding protein 1, NR1I3  -  nuclear receptor subfamily 1, group i, member 3, FOXA2  -  forkhead box a2, VPS72  -  vacuolar protein sorting 72 homolog (s. cerevisiae), MAGI2  -  membrane associated guanylate kinase, ww and pdz domain containing 2, PAX2  -  paired box 2, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), SOCS6  -  suppressor of cytokine signaling 6, HTRA1  -  htra serine peptidase 1, FLT4  -  fms-related tyrosine kinase 4, ORC2  -  origin recognition complex, subunit 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PAX9  -  paired box 9, CXCL12  -  chemokine (c-x-c motif) ligand 12, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), INHBB  -  inhibin, beta b, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FOXE1  -  forkhead box e1 (thyroid transcription factor 2), MLLT1  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 1, RGS5  -  regulator of g-protein signaling 5, PCGF2  -  polycomb group ring finger 2, KMT2A  -  lysine (k)-specific methyltransferase 2a, RIF1  -  rap1 interacting factor homolog (yeast), PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, CCL4  -  chemokine (c-c motif) ligand 4, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, MMP11  -  matrix metallopeptidase 11 (stromelysin 3), PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5, ARF4  -  adp-ribosylation factor 4, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, PSMD1  -  proteasome (prosome, macropain) 26s subunit, non-atpase, 1, CXCR2  -  chemokine (c-x-c motif) receptor 2, APP  -  amyloid beta (a4) precursor protein, CD34  -  cd34 molecule, AKAP10  -  a kinase (prka) anchor protein 10, DLG5  -  discs, large homolog 5 (drosophila), FASLG  -  fas ligand (tnf superfamily, member 6), AQP1  -  aquaporin 1 (colton blood group), MDFI  -  myod family inhibitor, FZD5  -  frizzled family receptor 5, FGFR3  -  fibroblast growth factor receptor 3, PTCH1  -  patched 1, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, FGF8  -  fibroblast growth factor 8 (androgen-induced), MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, PTH  -  parathyroid hormone, MEIS2  -  meis homeobox 2, ARHGDIB  -  rho gdp dissociation inhibitor (gdi) beta, CEACAM5  -  carcinoembryonic antigen-related cell adhesion molecule 5, PTHLH  -  parathyroid hormone-like hormone, PTK6  -  protein tyrosine kinase 6, INSL3  -  insulin-like 3 (leydig cell), S100A11  -  s100 calcium binding protein a11, CDK4  -  cyclin-dependent kinase 4, S100B  -  s100 calcium binding protein b, TMSB10  -  thymosin beta 10, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), KLHL20  -  kelch-like family member 20, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), NPPA  -  natriuretic peptide a, CDKN2C  -  cyclin-dependent kinase inhibitor 2c (p18, inhibits cdk4), IRF1  -  interferon regulatory factor 1, TRIM9  -  tripartite motif containing 9, HNF1A  -  hnf1 homeobox a, PDX1  -  pancreatic and duodenal homeobox 1, KITLG  -  kit ligand, CDK2  -  cyclin-dependent kinase 2, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, ZNF205  -  zinc finger protein 205, HCLS1  -  hematopoietic cell-specific lyn substrate 1, IRAK1  -  interleukin-1 receptor-associated kinase 1, CXCL13  -  chemokine (c-x-c motif) ligand 13, CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), RUFY3  -  run and fyve domain containing 3, NKX2-1  -  nk2 homeobox 1, DRD3  -  dopamine receptor d3, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), SMC3  -  structural maintenance of chromosomes 3, BAHD1  -  bromo adjacent homology domain containing 1, SFN  -  stratifin, GPC1  -  glypican 1, LATS1  -  large tumor suppressor kinase 1, ATM  -  ataxia telangiectasia mutated, MTMR4  -  myotubularin related protein 4, NOTCH3  -  notch 3, DHX34  -  deah (asp-glu-ala-his) box polypeptide 34, IFNG  -  interferon, gamma, CHEK1  -  checkpoint kinase 1, NFX1  -  nuclear transcription factor, x-box binding 1, NGF  -  nerve growth factor (beta polypeptide), NELFA  -  negative elongation factor complex member a, PPM1E  -  protein phosphatase, mg2+/mn2+ dependent, 1e, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, NKX2-2  -  nk2 homeobox 2, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TAX1BP3  -  tax1 (human t-cell leukemia virus type i) binding protein 3, MCL1  -  myeloid cell leukemia sequence 1 (bcl2-related), PKD1  -  polycystic kidney disease 1 (autosomal dominant), TEK  -  tek tyrosine kinase, endothelial, DLX2  -  distal-less homeobox 2, TFAP2B  -  transcription factor ap-2 beta (activating enhancer binding protein 2 beta), RARG  -  retinoic acid receptor, gamma, NF2  -  neurofibromin 2 (merlin), PKP2  -  plakophilin 2, LTK  -  leukocyte receptor tyrosine kinase, RGS6  -  regulator of g-protein signaling 6, IHH  -  indian hedgehog, RBL1  -  retinoblastoma-like 1 (p107), GRIK1  -  glutamate receptor, ionotropic, kainate 1, PIAS4  -  protein inhibitor of activated stat, 4, GRIK2  -  glutamate receptor, ionotropic, kainate 2, ARID4A  -  at rich interactive domain 4a (rbp1-like), AP2M1  -  adaptor-related protein complex 2, mu 1 subunit, SRSF6  -  serine/arginine-rich splicing factor 6, EPCAM  -  epithelial cell adhesion molecule, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0007420,brain development,5.54E-04,4.11E-02,2.26,8230,114,830,26,"[CADM1  -  cell adhesion molecule 1, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, FZD5  -  frizzled family receptor 5, NKX2-1  -  nk2 homeobox 1, COX17  -  cox17 cytochrome c oxidase copper chaperone, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, BRCA2  -  breast cancer 2, early onset, DLX2  -  distal-less homeobox 2, PTCH1  -  patched 1, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), DCX  -  doublecortin, PHGDH  -  phosphoglycerate dehydrogenase, ESR2  -  estrogen receptor 2 (er beta), HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, ATM  -  ataxia telangiectasia mutated, AGTR2  -  angiotensin ii receptor, type 2, CD9  -  cd9 molecule, FZD1  -  frizzled family receptor 1, ALX1  -  alx homeobox 1, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), ARF4  -  adp-ribosylation factor 4, DFFB  -  dna fragmentation factor, 40kda, beta polypeptide (caspase-activated dnase), NKX2-2  -  nk2 homeobox 2, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase)]"GO:0016053,organic acid biosynthetic process,5.61E-04,4.14E-02,3.93,8230,107,235,12,"[GLUL  -  glutamate-ammonia ligase, BGN  -  biglycan, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, ACACA  -  acetyl-coa carboxylase alpha, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SHMT1  -  serine hydroxymethyltransferase 1 (soluble), ALOX12  -  arachidonate 12-lipoxygenase, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), FASN  -  fatty acid synthase, LPL  -  lipoprotein lipase]"GO:0046394,carboxylic acid biosynthetic process,5.61E-04,4.11E-02,3.93,8230,107,235,12,"[GLUL  -  glutamate-ammonia ligase, BGN  -  biglycan, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, ACACA  -  acetyl-coa carboxylase alpha, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), SHMT1  -  serine hydroxymethyltransferase 1 (soluble), ALOX12  -  arachidonate 12-lipoxygenase, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), FASN  -  fatty acid synthase, LPL  -  lipoprotein lipase]"GO:0030855,epithelial cell differentiation,5.80E-04,4.23E-02,1.77,8230,207,987,44,"[CSTA  -  cystatin a (stefin a), CBFA2T2  -  core-binding factor, runt domain, alpha subunit 2; translocated to, 2, AKR1C3  -  aldo-keto reductase family 1, member c3, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, TAGLN  -  transgelin, NKX2-1  -  nk2 homeobox 1, TDRD7  -  tudor domain containing 7, PSAP  -  prosaposin, PTCH1  -  patched 1, FGF8  -  fibroblast growth factor 8 (androgen-induced), NUMA1  -  nuclear mitotic apparatus protein 1, FLG  -  filaggrin, SFN  -  stratifin, GLI3  -  gli family zinc finger 3, BCCIP  -  brca2 and cdkn1a interacting protein, KRT10  -  keratin 10, LATS1  -  large tumor suppressor kinase 1, USH1C  -  usher syndrome 1c (autosomal recessive, severe), NF2  -  neurofibromin 2 (merlin), PTHLH  -  parathyroid hormone-like hormone, AIMP2  -  aminoacyl trna synthetase complex-interacting multifunctional protein 2, KRT14  -  keratin 14, FZD1  -  frizzled family receptor 1, PTK6  -  protein tyrosine kinase 6, PPARG  -  peroxisome proliferator-activated receptor gamma, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, TGFB1  -  transforming growth factor, beta 1, IGF1  -  insulin-like growth factor 1 (somatomedin c), SOX11  -  sry (sex determining region y)-box 11, EVPL  -  envoplakin, S100A7  -  s100 calcium binding protein a7, BCL2  -  b-cell cll/lymphoma 2, SMAD4  -  smad family member 4, PDX1  -  pancreatic and duodenal homeobox 1, CD34  -  cd34 molecule, BMPR2  -  bone morphogenetic protein receptor, type ii (serine/threonine kinase), HDAC1  -  histone deacetylase 1, ERCC2  -  excision repair cross-complementing rodent repair deficiency, complementation group 2, MYO6  -  myosin vi, THRA  -  thyroid hormone receptor, alpha, STK4  -  serine/threonine kinase 4, FOXA2  -  forkhead box a2, SCEL  -  sciellin]"GO:0014805,smooth muscle adaptation,6.08E-04,4.40E-02,82.3,8230,4,50,2,"[IL1B  -  interleukin 1, beta, CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0071548,response to dexamethasone,6.10E-04,4.39E-02,6.03,8230,10,819,6,"[CRH  -  corticotropin releasing hormone, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, TGFB1  -  transforming growth factor, beta 1, STAR  -  steroidogenic acute regulatory protein, AGTR2  -  angiotensin ii receptor, type 2, AQP1  -  aquaporin 1 (colton blood group)]"GO:0002480,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent",6.44E-04,4.60E-02,5.72,8230,9,959,6,"[HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, HLA-G  -  major histocompatibility complex, class i, g, LNPEP  -  leucyl/cystinyl aminopeptidase, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e]"GO:0019747,regulation of isoprenoid metabolic process,6.52E-04,4.63E-02,48.99,8230,2,168,2,"[AKR1C3  -  aldo-keto reductase family 1, member c3, NPC2  -  niemann-pick disease, type c2]"GO:0048662,negative regulation of smooth muscle cell proliferation,6.68E-04,4.71E-02,3.53,8230,26,985,11,"[COMT  -  catechol-o-methyltransferase, ANG  -  angiogenin, ribonuclease, rnase a family, 5, APOD  -  apolipoprotein d, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, NPR3  -  natriuretic peptide receptor c/guanylate cyclase c (atrionatriuretic peptide receptor c), NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), VIP  -  vasoactive intestinal peptide, PPARG  -  peroxisome proliferator-activated receptor gamma, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), IFNG  -  interferon, gamma, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35)]"GO:0007155,cell adhesion,6.74E-04,4.72E-02,1.69,8230,521,515,55,"[CSTA  -  cystatin a (stefin a), SVEP1  -  sushi, von willebrand factor type a, egf and pentraxin domain containing 1, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), PVRL3  -  poliovirus receptor-related 3, DSC2  -  desmocollin 2, CTGF  -  connective tissue growth factor, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, GP9  -  glycoprotein ix (platelet), CDON  -  cell adhesion associated, oncogene regulated, CTNND2  -  catenin (cadherin-associated protein), delta 2, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, NLGN1  -  neuroligin 1, NCAM1  -  neural cell adhesion molecule 1, STXBP1  -  syntaxin binding protein 1, SORBS3  -  sorbin and sh3 domain containing 3, WISP2  -  wnt1 inducible signaling pathway protein 2, CCL4  -  chemokine (c-c motif) ligand 4, EZR  -  ezrin, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CD22  -  cd22 molecule, CXADR  -  coxsackie virus and adenovirus receptor, APP  -  amyloid beta (a4) precursor protein, MOG  -  myelin oligodendrocyte glycoprotein, VWF  -  von willebrand factor, NUAK1  -  nuak family, snf1-like kinase, 1, CD34  -  cd34 molecule, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, DLG5  -  discs, large homolog 5 (drosophila), MSN  -  moesin, CADM1  -  cell adhesion molecule 1, PKD1  -  polycystic kidney disease 1 (autosomal dominant), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, ICAM2  -  intercellular adhesion molecule 2, SLIT2  -  slit homolog 2 (drosophila), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, COL3A1  -  collagen, type iii, alpha 1, CD9  -  cd9 molecule, TYRO3  -  tyro3 protein tyrosine kinase, PKP2  -  plakophilin 2, PECAM1  -  platelet/endothelial cell adhesion molecule 1, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), ALX1  -  alx homeobox 1, EPHA3  -  eph receptor a3, LAMC2  -  laminin, gamma 2, ROM1  -  retinal outer segment membrane protein 1, SGCE  -  sarcoglycan, epsilon, COL6A1  -  collagen, type vi, alpha 1, BCL2  -  b-cell cll/lymphoma 2, KITLG  -  kit ligand, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0044702,single organism reproductive process,6.94E-04,4.83E-02,1.48,8230,497,999,89,"[AKR1C3  -  aldo-keto reductase family 1, member c3, DNAJA1  -  dnaj (hsp40) homolog, subfamily a, member 1, GNRH1  -  gonadotropin-releasing hormone 1 (luteinizing-releasing hormone), NKX2-1  -  nk2 homeobox 1, TDRD7  -  tudor domain containing 7, HSF1  -  heat shock transcription factor 1, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, BRCA2  -  breast cancer 2, early onset, BRDT  -  bromodomain, testis-specific, PSAP  -  prosaposin, PVRL3  -  poliovirus receptor-related 3, MTOR  -  mechanistic target of rapamycin (serine/threonine kinase), PATZ1  -  poz (btb) and at hook containing zinc finger 1, CXCL12  -  chemokine (c-x-c motif) ligand 12, APOB  -  apolipoprotein b, BCL2L11  -  bcl2-like 11 (apoptosis facilitator), INHBB  -  inhibin, beta b, PMCH  -  pro-melanin-concentrating hormone, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, DYNLL1  -  dynein, light chain, lc8-type 1, FSHR  -  follicle stimulating hormone receptor, ATM  -  ataxia telangiectasia mutated, PGR  -  progesterone receptor, CEP57  -  centrosomal protein 57kda, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b), BPY2C  -  basic charge, y-linked, 2c, SOX30  -  sry (sex determining region y)-box 30, HOXB13  -  homeobox b13, KMT2B  -  lysine (k)-specific methyltransferase 2b, SOX2  -  sry (sex determining region y)-box 2, CCL2  -  chemokine (c-c motif) ligand 2, HOXD13  -  homeobox d13, IL1B  -  interleukin 1, beta, SOX3  -  sry (sex determining region y)-box 3, ODF2  -  outer dense fiber of sperm tails 2, BIK  -  bcl2-interacting killer (apoptosis-inducing), TSSK1B  -  testis-specific serine kinase 1b, NHLH2  -  nescient helix loop helix 2, CGB  -  chorionic gonadotropin, beta polypeptide, CALCA  -  calcitonin-related polypeptide alpha, SPAG6  -  sperm associated antigen 6, AKAP4  -  a kinase (prka) anchor protein 4, CITED2  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 2, CADM1  -  cell adhesion molecule 1, PKD1  -  polycystic kidney disease 1 (autosomal dominant), CRIP1  -  cysteine-rich protein 1 (intestinal), CELF3  -  cugbp, elav-like family member 3, FZD5  -  frizzled family receptor 5, NIPBL  -  nipped-b homolog (drosophila), STAR  -  steroidogenic acute regulatory protein, UBC  -  ubiquitin c, FGF8  -  fibroblast growth factor 8 (androgen-induced), RARG  -  retinoic acid receptor, gamma, ESR2  -  estrogen receptor 2 (er beta), AMH  -  anti-mullerian hormone, PLAG1  -  pleiomorphic adenoma gene 1, ESR1  -  estrogen receptor 1, CD9  -  cd9 molecule, SSTR3  -  somatostatin receptor 3, TYRO3  -  tyro3 protein tyrosine kinase, GRN  -  granulin, DIAPH2  -  diaphanous-related formin 2, FZD1  -  frizzled family receptor 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, DNALI1  -  dynein, axonemal, light intermediate chain 1, IHH  -  indian hedgehog, INSL3  -  insulin-like 3 (leydig cell), ANG  -  angiogenin, ribonuclease, rnase a family, 5, PCYT1B  -  phosphate cytidylyltransferase 1, choline, beta, DAZ1  -  deleted in azoospermia 1, IGF1R  -  insulin-like growth factor 1 receptor, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, COL9A3  -  collagen, type ix, alpha 3, TGFB1  -  transforming growth factor, beta 1, GATA3  -  gata binding protein 3, IGF1  -  insulin-like growth factor 1 (somatomedin c), SCGB1A1  -  secretoglobin, family 1a, member 1 (uteroglobin), FEM1B  -  fem-1 homolog b (c. elegans), PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, CSN3  -  casein kappa, ELL3  -  elongation factor rna polymerase ii-like 3, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), E2F1  -  e2f transcription factor 1, FANCL  -  fanconi anemia, complementation group l, TUBGCP3  -  tubulin, gamma complex associated protein 3, DDX4  -  dead (asp-glu-ala-asp) box polypeptide 4, BCL2  -  b-cell cll/lymphoma 2, KITLG  -  kit ligand, CCIN  -  calicin]"GO:0031998,regulation of fatty acid beta-oxidation,7.01E-04,4.85E-02,26.27,8230,10,94,3,"[TWIST1  -  twist basic helix-loop-helix transcription factor 1, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, PPARA  -  peroxisome proliferator-activated receptor alpha]"GO:0046836,glycolipid transport,7.29E-04,5.01E-02,"1,371.67",8230,1,6,1,"[NPC2  -  niemann-pick disease, type c2]"GO:0002705,positive regulation of leukocyte mediated immunity,7.55E-04,5.16E-02,2.77,8230,48,991,16,"[CADM1  -  cell adhesion molecule 1, HLA-A  -  major histocompatibility complex, class i, a, HLA-C  -  major histocompatibility complex, class i, c, P2RX7  -  purinergic receptor p2x, ligand-gated ion channel, 7, HLA-G  -  major histocompatibility complex, class i, g, HLA-F  -  major histocompatibility complex, class i, f, HLA-E  -  major histocompatibility complex, class i, e, FADD  -  fas (tnfrsf6)-associated via death domain, PRKCZ  -  protein kinase c, zeta, IL1B  -  interleukin 1, beta, IL12B  -  interleukin 12b (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40), NCR3  -  natural cytotoxicity triggering receptor 3, IL12A  -  interleukin 12a (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35), FOXP3  -  forkhead box p3, IL23R  -  interleukin 23 receptor, PVRL2  -  poliovirus receptor-related 2 (herpesvirus entry mediator b)]"GO:0032355,response to estradiol,7.66E-04,5.20E-02,3.09,8230,80,500,15,"[UCN  -  urocortin, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, TH  -  tyrosine hydroxylase, PDGFRB  -  platelet-derived growth factor receptor, beta polypeptide, PTCH1  -  patched 1, CRYAB  -  crystallin, alpha b, CTGF  -  connective tissue growth factor, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, ESR1  -  estrogen receptor 1, OGG1  -  8-oxoguanine dna glycosylase, HTR6  -  5-hydroxytryptamine (serotonin) receptor 6, g protein-coupled, SSTR3  -  somatostatin receptor 3, NQO1  -  nad(p)h dehydrogenase, quinone 1, NRF1  -  nuclear respiratory factor 1, GH1  -  growth hormone 1]"GO:0022610,biological adhesion,7.99E-04,5.40E-02,1.68,8230,523,515,55,"[CSTA  -  cystatin a (stefin a), SVEP1  -  sushi, von willebrand factor type a, egf and pentraxin domain containing 1, CDH1  -  cadherin 1, type 1, e-cadherin (epithelial), PVRL3  -  poliovirus receptor-related 3, DSC2  -  desmocollin 2, CTGF  -  connective tissue growth factor, SSX2IP  -  synovial sarcoma, x breakpoint 2 interacting protein, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, GP9  -  glycoprotein ix (platelet), CDON  -  cell adhesion associated, oncogene regulated, CTNND2  -  catenin (cadherin-associated protein), delta 2, MLLT4  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 4, NLGN1  -  neuroligin 1, NCAM1  -  neural cell adhesion molecule 1, STXBP1  -  syntaxin binding protein 1, SORBS3  -  sorbin and sh3 domain containing 3, WISP2  -  wnt1 inducible signaling pathway protein 2, CCL4  -  chemokine (c-c motif) ligand 4, EZR  -  ezrin, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CD22  -  cd22 molecule, CXADR  -  coxsackie virus and adenovirus receptor, MOG  -  myelin oligodendrocyte glycoprotein, APP  -  amyloid beta (a4) precursor protein, VWF  -  von willebrand factor, CD34  -  cd34 molecule, NUAK1  -  nuak family, snf1-like kinase, 1, ATP4B  -  atpase, h+/k+ exchanging, beta polypeptide, DLG5  -  discs, large homolog 5 (drosophila), MSN  -  moesin, CADM1  -  cell adhesion molecule 1, PKD1  -  polycystic kidney disease 1 (autosomal dominant), ITGA4  -  integrin, alpha 4 (antigen cd49d, alpha 4 subunit of vla-4 receptor), ITGA9  -  integrin, alpha 9, ICAM2  -  intercellular adhesion molecule 2, SLIT2  -  slit homolog 2 (drosophila), ITGB5  -  integrin, beta 5, ITGB7  -  integrin, beta 7, COL3A1  -  collagen, type iii, alpha 1, CD9  -  cd9 molecule, TYRO3  -  tyro3 protein tyrosine kinase, PKP2  -  plakophilin 2, PECAM1  -  platelet/endothelial cell adhesion molecule 1, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), ALX1  -  alx homeobox 1, EPHA3  -  eph receptor a3, LAMC2  -  laminin, gamma 2, ROM1  -  retinal outer segment membrane protein 1, SGCE  -  sarcoglycan, epsilon, COL6A1  -  collagen, type vi, alpha 1, BCL2  -  b-cell cll/lymphoma 2, KITLG  -  kit ligand, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha]"GO:0002253,activation of immune response,8.11E-04,5.45E-02,4.21,8230,296,66,10,"[HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CD14  -  cd14 molecule, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, ACTG1  -  actin, gamma 1, FYN  -  fyn oncogene related to src, fgr, yes, ATF2  -  activating transcription factor 2, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, C1QB  -  complement component 1, q subcomponent, b chain, C1R  -  complement component 1, r subcomponent, C1S  -  complement component 1, s subcomponent]"GO:0002479,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent",8.15E-04,5.44E-02,3.64,8230,65,417,12,"[ITGB5  -  integrin, beta 5, HLA-A  -  major histocompatibility complex, class i, a, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, TAPBP  -  tap binding protein (tapasin), HLA-G  -  major histocompatibility complex, class i, g, PSMA4  -  proteasome (prosome, macropain) subunit, alpha type, 4, HLA-F  -  major histocompatibility complex, class i, f, PSMA3  -  proteasome (prosome, macropain) subunit, alpha type, 3, HLA-E  -  major histocompatibility complex, class i, e, UBC  -  ubiquitin c, CYBA  -  cytochrome b-245, alpha polypeptide, PSMB5  -  proteasome (prosome, macropain) subunit, beta type, 5]"GO:0035304,regulation of protein dephosphorylation,8.37E-04,5.55E-02,5.02,8230,14,819,7,"[GBA  -  glucosidase, beta, acid, PPP2R5A  -  protein phosphatase 2, regulatory subunit b', alpha, ADORA1  -  adenosine a1 receptor, TGFB1  -  transforming growth factor, beta 1, CALM3  -  calmodulin 3 (phosphorylase kinase, delta), DLC1  -  deleted in liver cancer 1, YWHAB  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide]"GO:0009187,cyclic nucleotide metabolic process,8.65E-04,5.70E-02,3.88,8230,30,707,10,"[HTR2C  -  5-hydroxytryptamine (serotonin) receptor 2c, g protein-coupled, PTH  -  parathyroid hormone, PDE5A  -  phosphodiesterase 5a, cgmp-specific, CALCRL  -  calcitonin receptor-like, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), PTHLH  -  parathyroid hormone-like hormone, PDE3B  -  phosphodiesterase 3b, cgmp-inhibited, NPPA  -  natriuretic peptide a, AQP1  -  aquaporin 1 (colton blood group), PDE4A  -  phosphodiesterase 4a, camp-specific]"GO:0032787,monocarboxylic acid metabolic process,8.65E-04,5.67E-02,2.74,8230,183,279,17,"[AKR1C3  -  aldo-keto reductase family 1, member c3, BGN  -  biglycan, TH  -  tyrosine hydroxylase, SHMT1  -  serine hydroxymethyltransferase 1 (soluble), CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), ALOX12  -  arachidonate 12-lipoxygenase, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PTGDS  -  prostaglandin d2 synthase 21kda (brain), LPL  -  lipoprotein lipase, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PC  -  pyruvate carboxylase, HADH  -  hydroxyacyl-coa dehydrogenase, PTPLB  -  protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, ACACA  -  acetyl-coa carboxylase alpha, PPARA  -  peroxisome proliferator-activated receptor alpha, FASN  -  fatty acid synthase]"GO:0048522,positive regulation of cellular process,8.80E-04,5.74E-02,1.37,8230,2597,252,109,"[S1PR2  -  sphingosine-1-phosphate receptor 2, DAPK2  -  death-associated protein kinase 2, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), APOB  -  apolipoprotein b, KLK6  -  kallikrein-related peptidase 6, INHBB  -  inhibin, beta b, GAB2  -  grb2-associated binding protein 2, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, FLNA  -  filamin a, alpha, CYTH3  -  cytohesin 3, ACACA  -  acetyl-coa carboxylase alpha, GDF5  -  growth differentiation factor 5, CDC42EP4  -  cdc42 effector protein (rho gtpase binding) 4, IL5  -  interleukin 5 (colony-stimulating factor, eosinophil), SORBS3  -  sorbin and sh3 domain containing 3, PSMB1  -  proteasome (prosome, macropain) subunit, beta type, 1, RRAGB  -  ras-related gtp binding b, PAXIP1  -  pax interacting (with transcription-activation domain) protein 1, CCL14  -  chemokine (c-c motif) ligand 14, CCL4  -  chemokine (c-c motif) ligand 4, CCL2  -  chemokine (c-c motif) ligand 2, SOX2  -  sry (sex determining region y)-box 2, IL1B  -  interleukin 1, beta, LPL  -  lipoprotein lipase, CCL3  -  chemokine (c-c motif) ligand 3, MNAT1  -  mnat cdk-activating kinase assembly factor 1, LDB1  -  lim domain binding 1, RHEB  -  ras homolog enriched in brain, CALCRL  -  calcitonin receptor-like, CADM1  -  cell adhesion molecule 1, GLUL  -  glutamate-ammonia ligase, MDFI  -  myod family inhibitor, FGF1  -  fibroblast growth factor 1 (acidic), KRT6A  -  keratin 6a, COL3A1  -  collagen, type iii, alpha 1, MEIS2  -  meis homeobox 2, PPARA  -  peroxisome proliferator-activated receptor alpha, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, SUMO3  -  small ubiquitin-like modifier 3, S100B  -  s100 calcium binding protein b, CDK4  -  cyclin-dependent kinase 4, ADCYAP1R1  -  adenylate cyclase activating polypeptide 1 (pituitary) receptor type i, RORB  -  rar-related orphan receptor b, S100A4  -  s100 calcium binding protein a4, NPR1  -  natriuretic peptide receptor a/guanylate cyclase a (atrionatriuretic peptide receptor a), COMT  -  catechol-o-methyltransferase, CDK5R2  -  cyclin-dependent kinase 5, regulatory subunit 2 (p39), IRF1  -  interferon regulatory factor 1, BTRC  -  beta-transducin repeat containing e3 ubiquitin protein ligase, NR2C1  -  nuclear receptor subfamily 2, group c, member 1, KITLG  -  kit ligand, FBLN2  -  fibulin 2, ZNF205  -  zinc finger protein 205, AKR1C3  -  aldo-keto reductase family 1, member c3, DRD3  -  dopamine receptor d3, AES  -  amino-terminal enhancer of split, NR5A1  -  nuclear receptor subfamily 5, group a, member 1, ADRB3  -  adrenoceptor beta 3, SFN  -  stratifin, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, ABLIM3  -  actin binding lim protein family, member 3, NPAT  -  nuclear protein, ataxia-telangiectasia locus, ATM  -  ataxia telangiectasia mutated, NLGN1  -  neuroligin 1, DPYSL2  -  dihydropyrimidinase-like 2, FASN  -  fatty acid synthase, NOTCH3  -  notch 3, HLA-A  -  major histocompatibility complex, class i, a, STXBP1  -  syntaxin binding protein 1, GRAP2  -  grb2-related adaptor protein 2, TOM1L1  -  target of myb1 (chicken)-like 1, PEA15  -  phosphoprotein enriched in astrocytes 15, AKT2  -  v-akt murine thymoma viral oncogene homolog 2, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, NELFA  -  negative elongation factor complex member a, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, KMT2B  -  lysine (k)-specific methyltransferase 2b, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, FYN  -  fyn oncogene related to src, fgr, yes, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, CYBA  -  cytochrome b-245, alpha polypeptide, STK4  -  serine/threonine kinase 4, CALCR  -  calcitonin receptor, RAN  -  ran, member ras oncogene family, DLX2  -  distal-less homeobox 2, ALOX12  -  arachidonate 12-lipoxygenase, SLIT2  -  slit homolog 2 (drosophila), UBC  -  ubiquitin c, TWIST1  -  twist basic helix-loop-helix transcription factor 1, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, DLC1  -  deleted in liver cancer 1, MAP2K5  -  mitogen-activated protein kinase kinase 5, GRN  -  granulin, NQO1  -  nad(p)h dehydrogenase, quinone 1, RPS6KB1  -  ribosomal protein s6 kinase, 70kda, polypeptide 1, ALX1  -  alx homeobox 1, ANG  -  angiogenin, ribonuclease, rnase a family, 5, PIAS4  -  protein inhibitor of activated stat, 4, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), HNRNPAB  -  heterogeneous nuclear ribonucleoprotein a/b, PRKDC  -  protein kinase, dna-activated, catalytic polypeptide, ERCC8  -  excision repair cross-complementing rodent repair deficiency, complementation group 8, CCND2  -  cyclin d2, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, YWHAH  -  tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide, THY1  -  thy-1 cell surface antigen, THRA  -  thyroid hormone receptor, alpha, MLLT10  -  myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, drosophila); translocated to, 10]"GO:0051251,positive regulation of lymphocyte activation,8.83E-04,5.72E-02,7.26,8230,189,36,6,"[HLA-A  -  major histocompatibility complex, class i, a, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, FYN  -  fyn oncogene related to src, fgr, yes, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), IL1B  -  interleukin 1, beta]"GO:0045109,intermediate filament organization,9.22E-04,5.94E-02,4.95,8230,14,831,7,"[KRT9  -  keratin 9, PKP2  -  plakophilin 2, NEFL  -  neurofilament, light polypeptide, PKP1  -  plakophilin 1 (ectodermal dysplasia/skin fragility syndrome), KRT14  -  keratin 14, NEFM  -  neurofilament, medium polypeptide, NEFH  -  neurofilament, heavy polypeptide]"GO:0031099,regeneration,9.41E-04,6.02E-02,2.55,8230,74,829,19,"[EIF4A1  -  eukaryotic translation initiation factor 4a1, TEK  -  tek tyrosine kinase, endothelial, CDK4  -  cyclin-dependent kinase 4, TGFB1  -  transforming growth factor, beta 1, IGFBP1  -  insulin-like growth factor binding protein 1, CSPG5  -  chondroitin sulfate proteoglycan 5 (neuroglycan c), CCL2  -  chemokine (c-c motif) ligand 2, CXCL12  -  chemokine (c-x-c motif) ligand 12, TGFBR2  -  transforming growth factor, beta receptor ii (70/80kda), KLK6  -  kallikrein-related peptidase 6, CTNNA1  -  catenin (cadherin-associated protein), alpha 1, 102kda, BCL2  -  b-cell cll/lymphoma 2, GAP43  -  growth associated protein 43, PDX1  -  pancreatic and duodenal homeobox 1, PLG  -  plasminogen, GAS6  -  growth arrest-specific 6, NRF1  -  nuclear respiratory factor 1, F7  -  coagulation factor vii (serum prothrombin conversion accelerator), PPARG  -  peroxisome proliferator-activated receptor gamma]"GO:0033128,negative regulation of histone phosphorylation,9.56E-04,6.09E-02,"2,057.50",8230,2,2,1,[TWIST1  -  twist basic helix-loop-helix transcription factor 1]GO:2000276,negative regulation of oxidative phosphorylation uncoupler activity,9.56E-04,6.06E-02,"2,057.50",8230,2,2,1,[TWIST1  -  twist basic helix-loop-helix transcription factor 1]GO:0002376,immune system process,9.65E-04,6.07E-02,2.28,8230,1222,68,23,"[HLA-A  -  major histocompatibility complex, class i, a, TYROBP  -  tyro protein tyrosine kinase binding protein, HLA-DPA1  -  major histocompatibility complex, class ii, dp alpha 1, FCGRT  -  fc fragment of igg, receptor, transporter, alpha, C1QB  -  complement component 1, q subcomponent, b chain, HLA-DPB1  -  major histocompatibility complex, class ii, dp beta 1, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), C1R  -  complement component 1, r subcomponent, IL1B  -  interleukin 1, beta, C1S  -  complement component 1, s subcomponent, CCL3  -  chemokine (c-c motif) ligand 3, FGF1  -  fibroblast growth factor 1 (acidic), ITGB5  -  integrin, beta 5, HLA-DRA  -  major histocompatibility complex, class ii, dr alpha, CD14  -  cd14 molecule, TAPBP  -  tap binding protein (tapasin), TYRO3  -  tyro3 protein tyrosine kinase, ACTG1  -  actin, gamma 1, PRKAR2B  -  protein kinase, camp-dependent, regulatory, type ii, beta, ATF2  -  activating transcription factor 2, FYN  -  fyn oncogene related to src, fgr, yes, MAP3K5  -  mitogen-activated protein kinase kinase kinase 5, CYBA  -  cytochrome b-245, alpha polypeptide]"GO:0006693,prostaglandin metabolic process,9.74E-04,6.10E-02,13.06,8230,15,168,4,"[AKR1C3  -  aldo-keto reductase family 1, member c3, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor), PTGDS  -  prostaglandin d2 synthase 21kda (brain)]"GO:0006692,prostanoid metabolic process,9.74E-04,6.07E-02,13.06,8230,15,168,4,"[AKR1C3  -  aldo-keto reductase family 1, member c3, CD74  -  cd74 molecule, major histocompatibility complex, class ii invariant chain, PTGDS  -  prostaglandin d2 synthase 21kda (brain), MIF  -  macrophage migration inhibitory factor (glycosylation-inhibiting factor)]"GO:0001656,metanephros development,9.80E-04,6.07E-02,3.44,8230,29,907,11,"[GLI3  -  gli family zinc finger 3, HOXA11  -  homeobox a11, CITED1  -  cbp/p300-interacting transactivator, with glu/asp-rich carboxy-terminal domain, 1, PAX2  -  paired box 2, BCL2  -  b-cell cll/lymphoma 2, NIPBL  -  nipped-b homolog (drosophila), AGTR2  -  angiotensin ii receptor, type 2, SPRY1  -  sprouty homolog 1, antagonist of fgf signaling (drosophila), SLIT2  -  slit homolog 2 (drosophila), GDF11  -  growth differentiation factor 11, FGF8  -  fibroblast growth factor 8 (androgen-induced)]"GO:0071396,cellular response to lipid,9.83E-04,6.05E-02,2.1,8230,184,576,27,"[AKR1C3  -  aldo-keto reductase family 1, member c3, PAX2  -  paired box 2, ALOX12  -  arachidonate 12-lipoxygenase, PTCH1  -  patched 1, APOB  -  apolipoprotein b, MDM2  -  mdm2 oncogene, e3 ubiquitin protein ligase, RARG  -  retinoic acid receptor, gamma, CD14  -  cd14 molecule, ESR1  -  estrogen receptor 1, AGTR2  -  angiotensin ii receptor, type 2, SSTR3  -  somatostatin receptor 3, LTK  -  leukocyte receptor tyrosine kinase, PTK6  -  protein tyrosine kinase 6, IFNG  -  interferon, gamma, EPHA3  -  eph receptor a3, CPS1  -  carbamoyl-phosphate synthase 1, mitochondrial, CSF2  -  colony stimulating factor 2 (granulocyte-macrophage), LBP  -  lipopolysaccharide binding protein, CCL2  -  chemokine (c-c motif) ligand 2, IL1B  -  interleukin 1, beta, CCL3  -  chemokine (c-c motif) ligand 3, CRH  -  corticotropin releasing hormone, TNFRSF1A  -  tumor necrosis factor receptor superfamily, member 1a, TNFAIP3  -  tumor necrosis factor, alpha-induced protein 3, TNFRSF1B  -  tumor necrosis factor receptor superfamily, member 1b, AQP1  -  aquaporin 1 (colton blood group), IRAK1  -  interleukin-1 receptor-associated kinase 1]"